<SEC-DOCUMENT>0001437749-24-010874.txt : 20240403
<SEC-HEADER>0001437749-24-010874.hdr.sgml : 20240403
<ACCEPTANCE-DATETIME>20240403161521
ACCESSION NUMBER:		0001437749-24-010874
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240513
FILED AS OF DATE:		20240403
DATE AS OF CHANGE:		20240403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZEVRA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001434647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				205894398
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36913
		FILM NUMBER:		24818888

	BUSINESS ADDRESS:	
		STREET 1:		1180 CELEBRATION BOULEVARD, SUITE 103
		CITY:			CELEBRATION
		STATE:			FL
		ZIP:			34747
		BUSINESS PHONE:		(321) 939-3416

	MAIL ADDRESS:	
		STREET 1:		1180 CELEBRATION BOULEVARD, SUITE 103
		CITY:			CELEBRATION
		STATE:			FL
		ZIP:			34747

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEMPHARM, INC
		DATE OF NAME CHANGE:	20130530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEMPHARM INC
		DATE OF NAME CHANGE:	20080507
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>zvra20240303_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:srt-types="http://fasb.org/srt-types/2017-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:zvra="http://www.kempharm.com/20231231" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"><head>
	<title>zvra20240303_def14a.htm</title>


	<!-- Generated by ThunderDome Portal - 4/3/2024 2:55:13 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none;"><ix:header><ix:hidden>
<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="dei:AmendmentFlag" id="ixv-8719">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="dei:EntityCentralIndexKey" id="ixv-8720">0001434647</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="dei:DocumentType" id="c2">DEF 14A</ix:nonNumeric></ix:hidden>
<ix:references>
<link:schemaRef xlink:href="zvra-20231231.xsd" xlink:type="simple"/></ix:references>
<ix:resources>
<xbrli:context id="d_2023-01-01_2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOTotalAdjustmentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOTotalAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2021-01-01_2021-12-31_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO3Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO2Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO1Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_IndividualAxis-CurrentCEOMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001434647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="NonApplicable"><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unit></ix:resources>
</ix:header></div>
<div>&#160;</div>

<div>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><a href="#toc" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt">Table of Contents</a></p>

<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>UNITED STATES </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Washington, DC 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-family: &quot;Times New Roman&quot;; font-size: 12pt; font-variant: normal; text-align: center; margin: 0pt;"><span style="-sec-ix-hidden:c2"><b>SCHEDULE 14A</b><b> </b></span></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Rule 14a-101) </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>INFORMATION REQUIRED IN PROXY STATEMENT </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>SCHEDULE 14A INFORMATION </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Proxy Statement Pursuant to Section</b>&#160;<b>14(a) of the </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities Exchange Act of 1934 </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Amendment No.</b>&#160;&#160;&#160;&#160;<b>) </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Filed by the Registrant&#160;&#160;&#9746;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Filed by a Party other than the Registrant&#160;&#160;&#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Check the appropriate box:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Preliminary Proxy Statement</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Confidential, for Use of the Commission Only</b>&#160;<b>(as permitted by Rule 14a-6(e)(2))</b></p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Definitive Proxy Statement</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Definitive Additional Materials</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Soliciting Material under &#167;240.14a-12</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; font-variant: normal; text-align: center; margin: 0pt;"><b><ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="dei:EntityRegistrantName" id="c3">Zevra Therapeutics, Inc.</ix:nonNumeric></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Name of Registrant as Specified in its Charter) </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Payment of Filing Fee (Check all boxes that apply):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">No fee required</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Fee paid previously with preliminary materials</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<hr style="height: 3px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 0 0 3pt 0"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
</div>

<div>&#160;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>&#160;ZEVRA THERAPEUTICS, INC.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>1180 Celebration Boulevard, Suite 103</b><br/>
<b>Celebration, FL 34747</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>To Be Held On May 13, 2024</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Dear Stockholder:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">You are cordially invited to attend the 2024&#160;Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of&#160;<b>ZEVRA THERAPEUTICS, INC.</b>, a Delaware corporation (&#8220;Zevra,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;). The meeting will be held on Monday, May 13, 2024, at 9:00 am EST&#160;and will be held virtually on the internet at <span style="text-decoration: underline; ">www.meetnow.global/M2S695X</span>&#160;for the following purposes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>1.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To elect Thomas D. Anderson, Neil F. McFarlane,&#160;and Alvin Shih, M.D.&#160;to the Company&#8217;s board of directors as Class III directors to hold office until the 2027&#160;annual meeting of stockholders, and until their respective successors shall have been duly elected and qualified;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>2.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To ratify the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>3.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To approve, on an advisory and non-binding basis, the compensation of the Company&#8217;s named executive officers; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>4.</b></p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To approve&#160;amendments to the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">These items of business are more fully described in the Proxy Statement accompanying this Notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The record date for the Annual Meeting is March 22, 2024. Only stockholders of record at the close of business on that date may vote at the meeting or any continuation, adjournment or postponement thereof. A complete list of such stockholders will be open to the examination of any stockholder for a period of ten days prior to the Annual Meeting for a purpose germane to the meeting during ordinary business hours at the Company&#8217;s principal executive offices.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">By Order of the Board of Directors</p>
			</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">/s/ R. LaDuane Clifton</p>
			</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">R. LaDuane Clifton, MBA, CPA</p>
			</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Chief Financial Officer, Secretary and Treasurer</p>
			</td>
			<td style="vertical-align: middle; width: 25%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Celebration, FL</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">April 3, 2024</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="width: 1%; border-top: 2px solid black; border-bottom: 2px solid black; border-left: 2px solid black;">&#160;</td>
			<td style="width: 98%; border-top: 2px solid black; border-bottom: 2px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>THE STOCKHOLDER MEETING TO BE HELD ON MONDAY, MAY 13, 2024</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>This Proxy Statement and our 10-K for the year ended December 31, 2023,</b>&#160;<b>are available at</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><span style="text-decoration: underline; ">www.envisionreports.com/ZVRA</span></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><b>Pursuant to the internet proxy rules promulgated by the Securities and Exchange Commission, the Company has elected to provide access to its proxy materials over the internet. Accordingly, stockholders of record at the close of business on March 22, 2024,</b>&#160;<b>will receive a Notice of Internet Availability of Proxy Materials and may vote at the Annual Meeting and any continuation, adjournment or postponement thereof. The Company expects to mail the Notice of Internet Availability of Proxy Materials on or about April 3, 2024.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><b>You are cordially invited to attend the meeting virtually on the internet. Whether or not you expect to attend the meeting, please vote by returning your proxy card, over the telephone, or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you will still be able to change your vote virtually during the meeting if you attend. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><b>If you plan to attend the meeting virtually, please follow the registration instructions as outlined in the Proxy Statement accompanying this Notice.</b>&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>
			</td>
			<td style="width: 1%; border-top: 2px solid black; border-bottom: 2px solid black; border-right: 2px solid black;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="toc" title="toc" href="#"></a>TABLE OF CONTENTS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Page</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#proxystatement" style="-sec-extract:exhibit;">PROXY STATEMENT</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#proxystatement">1</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#questionsandanswers" style="-sec-extract:exhibit;">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#questionsandanswers">1</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#prop1" style="-sec-extract:exhibit;">PROPOSAL 1: ELECTION OF DIRECTORS</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#prop1">7</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#inforegardingbod" style="-sec-extract:exhibit;">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#inforegardingbod">10</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#prop2" style="-sec-extract:exhibit;">PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#prop2">18</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#peop3" style="-sec-extract:exhibit;">PROPOSAL 3: NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#peop3">20</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#prop4" style="-sec-extract:exhibit;">PROPOSAL 4: APPROVAL OF AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#prop4">21</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#execofficers" style="-sec-extract:exhibit;">EXECUTIVE OFFICERS</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#execofficers">30</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#securityownership" style="-sec-extract:exhibit;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#securityownership">31</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#delisection16a" style="-sec-extract:exhibit;">DELINQUENT SECTION 16(A) REPORTS</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#delisection16a">33</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#execcomp" style="-sec-extract:exhibit;">EXECUTIVE COMPENSATION</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#execcomp">34</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#dircomp" style="-sec-extract:exhibit;">DIRECTOR COMPENSATION</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#dircomp">45</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#secauthorizedequityplans" style="-sec-extract:exhibit;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER THE EQUITY COMPENSATION PLANS</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#secauthorizedequityplans">48</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#transactionsrelpersons" style="-sec-extract:exhibit;">TRANSACTIONS WITH RELATED PARTIES</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#transactionsrelpersons">49</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#household" style="-sec-extract:exhibit;">HOUSEHOLDING OF PROXY MATERIALS</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#household">51</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#othermatters" style="-sec-extract:exhibit;">OTHER MATTERS</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a class="tocPGNUM" href="#othermatters">52</a></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 95%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#Amended_EIP" style="-sec-extract:exhibit;">ANNEX A:&#160;AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN</a></p>
			</td>
			<td style="vertical-align: middle; width: 5%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><a href="#Amended_EIP" style="-sec-extract:exhibit;">A-1</a></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Forward-Looking Statements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Certain statements herein constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause the actual results, performance or achievements of the Company and its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The words or phrases &#8220;guidance,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimates,&#8221; &#8220;forecast&#8221; and similar words or expressions are intended to identify such forward-looking statements. In addition, any statements that refer to expectations or other characterizations of future events or circumstances, such as statements about our business plans, strategies and initiatives, and our corporate governance initiatives, are forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other important factors, some of which are beyond our control and are difficult to predict. These forward-looking statements are based on information currently available to us and our current plans or expectations and are subject to a number of known and unknown uncertainties, risks and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These and other important factors are described in detail in the &#8220;Risk Factors&#8221; section of our Annual Report on Form 10-K for the year ended December 31, 2023, and our other filings with the Securities and Exchange Commission. Other unknown or unpredictable factors also could have material adverse effects on our future results, performance or achievements. In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed herein may not occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date hereof. The Company does not undertake any obligation to publicly update or revise any forward-looking statements because of new information, future events or otherwise.&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">i</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>ZEVRA THERAPEUTICS, INC. </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>1180 Celebration Boulevard, Suite 103</b><br/>
<b>Celebration, FL 34747</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="proxystatement" title="proxystatement" href="#"></a>PROXY STATEMENT</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>FOR THE 2024</b>&#160;<b>ANNUAL MEETING OF STOCKHOLDERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>TO BE HELD ON MAY 13, 2024, AT 9:00 A.M. EASTERN TIME</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="questionsandanswers" title="questionsandanswers" href="#"></a>QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Why did I receive a notice regarding the availability of proxy materials on the internet?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Pursuant to rules adopted by the Securities and Exchange Commission (the &#8220;SEC&#8221;), we have elected to provide access to our proxy materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the &#8220;Notice&#8221;) because the Board of Directors (the &#8220;Board&#8221;) of Zevra Therapeutics, Inc. (sometimes referred to as &#8220;us,&#8221; &#8220;we,&#8221; the &#8220;Company&#8221; or &#8220;Zevra&#8221;) is soliciting your proxy to vote at the 2024&#160;Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;), including at any continuation, adjournments or postponements of the meeting. All stockholders as of the Record Date will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We intend to mail the Notice on or about April 3, 2024, to all stockholders of record entitled to vote at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Will I receive any other proxy materials by mail?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We may send to our stockholders on the Record Date this proxy statement, the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, and a proxy card, along with a copy of the Notice, on or after April 15, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How do I attend the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Annual Meeting will be a completely virtual meeting of stockholders, which will be conducted exclusively by webcast. You are entitled to participate in the Annual Meeting only if you were a stockholder of the Company as of the close of business on March&#160;22, 2024&#160;(the &#8220;Record Date&#8221;), or if you hold a valid proxy for the Annual Meeting. No physical meeting will be held.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">You will be able to attend the Annual Meeting online and submit your questions during the Annual Meeting by visiting <span style="text-decoration: underline; ">www.meetnow.global/M2S695X</span>. You also will be able to vote your shares online by attending the Annual Meeting by webcast.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">To participate in the Annual Meeting, you will need to review the information included on your Notice, on your proxy card or on the instructions that accompanied your proxy materials. You will need a password to enter the Annual Meeting. Your password for the Annual Meeting is included in your Notice, on your proxy card or on the instructions that accompanied your proxy materials. If you virtually, enter the meeting using your password, you will be considered present for purposes of the Annual Meeting and your shares will be counted toward the Annual Meeting quorum requirement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you hold your shares through an intermediary, such as a bank or broker, you must register in advance using the instructions below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Annual Meeting will begin promptly at 9:00 a.m., Eastern Time. We encourage you to access the Annual Meeting prior to the start time, leaving ample time for the check in process. Please follow the registration instructions as outlined in this proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Why are you holding a virtual meeting instead of a physical meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We believe that hosting a virtual meeting will enable more of our stockholders to attend and participate in the meeting since our stockholders can participate from any location around the world with internet access.</p>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Who can vote at the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Only stockholders of record at the close of business on the Record Date or holders of a valid proxy will be entitled to vote at the Annual Meeting. On the Record Date, there were 41,850,494 shares of the Company&#8217;s common stock (the &#8220;Common Stock&#8221;) outstanding and entitled to vote.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Stockholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If at the close of business on the Record Date, your shares were registered directly in your name with our transfer agent, Computershare Trust Company, N.A. (&#8220;Computershare&#8221;), then you are a stockholder of record. As a stockholder of record, you may vote virtually at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy over the telephone or on the internet as instructed below or return the proxy card we may mail to you to ensure your vote is counted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Beneficial Owner: Shares Registered in the Name of a Broker, Bank, or Other Nominee</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If at the close of business on the Record Date,<b> </b>your shares were held, not in your name, but rather in an account at a broker, bank, or other nominee, then you are the beneficial owner of shares held in &#8220;street name&#8221; and the Notice is<b> </b>being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker, bank, or other nominee regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting by registering to attend in accordance with the instructions provided below. However, since you are not the stockholder of record, you may not vote your shares virtually at the Annual Meeting unless you request and obtain a valid legal proxy from your broker, bank, or other nominee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What am I voting on?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">There are four&#160;matters scheduled for a vote:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Election of Thomas D. Anderson, Neil F. McFarlane, and Alvin Shih, M.D.&#160;to the Company&#8217;s board of directors as Class III directors to hold office until the 2027&#160;annual meeting of stockholders, and until their respective successors shall have been duly elected and qualified (Proposal 1);</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Ratification of the appointment by the audit committee of the Board (the &#8220;Audit Committee&#8221;) of&#160;Ernst &amp; Young LLP (&#8220;EY&#8221;) as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024&#160;(Proposal 2);</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To approve, on an advisory and non-binding basis, the compensation of the Company&#8217;s named executive officers; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To approve amendments to the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How do I register to attend the Annual Meeting virtually on the internet?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you are a registered stockholder (i.e., you hold your shares through our transfer agent, Computershare), you do not need to register to attend the Annual Meeting. Please follow the instructions on the notice or proxy card that you received.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you hold your shares through an intermediary, such as a bank or broker, you must register in advance to attend the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">To register to attend the Annual Meeting online, you must submit proof of your proxy power (legal proxy) reflecting your Zevra&#160;holdings along with your name and email address to Computershare. Requests for registration must be labeled as &#8220;Legal Proxy&#8221; and be received no later than 5:00 p.m., Eastern Time, on May 9, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">You will receive confirmation of your registration by email after we receive your registration materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Requests for registration should be directed as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If by email:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Forward the email from your broker, or attach an image of your legal proxy, to <span style="text-decoration: underline; ">legalproxy@computershare.com</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If by mail:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Mail a copy of your legal proxy to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Computershare</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Zevra Legal Proxy</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">P.O. Box 43001</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Providence, RI 02940-3001</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What if another matter is properly brought before the meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How do I vote?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">For Proposal 1, you may either vote &#8220;For&#8221; all the nominees to the Board or you may &#8220;Withhold&#8221; your vote for any nominee you specify. For Proposals 2, 3, and 4, you may vote &#8220;For&#8221; or &#8220;Against&#8221; or abstain from voting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The procedures for voting are fairly simple:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Stockholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you are a stockholder of record, you may vote online at the Annual Meeting, vote by proxy over the telephone, vote by proxy online, or vote by proxy using and mailing a proxy card that you may request or that we may elect to deliver at a later time. Whether or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote online during the Annual Meeting even if you have already voted by proxy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote online at the Annual Meeting, register for the Annual Meeting using the instructions above.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To vote via&#160;telephone, dial toll-free 1-800-652-8683 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the Notice or proxy card. Your telephone vote must be received by 8:59 a.m. Eastern Time&#160;on May 13, 2024, to be counted.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote online prior to the Annual Meeting, go to <span style="text-decoration: underline; ">http://www.envisionreports.com/ZVRA</span>&#160;to complete an electronic proxy card. You will be asked to provide the company number and control number from the Notice or proxy card. Your internet vote must be received by 8:59 a.m. Eastern Time&#160;on May&#160;13, 2024, to be counted.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">To vote by mail using the proxy card, if you request one or we elect to deliver one, simply complete, sign and date the&#160;proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Beneficial Owner: Shares Registered in the Name of Broker, Bank, or Other Nominee</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you are a beneficial owner of shares registered in the name of your broker, bank, or other nominee, you should have received a Notice containing voting instructions<b> </b>from that organization rather than from us. Simply follow the voting instructions in the Notice to ensure that your vote is counted. To vote online at the Annual Meeting, you must obtain a valid legal proxy from your broker, bank or other nominee. Follow the instructions from your broker, bank or other nominee included with these proxy materials, or contact your broker, bank or other nominee to request a proxy form.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How many votes do I have?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">On each matter to be voted upon, you have one vote for each share of Common Stock you own at the close of business on the Record Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What happens if I do not vote?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Stockholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you are a stockholder of record as of the Record Date and do not vote prior to the Annual Meeting online, by telephone, by completing your proxy card, or during the Annual Meeting online, your shares will not be voted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Beneficial Owner: Shares Registered in the Name of Broker, Bank, or Other Nominee</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you are a beneficial owner and do not instruct your broker, bank or other nominee how to vote your shares, the question of whether your broker, bank or other nominee will still be able to vote your shares depends on whether the New York Stock Exchange (&#8220;NYSE&#8221;) deems the particular proposal to be a &#8220;routine&#8221; matter. Brokers and nominees can use their discretion to vote &#8220;uninstructed&#8221; shares with respect to matters that are considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters. Under the rules and interpretations of the NYSE, &#8220;non-routine&#8221; matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation (including any advisory stockholder votes on executive compensation and on the frequency of stockholder votes on executive compensation), and certain corporate governance proposals, even if management-supported.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In this regard, Proposal 1 (election of directors), Proposal 3 (approval on an advisory and non-binding of the compensation of the Company&#8217;s named executive officers), and Proposal 4 (approval of amendments to the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan) are considered to be &#8220;non-routine&#8221; under NYSE rules, meaning that your broker or nominee may not vote your shares on these proposals in the absence of your voting instructions. However, Proposal 2 (ratification of the appointment by the Audit Committee of EY as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024) is considered to be a &#8220;routine&#8221; matter under NYSE rules, meaning that if you do not return voting instructions to your broker or nominee by its deadline, your shares may be voted by your broker or nominee in its discretion on Proposal 2.&#160; However, we understand that certain brokerage firms have elected not to vote even on &#8220;routine&#8221; matters without your voting instructions. If your bank, broker or other nominee has made this decision, and you do not provide voting instructions, your vote will not be cast for Proposal 2. Accordingly, we urge you to direct your bank, broker or other nominee how to vote by returning your voting materials as instructed or by obtaining a proxy from your broker or other nominee in order to vote your shares electronically at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What if I return a proxy card or otherwise vote but do not make specific choices?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;For&#8221; the election of all three director nominees, &#8220;For&#8221; the ratification of the appointment by the Audit Committee of EY&#160;as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2024, &#8220;For&#8221; the approval on an advisory and non-binding of the compensation of the Company&#8217;s named executive officers, and &#8220;For&#8221; the approval of amendments to the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan. If any other matter is properly presented at the Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Who is paying for this proxy solicitation?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees<b> </b>may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks, and other agents for the cost of forwarding proxy materials to beneficial owners.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What does it mean if I receive more than one Notice?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If you receive more than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the applicable Notice to ensure that all of your shares are voted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Can I change my vote after submitting my proxy?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Stockholder of Record: Shares Registered in Your Name</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Before the Annual Meeting:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">You may grant a subsequent proxy by telephone.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">You may grant a subsequent proxy online.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">You may submit another properly completed proxy card with a later date.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">You may send a timely written notice that you are revoking your proxy to our Corporate Secretary at 1180 Celebration Boulevard, Suite 103, Celebration, FL, 34747.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">During the Annual Meeting:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">You may attend the Annual Meeting and vote online. Simply attending the meeting will not, by itself, revoke your proxy.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Your most current proxy card, telephone or internet proxy is the one that is counted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><i>Beneficial Owner: Shares Registered in the Name of Broker, Bank, or Other Nominee</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>When are stockholder proposals and director nominations due for next year</b>&#8217;<b>s annual meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Stockholders who intend to have a proposal considered for inclusion in next year&#8217;s proxy materials for presentation at our 2025&#160;annual meeting of stockholders pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) must submit the proposal in writing by December 4, 2024, to our Corporate Secretary at 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747. If you wish to submit a proposal (including a director nomination) for presentation at the meeting that is not to be included in next year&#8217;s proxy materials, you must do so by February 12, 2025, but no earlier than January 13, 2025; provided, however that if next year's annual meeting is advanced more than 30 days prior to or delayed by more than 30 days after May 13, 2025, your proposal must be submitted (i) not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting; or if later, (ii) the tenth day following the day on which public announcement of the date of such meeting is first made. You are also advised to review our bylaws, which contain additional requirements about advance notice of stockholder proposals and director nominations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In addition to satisfying the foregoing requirements under our bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Stockholders may obtain our proxy statement (and any amendments and supplements thereto) and other documents as and when filed with the SEC without charge from the SEC&#8217;s website at: <span style="text-decoration: underline; ">www.sec.gov</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How are votes counted?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Votes will be counted by the inspector of election appointed for the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What are </b>&#8220;<b>broker non-votes</b>&#8221;<b>? </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">As discussed above, when a beneficial owner of shares held in &#8220;street name&#8221; does not give instructions to the broker or nominee holding the shares as to how to vote on matters deemed by the NYSE to be &#8220;non-routine,&#8221; the broker or nominee cannot vote the shares. These unvoted shares are counted as &#8220;broker non-votes.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How many votes are needed to approve each proposal? </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table summarizes the minimum vote needed to approve each proposal and the effect of abstentions and broker non-votes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proposal </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proposal Description</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Vote Required for Approval</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Effect of Votes </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Withheld or </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Abstentions</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Effect of Broker Non-</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Votes</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Election of Directors</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The plurality of the votes of the holders of shares present and entitled to vote on the proposal. The three nominees receiving the most &#8220;For&#8221;&#160;votes will be elected as Class III directors.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Votes withheld will not be counted as votes cast and will have no effect.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Abstentions are not applicable</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Broker non-votes will not be counted as votes cast and will have no effect</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Ratification of the&#160;appointment of Ernst &amp; Young&#160;LLP as the&#160;Company&#8217;s independent registered public accounting firm for its fiscal year ending December 31, 2024</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#8220;For&#8221;&#160;votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter will ratify the appointment.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Abstentions will be counted as votes &#8220;Against&#8221;&#160;this proposal</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">As brokers have discretion to vote, we do not expect any broker non-votes on this proposal. (1)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">To approve, on an advisory and non-binding basis, the compensation of the Company&#8217;s named executive officers as disclosed in the proxy materials.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">For&#8221;&#160;votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter will approve the proposal.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Abstentions will be counted as votes &#8220;Against&#8221;&#160;this proposal</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Broker non-votes will have no effect on this proposal</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">To approve, amendments to the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#8220;For&#8221;&#160;votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter will approve the proposal.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Abstentions will be counted as votes &#8220;Against&#8221;&#160;this proposal</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Broker non-votes will have no effect on this proposal</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 6%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 30%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 15%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="9" style="vertical-align: top; width: 85%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(1)&#160;&#160;&#160;&#160;&#160;This proposal is considered to be a &#8220;routine&#8221;&#160;matter under NYSE rules. Accordingly, if you hold your shares in street name and do not provide voting instructions to your broker, bank, or other agent that holds your shares, your broker, bank, or other nominee has discretionary authority under NYSE rules to vote your shares on this proposal. However, we understand that certain brokerage firms have elected not to vote even on &#8220;routine&#8221;&#160;matters without your voting instructions. If your bank, broker or other nominee has made this decision, and you do not provide voting instructions, your vote will not be cast for Proposal 2. Accordingly, we urge you to direct your bank, broker or other nominee how to vote by returning your voting materials as instructed or by obtaining a proxy from your broker or other nominee in order to vote your shares electronically at the Annual Meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>What is the quorum requirement?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders<b> </b>holding<b> </b>at least a majority of the outstanding shares entitled to vote are present at the meeting in person or represented by proxy. At the close of business on the Record Date, there were 41,850,494&#160;shares<b> </b>outstanding and entitled to vote. <b>Thus, the holders of 20,925,247&#160;shares must be present in person or represented by proxy at the meeting to have a quorum.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Your shares will be counted towards the quorum only if you submit a valid proxy by telephone, internet or proxy card (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote online during the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn the meeting to another date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>How can I find out the results of the voting at the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We intend to announce preliminary voting results at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form&#160;8-K within four business days after the meeting, we intend to file a Form&#160;8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form&#160;8-K to publish the final results.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop1" title="prop1" href="#"></a>PROPOSAL 1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ELECTION OF DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our Board is divided into three classes. Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a three-year term. Vacancies on the Board may be filled only by persons elected by a majority of the remaining directors. A director elected by the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the director&#8217;s successor is duly elected and qualified.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Board presently has eight&#160;members. The current class structure is as follows: Class III, whose current term will expire at the Annual Meeting and, if elected at the Annual Meeting, whose subsequent term will expire at the 2027&#160;annual meeting of stockholders; Class I, whose term will expire at the 2025&#160;annual meeting of stockholders; and Class II, whose term will expire at the 2026 annual meeting of stockholders. The current Class III directors are Thomas D. Anderson, Neil F. McFarlane and Alvin Shih, M.D.; the current Class I directors are Tamara A. Favorito and Wendy Dixon, Ph.D.; and the current Class II directors are John B. Bode, Douglas W. Calder, and Corey Watton. Each of the nominees listed below is currently a Class III director of the Company. Mr. Anderson&#160;and Dr. Shih were&#160;recommended to serve as directors by a third-party search firm and were&#160;appointed to the Board in August 2023 and January 2024, respectively. Mr. McFarlane became a director in October 2023, at the time that he was appointed as the Company's President and Chief Executive Officer.&#160;If elected at the Annual Meeting, each of these nominees would serve until the 2027&#160;annual meeting of our stockholders and until his successor has been duly elected and qualified, or, if sooner, until the director&#8217;s death, resignation or removal. It is our policy to encourage directors and nominees for director to attend the Annual Meeting. Tamara A. Favorito is the only&#160;incumbent directors who attended the 2023&#160;annual meeting of our stockholders.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the three<b> </b>nominees named below. If any nominee becomes unable to serve or for good cause will not serve as a director, shares that would have been voted for that nominee may instead be voted for the election of a substitute nominee proposed by our Board. Each person nominated for election has agreed to serve if elected. Our management has no reason to believe that any nominee would be unable to serve.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NOMINEES FOR ELECTION AS A CLASS III DIRECTOR FOR A THREE-YEAR TERM EXPIRING AT THE 2027</b>&#160;<b>ANNUAL MEETING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Thomas D. Anderson</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Thomas D. Anderson has served as a director of our Company since August 2023. Mr. Anderson is a 35-year veteran of the biopharma industry and has led and been a part of high-growth organizations for much of his career. Mr. Anderson has served as chief executive officer and director of SwanBio Therapeutics since September&#160;2019 until semi-retirement in October 2023, and subsequently resigned his board directorship in March 2024. Prior to that, he served as the chief commercial strategy officer of Sage Therapeutics, Inc. from 2014 to 2018. Between 2004 and 2014, Mr. Anderson was a senior operating executive with Shire Pharmaceuticals Group in a number of operational and strategic roles in both rare diseases and specialty pharmaceuticals. Prior to Shire, he spent 17 years at Johnson &amp; Johnson's pharmaceutical companies, McNeil and Janssen, in various business capacities. Mr. Anderson is also an investor partner at Robin Hood Ventures in Philadelphia, Pennsylvania. Mr. Anderson earned his MBA from the University of Notre Dame&#8217;s Mendoza College of Business Administration. He received his BS in civil engineering from the P.C. Rossin College of Engineering at Lehigh University. Our Board believes that Mr. Anderson&#8217;s significant leadership experience in the biotechnology industry and his experience in rare disease qualifies him to serve on the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Neil F. McFarlane</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Neil F. McFarlane has served as our president, chief executive officer, and a director of our Company since October 2023. Mr. McFarlane has served as a member of the board of directors of Collegium Pharmaceutical Inc. since April 2022. Previously, Mr. McFarlane&#160;served as the chief executive officer and a member of the board of directors of Adamas Pharmaceuticals, Inc. from September 2019 until its acquisition by Supernus Pharmaceuticals, Inc. in November 2021. Mr. McFarlane worked as an independent consultant between June 2019 and August 2019 and again between December&#160;2021 and September 2023 providing consulting services for biotechnology, pharmaceutical, and financial services companies. From August 2016 to May 2019, Mr. McFarlane served as the chief operating officer of Retrophin, Inc., now known as Travere Therapeutics, Inc., where he was responsible for overseeing operations. From 2011 to 2016 Mr. McFarlane served as vice president and general manager of UCB, Inc.'s U.S. Immunology Business Unit and as vice president for its Global Bone Business Unit in collaboration with Amgen Inc. Prior to his positions at UCB, Mr. McFarlane held positions of increasing responsibility with Genzyme Corporation (&#8220;Genzyme&#8221;) and Sangstat Medical Corporation prior to its acquisition by Genzyme. Mr. McFarlane previously served as an officer and enlisted soldier in the United States Army Reserves. He received his B.S. degree and M.S. degree in Nursing from the University of Florida. Our Board believes that Mr. McFarlane&#8217;s over 20 years of global biopharmaceutical and life sciences experience provide him with the qualifications and skills to serve as a director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Alvin Shih, M.D.</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Alvin Shih, M.D. has served as a director of our Company since January 2024. Dr. Shih has broad experience in drug development, spanning multiple indications with a focus on rare diseases, including as the chief operating officer and founding member of Pfizer Inc.'s rare disease research unit from May 2010 to May 2014. Most recently, he has served as president and chief executive officer of Catamaran Bio, Inc. since February 2021. Prior to his current role, from July 2019 to December 2020 he served as&#160;the chief executive officer of Disarm Therapeutics, a biotechnology company that developed therapeutics for neurodegenerative diseases and that was acquired by Eli Lilly in October 2020.&#160;Before that, Dr. Shih was chief executive officer of Enzyvant Therapeutics from November 2016 to February 2019, where he led the company's&#160;cell/tissue-based therapy development for treating a rare immunological disease. He was also the executive vice president and head of research&#160;at Retrophin, Inc. where he worked on therapies for multiple disease indications. Dr. Shih previously worked in management consulting at McKinsey &amp; Company and L.E.K. Consulting, LLC. He&#160;received his medical degree&#160;from the University of Alabama and completed his residency training at Massachusetts General Hospital. Dr. Shih received his&#160;M.B.A. from the Kellogg School of Management at Northwestern University. The Board believes that Dr. Shih&#8217;s significant leadership experience in the biotechnology industry and his experience in rare disease qualifies him to serve on the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Vote Required</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Directors are elected by a plurality of the votes of the holders of shares present in person or represented by proxy and entitled to vote on the election of directors. Accordingly, the three nominees receiving the highest number of affirmative votes will be elected.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>THE BOARD OF DIRECTORS RECOMMENDS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>A VOTE IN FAVOR OF EACH NOMINEE NAMED ABOVE.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>CLASS I DIRECTORS CONTINUING IN OFFICE UNTIL THE 2025</b>&#160;<b>ANNUAL MEETING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Wendy Dixon, Ph.D.</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Wendy Dixon, Ph.D. has served as a director of our Company since April 2023. Dr.&#160;Dixon has more than 40 years of biopharmaceutical industry experience in drug development with leadership roles in regulatory affairs and commercial capabilities. She currently serves on the board of directors of Arivinas, Inc. since June 2020, Black Diamond Therapeutics, Inc. since April 2022, and Iovance Biotherapeutics, Inc. since June 2022. Previously, Dr. Dixon has served on the boards&#160;of directors of Alkermes plc from January 2011 to May 2022, bluebird bio, Inc. from May 2013 to June 2021, Incyte from May 2010 to May 2022, Sesen Bio, Inc. (formerly Eleven Biotherapeutics, Inc.) from October 2014 to February 2020, Voyager Therapeutics, Inc. from January 2017 to January 2021, and&#160;was formerly on the boards of Ardea Biosciences from 2011 until 2012 when Ardea was acquired by AstraZeneca plc, Furiex Pharmaceuticals from 2010 until 2014 when Furiex was acquired by Actavis plc, Dentsply International from July 2005 to July 2010, and Orexigen Therapeutics, Inc. from April 2010 until January 2016. From December 2001 to May 2009, Dr. Dixon was chief marketing officer and president of global marketing at Bristol Myers Squibb,&#160;and served as a senior vice president of marketing at Merck from 1996 to 2001. Earlier in her career, she held executive management positions at West Pharmaceuticals, Osteotech and Centocor, as well as roles at SmithKline and French (now GlaxoSmithKline) in marketing, regulatory affairs, project management and as a biochemist. Dr. Dixon holds a Ph.D. in biochemistry and an M.Sc. and B.Sc. in Natural Science from the University of Cambridge.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Tamara A. Favorito</i></b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Tamara A. Favorito&#160;has served as a director and chair of the audit committee of our Company since August 2021, and as our board chair since May 2023. Ms. Favorito&#160;has more than 30 years of life sciences industry experience including 20 years as a chief financial officer. She currently serves as a board member and audit committee chair of Artelo Biosciences, Inc. since March 2021 and Kintara Therapeutics, Inc. since April 2021, both publicly-traded clinical-development stage companies. Ms. Favorito&#160;served on the board of directors of Beacon Discovery, Inc. from 2018 until their acquisition in March 2021. Ms. Favorito&#160;was interim chief financial officer of Immunic, Inc., a publicly-traded clinical-stage drug development company in 2019. She served as chief financial officer&#160;of Signal Genetics, Inc. (now Viridian Therapeutics, Inc.), a publicly-traded molecular diagnostics company, from 2014 to 2017, HemaQuest Pharmaceuticals, Inc., a venture-backed clinical-stage drug development company, from 2010 to 2014 and Favrille, Inc. (now MMR Global, Inc.), a publicly-traded clinical-stage drug development company, from 2001 to 2009. Earlier in her career, she spent eight years in public accounting with Deloitte &amp; Touche LLP and PricewaterhouseCoopers LLP. Ms. Favorito&#160;is a certified public accountant (inactive). She received an MBA, emphasis in Finance, from Georgia State University, and a BBA, emphasis in Accounting, from Valdosta State University. Our Board believes that Ms. Favorito's&#160;deep experience in corporate management, finance and life science as chief financial officer of multiple public companies provides her with the qualifications and skills to serve as a director of our Company. Her extensive experience includes leading multiple private and public financings and&#160;M&amp;A transactions as well as leading the finance, investor relations, human resources, administration and managed care functions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>CLASS II DIRECTORS CONTINUING IN OFFICE UNTIL THE 2026</b>&#160;<b>ANNUAL MEETING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>John B. Bode</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">John B. Bode has served as a director of our Company since April 2023, and as the chair of the nominating and corporate governance committee since May 2023. Since February 2015, Mr. Bode has been the owner and managing director of Aerie Investments, LLC, an investment company focused on assisting legacy media companies and digital media start-ups with business development, strategic initiatives, and raising capital. Mr. Bode currently serves as&#160;the chief financial officer and chief transformation officer of Postmedia Network Canada Corp., a publishing company whose shares are traded on the Toronto Stock Exchange.&#160; Since September 2022, he has served&#160;as the interim chief executive officer&#160;of Fision Holdings, Inc. and previously served as an independent member of its board of directors from March 2018 to September 2022. Mr. Bode&#8217;s past corporate experience includes many years serving as a key executive and/or financial officer for leading public companies Prior to the founding of Aerie Investments, LLC, Mr. Bode was the chief financial officer of the Tribune Publishing Company from October 2013 to January 2015. From January 2011 to September 2013, Mr. Bode served as the chief financial officer of Source Interlink Companies, one of the largest enthusiast media companies in the United States&#160;and a leading distributor of periodicals,&#160;after serving in other accounting and finance roles with Source Interlink since 2002. Mr. Bode currently serves as on the board of The McClatchy Company, a leading privately-held publisher of newspapers, as well as of SPAR Group, Inc., a leading global provider of merchandising, marketing and distribution services that is listed on the Nasdaq. He was previously employed&#160;as a certified public accountant for BDO Seidman. Mr. Bode received a BS in accounting from Notre Dame University.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Douglas W. Calder</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Douglas W. Calder has served as a director of our Company since April 2023. Since 2015, Mr. Calder has served&#160;as president and a director of Vycellix, Inc and its subsidiaries and affiliates. He has also served as a member of the board of directors for NextGenNK since June 2019; member of the board of directors of BioFlorida since January 2019, and a member of the Society for Natural Immunity since July 2018. Mr. Calder has more than 30 years of life science executive experience, having served in various senior executive roles for Florida-based biotechnology companies and research institutes including Viragen, Accentia Biopharmaceuticals, Biovest International and the Vaccine &amp; Gene Therapy Institute of Florida, as well as having formerly served as a registered financial portfolio manager with a focus on life science equities with the New York Stock Exchange member firms, Gruntal &amp; Co. and Dean Witter Reynolds. Mr. Calder received a BA from Florida State University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Corey Watton</i></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#65279;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Corey Watton has served as a director of our Company since April 2023. Mr. Watton currently serves as president and chief executive officer of Fusion Medical Staffing, LLC, since September 2023.&#160;Prior to his CEO role, Mr. Watton served as chief financial officer from August 2019 until September 2023.&#160;In that role he oversaw finance, project management, operations, facilities and legal, and previously oversaw human resources as well. From April 2009 through July 2019, he served as the chief financial officer of Home Instead Senior Health Care, a global leader in in-home health care, where he oversaw finance, subsidiary companies and the financial arm of an international subsidiary. He previously was a partner&#160;of Lutz &amp; Company, a regional accounting firm from 1996 to 2009. Mr. Watton is a certified public accountant and received a BS in Finance and Accounting from University of Nebraska-Lincoln.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="inforegardingbod" title="inforegardingbod" href="#"></a>INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>DIRECTOR INDEPENDENCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">As required under the Nasdaq Stock Market (&#8220;Nasdaq&#8221;)&#160;listing standards, a majority of the members of our Board must qualify as &#8220;independent,&#8221; as affirmatively determined by the Board. Our Board consults with our counsel to ensure that the Board&#8217;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of &#8220;independent,&#8221; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and the Company, its senior management and its independent registered public accounting firm, the Board has affirmatively determined that the following seven&#160;directors are independent directors within the meaning of the applicable Nasdaq listing standards: Mr. Anderson, Mr. Bode, Mr. Calder, Dr. Dixon, Ms. Favorito, Dr. Shih&#160;and Mr. Watton.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In making this determination, the Board found that none of these directors had a material or other disqualifying relationship with us. The Board considered the current and prior relationships that each non-employee director has with us and all other facts and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director. Mr. McFarlane, our president and chief executive officer is&#160;not an independent director&#160;by virtue of his&#160;employment with the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In 2023, our Board had determined that Matthew R. Plooster, Christopher A. Posner, Joseph B. Saluri, and David S. Tierney, M.D. qualified as independent during the period they served on our Board in 2023 and until their respective departures, and that Richard W. Pascoe, our former chief executive officer, and Travis C. Mickle, Ph.D., our former president, were not independent directors in 2023 by virtue of their employment with the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>FAMILY RELATIONSHIPS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">There are no family relationships among any of our directors or executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>BOARD LEADERSHIP STRUCTURE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Based on the Company&#8217;s present circumstances, the Board believes that the Company and its stockholders are best served by having Ms. Favorito serve as its Board Chair and Mr. McFarlane serve as its President and Chief Executive Officer. Our current leadership structure permits Mr. McFarlane to focus his attention on managing our business and permits Ms. Favorito to manage the Board and oversee the Company&#8217;s strategy and corporate governance. We believe that this governance structure best reinforces the independence of the Board from management. In addition, we believe the Board Chair is well-positioned to act as a bridge between management and the independent directors, facilitating the regular flow of information. Among other duties, the Board Chair may represent the Board in communications with stockholders and other stakeholders and provide input on the structure and composition of the Board. Accordingly, we believe our current leadership structure is the optimal structure for us at this time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">However, our Board of Directors will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate. During its routine review of the Board&#8217;s leadership structure, the Board and the Company regularly consider the circumstances under which the roles of Board Chair and Chief Executive Officer could most effectively serve the Company&#8217;s and its stockholders&#8217; interests if combined. From time to time, the Company proactively engages with stockholders throughout the year to learn their perspectives on significant issues, and intends to continue to do so, including with respect to gathering stockholder perspectives on Board leadership structure. If, in the future, the Board Chair is a member of management or does not otherwise qualify as independent, the Board may in its discretion consider the appointment of a lead independent director. If appointed, the lead independent director&#8217;s responsibilities would include, but would not be limited to, presiding over all meetings of the Board of Directors at which the Board Chair is not present, including any executive sessions of the independent directors, approving the Board&#8217;s meeting schedules and agendas, and acting as liaison between the independent directors of the Board and the Chief Executive Officer and the Board Chair.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>BOARD DIVERSITY MATRIX</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td colspan="5" style="vertical-align: top; width: 88%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-width: 1px; border-style: solid; border-color: black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Board Diversity Matrix (As of April 3, 2024)</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -1pt;">Total Number of Directors</p>
			</td>
			<td colspan="4" style="vertical-align: bottom; width: 36%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-left: 1px solid black; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Female</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Male</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-Binary</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Did Not Disclose Gender</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><b>Part I: Gender Identity</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: bottom; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: 8pt;">Directors</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">6</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;"><b>Part II: Demographic Background</b></p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">&#160;</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">African American or Black</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">Alaskan Native or Native American</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">Asian</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">1</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">Hispanic or Latinx</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">Native Hawaiian or Pacific Islander</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">White</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">Two or More Races or Ethnicities</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">LGBTQ+</p>
			</td>
			<td colspan="4" style="vertical-align: top; width: 36%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 52%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -2pt;">Did Not Disclose Demographic Background</p>
			</td>
			<td colspan="4" style="vertical-align: top; width: 36%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ROLE OF THE BOARD IN RISK OVERSIGHT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">One of the Board&#8217;s key functions is informed oversight of our risk management process. The Board does not have a standing risk management committee, but rather administers this oversight function directly through the Board as a whole, as well as through various Board standing committees that address risks inherent in their respective areas of oversight. The Board and its committees re-assess the Company&#8217;s risk environment on an ongoing basis&#160;and consult with outside parties as needed from time to time in addressing both current and anticipated future risks. The Board elects to retain direct oversight responsibility for risks that are most effectively overseen by simultaneously leveraging broader areas of director expertise. Additionally, while the Board and its committees all review risks over the short-, intermediate-, and long-term, the Board more frequently elects to retain direct oversight over short-term or immediate risks. In particular, our Board is responsible for monitoring and assessing strategic risk exposure, including a determination of the nature and level of risk appropriate for the Company. Our Audit Committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. Additionally, our Board considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee oversight of cybersecurity and other information technology risks. The Audit Committee oversees management&#8217;s implementation of our cybersecurity risk management program. The Audit Committee also provides oversight and assistance in connection with our legal, regulatory and ethical compliance programs as established by management and the Board. The nominating and corporate governance committee of the Board (the &#8220;Nominating and Corporate Governance Committee&#8221;) oversees all aspects of our corporate governance functions and related risks. The compensation committee of the Board (the &#8220;Compensation Committee&#8221;) assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Management&#8217;s involvement in day-to-day risk management enables the Company&#8217;s disclosure committee, which consists of members of management, to assist our Chief Executive Officer and Chief Financial Officer in the effective design, establishment, maintenance, review, and evaluation of the Company&#8217;s disclosure controls and procedures. The Company&#8217;s management, led by our Chief Executive Officer and executive team, implements and supervises day-to-day risk management processes. Both the Board as a whole and the various standing committees receive periodic reports from our employees responsible for risk management, as well as incidental reports as matters may arise. It is the responsibility of the committee chairs to report findings regarding material risk exposures to the Board as quickly as possible. The Board does not believe that its role in the oversight of our risks affects the Board&#8217;s leadership structure.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Board is also committed to prioritizing environmental, social, and governance (&#8220;ESG&#8221;) issues. Our Board works closely with our management team to promote awareness of ESG issues and to integrate ESG promotion into our long-term business strategy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>MEETINGS OF THE BOARD OF DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our Board met fifteen<b> </b>times during 2023. Each Board member attended 75% or more of the aggregate number of meetings of the Board and of the committees on which he or she served during the portion of 2023&#160;for which he<b> </b>or she<b> </b>was a director or committee member.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">As required under the applicable Nasdaq listing standards, in the fiscal year ending December 31, 2023, our independent directors met seven times in regularly scheduled executive sessions at which only our independent directors were present.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Information Regarding Committees of the Board of Directors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Board has three committees:<b> </b>the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. The following table provides current membership for each of the Board committees and the 2023 meeting information for each of the Board committees.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Audit</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Nominating and Corporate </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Governance</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Thomas D. Anderson</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X*</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt; text-indent: 9pt;">John B. Bode</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;X*</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt; text-indent: 9pt;">Douglas W. Calder</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt; text-indent: 9pt;">Wendy Dixon, Ph.D.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tamara A. Favorito</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;X*</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt; text-indent: 9pt;">Neil F. McFarlane</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 49%;">Alvin Shih, M.D.</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">X</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%; text-align: center;">X</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Corey Watton</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">X</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Total meetings in 2023</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 49%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 49%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">*&#160;&#160;&#160;&#160;&#160;Committee Chair</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 16%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Below is a description of each committee of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Audit Committee</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The Audit Committee reviews our internal accounting procedures and consults with and reviews the services provided by our independent registered public accounting firm. Our Audit Committee consists of four&#160;directors, John B. Bode,&#160;Wendy Dixon, Ph.D., Tamara A. Favorito, and Corey Watton. Our Board has determined that each of Mr. Bode, Dr. Dixon, Ms. Favorito,&#160;and Mr. Watton&#160;are independent directors under Nasdaq listing rules and under Rule 10A-3 under the Exchange Act.<b> </b>Ms. Favorito&#160;is the chair of the Audit Committee.&#160;Our Board has determined that both Ms. Favorito&#160;is considered to be an &#8220;audit committee financial expert&#8221; as defined by SEC rules and regulations and based on a qualitative assessment of her&#160;level of financial expertise, knowledge and experience based on a number of factors including her previous business experience as described above under the sections titled &#8220;Class I Directors Continuing in Office Until the 2025 Annual Meeting,&#8221; and "Class II Directors Continuing in Office until the 2026 Annual Meeting,&#8221; respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">David S. Tierney, M.D. served on the Audit Committee until January 2023 and Christopher A. Posner served on the Audit Committee until April 2023. In 2023, our Board had determined each of Dr. Tierney and Mr. Posner were independent directors under Nasdaq listing rules and under Rule 10A-3 under the Exchange Act during the period for which they served on the Audit Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The principal duties and responsibilities of the Audit Committee include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">appointing and retaining an independent registered public accounting firm to audit our financial statements, assessing its independence from the Company, overseeing the independent registered public accounting firm&#8217;s work and determining the independent registered public accounting firm&#8217;s compensation;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">approving in advance all audit services and non-audit services to be provided to us by our independent registered public accounting firm;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Setting hiring policies for the employees or former employees of our independent registered public accounting firm;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls, auditing or compliance matters, as well as for the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">reviewing and discussing with management and our independent registered public accounting firm the results of the annual audit, the independent registered public accounting firm&#8217;s review of our quarterly financial statements, and our earnings press releases;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">conferring with management and our independent registered public accounting firm about the scope, adequacy and effectiveness of our internal accounting control and our financial reporting.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">reviewing and approving related person transactions;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing the results of management&#8217;s efforts to monitor compliance with our programs and policies designed to ensure adherence to applicable laws and rules, as well as to our Code of Conduct; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing and discussing with management and our independent registered public accounting firm, as appropriate, our guidelines and policies with respect to risk assessment and risk management, including relating to our accounting matters, financial reporting, legal and regulatory compliance, and information technology, including cybersecurity and data privacy, and the steps taken by management to monitor and control such exposures.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Audit Committee met five times during the last fiscal year. Our Board has adopted a written audit committee charter that is available to our stockholders at <span style="text-decoration: underline; ">www.zevra.com</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Report of the Audit Committee of the Board of Directors (1)</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2023,&#160;with our management. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by Auditing Standard No. 1301, <i>Communications with Audit Committees,</i> as adopted by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;). The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent registered public accounting firm&#8217;s communications with the Audit Committee concerning independence and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to our Board that the audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Tamara A. Favorito&#160;(Chair)</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">John B. Bode</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Wendy Dixon, Ph.D.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Corey Watton</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The material in this report is not &#8220;soliciting material,&#8221;&#160;is not deemed &#8220;filed&#8221;&#160;with the Commission and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Compensation Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Compensation Committee is composed of four&#160;directors, Thomas D. Anderson, Douglas W. Calder, Alvin Shih, M.D., and Corey Watton. All members of our Compensation Committee are independent under the Nasdaq listing rules, including with respect to service on a compensation committee, and each is a non-employee member of our Board as defined in Rule 16b-3 under the Exchange Act. Mr. Anderson&#160;is the chair of the Compensation Committee. Our Board has determined that the composition of the Compensation Committee satisfies the applicable independence requirements under, and the functioning of our Compensation Committee, complies with the applicable requirements of the Nasdaq listing rules and SEC rules and regulations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Joseph B. Saluri served on the Compensation Committee until January 2023, David S. Tierney, M.D. served on the Compensation Committee until April 2023, and Matthew Plooster served on the Compensation Committee until August 2023. In 2023, our Board had determined each Mr. Saluri, Dr. Tierney, and Mr. Plooster were independent under the Nasdaq listing rules, including with respect to service on a compensation committee, and each was a non-employee member of our Board as defined in Rule 16b-3 under the Exchange Act, during the period for which they served on the Compensation Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The principal duties and responsibilities of the Compensation Committee include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing our overall compensation strategy and policies, establishing and approving, or, if it deems appropriate, recommending to the Board, performance goals and objectives relevant to the compensation of our chief executive officer, evaluating the performance of our chief executive officer in light of those goals and objectives and setting, or recommending to the full Board for approval, the compensation of our chief executive officer, including incentive-based and equity-based compensation, based on that evaluation;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">setting, or recommending to the full Board for approval, the compensation of our other executive officers;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">exercising administrative authority under our stock plans, as well as stock appreciation rights plans, pension and profit-sharing plans, incentive plans, stock bonus plans, stock purchase plans, bonus plans, deferred compensation plans, or any other similar programs which may be adopted from time to time;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">setting, or recommending to the full Board for approval, the type and amount of compensation to be paid to our directors;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">manage the appointment, compensation and oversight of any compensation consultant retained by the Compensation Committee;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing and discussing with management the compensation discussion and analysis that we may be required from time to time to include in SEC filings; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">preparing a compensation committee report on executive compensation as may be required from time to time to be included in our annual proxy statements or annual reports on Form 10-K filed with the SEC.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Compensation Committee met four times during 2023. Our Board has adopted a written compensation committee charter that is available to our stockholders at <span style="text-decoration: underline; ">www.zevra.com</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Compensation Committee Processes and Procedures</i>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Typically, the Compensation Committee meets three times per year, but may meet with greater or lesser frequency, as deemed necessary by the Compensation Committee. The agenda for each meeting is usually developed by the chair of the Compensation Committee, in consultation with our chief executive officer. The Compensation Committee meets regularly in executive sessions. However, from time to time, various members of management and other employees as well as outside advisors or consultants<b> </b>may be invited by the Compensation Committee to make<b> </b>presentations, to provide financial or other<b> </b>background information or advice or to otherwise participate in Compensation Committee meetings. Our chief executive officer may not participate in, or be present during, any deliberations or determinations of the Compensation Committee regarding his compensation. The charter of the Compensation Committee grants the Compensation Committee full access to all books, records, facilities and personnel of the Company. In addition, under the Compensation Committee&#8217;s charter, the Compensation Committee has the authority to obtain, at the expense of the Company, advice and assistance from internal and external legal, accounting or other advisors and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. The Compensation Committee has direct responsibility for the oversight of the work of any advisers engaged for the purpose of advising the Compensation Committee. In particular, the Compensation Committee has the authority to retain compensation consultants to assist in its evaluation of<b> </b>executive<b> </b>and director compensation, including the authority to approve the consultant&#8217;s reasonable fees and other retention terms. Under the Compensation Committee&#8217;s charter, the Compensation Committee may select, or receive advice from, a compensation consultant, legal counsel or other adviser to the Compensation Committee, other than in-house legal counsel and certain other types of advisers, only after taking into consideration six factors, prescribed by the SEC and Nasdaq, that bear upon the adviser&#8217;s independence. However, there is no requirement that any adviser be independent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In 2023, the Compensation Committee engaged Mercer (US) LLC ("Mercer") as a compensation consultant, who provided reports and recommendations for the Compensation Committee&#8217;s consideration when making compensation decisions for our non-employee directors and executive officers in 2023. The Compensation Committee has considered the adviser independence factors required under SEC and Nasdaq rules as they relate to Mercer and has determined that Mercer&#8217;s work does not raise a conflict of interest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Under its charter, the Compensation Committee may form, and delegate authority to, subcommittees as appropriate. In 2015, the Compensation Committee formed<b> </b>a single-person non-officer stock award committee, currently composed of our chief executive officer,&#160;to which it delegated authority to grant, without any further action required by the Compensation Committee, stock awards to employees who are not officers of the Company, provided that such grants are made in accordance with guidelines established by the Compensation Committee. The purpose of this delegation of authority is to enhance the flexibility of our stock award administration and to facilitate the timely grant of stock awards to non-management employees, particularly new employees, within specified limits approved by the Compensation Committee. In particular, the single-person non-officer stock award committee may not grant stock awards to acquire more than 150% of the annual grant amount based on the 50<sup style="vertical-align:top;line-height:120%;">th</sup> percentile of the annual long-term incentive amount by position based on the data provided by Mercer, and all grants made by this committee must be made to persons below the level of senior vice president, and are subject to vesting periods approved by the Compensation Committee. As part of the Compensation Committee&#8217;s oversight function, the minutes of each meeting and copies of each action by unanimous written consent of the single-member committee are to be sent to the members of the Compensation Committee. In 2023, the single-member committee exercised its authority to grant options to purchase an aggregate of 478,650 shares<b> </b>to new-hired non-officer employees.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Compensation Committee endeavors to make significant adjustments to annual compensation, determine bonus and equity awards and establish new performance objectives at one or more meetings held during the first quarter of the year. However, the Compensation Committee also considers matters related to individual compensation, such as compensation for new executive hires, as well as high-level strategic issues, such as the efficacy of our compensation strategy, potential modifications to that strategy and new trends, plans or approaches to compensation, at various meetings throughout the year. Generally, the Compensation Committee&#8217;s process comprises two related elements:<b> </b>the determination of compensation levels and the establishment of performance objectives for the current year. For executives other than the chief executive officer, the Compensation Committee solicits and considers evaluations and recommendations submitted to it<b> </b>by the chief executive officer and executive chairman.<b> </b>In the case of the chief executive officer and executive chairman, the evaluation of their performance is conducted by the Compensation Committee, which determines any adjustments to their<b> </b>compensation<b> </b>as well as awards to be granted. For all executive officers, as part of its deliberations, the Compensation Committee may review and consider, as appropriate,<b> </b>materials such as financial reports and projections, operational data, tax and accounting information, tally sheets that set forth the total compensation that may become payable to executives in various hypothetical scenarios, executive stock ownership information, company stock performance data, analyses of historical executive compensation levels and current Company-wide compensation levels and recommendations of the Compensation Committee&#8217;s compensation consultant, including analyses of executive compensation paid at other companies identified by the consultant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Nominating and Corporate Governance Committee </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Nominating and Corporate Governance Committee is composed of three directors, Thomas D. Anderson, John B. Bode, and Alvin Shih, M.D.&#160;Mr. Bode&#160;is the chair of the Nominating and Corporate Governance Committee. All members of the Nominating and Corporate Governance Committee are independent under the Nasdaq listing standards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Joseph B. Saluri served on the Nominating Committee until October 2023, Matthew Plooster served on the Nominating Committee until August 2023, and David S. Tierney, M.D., served on the Nominating Committee until April 2023. In 2023, our Board had determined each Mr. Saluri, Mr. Plooster, and Dr. Tierney were independent under the Nasdaq listing standards during the period for which they served on the Nominating Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The principal duties and responsibilities of the Nominating and Corporate Governance Committee include:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">identifying, reviewing and evaluating candidates to serve as our directors (consistent with criteria approved by the Board);</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing and evaluating incumbent directors and the performance of the full Board and Board committees;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">recommending to the Board candidates for election to the Board;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">making recommendations to the Board regarding the membership of the committees of the Board;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">overseeing and reviewing the processes and procedures used to provide information to the Board and its committees;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing with the Chief Executive Officer the plans for succession to the offices of Chief Executive Officer and other key executive officers and making recommendations to the Board with respect to succession planning;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">reviewing Company policy statements to determine their adherence to our Code of Conduct and considering any request by our directors or executive officers for a waiver from the Code of Conduct; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">overseeing and reviewing the Company&#8217;s corporate governance functions on behalf of the Board, including reviewing and assessing the adequacy of our Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws and Board committee charters.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Nominating and Corporate Governance Committee met two&#160;times during 2023. The Board has adopted a written Nominating and Corporate Governance Committee charter that is available to our stockholders at <span style="text-decoration: underline; ">www.zevra.com</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Nominating and Corporate Governance Committee appreciates the value of thoughtfully refreshing the Board over time, and regularly identifies and considers qualities, skills and other director attributes that would enhance the composition of the Board. The Committee continuously evaluates the need for greater diversity in the composition of the Board in light of its view that new and varied perspectives can provide a valuable benefit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Nominating and Corporate Governance Committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. The Nominating and Corporate Governance Committee also intends to consider such factors as possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs of the Company, demonstrated excellence in his or her field, having the integrity, experience, ability to exercise sound business judgment, commitment,&#160;independence for purposes of the Nasdaq listing standards, skills, diversity, expertise appropriate for the Company, and having the commitment to rigorously represent the long-term interests of the Company&#8217;s stockholders. However, the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time and within the context of the current needs of the Board and the Company with the goal to maintain a balance of knowledge, experience and capability in various areas germane to the business. Candidates for director nominees are reviewed in the context of the current composition of the Board, the operating requirements of the Company and the long-term interests of stockholders. In conducting this assessment, the Nominating and Corporate Governance Committee typically considers diversity, age, skills and such other factors as it deems appropriate, given the current needs of the Board and the Company, to maintain a balance of knowledge, experience and capability. In the case of incumbent directors whose terms of office are set to expire, the Nominating and Corporate Governance Committee reviews these directors&#8217; overall service to the Company during their terms, including the number of meetings attended, level of participation, quality of performance and any other relationships and transactions that might impair the directors&#8217; independence. In the case of new director candidates, the Nominating and Corporate Governance Committee also determines whether the nominee is independent, which determination is based upon applicable Nasdaq listing standards, applicable SEC rules and regulations and the advice of counsel, if necessary. The Nominating and Corporate Governance committee then uses its network of contacts to compile a list of potential candidates, but may also engage, if it deems appropriate, a professional search firm. The Nominating and Corporate Governance Committee conducts any appropriate and necessary inquiries into the backgrounds and qualifications of possible candidates after considering the function and needs of the Board. The Nominating and Corporate Governance Committee meets to discuss and consider the candidates&#8217; qualifications and then selects a nominee for recommendation to the Board by majority vote.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Nominating and Corporate Governance Committee will consider director candidates recommended by stockholders. The Nominating and Corporate Governance Committee does not intend to alter the manner in which it evaluates candidates, including the minimum criteria set forth above, based on whether or not the candidate was recommended by a stockholder. Stockholders who wish to recommend individuals for consideration by the Nominating and Corporate Governance Committee to become nominees for election to the Board may do so by delivering a written recommendation to the Nominating and Corporate Governance Committee c/o Zevra Therapeutics, Inc., 1180 Celebration Blvd. Suite 103, Celebration, FL 34747, Attn: Corporate Secretary, at least 90 days, but not more than 120 days, prior to the anniversary date of the preceding year&#8217;s annual meeting of stockholders. Submissions must include the full name age, business address and residence address of the proposed nominee, a description of the proposed nominee&#8217;s business experience for at least the previous five years, complete biographical information for the proposed nominee, a description of the proposed nominee&#8217;s qualifications as a director, the name and address of the stockholder on whose behalf the submission is made and the number and class of the Company&#8217;s shares that are beneficially owned by such stockholder and such nominee as of the date of submission, including the date that such shares were acquired by such nominee. Any such submission must be accompanied by the written consent of the proposed nominee to be named as a nominee and to serve as a director if elected.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Board has adopted a formal process by which stockholders may communicate with the Board or any of its directors. Stockholders who wish to communicate with the Board may do so by sending written communications addressed to Zevra Therapeutics, Inc., 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747, Attn: Corporate Secretary. Each communication must set forth:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the name and address of the stockholder on whose behalf the communication is sent; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the number and class of shares of the Company that are owned beneficially by such stockholder as of the date of the communication.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Corporate Secretary will review each communication. The Corporate Secretary will forward such communication to the Board or to any individual director to whom the communication is addressed unless the communication contains advertisements or solicitations or is unduly hostile, threatening or similarly inappropriate, in which case the Corporate Secretary shall discard the communication. These screening procedures have been approved by a majority of the independent directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">All communications directed to the Audit Committee in accordance with our open-door policy for reporting complaints regarding accounting and auditing matters that relate to questionable accounting or auditing matters involving the Company will be promptly and directly forwarded to the chair of the Audit Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>CODE OF ETHICS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We have adopted the Zevra Therapeutics, Inc. Code of Business Conduct and Ethics (the &#8220;Code of Conduct&#8221;), that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. The Code of Conduct is available on our website at <span style="text-decoration: underline; ">www.zevra.com</span>. If we make any substantive amendments to the Code of Conduct or grant any waiver from a provision of the Code of Conduct to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>POLICY ON HEDGING AND SPECULATIVE TRADING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our insider trading and window period policy prohibits our employees and directors from engaging in short sales, transactions in put or call options, hedging transactions, margin accounts or other inherently speculative transactions with respect to our stock at any time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="prop2" title="prop2" href="#"></a>PROPOSAL 2</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Audit Committee has selected EY&#160;as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2024,&#160;and has further recommended that the Board submit the appointment of its independent registered public accounting firm for ratification by the stockholders at the Annual Meeting. EY&#160;has audited the Company&#8217;s financial statements since 2022. Representatives of EY&#160;are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Neither the Company&#8217;s Amended and Restated Bylaws nor other governing documents or law require stockholder ratification of the appointment of EY&#160;as the Company&#8217;s independent registered public accounting firm. However, the audit committee is submitting the appointment of EY&#160;to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the appointment, the Audit Committee will reconsider whether or not to retain EY. Even if the appointment is ratified, the Audit Committee in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of the Company and its stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">EY has served as the Company&#8217;s independent registered public accounting firm since June 14, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PRINCIPAL ACCOUNTANT FEES AND SERVICES </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table represents aggregate fees billed to the Company for the fiscal years ended December 31, 2023,&#160;and December 31, 2022, by EY, the Company&#8217;s principal accountant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal Year Ended (1)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2022</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(in thousands)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Fees (2)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">960</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">630</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit-related Fees (3)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Tax Fees (4)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">All Other Fees (5)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total Fees</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><b>960</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><b>$</b></td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;"><b>630</b></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">All fees described in this table and corresponding footnotes were pre-approved by the Audit Committee.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Audit Fees are fees for the annual audit and quarterly reviews of the Company's financial statements, audits required by public company regulation, professional consultations with respect to accounting issues, registration statement filings and issuance of consents and similar matters.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Audit-related Fees are fees for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under &#8220;Audit Fees.&#8221;&#160;No Audit-related Fees were billed in fiscal year 2023&#160;or 2022.&#160;</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Tax Fees are fees for tax compliance, planning and preparation. No Tax Fees were billed in fiscal year 2023&#160;or 2022.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">All Other Fees are fees for products and services other than the services described above. No Other Fees were billed in fiscal year 2023&#160;or 2022.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>PRE-APPROVAL POLICIES AND PROCEDURES</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Audit Committee has adopted a policy and procedures for the pre-approval of audit and non-audit services rendered by the Company&#8217;s independent registered public accounting firm. The policy generally pre-approves specified services in the defined categories of audit services, audit-related services, tax services and other permissible non-audit services, so long as such non-audit services will not impair the independent registered public accounting firm&#8217;s independence and are consistent with applicable rules and regulations, up to specified amounts. Pre-approval may also be given as part of the Audit Committee&#8217;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual, explicit, case-by-case basis before the independent registered public accounting firm is engaged to provide each service. The pre-approval of services may be delegated to one or more of the Audit Committee&#8217;s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Audit Committee has determined that the rendering of services other than audit services by EY&#160;was compatible with maintaining the independent registered public accounting firm&#8217;s independence.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Vote Required</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The affirmative vote of the majority of shares present or represented by proxy at the meeting&#160;and entitled to vote is required to ratify the appointment of EY.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>THE BOARD OF DIRECTORS RECOMMENDS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>A VOTE IN FAVOR OF PROPOSAL 2</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="peop3" title="peop3" href="#"></a>PROPOSAL 3</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">Under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, and Section&#160;14A of the Exchange Act, the Company&#8217;s stockholders are entitled to vote to approve, on an advisory and non-binding basis, the compensation of the Company&#8217;s named executive officers as disclosed in this proxy statement in accordance with SEC rules. This advisory and non-binding vote is commonly referred to as a &#8220;say-on-pay&#8221; vote.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">This say-on-pay vote is not intended to address any specific item of compensation, but rather the overall compensation of the Company&#8217;s named executive officers and the policies and practices described in this proxy statement.&#160;The compensation of the Company&#8217;s named executive officers subject to the say-on-pay vote is disclosed in the compensation tables and the related narrative disclosures that accompany the compensation tables contained in the &#8220;Executive Compensation&#8221; section of this proxy statement.&#160;&#160;As described in those disclosures, the Company generally seeks to target its executive compensation to be at or near the median of the compensation paid to similarly situated executive officers of companies in our peer group for the applicable year.&#160;&#160;Compensation of the Company&#8217;s named executive officers is designed to enable the Company to attract, retain and motivate talented and experienced executives to lead the Company successfully in a competitive environment; to provide incentives that reward the achievement of performance goals that directly correlate to the enhancement of stockholder value; and to align the named executive officers&#8217; interests with those of stockholders through long-term incentives linked to company performance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">Accordingly, the Board is asking the stockholders to indicate their support for the compensation of the Company&#8217;s named executive officers as described in this proxy statement by casting a non-binding advisory vote &#8220;FOR&#8221; the following resolution:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">&#8220;RESOLVED, that the compensation paid to the Company&#8217;s named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the compensation tables and any related material disclosed in this proxy statement, is hereby APPROVED.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">Because the say-on-pay vote is advisory, it is not binding on the Board or the Company. Nevertheless, the views expressed by the stockholders, whether through this say-on-pay vote or otherwise, are important to management and the Board and, accordingly, the Board and the Compensation Committee intend to consider the results of this say-on-pay vote in making determinations in the future regarding executive compensation arrangements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">Unless the Board decides to modify its policy regarding the frequency of soliciting say-on-pay votes, the next scheduled say-on-pay vote will be at the 2027 Annual Meeting of Stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Vote Required</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The affirmative vote of the majority of shares present or represented by proxy at the meeting&#160;and entitled to vote is required to approve, on an advisory and non-binding basis, the compensation of the Company&#8217;s named executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>THE BOARD OF DIRECTORS RECOMMENDS</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>A VOTE IN FAVOR OF PROPOSAL 3</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="prop4" title="prop4" href="#"></a>PROPOSAL 4</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>APPROVAL OF AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>PROPOSAL 4</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">Our 2014 Equity Incentive Plan originally became effective on April 1, 2015, in connection with our initial public offering and was subsequently amended and restated in 2021 upon the approval of the Board and stockholders (as it was amended and restated, the &#8220;<b><i>Existing Plan</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 18pt;">On February 22, 2024, the Board approved further amending and restating the Existing Plan, subject to stockholder approval of this Proposal 4.&#160; We refer to the Existing Plan, as it was so amended and restated by the Board as the &#8220;<b><i>A&amp;R Plan</i></b>&#8221; throughout this proposal. A copy of the A&amp;R Plan is attached to this proxy statement as <span style="text-decoration: underline; "><b>Annex A</b></span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt; text-indent: 18pt;">A description of the material terms of the A&amp;R Plan is included below. The material differences between the terms of the Existing Plan and terms of the A&amp;R Plan are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-11pt;"><i>&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Limit</i>: The A&amp;R Plan provides that an additional&#160;6,000,000 shares may be issued pursuant to&#160;awards granted under the A&amp;R Plan.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-11pt;"><i>&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Extension of Term</i>: The A&amp;R Plan includes a term that is approximately three years longer than the Existing Plan, thus extending the latest date on which incentive stock options may be granted under the A&amp;R Plan as well as the annual automatic share increase.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;text-indent:-11pt;"><i>&#9679;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Non-Employee Director Compensation Limitation.</i>&#160;Like the Existing Plan, the A&amp;R Plan maintains the limit on compensation granted or paid, as applicable, to any individual for service as a non-employee director, which is generally $500,000 per year (as described in more detail below).&#160;&#160;Consulting fees or other compensation the Company or any of its subsidiaries may pay or provide to any non-employee director for services in addition to the services normally performed by a non-employee director shall not be included in calculating such limits. The Board may make exceptions to this limit for individual non-employee directors in extraordinary circumstances, as the Board may determine in its discretion, provided that the non-employee director receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation decisions involving non-employee directors.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -2pt;"><b>Why We Are Asking Our Stockholders to Approve the A&amp;R Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">We are seeking stockholder approval of the A&amp;R Plan to, among other things, increase the number of shares available for the grant of stock options, restricted stock unit awards and other awards by 6,000,000 shares, and to extend the latest date on which incentive stock options may be granted under the A&amp;R Plan as well as the annual automatic share increase to a date ten years from the date the A&amp;R Plan is approved by stockholders, or on or about May 12, 2034, which is an extension of&#160; approximately three years, each of which will enable us to have a competitive equity incentive program to continue to compete with our peer group for key talent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Our stockholders&#8217; approval of the A&amp;R Plan will allow us to grant stock options, restricted stock unit awards and other awards at levels determined appropriate by the Board or Compensation Committee. The A&amp;R Plan will also allow us to further utilize a broad array of equity incentives in order to secure and retain the services of our employees, directors and consultants, and to provide long-term incentives that align the interests of our employees, directors and consultants with the interests of our stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -2pt;"><b>Stockholder Approval</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">If this Proposal 4&#160;is approved by our stockholders, the A&amp;R Plan will become effective as of the date of the Annual Meeting. In the event that our stockholders do not approve this Proposal 4, the A&amp;R Plan will not become effective, and the Existing Plan will continue in its current form.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -1pt;"><b>Why You Should Vote to Approve the A&amp;R Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -2pt;"><b>Equity Awards Are an Important Part of Our Compensation Philosophy</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">The Board believes that the grant of equity awards is a key element underlying our ability to attract, retain and motivate our employees, directors and consultants because of the strong competition for highly trained and experienced individuals in commercial stage pharmaceutical&#160;companies. Therefore, the Board believes that the A&amp;R Plan is in the best interests of our business and our stockholders and recommends a vote in favor of this Proposal 4.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The A&amp;R Plan will allow us to continue to utilize equity awards as long-term incentives to secure and retain the services of our employees, directors and consultants, consistent with our compensation philosophy and common compensation practices for our industry. To date, equity awards have been a key aspect of our program to attract and retain key employees, directors and consultants. We believe the use of equity awards strongly aligns the interests of our employees with those of our stockholders by placing a considerable proportion of our employees&#8217; total compensation &#8220;at risk&#8221; because it is contingent on the appreciation in value of our common stock. In addition, we believe equity awards encourage employee ownership of our common stock and promote employee retention through the reward of long-term Company performance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -1pt;"><b>We Carefully Manage the Use of Equity Awards and Dilution Is Reasonable</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Our compensation philosophy reflects broad-based eligibility for equity awards. However, we recognize that equity awards dilute existing stockholders, and, therefore, we are mindful to responsibly manage the growth of our equity compensation program. We are committed to effectively monitoring our equity compensation share reserve, including our &#8220;burn rate,&#8221; to ensure that we maximize stockholders&#8217; value by granting the appropriate number of equity awards necessary to attract, reward, and retain employees,&#160;directors and consultants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Overhang</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">The following tables provide certain information regarding our use of equity awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>As of December 31, 2023</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total number of shares of common stock subject to outstanding stock options</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,023,142</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average exercise price of outstanding stock options</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8.40</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average remaining term of outstanding stock options</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total number of shares of common stock available for grant under our Existing Plan</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,348,885</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>As of March 22, 2024 (Record Date)</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total number of shares of common stock outstanding</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">41,850,494</td>
			<td style="width: 1%; margin-left: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Per-share closing price of common stock as reported on Nasdaq</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">$5.76</td>
			<td style="width: 1%; margin-left: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Burn Rate</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The following table provides detailed information regarding the activity related to our Existing Plan&#160;for fiscal years 2023, 2022, and 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 10%; width: 80%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal Year 2023</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal Year 2022</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fiscal Year 2021</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 43%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total number of shares of common stock subject to stock options granted</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5,231,734</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,484,245</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">869,383</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Weighted-average number of shares of common stock</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">35,452,460</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">34,488,800</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">29,766,347</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Burn Rate (1)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14.8</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.3</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2.9</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 80%; margin-right: 10%; margin-left: 10%;">

		<tbody><tr>
			<td style="width: 3%;">(1)</td>
			<td style="width: 97%; text-align: justify;">Burn Rate is calculated as: (shares subject to stock options granted + shares subject to time-based full value awards granted + shares subject to performance-based full value awards vested or earned)/weighted average common shares outstanding.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The A&amp;R Plan includes provisions that are designed to protect our stockholders&#8217; interests and to reflect corporate governance best practices, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>No discounted stock options or stock appreciation rights</i>. All stock options and stock appreciation rights granted under the A&amp;R Plan must have an exercise price equal to or greater than the fair market value of our common stock on the date the stock option or stock appreciation right is granted.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>No liberal change in control definition</i>. The change in control definition in the A&amp;R Plan is not a &#8220;liberal&#8221;&#160;definition. A change in control transaction must actually occur in order for the change in control provisions in the A&amp;R Plan to be triggered.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Limit on non-employee director compensation</i>. The aggregate value of all compensation granted or paid, as applicable, to any individual for service as a non-employee director with respect to any period commencing on the date of the annual meeting of stockholders for a particular year and ending on the day immediately prior to the date of the annual meeting of stockholders for the next subsequent year, including awards granted and cash fees paid by the Company to such non-employee director, will generally not exceed $500,000&#160;in total value calculating the value of any equity awards based on the grant date fair value of such equity awards for financial reporting purposes.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Clawback policy</i>. All awards granted to our executive officers under the A&amp;R Plan are subject to our clawback policy.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Vote Required</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">At the Annual Meeting, the stockholders are being asked to approve the A&amp;R Plan. The affirmative vote of the majority of shares present or represented by proxy at the meeting and entitled to vote is required to approve the A&amp;R Plan.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>THE BOARD OF DIRECTORS RECOMMENDS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>A VOTE IN FAVOR OF PROPOSAL 4</b>.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt 0pt 6pt;"><b>Description of the A&amp;R Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The material features of the A&amp;R Plan are described below. The following description of the A&amp;R Plan is a summary only and is qualified in its entirety by reference to the complete text of the A&amp;R Plan. Stockholders are urged to read the actual text of the A&amp;R Plan in its entirety, which is attached to this proxy statement as <b><span style="text-decoration: underline; ">Annex A</span></b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt 0pt 6pt;"><b>Purpose</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">The A&amp;R Plan is designed to secure and retain the services of our employees, non-employee directors and consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and our affiliates, and to provide a means by which such persons may be given an opportunity to benefit from increases in the value of our common stock. The A&amp;R Plan is also designed to align employees&#8217; interests with stockholder interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">If the A&amp;R Plan is not approved by our stockholders, the A&amp;R Plan will not become effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><b>Types of Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The terms of the A&amp;R Plan provide for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards, and other awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"><b>Shares Available for Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Subject to adjustment for certain changes in our capitalization, the aggregate number of shares of our common stock that may be issued under the A&amp;R Plan will not exceed the sum of (i)&#160;14,985,108 shares of common stock (which includes shares issued or transferred pursuant to awards under the Existing Plan plus an additional 6,000,000 shares), and (ii)&#160;any shares subject to outstanding stock awards granted under the Existing Plan that, from and after the effective date of the A&amp;R Plan, (A)&#160;expire or terminate for any reason prior to exercise or settlement, (B)&#160;are forfeited, cancelled or otherwise returned to us because of the failure to meet a contingency or condition required for the vesting of such shares, or (C)&#160;are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock award. In addition, the share reserve will be automatically increased each year beginning on January 1, 2025, and ending on (and including) January 1, 2034, by the lesser of (a) four percent of the number of shares of our capital stock outstanding on December 31 of the preceding calendar year and (b) such lesser number determined by the Board. As of March 22, 2024, there were 7,819,683 shares subject to outstanding awards under the Existing Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The following actions will not result in an issuance of shares of our common stock under the A&amp;R Plan and accordingly will not reduce the number of shares of our common stock available for issuance under the A&amp;R Plan: (i) the expiration or termination of any portion of an award granted under the A&amp;R Plan without the shares covered by such portion of the award having been issued; or (ii) the settlement of any portion of an award granted under the A&amp;R Plan in cash.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">If any shares of our common stock issued pursuant to an award granted under the A&amp;R Plan are forfeited back to or repurchased by us because of the failure to meet a contingency or condition required for the vesting of such shares, then such shares will become available again for issuance under the A&amp;R Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Eligibility</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">All of our (including our affiliates&#8217;) employees, non-employee directors and consultants are eligible to participate in the A&amp;R Plan and may receive all types of awards other than incentive stock options. Incentive stock options may be granted under the A&amp;R Plan only to our (including our affiliates&#8217;) employees.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">As of March 22, 2024, we (including our affiliates) had approximately 80 employees and&#160;7&#160;non-employee directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Administration</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The A&amp;R Plan will be administered by our Board, which may in turn delegate some or all of the administration of the A&amp;R Plan to a committee or committees composed of members of the Board. Our Board has delegated concurrent authority to administer the A&amp;R Plan to our Compensation Committee, but may, at any time, revest in itself some or all of the power delegated to our Compensation Committee. Our Board and Compensation Committee are each considered to be a Plan Administrator for purpose of this Proposal 4.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Subject to the terms of the A&amp;R Plan, the Plan Administrator may determine the recipients, the types of awards to be granted, the number of shares of our common stock subject to or the cash value of awards, and the terms and conditions of awards granted under the A&amp;R Plan, including the period of their exercisability and vesting. Among other authority, the Plan Administrator also has the authority to amend outstanding awards, provided that no such amendment materially impairs the rights of the holder of such stock awards, to reprice options or to exchange underwater options for cash or other stock awards, and to provide for accelerated exercisability and vesting of awards. Subject to the limitations set forth below, the Plan Administrator also determines the fair market value applicable to an award and the exercise or strike price of stock options and stock appreciation rights granted under the A&amp;R Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The Plan Administrator may also delegate to one or more executive officers the authority to designate employees who are not executive officers to be recipients of certain awards and the number of shares of our common stock subject to such awards. Under any such delegation, the Plan Administrator will specify the total number of shares of our common stock that may be subject to the awards granted by such executive officer. The executive officer may not grant an award to himself or herself.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Limit on Non-Employee Director Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">As noted above, the A&amp;R Plan contains a limit on the aggregate value of all compensation granted or paid, as applicable, to any individual for service as a non-employee director with respect to any period commencing on the date of the annual meeting of stockholders for a particular year and ending on the day immediately prior to the date of the annual meeting of stockholders for the next subsequent year.&#160; Consulting fees or other compensation that may be paid to any non-employee director shall not be included in calculating such limits.&#160; Additionally, the Plan Administrator may make exceptions to this limit for individual non-employee directors in extraordinary circumstances, as the plan administrator may determine in its discretion, subject to the limitations in the A&amp;R Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Stock Options</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Stock options may be granted under the A&amp;R Plan pursuant to stock option agreements. The A&amp;R Plan permits the grant of stock options that are intended to qualify as incentive stock options, or ISOs, and nonstatutory stock options, or NSOs.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The exercise price of a stock option granted under the A&amp;R Plan may not be less than 100% of the fair market value of the common stock subject to the stock option on the date of grant (or 110%, in some cases, as described below). Stock options will vest as determined by the Plan Administrator at the rate specified in the stock option agreement. The term of stock options granted under the A&amp;R Plan may not exceed ten years from the date of grant (or five years, in some cases, as described below). Acceptable forms of consideration for the purchase of our common stock pursuant to the exercise of a stock option under the A&amp;R Plan will be determined by the Plan Administrator and may include payment: (i) by cash, check, bank draft or money order payable to us; (ii) pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board; (iii) by delivery to us of shares of our common stock (either by actual delivery or attestation); (iv) by a net exercise arrangement (for NSOs only); or (v) in other legal consideration approved by the Plan Administrator. Except as otherwise provided in a participant&#8217;s stock option agreement or other written agreement with us or one of our affiliates, if a participant&#8217;s continuous service with us or any of our affiliates:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">terminates other than for cause (as defined in the A&amp;R Plan) or due to death or disability (as defined in the A&amp;R Plan), the participant may exercise any vested stock options for up to three months following termination;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">terminates due to the participant&#8217;s disability, the participant may exercise any vested stock options for up to 12 months following termination;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">terminates due to the participant&#8217;s death (or the participant dies within a specified period following termination), the participant&#8217;s beneficiary may exercise any vested stock options for up to 18 months following the participant&#8217;s death; or</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">is terminated for cause, all stock options held by the participant will terminate upon the participant&#8217;s termination and the participant will be prohibited from exercising any stock option from and after such termination date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The post-termination exercise period applicable to a participant&#8217;s stock option may be extended under specific circumstances provided in the A&amp;R Plan, but in no event may a stock option be exercised after its original expiration date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Generally, a participant may not transfer a stock option granted under the A&amp;R Plan other than by will or the laws of descent and distribution or, subject to approval by the Plan Administrator, pursuant to a domestic relations order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Limitations on Incentive Stock Options</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In accordance with current federal tax laws, the aggregate fair market value, determined at the time of grant, of shares of our common stock with respect to ISOs that are exercisable for the first time by a participant during any calendar year under all of our stock plans may not exceed $100,000. The stock options or portions of stock options that exceed this limit or otherwise fail to qualify as ISOs are treated as NSOs. No ISO may be granted to any person who, at the time of grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power unless the following conditions are satisfied:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the exercise price of the ISO must be at least 110% of the fair market value of the common stock subject to the ISO on the date of grant; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">&#160;</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the term of the ISO must not exceed five years from the date of grant.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Subject to adjustment for certain changes in our capitalization, the aggregate maximum number of shares of our common stock that may be issued pursuant to the exercise of ISOs under the A&amp;R Plan is 19,600,000 shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Stock Appreciation Rights</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt; text-align: justify;">Stock appreciation rights may be granted under the A&amp;R Plan pursuant to stock appreciation right agreements. Each stock appreciation right is denominated in common stock share equivalents. The strike price of each stock appreciation right will be determined by the Plan Administrator but will in no event be less than 100% of the fair market value of the common stock subject to the stock appreciation right on the date of grant. The term of stock appreciation rights granted under the A&amp;R Plan may not exceed ten years from the date of grant. The Plan Administrator may also impose restrictions or conditions upon the vesting of stock appreciation rights that it deems appropriate. The appreciation distribution payable upon exercise of a stock appreciation right may be paid in shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan Administrator and set forth in the stock appreciation right agreement. Stock appreciation rights will be subject to the same conditions upon termination of continuous service and restrictions on transfer as stock options under the A&amp;R Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Restricted Stock Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Restricted stock awards may be granted under the A&amp;R Plan pursuant to restricted stock award agreements. A restricted stock award may be granted in consideration for cash, check, bank draft or money order payable to us, the participant&#8217;s services performed for us, or any other form of legal consideration acceptable to the Plan Administrator. Shares of our common stock acquired under a restricted stock award may be subject to forfeiture to or repurchase by us in accordance with a vesting schedule to be determined by the Plan Administrator. Rights to acquire shares of our common stock under a restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted stock award agreement. Upon a participant&#8217;s termination of continuous service for any reason, any shares subject to restricted stock awards held by the participant that have not vested as of such termination date may be forfeited to or repurchased by us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Restricted Stock Unit Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Restricted stock unit awards may be granted under the A&amp;R Plan pursuant to restricted stock unit award agreements. Payment of any purchase price may be made in any form of legal consideration acceptable to the Plan Administrator. A restricted stock unit award may be settled by the delivery of shares of our common stock, in cash, in a combination of cash and stock, or in any other form of consideration determined by the Plan Administrator and set forth in the restricted stock unit award agreement. Restricted stock unit awards may be subject to vesting in accordance with a vesting schedule to be determined by the Plan Administrator. Except as otherwise provided in a participant&#8217;s restricted stock unit award agreement or other written agreement with us, restricted stock units that have not vested will be forfeited upon the participant&#8217;s termination of continuous service for any reason.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Performance Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The A&amp;R Plan allows us to grant performance cash and performance stock awards. A performance award is an award that may vest or may be exercised, or that may become earned and paid, contingent upon the attainment of certain performance goals during a performance period. A performance award may require the completion of a specified period of continuous service. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Plan Administrator in its discretion. In addition, to the extent permitted by applicable law and the applicable award agreement, the Plan Administrator may determine that cash may be used in payment of performance awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Performance goals under the A&amp;R Plan will be based on any one or more of the following performance criteria: (i) earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii) earnings before interest, taxes, depreciation and amortization; (iv) earnings before interest, taxes, depreciation, amortization and legal settlements; (v) earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (viii) total stockholder return; (ix) return on equity or average stockholder&#8217;s equity; (x) return on assets, investment, or capital employed; (xi) stock price; (xii) margin (including gross margin); (xiii) income (before or after taxes); (xiv) operating income; (xv) operating income after taxes; (xvi) pre-tax profit; (xvii) operating cash flow; (xviii) sales or revenue targets; (xix) increases in revenue or product revenue; (xx) expenses and cost reduction goals; (xxi) improvement in or attainment of working capital levels; (xxii) economic value added (or an equivalent metric); (xxiii) market share; (xxiv) cash flow; (xxv) cash flow per share; (xxvi) share price performance; (xxvii) debt reduction; (xxviii) implementation or completion of projects or processes; (xxix) customer satisfaction; (xxx) stockholders&#8217; equity; (xxxi) capital expenditures; (xxxii) debt levels; (xxxiii) operating profit or net operating profit; (xxxiv) workforce diversity; (xxxv) growth of net income or operating income; (xxxvi) billings; (xxxvii) bookings; (xxxviii) the number of customers, including but not limited to customers users; (xxxix) employee retention; (xl) pre-clinical development related compound goals; (xli) financing; (xlii) regulatory milestones,&#160;including approval of a compound; (xliii) stockholder liquidity; (xliv) corporate governance and compliance; (xlv) product commercialization; (xlvi) intellectual property; (xlvii) personnel matters; (xlviii) progress of internal research or clinical programs; (xlix) progress of partnered programs; (l) implementation or completion of projects and processes; (li) partner satisfaction;&#160;(lii)&#160;budget management; (liii) clinical achievements; (liv) completing phases of a clinical study (including the treatment phase); (lv) announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or generally; (lvi) timely completion of clinical trials; (lvii) submission of INDs and NDAs and other regulatory achievements; (lviii) partner or collaborator achievements; (lix) internal controls, including those related to the Sarbanes-Oxley Act of 2002; (lx) research progress, including the development of programs; (lxi) investor relations, analysts and communication; (lxii) manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities); (lxiii) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; (lxiv) establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#8217;s products (including with group purchasing organizations, distributors and other vendors); (lxv) supply chain achievements (including establishing relationships with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#8217;s products); (lxvi) co-development, co-marketing, profit sharing, joint venture or other similar arrangements; and (lxvii) and other measures of performance selected by the Plan Administrator.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Performance goals may be based on a Company-wide basis, with respect to one or more business units, divisions, affiliates or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Plan Administrator (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of any &#8220;extraordinary items&#8221; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles, (12) to exclude the effects of the timing of acceptance for review and/or approval of submissions to the Food and Drug Administration or any other regulatory body and (13) to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In addition, the Plan Administrator retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of performance goals and to define the manner of calculating the performance criteria it selects to use for such performance period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the stock award agreement or the written terms of a performance cash award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">In addition, the Plan Administrator retains the discretion to define the manner of calculating the performance criteria it selects to use for a performance period and to reduce or eliminate the compensation or economic benefit due upon the attainment of any performance goal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Other Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Other forms of awards valued in whole or in part by reference to, or otherwise based on, our common stock may be granted either alone or in addition to other awards under the A&amp;R Plan. Subject to the terms of the A&amp;R Plan, the Plan Administrator will have sole and complete authority to determine the persons to whom and the time or times at which such other awards will be granted, the number of shares of our common stock to be granted and all other terms and conditions of such other awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Clawback Policy</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Awards granted to our executive officers under the A&amp;R Plan will be subject to recoupment in accordance with any clawback policy that we adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or that is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Changes to Capital Structure</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">In the event of certain capitalization adjustments, the Plan Administrator will appropriately and proportionately adjust: (i) the class(es) and maximum number of shares of our common stock subject to the A&amp;R Plan; (ii) the class(es) and maximum number of shares of our common stock that may be issued pursuant to the exercise of ISOs; (iii) the class(es) and maximum number of securities that may be awarded to any person subject to the non-employee director compensation limitation; and (iv) the class(es) and number of shares of our common stock and the exercise, strike or purchase price per share of our common stock subject to outstanding awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Corporate Transaction and Change in Control </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The following applies to each outstanding award under the A&amp;R Plan in the event of a corporate transaction (as defined in the A&amp;R Plan and described below) or a change in control (as defined in the A&amp;R Plan and described below), unless provided otherwise in the applicable award agreement, in any other written agreement between a participant and the Company or an affiliate, or in any director compensation policy of the Company. For purposes of this Proposal 4, the term &#8220;<b><i>Transaction</i></b>&#8221; will mean such corporate transaction or change in control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">In the event of a Transaction, the Plan Administrator may</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">arrange for the assumption, continuation or substitution of a stock award by a successor corporation;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 98%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">arrange for the assignment of any reacquisition or repurchase rights held by us to a successor corporation;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 98%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">accelerate the vesting of the stock award and provide for its termination prior to the effective time of the corporate transaction;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 98%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">arrange for the lapse, in whole or in part, of any reacquisition or repurchase right held by us; or</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 98%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 1%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">cancel the stock award prior to the transaction in exchange for a cash payment, which may be reduced by the exercise price payable in connection with the stock award.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The administrator is not obligated to treat all stock awards or portions of stock awards, even those that are of the same type, in the same manner. The administrator may take different actions with respect to the vested and unvested portions of a stock award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Under the A&amp;R Plan, a &#8220;corporate transaction&#8221; generally means the consummation of any one or more of the following events: (1) a sale or other disposition of all or substantially all of our assets; (2) a sale or other disposition of at least 50% of our outstanding securities; (3) a merger, consolidation or similar transaction where we do not survive the transaction; or (4) a merger, consolidation or similar transaction where we do survive the transaction but the shares of our common stock outstanding immediately before such transaction are converted or exchanged into other property by virtue of the transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Under the A&amp;R Plan, a &#8220;change in control&#8221; generally means the occurrence of any one or more of the following events: (1) the acquisition by any person, entity or group of our securities representing more than 50% of the combined voting power of our then outstanding securities, other than by virtue of a merger, consolidation, or similar transaction; (2) a consummated merger, consolidation or similar transaction in which our stockholders immediately before such transaction do not own, directly or indirectly, more than 50% of the combined voting power of the surviving entity (or the parent of the surviving entity) in substantially the same proportions as their ownership immediately prior to such transaction; (3) a consummated sale, lease, exclusive license or other disposition of all or substantially all of our assets, other than to an entity, more than 50% of the combined voting power of which is owned by our stockholders in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such transaction; or (4) when a majority of our board of directors becomes comprised of individuals who were not serving on our board of directors on the date the A&amp;R Plan was adopted by our board of directors (the &#8220;incumbent board of directors&#8221;), or whose nomination, appointment, or election was not approved by a majority of the incumbent board of directors still in office.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Plan Amendments and Termination</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The Plan Administrator will have the authority to amend or terminate the A&amp;R Plan at any time. However, except as otherwise provided in the A&amp;R Plan, no amendment or termination of the A&amp;R Plan may materially impair a participant&#8217;s rights under his or her outstanding awards without the participant&#8217;s consent. We will obtain stockholder approval of any amendment to the A&amp;R Plan as required by applicable law and listing requirements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>U.S. Federal Income Tax Consequences</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The following is a summary of the principal United States federal income tax consequences to participants and us with respect to participation in the A&amp;R Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state or foreign jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each participant should consult the participant&#8217;s tax adviser regarding the federal, state, local and other tax consequences of the grant or exercise of an award or the disposition of stock acquired the A&amp;R Plan. The A&amp;R Plan is not qualified under the provisions of Section 401(a) of the Code and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness and the satisfaction of our tax reporting obligations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">27</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Nonstatutory Stock Options</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Generally, there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those shares will be equal to his or her fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain holding period for those shares will begin on that date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Incentive Stock Options</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The A&amp;R Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in Section 422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date the stock option was granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax basis in that share will be long-term capital gain or loss.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">If, however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price. However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option is exercised.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">We are not allowed a tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy our reporting requirements with respect to that amount.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Restricted Stock Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Generally, the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days following his or her receipt of the restricted stock award, to recognize ordinary income, as of the date the recipient receives the restricted stock award, equal to the excess, if any, of the fair market value of the stock on the date the restricted stock award is granted over any amount paid by the recipient for the stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Restricted Stock Unit Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Generally, the recipient of a restricted stock unit award structured to comply with the requirements of Section 409A of the Code or an exception to Section 409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. To comply with the requirements of Section 409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another date, unless the restricted stock unit award otherwise complies with or qualifies for an exception to the requirements of Section 409A of the Code (including delivery upon achievement of a performance goal), in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any taxes owed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">The recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock unit award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">28</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Stock Appreciation Rights</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Generally, if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date, the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation right.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Section 162(m) Limitations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In general, under Section 162(m) of the Code, income tax deductions of publicly traded corporations may be limited to the extent total compensation for certain current or former executive officers exceeds $1 million in any one taxable year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>New Plan Benefits </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Other than awards that will be made automatically under our non-employee director compensation program which, as of the date of this proxy statement, consists of an annual award of a stock option for a total of 39,200 shares of common stock (or, for the non-employee chairman, 49,200 shares) for each of our non-employee directors ("Annual Grant") and an initial award of a stock option upon each non-employee director's commencement of service on the Board covering 1.5 times the number of shares covered by the Annual Grant, awards under the A&amp;R Plan are subject to the discretion of the plan administrator and no determinations have been made by the plan administrator as to any future awards that may be granted pursuant to the A&amp;R Plan. Therefore, it is not possible to determine the benefits that will be received in the future by participants in the A&amp;R Plan. However, our directors and executive officers are eligible to receive awards under the A&amp;R Plan and could benefit from the grant of equity-based awards under the A&amp;R Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt; text-indent: 9pt;"><b>Additional Prior Award Information</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The following table sets forth, with respect to the individuals and groups identified therein, information regarding stock options, restricted stock awards and performance share awards that have been granted to such individuals and groups under the Existing Plan through March 22, 2024:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -1pt; text-align: justify; text-indent: 9pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of Stock Options (1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of Restricted Stock Unit Awards (1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="background-color:#ffffff;">Dollar Value of Restricted Stock Unit Awards (1)</span></b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Named Executive Officers</i>:</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Neil F. McFarlane, <i>President, Chief Executive Officer and Director</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">700,000</p>
			</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">$4,032,000</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Travis Mickle, Ph.D., <i>Former President, Chief Executive Officer and Director</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">636,898</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">547,945</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$3,156,163</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Richard W. Pascoe, <i>Former Chief Executive Officer and Director</i></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">948,848</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Christal M.M. Mickle, <i>Former Interim Chief Executive Officer</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">414,787</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">77,000</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$443,520</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">R. LaDuane Clifton, CPA, <i>Chief Financial Officer, Secretary and Treasurer</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">665,466</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">130,000</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$748,800</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Josh Schafer, <i>Chief Commercial Officer and EVP, Business Development</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">106,000</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$610,560</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>All Current Executive Officers as a Group (6&#160;persons)</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,890,579</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,092,000</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$6,289,920</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>All Current Non-Employee Directors as a Group (7</i>&#160;<i>persons)</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">439,500</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">&#8212;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">&#8212;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Director Nominees:</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Thomas D. Anderson</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">58,800</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">&#8212;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Neil F. McFarlane</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">700,000</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$4,032,000</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Alvin Shih, M.D.</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">58,800</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">&#8212;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Each associate of any such directors, executive officers or nominees</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Each other person who received or is to receive 5 percent of such options, warrants or rights</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>All Current Non-Executive Officer Employees as a group (75</i>&#160;<i>persons)</i></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3,420,116</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">527,158</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:auto;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: auto; text-align: center;">$3,036,430</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 98%; margin-right: 1%; margin-left: 1%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="width: 3%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0px; vertical-align: top;">(1)</td>
			<td style="width: 97%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: justify;">Share numbers shown do not take into account shares subject to awards that that have been cancelled, forfeited or expired unexercised. The closing price per share of our common stock on March 22, 2024,&#160;was $5.76.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt 0pt -1pt;"><b>Interest of Certain Persons in the Second A&amp;R Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Stockholders should understand that our executive officers and non-employee directors may be considered to have an interest in the approval of the A&amp;R Plan because they may in the future receive awards under the A&amp;R Plan. Nevertheless, the Board believes that it is important to provide incentives and rewards for superior performance and the retention of experienced directors and officers by adopting the A&amp;R Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>The Board of Directors Recommends</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>A Vote in Favor of Proposal 4.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="execofficers" title="execofficers" href="#"></a>EXECUTIVE OFFICERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table sets forth information concerning our executive officers as of April 3, 2024:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Position</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Neil F. McFarlane</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">51</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President, Chief Executive Officer and Director</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 45%;">R. LaDuane Clifton, MBA, CPA</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%; text-align: center;">51</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 48%;">Chief Financial Officer, Secretary and Treasurer</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 45%;">Sven Guenther, Ph.D.</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%; text-align: center;">52</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 48%;">Chief Scientific Officer</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Christal M.M. Mickle, M.A.</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">45</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Development Officer; Co-Founder</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 45%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Joshua Schafer</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">53</p>
			</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Commercial Officer &amp; Executive Vice President, Business Development</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 45%;">Adrian Quartel, M.D., FFPM</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: middle; width: 5%; text-align: center;">63</td>
			<td style="vertical-align: top; width: 1%;">&#160;</td>
			<td style="vertical-align: top; width: 48%;">Chief Medical Officer</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Executive Officers</span></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Neil F. McFarlane</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Biographical information regarding Mr. McFarlane is set&#160;forth under &#8220;Nominees for Election as a Class III Director for a Three-year Term Expiring at the 2027&#160;Annual Meeting.&#8221;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt 0pt -1pt;"><b><i>R. LaDuane Clifton, MBA, CPA</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">R. LaDuane Clifton, MBA, CPA, has served as our chief financial officer&#160;since June 2015 and as our secretary and treasurer since February 2016. He is responsible for the company&#8217;s financial, operating and compliance activities. Previously, Mr. Clifton served as our vice president of finance and corporate controller from April 2015 to June 2015. Prior to joining our company, Mr. Clifton served in a variety of positions with The LGL Group, Inc., a publicly-held&#160;producer of industrial and commercial products and services, from August 2009 to February 2015, including chief financial officer, secretary and treasurer from December 2012 to February 2015, chief accounting officer and secretary from March 2010 to December 2012, and corporate controller from August 2009 to March 2010. From August 2008 to August 2009, Mr. Clifton served as the chief financial officer of a21, Inc., a publicly-held holding company with businesses in stock photography and the online retail and manufacturer of framed art, and as its corporate controller from March 2007 to August 2008. Mr. Clifton served in a variety of finance and medical cost analysis roles with Aetna, Inc., a publicly-held provider of healthcare benefits, from August 1991 to August 2004. Mr. Clifton was an auditor with KPMG, LLP from August 2004 to March 2007. Mr. Clifton received his B.B.A. and M.B.A. degrees from the University of North Florida and is a certified public accountant in the state of Florida.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt -9pt; text-indent: 9pt;"><b><i>Sven Guenther, Ph.D.</i></b></p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Sven Guenther, Ph.D. has served as our chief scientific officer since January 2023. Dr. Guenther was one of the first members of Zevra, he joined our Company as our group leader of research in 2007, and served as our executive vice president, research and development, from May 2014 to January 2023. In this role, he was a key contributor to the strategy and execution of all of Zevra&#8217;s early discovery work, as well as, the development and approval of three NDAs. As chief scientific officer, he continues to lead Zevra&#8217;s research team and play a central role in the advancement of the Company&#8217;s pipeline. Dr. Guenther previously served as a research scientist for New River Pharmaceuticals, where he was part of the development team for VYVANSE. He earned his Ph.D. from the University of Iowa and is listed as an inventor on numerous patents, as well as an author of several research papers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b style="font-size: 10pt;"><i>Christal M.M. Mickle, M.A.</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Christal M.M. Mickle, M.A. has served as our chief development officer since January 2023. Ms. Mickle, who co-founded and has held a variety of positions at Zevra, also served as interim president and chief executive officer from June 2023 to October 2023. She previously served as senior vice president, operations and product development from June 2022 to January 2023. In this role, she managed the development of each of Zevra's products through strategic collaborations across the various drug development disciplines including clinical, regulatory, nonclinical, and manufacturing, enabling efficient use of funds and the ability to meet timelines and&#160;milestones. From January 2018 through June 2022, Ms. Mickle served as Zevra's vice president, product development and operations. Before co-founding Zevra in 2006, Ms. Mickle started her career as a research associate for New River Pharmaceuticals, preparing compounds in ADHD, pain, and thyroid dysfunctions for further study. Throughout her more than 20 years in the pharmaceutical industry, Ms. Mickle has been involved in early discovery as a medicinal chemist, starting and helping build a pharmaceutical company, and interacting with the FDA. In addition, her efforts managing a team of talented scientists has led to the approval of three NDAs. Ms. Mickle received her M.A. degree in Medicinal Chemistry from the University of Virginia and her B.A. and B.S. degrees in Chemistry and Biochemistry, respectively, from Virginia Polytechnic Institute and State University. She is also listed as an inventor on several patents.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Joshua Schafer</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Joshua Schafer&#160;has served as our chief commercial officer and executive vice president, business development&#160;since January 2023. Mr. Schafer brings to Zevra over 25 years of pharmaceutical commercial, new product development and merger and acquisition (&#8220;M&amp;A&#8221;) experience. Mr. Schafer previously served as senior vice president and general manager of the Autoimmune and Rare Disease business at Mallinckrodt Pharmaceuticals from December 2020 to November 2022. Prior to that at Mallinckrodt Pharmaceuticals, he served as chief strategy and business officer from September 2019 to December 2020 and senior vice president of business development and general manager from January 2018 to September 2019. Prior to Mallinckrodt, Mr. Schafer served as vice president and oncology therapeutic area head, global marketing and strategy at Astellas Pharmaceuticals, where he was responsible for building the company's global oncology franchise, and also held senior roles at Takeda Pharmaceuticals, Accenture (formerly Anderson Consulting), G. D. Searle &amp; Co. (later acquired by Pfizer) and Cognia Corporation. During his professional career, he has successfully led over $16 billion in aggregate M&amp;A transactions. Mr. Schafer currently serves as a board member of Pharnext SA and Shuttle Pharmaceuticals. He received his B.A. in Biology and German at the University of Notre Dame, and both an M.S. in Biotechnology and an M.B.A. from Northwestern University.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt -9pt 0pt -1pt;"><b><i>Adrian Quartel, M.D., FFPM</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Adrian Quartel, M.D., FFPM, has served as our chief medical officer since January 2023, and previously served as the chief medical officer of Acer Therapeutics from February 2022 until January 2023, where he played a key role in guiding clinical development, medical affairs and regulatory compliance. Prior to that, he was the chief medical officer at Adamas Pharmaceuticals, a company focused on drug development for neurological diseases, from September 2020 until February 2022. From June 2017 until September 2020, Dr. Quartel served as the group vice president of global medical affairs at BioMarin Pharmaceuticals Inc., where he spearheaded the launch of six treatments for rare diseases or genetic disorders, including KUVAN, VIMIZIM, and BRINEURA. Before his tenure at BioMarin, Dr. Quartel oversaw clinical development and held senior medical leadership positions at Astellas Pharma, Inc. from January 2004 until September 2006, at Chiltern, a specialist contract research organization, from September 2006 to July 2007, and ICON Clinical Research from August 2001 to January 2004. In addition, Dr. Quartel worked as a clinical research fellow at UCLA Cedar Sinai and as a resident in cardio-thoracic surgery at Erasmus University Medical Center. He holds an M.D. from Erasmus University Medical School, Rotterdam, and has a postgraduate specialization in pharmaceutical medicine from the Faculty of Pharmaceutical Medicine in London. Dr. Quartel is board certified by the General Medical Council (GMC) in pharmaceutical medicine in the United Kingdom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">30</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="securityownership" title="securityownership" href="#"></a>SECURITY OWNERSHIP OF</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table sets forth the beneficial ownership of our common stock as of the Record Date for:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">each person, or group of affiliated persons, who is known by us to beneficially own more than 5% of our common stock;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">each of our named executive officers;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">each of our directors; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">all of our current executive officers and directors as a group.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The percentage ownership information shown in the table is based upon 41,850,494 shares of common stock outstanding as of the Record Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include (a) shares of common stock issuable pursuant to the exercise of stock options or warrants that are either immediately exercisable or exercisable on or before May 22, 2024, which is 60 days after the Record Date, and (b) restricted stock units vesting on or before May 22, 2024, which is 60 days after the Record Date. These shares are deemed to be outstanding and beneficially owned by the person holding those options or warrants or restricted stock units for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Except as otherwise noted below, the address for persons listed in the table is c/o Zevra Therapeutics, Inc., 1180 Celebration Boulevard, Suite 103, Celebration, FL 34747.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of Shares </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Beneficially </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Owned</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Percentage </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of Shares </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Beneficially </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Owned</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><span style="text-decoration: underline; "><b>Name of Beneficial Owner[**]</b></span></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>&#160;</b></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Principal Stockholders:</i></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Nantahala Capital Management, LLC (1)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">2,453,405</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.9%</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">BlackRock, Inc. (2)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">2,410,289</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">5.8%</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Named Executive Officers and Directors:</i></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;"><i>&#160;</i></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i>&#160;</i></td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Neil F. McFarlane</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">R. LaDuane Clifton, MBA, CPA&#160;(3)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">253,599</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Sven Guenther, Ph.D. (4)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">202,215</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Christal M.M. Mickle, M.A. (5)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">274,990</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Joshua Schafer&#160;(6)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">78,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-left: 9pt;">Adrian Quartel, M.D., FFPM</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Travis Mickle, Ph.D. (7)</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">817,212</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.9%</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Richard W. Pascoe (8)</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">29,973</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Thomas D. Anderson (9)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">29,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">John B. Bode (10)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">39,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Douglas W. Calder (11)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">19,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Wendy Dixon, Ph.D. (12)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">19,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Tamara A. Favorito (13)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">79,919</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Alvin Shih, M.D. (14)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">19,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Corey Watton (15)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">20,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">All current directors and executive officers as a group (13&#160;persons) (16)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,037,823</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">2.4%</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">* Represents beneficial ownership of less than 1%.</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">31</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[**]</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company has not included in this beneficial ownership table information regarding the holdings of Samuel J. Braun, as filed on a Schedule 13G/A filed by Samuel J. Braun with the SEC on January 12, 2022, because the Company has reason to believe that such information is not complete or accurate.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(1)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As reported on a Schedule 13G filed by Nantahala Capital Management, LLC (&#8220;Nantahala&#8221;), Wilmot B. Harkey, and Daniel Mack on February 14, 2024. Each of the reporting persons has shared voting and dispositive power over 2,453,405 shares. Nantahala may be deemed to be the beneficial owner of the 2,453,405 shares held by funds and separately managed accounts under its control, and as the managing members of Nantahala, each of Messrs. Harkey and Mack may be deemed to be a beneficial owner of those shares. The principal business address of each of the reporting persons is 130 Main St. 2<sup style="vertical-align:top;line-height:120%;">nd</sup>&#160;Floor, New Canaan, CT 06840.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(2)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As reported on a Schedule 13G filed by BlackRock, Inc. with the SEC on January 29, 2024.&#160;&#160;BlackRock, Inc. has sole voting power over 2,370,804 and sole dispositive power over 2,410,289 shares. The principal business address of BlackRock, Inc. is 50 Hudson Yards, New York, NY 10001.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 15,883 shares of common stock held directly by Mr. Clifton and (b) 237,716 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(4)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 2,740 shares of common stock held directly by Dr. Guenther and (b) 199,475 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(5)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 11,972&#160;shares of common stock held directly by Ms. Mickle, (b) 9,824 shares of common stock held by the Travis C. Mickle 2015 Dynasty Trust dated 7/21/2015 for which Ms. Mickle serves as trustee. (c) 96,153 shares of common stock held by Mickle Holdings, LLC, for which Dr. Mickle&#160;is the sole managing member, and (d) 15,242 shares of common stock held by Christal M.M. Mickle 2015 Gift Trust dated 7/21/2015, for which Dr. Mickle serves as trustee, and (e) 141,799 share of common stock underlying options&#160;that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(6)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 3,500&#160;shares of common stock held directly by Mr. Schafer and&#160;(b) 75,000&#160;shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(7)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 46,395 shares of common stock held directly by Dr. Mickle, (b) 9,824 shares of common stock held by the Travis C. Mickle 2015 Dynasty Trust dated 7/21/2015 for which Ms. Mickle serves as trustee. (c) 96,153 shares of common stock held by Mickle Holdings, LLC, for which Dr. Mickle is the sole managing member, and (d) 15,242 shares of common stock held by Christal M.M. Mickle 2015 Gift Trust dated 7/21/2015, for which Dr. Mickle serves as trustee, (e) 11,034 shares of common stock held be Mickle Investments, LLC, for which Dr. Mickle is the sole managing member,&#160;and (f) 638,564 shares of common stock underlying options&#160;that were exercisable as of April 25, 2023, the date of Dr. Mickle&#8217;s separation from the Company. Dr. Mickle was not with the Company on Record Date and the Company does not have access to current information regarding his share ownership.&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(8)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Based on last known information. Consists of 29,973 shares of common stock held by Mr. Pascoe&#160;as of June 1, 2023, the date of Mr. Pascoe&#8217;s separation from the Company. Mr. Pascoe was not with the Company on Record Date and the Company does not have access to current information regarding his share ownership.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">(9)</td>
			<td style="vertical-align: top; width: 98%;">Consists of (a) 10,000 shares of common stock held directly by Mr. Anderson and (b) 19,600 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(10)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 20,000&#160;shares of common stock held directly by Mr. Bode&#160;and (b) 19,600 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(11)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 19,600 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(12)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 19,600 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(13)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 719 shares of common stock directly held by Ms. Favorito and (b) 79,200 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">(14)</td>
			<td style="vertical-align: top; width: 98%;">Consists of 19,600 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(15)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 1,000 shares of common stock directly held by Mr. Watton and (b) 19,600 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(16)</p>
			</td>
			<td style="vertical-align: top; width: 98%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (a) 187,033 shares of common stock and (b) 850,790 shares of common stock underlying options that are exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="delisection16a" title="delisection16a" href="#"></a>DELINQUENT SECTION 16(A) REPORTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Section 16(a) of the Exchange Act requires the Company&#8217;s directors and executive officers, and persons who own more than ten percent of a registered class of the Company&#8217;s equity securities, or collectively, the Reporting Persons, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">To the Company&#8217;s knowledge, based solely on a review of the copies of such forms filed with the SEC and written representations of the Reporting Persons received by us, during the year ended December 31, 2023, all Section 16(a) filing requirements applicable to its Reporting Persons were complied with. During the year ended December 31, 2024, there was one late Form 3 for Alvin Shih, M.D., reporting no transactions, and one late Form 4 for Dr.&#160;Shih, reporting one transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="execcomp" title="execcomp" href="#"></a>EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">This section discusses the material components of the executive compensation program for our named executive officers for the year ended December 31, 2023,&#160;who are listed below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Neil F. McFarlane, our President, Chief Executive Officer and Director;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:44.5%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Travis Mickle, Ph.D., our former President, Chief Executive Officer and Director;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:44.5%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Richard W. Pascoe, our former Chief Executive Officer and Director;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:44.5%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Christal M.M. Mickle, M.A., our former Interim Chief Executive Officer, and our current Chief Development Officer;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:44.5%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">R. LaDuane Clifton, MBA, CPA, our Chief Financial Officer, Secretary and Treasurer; and</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:44.5%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:middle;width:0.9%;">&#160;</td>
			<td style="vertical-align:top;width:0.9%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;width:44.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Joshua Schafer, our Chief Commercial Officer and&#160;Executive Vice President, Business Development.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>2023 Summary Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table presents the compensation awarded to, earned by or paid to each of our named executive officers for the years ended December 31, 2023,&#160;and 2022, as applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name and Principal Position</b></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Year</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Salary<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Bonus<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Stock Awards</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)(8)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)(8)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-Equity</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Incentive Plan Compensation<br/>
			($)(9)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>All Other </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Compensation<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Neil F. McFarlane&#160;(1)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">157,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; text-align: center;">200,000</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">(6)</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">735,365</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">2,206,096</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">105,535</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">40,735</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(10)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">3,445,231</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">President, Chief Executive Officer and Director</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Travis Mickle, Ph.D. (2)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">186,520</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">2,204,788</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">354,085</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">848,045</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(11)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">3,593,438</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Former President, Chief Executive Officer and Director</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">590,186</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,515,290</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">282,680</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">12,200</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">2,400,356</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe (3)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">273,576</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">3,469,457</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">379,525</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(12)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">4,122,558</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Former Chief Executive Officer and Director</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">422,917</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">722,921</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">202,938</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">12,200</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,360,976</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Christal M.M. Mickle, M.A. (4)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">435,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,047,596</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">173,264</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">13,596</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(13)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,669,956</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Former Interim Chief Executive Officer</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">R. LaDuane Clifton, MBA, CPA</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">446,480</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,604,822</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">197,132</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">14,823</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(14)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">2,263,257</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Chief Financial Officer, Secretary and Treasurer</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">410,975</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">474,792</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">138,417</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">13,823</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,038,007</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Joshua Schafer&#160;(5)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 5%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">452,333</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">100,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(7)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,049,397</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">200,535</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">13,200</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(15)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 6%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">1,814,465</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 23%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">Chief Commercial Officer and&#160;Executive Vice President, Business Development</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 5%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 11%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Mr. McFarlane commenced employment with us on October 10, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Dr. Travis Mickle resigned from his role as the Company&#8217;s Chief Executive Officer on January 6, 2023. Dr. Travis Mickle served as the Company's President from January 6, 2023, until April 25, 2023. and was hired as a consultant effective April 25, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Mr. Pascoe served as the Company&#8217;s Chief Executive Officer from January 6, 2023, until June 1, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Ms. Christal Mickle served as the Company&#8217;s Interim Chief Executive Officer from June 1, 2023, until October 10, 2023.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">(5)</td>
			<td style="width: auto;">Mr. Schafer commenced employment with us on January 6, 2023.</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">During 2023, Mr. McFarlane received the first installment of his signing bonus to assist with his move to the vicinity of the Company&#8217;s headquarters. Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8212;Neil F. McFarlane&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">(7)</td>
			<td style="width: auto; text-align: justify;">The amount reflects a sign-on bonus paid to Mr. Schafer in connection with his commencement of employment. Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8212;Joshua Schafer&#8221;&#160;for further details.</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(8)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The amounts reflect the full grant date fair value for awards granted during 2023&#160;and 2022. The grant date fair value was computed in accordance with ASC Topic 718, Compensation&#8212;Stock Compensation. Unlike the calculations contained in our financial statements, this calculation does not give effect to any estimate of forfeitures related to service-based vesting but assumes that the executive will perform the requisite service for the award to vest in full. The assumptions we used in valuing options are described in Note K&#160;to our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. In accordance with the SEC rules, the amount reported herein for the performance-based restricted stock units (&#8220;PSUs&#8221;) granted to Dr. Travis Mickle ($2,204,788) is based upon the probable outcome of such conditions as of the grant date in accordance with ASC Topic 718. For Dr. Travis Mickle and Mr. Pascoe, the amounts reported in the Option Awards column include $354,085&#160;and $1,026,288, respectively, which represents the incremental fair value attributable to modifications made to such individual&#8217;s equity awards pursuant to their respective transition agreements. Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(9)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The amounts reflect non-equity incentive plan awards paid in 2024 and 2023 for performance during 2023 and 2022, respectively. Please refer to "Narrative to Summary Compensation Table - Short-Term Incentive Plan (Non-Equity Annual Bonus) Awards" for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(10)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The amount represents 401(k) employer matching contributions ($4,733), travel reimbursements ($14,865), gross-up tax payments ($1,137)&#160;and legal fee reimbursements incurred in connection with the negotiation of his employment agreement ($20,000). Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(11)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The amount represents 401(k) employer matching contributions ($10,000),&#160;cash severance payments ($498,740), COBRA premiums ($19,305) and consulting fees for his service as a consultant during 2023 ($320,000). Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(12)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The amount represents 401(k) employer matching contributions ($9,867), cash severance payments ($357,592) and COBRA premiums ($12,066). Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(13)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">The amount represents 401(k) employer matching contributions ($13,200), and premiums we paid for life insurance policies ($396). Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(14)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The amount represents 401(k) employer matching contributions ($13,200), premiums we paid for life insurance policies ($704) and gross-up tax payments ($919). Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(15)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">The amount represents 401(k) employer matching contributions ($13,200). Please refer to &#8220;Narrative to Summary Compensation Table&#8212;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for further details.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Narrative to 2023 Summary Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We review compensation at least annually for all employees, including our executives. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders, and a long-term commitment to the Company. We do not target a specific competitive position or a specific mix of compensation among base salary, bonus or long-term incentives. The Compensation Committee has historically determined our executives&#8217; compensation. Our Compensation Committee typically reviews and discusses management&#8217;s proposed compensation with the chief executive officer for all executives other than the chief executive officer. Based on those discussions and its discretion, our Compensation Committee, without members of management present, discusses and ultimately approves the compensation of our executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The primary elements of compensation for our named executive officers are base salary, annual cash bonuses and long-term, equity-based compensation awards. Our named executive officers also participate in employee benefit plans and programs that we offer to our other full-time employees on the same basis.&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Annual Base Salary</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Our named executive officers receive a base salary to compensate them for the satisfactory performance of duties to the Company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities. Our named executive officers&#8217; base salaries are reviewed periodically by our Compensation Committee, and adjustments may be made upon the approval of the Compensation Committee, in consultation with Mercer and management.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">In connection with Mr. Pascoe&#8217;s appointment as the Company&#8217;s Chief Executive Officer on January 6, 2023, Mr. Pascoe&#8217;s annual base salary increased to $592,000. Effective June 1, 2023, the Compensation Committee approved an increase in Ms. Christal Mickle&#8217;s base salary to $512,000 while she served as the Company&#8217;s interim President and Chief Executive Officer, which was then reduced&#160;its previous level of $392,000 upon the appointment of Mr. McFarlane in October 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Effective March&#160;1, 2024, our Compensation Committee approved an increase in the annual base salary for Mr. Clifton, Ms. Christal&#160;Mickle and Mr. Schafer to $464,000, $408,000 and $479,000, respectively. Mr. McFarlane did not receive a base salary increase in March 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Short-Term Incentive Plan (Non-Equity Annual Bonus) Awards</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">Our Board and Compensation Committee may make cash bonus and non-equity incentive plan awards in their discretion. For 2023, our named executive&#160;officers&#8217; target annual cash bonuses (expressed as a percentage of annual base salary) were as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b>&#160;<b>Target Annual Bonus </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(% of Annual Base Salary)</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Neil F. McFarlane</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">60</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Travis Mickle, Ph.D.</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">50</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">55</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Christal M.M. Mickle, M.A.</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">40</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">R. LaDuane Clifton, MBA, CPA</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">40</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Joshua Schafer</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">40</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our Compensation Committee generally determines annual bonuses for our named executive officers by multiplying (a) base salary, by (b) target cash bonus percentage, by (c) the level of achievement of corporate performance objectives. In addition, the Compensation Committee retains discretion to adjust annual bonuses as it determines to be appropriate to reflect company performance, individual performance or other factors that the committee believes to be appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Under the 2023&#160;annual bonus plan, the Board approved performance objectives based on the achievement of specified development, regulatory and financial milestones which included (i) the resubmission of the Arimoclomol&#160;New Drug Application to the FDA, (ii) receipt of topline data from the Phase 2 trial for KP1077 for the treatment of Idiopathic Hypersomnia (&#8220;IH&#8221;), (iii) IND clearance for KP1077 in narcolepsy, (iv) completion of a Board-approved value-creating rare disease pipeline expansion, (v) an increase in the number of institutional investors, and (vi) attainment of financial performance goals in accordance with the Board-approved operating plan. For each of our named executive officers who was eligible to receive an annual bonus for 2023, their annual bonus payments were linked directly to the percentage completion toward the accomplishment of these corporate objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">In February 2024, our Compensation Committee approved annual cash bonus awards to Mr. McFarlane, Mr. Clifton, Ms. Christal Mickle and Mr. Schafer of $105,535, $197,132, $173,264, and $200,535, respectively, for their services in 2023. Mr. McFarlane&#8217;s annual bonus 2023 was pro-rated in recognition of his partial year of employment. These award amounts were in recognition for Mr. McFarlane&#8217;s, Mr. Clifton&#8217;s, Ms. Christal&#160;Mickle's and Mr. Schafer's performance during the indicated year based on corporate objectives and are reflected in the &#8220;Non-Equity Incentive Plan Awards&#8221; column of the Summary Compensation Table above for 2023. Dr. Travis Mickle and Mr. Pascoe ceased to be eligible to receive an annual cash bonus for 2023 following the termination of their employment with us.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Long-Term Incentives</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our Amended and Restated 2014 Equity Incentive Plan (the &#8220;2014 Plan&#8221;) and our 2023 Employment Inducement Award Plan (the &#8220;2023 Plan&#8221;)&#160;authorize&#160;us to make grants to eligible recipients of non-qualified stock options, incentive stock options and other stock-based awards. All of our awards granted in 2023 under these plans&#160;were in the form of stock options and restricted stock unit awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We typically grant stock options at the start of employment to each executive and our other employees. Additionally, the Compensation Committee may grant additional equity in&#160;its discretion to provide additional targeted grants in appropriate circumstances, such as in connection with an employee taking on a new role at the Company. Typically, our stock options vest in equal annual installments over a period of four years, subject to continued service. However, our Compensation Committee may, from time to time, construct alternate vesting schedules as it determines are appropriate to motivate particular employees. Additionally, stock options granted to our employees may be subject to accelerated vesting in certain circumstances, as described in the section titled &#8220;&#8211;&#8211;Employment Arrangements and Potential Payments upon Termination of Employment.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">For employees who are not officers of the Company, we generally award stock options on the date the single-person non-officer stock award subcommittee of the Compensation Committee approves the grant. In 2015, the Compensation Committee formed a single-person non-officer stock award committee, currently composed of our chief executive officer, to which it delegated authority to grant, without any further action required by the Compensation Committee, stock awards to employees who are not officers of the Company, provided that such grants are made in accordance with guidelines established by the Compensation Committee. If employees are officers of the Company we award stock options on the date the Compensation Committee approves the grant. We set the option exercise price as the last reported sale price of our common stock on the Nasdaq Stock Market on the date of grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We awarded stock options to our named executive officers during 2023&#160;in the following amounts and with the vesting schedules indicated below. These options were granted&#160;with exercise prices equal to the fair market of our common stock on the date of grant, as determined by our Compensation Committee</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-width: 1px; border-style: solid; border-color: black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align: middle; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of Shares Subject to </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Options Granted</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Neil F. McFarlane</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">600,000 (1)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Travis Mickle, Ph.D.</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#8212;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Richard W. Pascoe</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">700,000 (1)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Christal M.M. Mickle, M.A.</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">300,000 (1)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-left: 1px solid black; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">R. LaDuane Clifton, MBA, CPA</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">459,726 (1)</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-left: 1px solid black; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Joshua Schafer</p>
			</td>
			<td style="vertical-align: top; width: 50%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">300,000 (1)</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 80%; margin-right: 10%; margin-left: 10%;">

		<tbody><tr>
			<td style="width: 3%; padding: 0px; vertical-align: top;">(1)</td>
			<td style="width: 97%; text-align: justify;">The option award vests in equal annual installments over a period of four years, subject to continued service.&#160; Additionally, the option award will vest in full and become immediately exercisable upon a change of control of the Company or if the executive is terminated without cause or resigns for good reason (each as defined in the executive&#8217;s employment agreement, discussed under the section entitled &#8220;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">In addition to the stock option grants described above, in 2023, we granted 547,945 PSUs to Dr. Travis Mickle under the 2014 Plan and 200,000 time-based restricted stock units (&#8220;RSUs&#8221;) to Mr. McFarlane under the 2023 Plan. The PSUs granted to Dr. Travis Mickle&#160;vest in full upon the Company&#8217;s achievement of a clinical and development milestone prior to December 31, 2024, subject to forfeiture upon certain disqualifying events. The RSUs granted to Mr. McFarlane vest in four equal annual installments, beginning on the first anniversary of Mr. McFarlane&#8217;s start date, subject to his continuous service to Company through each such vesting date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Other Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The amounts shown in the &#8220;All Other Compensation&#8221; column in the Summary Compensation Table consist of contributions to the 401(k) plan, tax gross-up payments associated with travel reimbursements that are generally available to all employees and premiums we paid for life insurance policies. We sponsor a 401(k) defined contribution plan in which our named executive officers may participate, subject to limits imposed by the Code, to the same extent as all of our other full-time employees. During 2023, we matched 100% of each eligible employee&#8217;s contributions up to 4% of total eligible compensation. Employees&#8217; pre-tax contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions. Employees are immediately and fully vested in their contributions, and our matching contribution is also immediately and fully vested when made. The 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. Additionally, our named executive officers are eligible to participate in certain of our employee benefit plans and programs, including medical and dental benefits, to the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Employment Arrangements and Potential Payments upon Termination of Employment</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Neil F. McFarlane</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">In October 2023, we entered into an employment agreement with Mr. McFarlane under which he serves as our President and Chief Executive Officer. Pursuant to the employment agreement, Mr. McFarlane is entitled to (i) an initial annual base salary of $700,000, (ii) an annual performance-based target bonus of 60% of his annual base salary, (iii) an initial award of an option to purchase 600,000 shares of the Company&#8217;s common stock and (iv) an initial award of RSUs covering 200,000 shares of the Company's common stock. The option and RSUs were granted to Mr. McFarlane under the 2023 Plan. In addition, Mr. McFarlane was entitled to receive reimbursement for commuting expenses (together with a tax gross-up related thereto), and a cash bonus of up to $350,000 to assist with his move to the Company&#8217;s headquarters (the &#8220;Relocation Bonus&#8221;), payable in two installments. The first installment of the Relocation Bonus was $200,000 and was paid shortly after the commencement of his employment.&#160; The second installment of the Relocation Bonus, which is $150,000, is payable upon his move to within fifty (50) miles of the Company&#8217;s headquarters prior to the first anniversary of the commencement of his employment, which is October 10, 2024. The Relocation Bonus is subject to repayment if Mr. McFarlane resigns for any reason (other than for &#8220;good reason,&#8221; as defined in Mr. McFarlane&#8217;s employment agreement) or is terminated for &#8220;cause&#8221; (as defined in Mr. McFarlane&#8217;s employment agreement), in either case, within two years after the commencement of his employment. Mr. McFarlane was also entitled to reimbursement of legal fees of up to $20,000 in connection with the negotiation of his employment agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Upon a termination of Mr. McFarlane&#8217;s employment&#160;without cause by the Company or resignation for good reason, Mr. McFarlane is entitled to receive (a) an amount of cash equal to 1.0 times annual base salary, (b) a pro-rated target annual bonus for the year in which termination occurs, (c) twelve months of Company paid COBRA continuation coverage, and (d) full vesting of his outstanding and unvested equity awards. However, if any such termination occurs within one month prior to or six months after a change in control, he will instead receive (a) an amount of cash equal to 1.5 times annual base salary, (b) a target annual bonus for the year in which termination occurs, (c) eighteen months of Company paid COBRA continuation coverage, and (d) full vesting of his outstanding and unvested equity awards. Upon Mr. McFarlane&#8217;s termination due to death or&#160;disability, Mr. McFarlane will receive a pro-rated target annual bonus. Mr. McFarlane is also subject to 12-month post-termination non-competition and non-solicitation restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Travis Mickle, Ph.D.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">In connection with Dr. Travis Mickle&#8217;s resignation as the Company&#8217;s Chief Executive Officer on January 6, 2023, the Company entered into a transition agreement (the &#8220;Mickle Transition Agreement&#8221;) and a consulting agreement (the &#8220;Consulting Agreement&#8221;) with Dr. Travis Mickle.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Pursuant to the terms of the Mickle Transition Agreement, in exchange for his execution of a release of claims in the Company&#8217;s favor, Dr. Travis Mickle became entitled to receive severance payments and benefits consisting of (i) continued payment of his base salary for 18 months following the date on which Dr. Travis Mickle&#8217;s employment with the Company ended, which was A<span style="background-color:#ffffff;">pril 25, 2023 </span>(the &#8220;Mickle Separation Date&#8221;), (ii) up to 18 months of continued medical, dental and vision coverage pursuant to COBRA and (iii) a one-time, lump sum bonus payment equal to a pro rata amount of his annual performance-based target bonus for 2023. In addition, immediately prior to the Mickle Separation Date, all outstanding options to purchase the Company&#8217;s common stock held by Dr. Travis Mickle vested in full, and such accelerated vested options may be exercised through the later of (i) the 18-month anniversary of the date of the Mickle Transition Agreement and (ii) the date of the termination of the Consulting Agreement.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Pursuant to the terms of the Consulting Agreement, Dr. Travis Mickle agreed to provide consulting services until April 25, 2024. In exchange for such services, Dr. Travis Mickle receives consulting fees of $40,000 per month. In addition, Dr. Travis Mickle was granted 547,945 PSUs under the 2014 Plan, which will vest in full upon the timely achievement of a clinical and development milestone, subject to forfeiture upon certain disqualifying events.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Richard W. Pascoe</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In connection with Mr. Pascoe&#8217;s appointment as the Company&#8217;s Chief Executive Officer on January 6, 2023, the Company and Mr. Pascoe entered into an amendment to his employment agreement, dated November 5, 2021 (the &#8220;Pascoe Amendment&#8221;). Pursuant to the Pascoe Amendment, (i) Mr. Pascoe&#8217;s annual base salary was increased to $592,000, (ii) his annual performance-based target bonus was increased to 55% of his annual base salary, and (iii) he became entitled to receive an option under the 2014 Plan to purchase 700,000 shares of the Company&#8217;s common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Upon Mr. Pascoe&#8217;s resignation as the Company&#8217;s Chief Executive Officer on June 1, 2023, the Company entered into a transition agreement with Mr. Pascoe (the &#8220;Pascoe Transition Agreement&#8221;). Mr. Pascoe continued to earn his Chief Executive Officer base salary and participate in the Company&#8217;s benefit plans. Pursuant to the terms of the Pascoe Transition Agreement, following his execution of a release of claims in the Company&#8217;s favor, Mr. Pascoe became entitled to receive severance payments and benefits consisting of (i) continued payment of his base salary for 12 months following the date on which Mr. Pascoe&#8217;s employment with the Company ended, which was June 1, 2023&#160;(the &#8220;Pascoe Separation Date&#8221;), (ii) up to 12 months of continued medical, dental and vision coverage pursuant to COBRA, (iii) an amount equal to Mr. Pascoe&#8217;s target annual bonus, pro-rated through the Pascoe Separation Date and (iv) accelerated vesting of his outstanding equity awards. In addition, the exercise period of vested options to purchase the Company&#8217;s common stock held by Mr. Pascoe were extended through the nine-month anniversary of the Pascoe Separation Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Christal M.M. Mickle, M.A.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In 2014, we entered into an employment agreement with Ms. Christal Mickle under which she serves as our Chief Development Officer (as amended, the &#8220;Mickle Agreement&#8221;). Pursuant to the Mickle Agreement, Ms. Christal Mickle is entitled to (i) an annual base salary and (ii) an annual performance-based bonus opportunity. Ms. Christal Mickle is also subject to 12-month post-termination non-competition and non-solicitation restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In the event that we terminate Ms. Christal Mickle without &#8220;cause&#8221; or she resigns for &#8220;good reason&#8221; (in each case, as defined in the Mickle Agreement), Ms. Christal Mickle will be entitled to receive (a) an amount equal to 12 months of her annual base salary, less applicable deductions, payable in accordance with our normal payroll schedule, (b) a pro-rated target annual bonus for the year in which termination occurs, (c) twelve months of Company paid COBRA continuation coverage, and (d) full vesting of her outstanding and unvested equity awards, except that if such termination occurs within 60 days before, upon or within one year following a sale that constitutes a &#8220;change in control event&#8221; as defined in Section 409A of the Code then in lieu of the payment described in clause (a), Ms. Christal Mickle will be entitled to a lump sum payment equal to her annual base salary. In the event that we terminate Ms. Christal Mickle with cause, Ms. Christal Mickle resigns without good reason, or the employment is terminated due to mutual agreement, death or disability, then Ms. Christal Mickle will not be entitled to receive severance benefits. Additionally, under the terms of the Mickle Agreement, if we undergo a change of control, all then unvested and outstanding equity awards shall become fully vested and immediately exercisable immediately prior to such change in control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In connection with Ms. Christal Mickle&#8217;s appointment as interim President and Chief Executive Officer on June 1, 2023, Zevra and Ms. Christal Mickle entered into a letter agreement pursuant to which she served as the Company&#8217;s interim Chief Executive Officer and President until a new Chief Executive Officer of the Company was appointed (which was October 10, 2023). During this transition period, she was paid at an annual rate of $512,000 while she served as interim President and Chief Executive Officer. Following the expiration of this transition period, the terms of Ms. Christal Mickle&#8217;s employment reverted to those terms as in effect immediately prior to her appointment as our interim President and Chief Executive Officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>R. LaDuane Clifton, MBA, CPA</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In 2015, we entered into an amended and restated employment agreement with Mr. Clifton under which he serves as our Chief Financial Officer (as amended, the &#8220;Clifton Agreement&#8221;). Pursuant to the Clifton Agreement, Mr. Clifton is entitled to (i) an annual base salary and (ii) an annual performance-based bonus opportunity. Mr. Clifton is also subject to 12-month post-termination non-competition and non-solicitation restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In the event that we terminate Mr. Clifton without &#8220;cause&#8221; or he resigns for &#8220;good reason&#8221; (in each case, as defined in the Clifton Agreement), Mr. Clifton will be entitled to receive (a) an amount equal to 12 months of his annual base salary, less applicable deductions, payable in accordance with our normal payroll schedule, (b) a pro-rated target annual bonus for the year in which termination occurs, (c) 12 months of Company paid COBRA continuation coverage and (d) full vesting of his outstanding equity awards, except that if such termination occurs upon or within one year following a sale that constitutes a &#8220;change in control event&#8221; as defined in Section 409A of the Code then in lieu of the payment described in clause (a) Mr. Clifton will be entitled to a lump sum payment equal to his annual base salary on the first regularly scheduled pay day immediately following the effective date of his termination. In the event that we terminate Mr. Clifton with cause, Mr. Clifton resigns without good reason, or the employment is terminated due to mutual agreement, death or disability, then Mr. Clifton will not be entitled to receive severance benefits. Under the terms of the Clifton Agreement, if we undergo a change of control, all then unvested and outstanding equity awards shall become fully vested and immediately exercisable immediately prior to such change in control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Joshua Schafer</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">In January 2023, we entered into an employment agreement with Mr. Schafer under which he serves as our Chief Commercial Officer and Executive Vice President of Business Development (the &#8220;Schafer Agreement&#8221;). Pursuant to the Schafer Agreement, Mr. Schafer is entitled to (i) an initial annual base salary of $460,000, (ii) an annual performance-based target bonus of 40% of his annual base salary and (iii) an initial award of an option to purchase 300,000 shares of the Company&#8217;s common stock. In addition, Mr. Schafer was entitled to receive a cash signing bonus of $100,000 in connection with his commencement of employment (the &#8220;Signing Bonus&#8221;). The Signing Bonus was subject to repayment if Mr. Schafer resigned for any reason (other than for &#8220;good reason,&#8221; as defined in the Schafer Agreement) or was terminated for &#8220;cause&#8221; (as defined in the Schafer Agreement), in either case, within six months after the commencement of his employment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Upon a termination of Mr. Schafer&#8217;s employment without cause by the Company or resignation for good reason, Mr. Schafer is entitled to receive (a) an amount equal to 12 months of his annual base salary, less applicable deductions, payable in accordance with our normal payroll schedule, (b) a pro-rated target annual bonus for the year in which termination occurs, (c) 12 months of Company paid COBRA continuation coverage, and (d) full vesting of his outstanding and unvested equity awards, except that if such termination occurs within one year following a sale that constitutes a &#8220;change in control event&#8221; as defined in Section 409A of the Code, then in lieu of the payment described in clause (a), Mr. Schafer will be entitled to a lump sum payment equal to 1.0 times his annual base salary. Upon Mr. Schafer&#8217;s termination due to death or disability, Mr. Schafer will receive a pro-rated target annual bonus. Mr. Schafer is also subject to 12-month post-termination non-competition and non-solicitation restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Outstanding Equity Awards at End of 2023</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table provides information about outstanding stock options held by each of our named executive officers at December 31, 2023. All of these options were granted under our 2007 stock incentive plan (the &#8220;2007 Plan&#8221;),&#160;our 2014 Plan, or the 2023 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 6%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 31%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option Awards (1)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%; border-bottom: 1px solid black;">&#160;</td>
			<td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 11%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Stock Awards<sup style="vertical-align:top;line-height:120%;">1</sup></b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"><b>&#160;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 7%;"><b>&#160;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"><b>&#160;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 7%;"><b>&#160;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"><b>&#160;</b></td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Grant Date</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Underlying</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Unexercised</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Options (#) </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercisable</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Underlying </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Unexercised </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Options (#) </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Unexercisable</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Price<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Expiration </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Shares or Units </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>of Stock That </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Have Not Vested</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(#)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Market Value of</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Shares or Units of </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Stock That Have</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Not Vested</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)(2)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Equity incentive plan awards: number of unearned shares, units or other rights that have not vested (#)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Equity incentive plan awards: market or payout value of unearned shares, units or other rights that have not vested ($) (2)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Neil F. McFarlane</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10/10/2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">600,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.75</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10/09/2033</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10/10/2023</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">200,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(4)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,310,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Travis Mickle, Ph. D. (5)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">07/30/2014</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,666</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">93.60</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">07/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">09/04/2015</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13,750</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">327.20</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">09/03/2025</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/11/2016</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9,375</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">201.92</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/10/2026</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/27/2017</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14,062</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">56.80</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/26/2027</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/25/2018</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">14,062</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">88.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/24/2028</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/06/2019</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">26,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">42.56</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/05/2029</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/25/2019</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8.26</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/24/2029</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/05/2020</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">26,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.98</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/04/2030</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">08/20/2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">263,743</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.06</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">08/19/2031</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/01/2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">267,156</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7.17</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/31/2032</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/06/2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%; text-align: right;">&#8212;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%; text-align: right;">&#8212;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">547,945</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(6)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,589,040</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe (7)</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">08/25/2015</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">625</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">304.32</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">05/24/2016</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">625</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">96.80</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">05/23/2017</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">625</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">63.20</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">05/22/2018</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">937</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">97.60</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">04/24/2019</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,875</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25.92</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">06/19/2020</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,875</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.34</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">06/17/2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15.47</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/10/2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">100,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.10</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/01/2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">127,286</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7.17</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/09/2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">700,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.54</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/29/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">R. LaDuane Clifton, MBA, CPA</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">04/15/2015</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,333</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">176.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">04/01/2025</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">06/25/2015</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,812</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">292.64</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">06/25/2025</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">09/04/2015</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">937</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">327.20</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">09/03/2025</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">02/11/2016</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,125</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">201.92</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">02/10/2026</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">01/27/2017</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,687</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">56.80</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">01/26/2027</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">01/25/2018</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,687</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">88.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">01/24/2028</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">02/06/2019</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">42.56</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">02/05/2029</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">11/25/2019</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8.26</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">11/24/2029</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">02/05/2020</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.98</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">02/04/2030</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">08/20/2021</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">41,211</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">41,212 (3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.06</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">08/19/2031</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">02/01/2022</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">20,871</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">62,615 (3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7.17</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">01/31/2032</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">01/09/2023</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">459,726(8)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.54</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">01/08/2023</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Christal M.M. Mickle, M.A.</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">07/09/2014</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">93.60</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">07/08/2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">09/04/2015</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,562</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">327.20</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">09/03/2025</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/11/2016</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">201.92</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/10/2026</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/07/2017</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,875</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">56.80</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/06/2027</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/25/2018</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1.875</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">88.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/24/2028</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/06/2019</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,750</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">42.56</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/05/2029</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/25/2019</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,250</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8.26</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/24/2029</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/05/2030</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3,750</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.98</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/04/2030</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">08/20/2021</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">24,191</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">24,192</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.06</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">08/19/2031</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">02/01/2022</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">12,523</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37,569</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(3)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7.17</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/31/2032</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/09/2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">300,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(8)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.54</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/08/2033</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Joshua Schafer</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 6%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/09/2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">300,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(8)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.54</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">01/08/2033</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 7%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 20px;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(1)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The option awards&#160;will vest in full and become immediately exercisable (i) in the event that the option holder is terminated by us without cause or resigns for good reason or (ii) immediately prior to any change in control of Zevra.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 20px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(2)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Market value calculated using the closing price per share of our common stock on December&#160;29, 2023 (the last trading day of 2023) of $6.55.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 20px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The shares underlying the options vest in equal annual installments over a period of four years beginning on the first anniversary of the grant date, subject to continued service.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 20px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(4)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The RSUs vest in equal annual installments over a period of four years beginning on the first anniversary of the grant date, subject to continued service. The award may be subject to accelerated vesting, as described above in the section entitled &#8220;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 20px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(5)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In connection with his transition agreement, Dr. Travis Mickle received accelerated vesting of his then outstanding equity awards. Please see the section entitled &#8220;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for additional details.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 20px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(6)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The PSUs were granted to Dr. Travis Mickle in connection with his consulting agreement and vest upon the Company&#8217;s achievement of a clinical and development milestone prior to December 31, 2024, subject to Dr. Mickle&#8217;s continued service to the Company.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 20px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(7)</p>
			</td>
			<td style="width: 1388px;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In connection with his transition agreement, Mr. Pascoe received accelerated vesting of his outstanding equity awards. Please see the section entitled &#8220;Employment Arrangements and Potential Payments upon Termination of Employment&#8221;&#160;for additional details.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 20px;">(8)</td>
			<td style="width: 1388px;">The shares underlying the option vest in equal annual installments over a period of four years beginning on January 6, 2024 through January 6, 2027, subject to continued service.</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Limitations on Liability and Indemnification Matters</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our amended and restated certificate of incorporation contains provisions that limit the liability of our current and former directors for monetary damages to the fullest extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for any breach of fiduciary duties as directors, except liability for:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt; text-align: justify;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any transaction from which the director derived an improper personal benefit.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">This limitation of liability does not apply to liabilities arising under federal securities laws and does not affect the availability of equitable remedies such as injunctive relief or rescission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Our amended and restated bylaws provide that we will indemnify our directors to the fullest extent permitted by Delaware law, subject to certain conditions. Our amended and restated bylaws also provide that, upon satisfaction of certain conditions, we are required to advance expenses incurred by a director in advance of the final disposition of any action or proceeding, and permit us, upon approval of the Board, to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her pursuant to our amended and restated bylaws. Our amended and restated bylaws also provide our Board with discretion to indemnify our officers and employees when determined appropriate by the Board.&#160;Our Board has the power to delegate the determination of whether indemnification shall be given to any such officers or other persons in the Board&#8217;s discretion. We have entered into and expect to continue to enter into agreements to indemnify our directors and executive officers. With certain exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors. We also maintain customary directors&#8217; and officers&#8217; liability insurance.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder&#8217;s investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against directors and officers as required by these indemnification provisions. At present, there is no pending litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought and, other than the securities litigation matter we previously disclosed under Part I, Item 3&#8212;Legal Proceedings in our Annual Report on Form 10-K, we are not aware of any threatened litigation that may result in claims for indemnification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Rule 10b5-1 Sales Plans</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Our directors and executive officers may from time to time adopt &#8220;Rule 10b5-1 trading arrangements&#8221; or &#8220;non-Rule 10b5-1 trading arrangements,&#8221; as each term is defined in Item 408(a) of Regulation S-K. Pursuant to such arrangements, they may contract with a broker to buy, sell, or otherwise trade in our securities, including shares our common stock, on a periodic basis. Our directors and executive officers also may buy, sell, or otherwise trade in our securities outside of a &#8220;Rule 10b5-1 trading arrangement&#8221; or a &#8220;non-Rule 10b5-1 trading arrangement,&#8221; when they are not in possession of material nonpublic information, subject to compliance with the terms of our insider trading policy.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Clawback Policy</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">In 2023, we adopted a compensation recovery, or &#8220;clawback,&#8221; policy (the &#8220;Clawback Policy&#8221;) in accordance with the Nasdaq listing standards and Exchange Act Rule 10D-1. Under the Clawback Policy, which applies to the Company&#8217;s current and former executive officers (as defined under Exchange Act Rule 10D-1), the Company is required to recoup the amount of any erroneously awarded compensation (as defined in the Clawback Policy) on a pre-tax basis within a specified lookback period in the event of any accounting Restatement (as defined in the Clawback Policy), subject to limited impracticability exceptions. The Clawback Policy is overseen and administered by the Compensation Committee. The full text of the Clawback Policy was included as Exhibit 97 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on April 1, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">41</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="ecd:PvpTableTextBlock" id="c4" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Pay Versus Performance </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In accordance with the SEC&#8217;s disclosure requirements regarding pay versus performance, or PVP, this section presents the SEC-defined &#8220;Compensation Actually Paid,&#8221; or CAP. Also required by the SEC, this section compares CAP to various measures used to gauge our performance. CAP is a supplemental measure to be viewed alongside performance measures as an addition to the philosophy and strategy of compensation-setting discussed elsewhere in the overview of the executive compensation program, not in replacement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Pay Versus Performance Table </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The following table sets forth information concerning the compensation of our named executive officers for each of the fiscal years ended December 31, 2023, 2022 and 2021, and our financial performance for each such fiscal year:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto; text-align: center;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;">
			<p style="text-indent: 0pt; margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Value of Initial Fixed $100 </b></p>

			<p style="text-indent: 0pt; margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Investment Based on:</b></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Current PEO</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Current PEO</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Travis Mickle, Ph.D.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(2)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Travis Mickle, Ph.D.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(2)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Richard W. Pascoe</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(3)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Richard W. Pascoe</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(3)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Christal M.M. Mickle</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(4)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Christal M.M. Mickle</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(4)</b></p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-PEO NEOs</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(5)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-PEO NEOs</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(5)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shareholder</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Return</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Net Income</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c6" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">3,445,231</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c7" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,975,770</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c8" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">3,593,438</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c9" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,385,998</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c10" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,122,558</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c11" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">3,308,589</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c12" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,669,956</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c13" contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,211,127</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c14" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,039,861</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c15" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,724,999</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c16" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">58.48</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">(<ix:nonFraction id="c17" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">46,049,000</ix:nonFraction>)</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c18" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c19" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c20" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,400,356</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c21" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,349,703</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c22" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c23" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c24" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c25" contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c26" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,199,492</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c27" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,106,040</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c28" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">40.98</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">(<ix:nonFraction id="c29" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">41,543,000</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2021</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c30" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c31" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c32" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,657,059</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c33" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,808,110</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c34" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c35" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c36" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;"><ix:nonFraction id="c37" contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c38" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">953,616</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c39" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">989,957</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><ix:nonFraction id="c40" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">77.77</ix:nonFraction></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">(<ix:nonFraction id="c41" contextRef="d_2021-01-01_2021-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">8,555,000</ix:nonFraction>)</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(1) Mr. McFarlane became our Chief Executive Officer on October 10, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(2) Dr. Travis Mickle served as the Company&#8217;s Chief Executive Officer in 2021, 2022 and from January 1, 2023 until January 6, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(3) Mr. Pascoe served as the Company&#8217;s Chief Executive Officer from January 6, 2023, until June 1, 2023. As noted below, Mr. Pascoe also served as a non-PEO NEO during 2022 and 2021, and his compensation for those years is reflected in the columns entitled &#8220;Average Summary Compensation Table Total for Non-PEO NEOs&#8221; and &#8220;Average Compensation Actually Paid to Non-PEO NEOs.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(4) Ms. Christal Mickle served as the Company&#8217;s Interim Chief Executive Officer from June 1, 2023, until October 10, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(5) Amounts represent the average compensation actually paid to our remaining named executive officers for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Year</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-PEO NEOs</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">R. LaDuane Clifton, MBA, CPA and Joshua Schafer</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe and R. LaDuane Clifton, MBA, CPA</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2021</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe, Sven Guenther, Ph.D. and R. LaDuane Clifton, MBA, CPA</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
</ix:nonNumeric>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="ecd:AdjToPeoCompFnTextBlock" id="c42" escape="true">
<div>
<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="20" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Adjustments</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"><b>Current PEO</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="3" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Travis C. Mickle, Ph.D.</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"><b>Richard W. Pascoe</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="4" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%; text-align: center;"><b style="font-size: 10pt; text-align: center;">Christal M.M. Mickle</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="4" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Average</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-PEO</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>NEOs</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Deduction for Amounts Reported under the </b>&#8220;<b>Stock Awards</b>&#8221; <b>and </b>&#8220;<b>Option Awards</b>&#8221; <b>Columns in the Summary Compensation Table for Applicable FY</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(<ix:nonFraction id="c44" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">2,941,461</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(<ix:nonFraction id="c45" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">2,558,873</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(<ix:nonFraction id="c46" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">3,469,457</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(<ix:nonFraction id="c47" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">1,047,596</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(<ix:nonFraction id="c48" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">1,327,110</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c49" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">4,472,000</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c50" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">3,589,040</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c51" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c52" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,590,000</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c53" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,013,274</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c54" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c55" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c56" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">2,814,000</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c57" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c58" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c59" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c60" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c61" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c62" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">13,320</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c63" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">11,795</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date </b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c64" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(<ix:nonFraction id="c65" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">237,607</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(<ix:nonFraction id="c66" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">158,512</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(<ix:nonFraction id="c67" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">14,553</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(<ix:nonFraction id="c68" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">11,821</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited</b> <b>during Applicable FY, determined as of Prior FY End</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c69" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c70" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c71" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c72" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c73" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date </b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c74" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c75" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c76" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c77" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c78" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c79" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c80" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c81" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c82" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"><ix:nonFraction id="c83" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:fixed-zero" decimals="-3">&#8212;</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>TOTAL ADJUSTMENTS</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c84" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-CurrentCEOMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,530,539</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"><ix:nonFraction id="c85" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO1Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">792,560</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(<ix:nonFraction id="c86" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO2Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0" sign="-">813,969</ix:nonFraction></td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c87" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO3Member" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">541,171</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"><ix:nonFraction id="c88" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOTotalAdjustmentsMember" unitRef="USD" name="ecd:AdjToCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">686,138</ix:nonFraction></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="c89" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><i>Relationship Between Financial Performance Measures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The graphs below compare the compensation actually paid to our PEOs and the average of the compensation actually paid to our remaining named executive officers, with (i) our cumulative TSR, and (ii) our net income, in each case, for the fiscal years ended December 31, 2023, 2022&#160;and 2021.&#160;TSR amounts reported in the graph assume an initial fixed investment of $100.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="proxy1pic.jpg" src="proxy1pic.jpg"/></div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">43</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
</ix:nonNumeric>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2023-01-01_2023-12-31" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="c91" escape="true">
<div style="text-align: center;"><img alt="proxy2pic.jpg" src="proxy2pic.jpg"/></div>

<div style="text-align: center;">&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div></ix:exclude>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
</ix:nonNumeric>

<div>&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="dircomp" title="dircomp" href="#"></a>DIRECTOR COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Our Compensation Committee has adopted a non-employee director compensation policy, which provides for cash stipends to be paid to each of our nonemployee directors for service on the Board and for service on the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. These stipends are payable in four equal quarterly installments on the last day of each quarter. The cash stipends payable under this policy were initially as follows for 2023:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Member Annual </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Service Stipend</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Chairman </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Additional Annual </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Service Stipend</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Board of Directors</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">40,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">7,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Compensation Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">10,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Nominating and Corporate Governance Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">7,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Lead independent director*</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Additionally, under this policy, each non-employee director who continues to serve as a non-employee member of our Board, following the annual meeting of our stockholders is eligible to receive an option to purchase 15,000 shares of our common stock at an exercise price equal to the last reported sale price of our common stock on The Nasdaq Stock Market on the date of grant. These stock options will vest and become exercisable in full on the earliest of (i) the first anniversary of the grant date, (ii) the day before the first annual stockholders meeting occurring after the grant date or (iii) immediately prior to a change in control of the Company, subject in each case to the director&#8217;s continued service on such vesting date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">Following the annual non-employee director compensation policy reviews undertaken by the Board, and based upon the recommendation of the Compensation Committee after consultation with Mercer, the Board elected to revise the policy, effective February 15, 2023. The table below summarizes cash compensation to be paid under the policy as amended effective February 15, 2023. Additionally, the Board revised the policy to increase the number of shares subject to the option to be granted annually under the policy from 15,000 to 39,200 (or, for the Chairman of the Board, 49,200).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Member Annual </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Service Stipend</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Chairman </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Additional Annual </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Service Stipend</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Board of Directors</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">40,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">75,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">9,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">22,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Compensation Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">7,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Nominating and Corporate Governance Committee</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">12,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Lead independent director*</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">* If one is appointed.</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">Effective May 3, 2023, the Board further amended the non-employee director compensation policy. In addition to the above, upon the commencement of a non-employee director&#8217;s initial term&#160;of service to the Board, such individual will automatically be granted a stock option covering 1.5x the number of shares covering the annual grants to non-employee directors. The initial grants will vest and become exercisable in three equal installments on the date that is one day prior to the date of the first three annual meeting of stockholders following the date of grant, subject accelerated vesting upon a change in control of the Company (and in each case, subject to continued service on the Board).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">45</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>2023</b>&#160;<b>Director Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table sets forth information regarding compensation earned for service on our Board during 2023&#160;by our non-employee directors. Mr. McFarlane, our President and Chief Executive Officer, was also a director during 2023&#160;but did not receive any additional compensation for his service as a director. Mr. McFarlane&#8217;s compensation as an executive officer is set forth above under &#8220;Executive Compensation&#8212;Summary Compensation Table.&#8221; Mr. Pascoe, our former Executive Chairman and Chief Executive Officer, and Dr. Travis Mickle, our former President and Chief Executive Officer, were&#160;also directors during 2023 but did not receive any additional compensation for their services on our Board. Mr. Pascoe and Dr. Travis Mickle's compensation as executive officers is set forth above under &#8220;Executive Compensation&#8212;Summary Compensation Table.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fees Earned </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>or Paid in Cash<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 2%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards (1)<br/>
			($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Matthew R. Plooster</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">53,768</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">206,419</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">260,187</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Christopher A. Posner</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">17,846</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">17,846</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Joseph B. Saluri</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">44,522</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">164,464</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">208,986</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">David S. Tierney, M.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16,571</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">16,571</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Thomas D. Anderson</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">23,791</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">219,244</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">243,035</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">John B. Bode</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">41,598</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">222,710</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">264,308</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Douglas W. Calder</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">35,308</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">222,710</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">258,018</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Wendy Dixon, Ph.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">40,604</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">233,396</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">274,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Tamara A. Favorito</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">121,882</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">202,507</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">324,389</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 54%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Corey Watton</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37,956</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">222,710</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">260,666</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt; vertical-align: top;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This column reflects the full grant date fair value for options granted during the year as measured pursuant to ASC Topic 718 as stock-based compensation in our financial statements. Unlike the calculations contained in our financial statements, this calculation does not give effect to any estimate of forfeitures related to service-based vesting but assumes that the director will perform the requisite service for the award to vest in full. The assumptions we used in valuing options are described in Note K&#160;to our audited financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. See the table below for the number of option awards outstanding as of December 31, 2023.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">46</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">The table below shows the aggregate number of option awards outstanding for each of our non-employee directors as of December 31, 2023:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Aggregate Option</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards Outstanding<br/>
			(#)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Matthew R. Plooster</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">86,512(1)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Christopher A. Posner</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">&#8212;</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Joseph B. Saluri</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">75,762(1)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">David S. Tierney, M.D.</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">37,020(1)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Thomas D. Anderson</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">58,800(2)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">John B. Bode</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">58,800(2)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Douglas W. Calder</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">58,800(2)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Wendy Dixon, Ph.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">58,800(2)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Tamara A. Favorito</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">86,700(3)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Corey Watton</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: center;">58,800(2)</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr>
			<td style="width: 18pt;">(1)</td>
			<td style="width: auto;">As of December 31, 2023, all shares underlying these options were vested.&#160;</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The shares underlying these options will vest in equal annual installments over a period of three years beginning one day prior to the date of the first annual meeting of stockholders following the day of grant and continuing for the next two annual meeting of stockholders, such that the option will be fully vested one day prior to the date of the third annual meeting of the stockholders following the day of the grant, subject to continued service.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As of December 31, 2023, 30,000 shares underlying these options were vested. Of the remaining shares underlying these options, (a) 7,500 will best on August 18, 2024, (b) 39,200 will vest on the earlier of (i) April 25, 2024, or (ii) one day prior to the date of the Annual Meeting, and (c) 10,000 shares underlying these options will vest on the earlier of (i) May 30, 2024, or (ii) one day prior to the Annual Meeting, subject to continued service.&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">47</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><a id="secauthorizedequityplans" title="secauthorizedequityplans" href="#"></a>SECURITIES AUTHORIZED FOR ISSUANCE UNDER THE EQUITY COMPENSATION PLANS</b>&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following table provides information with respect to all of our equity compensation plans in effect as of December 31, 2023. Information is included for the 2007 Plan,&#160;the 2014 Plan, the 2023 Plan and the 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>EQUITY COMPENSATION PLAN INFORMATION</b>&#160;<br/>
&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 55%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Plan Category</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of securities to be issued<br/>
			upon exercise of<br/>
			outstanding<br/>
			options, warrants and rights<br/>
			(#) (a)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Weighted-average<br/>
			exercise price of<br/>
			outstanding<br/>
			options, warrants and rights<br/>
			($) (b)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of securities </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>available for<br/>
			future issuance<br/>
			under equity<br/>
			compensation<br/>
			plans (excluding<br/>
			securities reflected<br/>
			in column (a))<br/>
			(#) (c)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Equity compensation plans approved by security holders</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">6,903,142</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(1)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">2,689,057</td>
			<td style="width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">(2)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Equity compensation plans not approved by security holders(3)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,120,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4.68</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">380,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Total</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">8,023,142</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,069,057</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="text-align: justify; font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Includes (i) options to purchase a total of 5,182&#160;shares of our common stock under the 2007 Plan and (ii) options to purchase a total of 6,897,960&#160;shares of common stock under the 2014 Plan.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(255, 255, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 1,348,885&#160;shares of common stock reserved for issuance under the 2014 Plan and 1,340,172&#160;shares of common stock reserved for issuance under the 2021&#160;ESPP.&#160;The number of shares of our common stock reserved for issuance under the 2014 Plan will automatically increase each year on January 1 from January 1, 2016, continuing through January 1, 2031, by (i) 4.0% of the total number of shares of our common stock outstanding on December 31 of the preceding calendar year, or (ii) a lesser number of shares determined by our Board. Pursuant to the terms of the 2014 Plan, an additional 1,661,386&#160;shares of common stock were added to the number of shares reserved for issuance under the 2014 Plan, effective January 1, 2024.</p>
			</td>
		</tr>
		<tr style="vertical-align: top; background-color: rgb(204, 238, 255);">
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of the 2023 Plan. For a summary of the 2023 Plan, see Note K to our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">48</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="transactionsrelpersons" title="transactionsrelpersons" href="#"></a>TRANSACTIONS WITH RELATED PERSONS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>RELATED-PERSON TRANSACTIONS POLICY AND PROCEDURES</b>&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">We have a related person transaction policy in writing that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. For purposes of our policy only, a related person transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related person is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our Audit Committee, or, if Audit Committee approval would be inappropriate, to another independent body of our Board, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our Code of Conduct, our employees and directors will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering related person transactions, our Audit Committee, or other independent body of our Board, will take into account the relevant available facts and circumstances including, but not limited to:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the risks, costs and benefits to us;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the impact on a director&#8217;s independence in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the availability of other sources for comparable services or products; and</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 9pt;">&#160;</td>
			<td style="width: 9pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The policy requires that, in determining whether to approve, ratify or reject a related person transaction, our Audit Committee, or other independent body of our Board, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our stockholders, as our Audit Committee, or other independent body of our Board, determines in the good faith exercise of its discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Certain Transactions </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The following are certain transactions, arrangements and relationships with persons who are, or were during the period beginning January 1, 2022, our directors, executive officers or stockholders owning 5% or more of our outstanding common shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">49</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Indemnification Agreements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">Our amended and restated certificate of incorporation contains provisions limiting the liability of directors, and our amended and restated bylaws provide that we will indemnify each of our directors to the fullest extent permitted under Delaware law. Our amended and restated certificate of incorporation and amended and restated bylaws also provide our Board with discretion to indemnify our officers and employees when determined appropriate by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">In addition, we have entered into indemnification agreements with our directors and executive officers. For more information regarding these agreements, see &#8220;Executive Compensation&#8212;Limitations on Liability and Indemnification Matters.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">50</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="household" title="household" href="#"></a>HOUSEHOLDING OF PROXY MATERIALS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 9pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Notices of Internet Availability of Proxy Materials or other Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single Notice of Internet Availability of Proxy Materials or other Annual Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">This year, we and a number of brokers with account holders who are our stockholders will be &#8220;householding&#8221; our proxy materials. A single Notice of Internet Availability of Proxy Materials, or other Annual Meeting materials, as applicable, will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from one or more of the affected stockholders. Once you have received notice from us or your broker that we or they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent. We agree to deliver promptly, upon written or oral request, a separate copy of the proxy materials, as requested, to any stockholder at the shared address to which a single copy of those documents was delivered. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate Notice of Internet Availability of Proxy Materials or other Annual Meeting materials, please notify your broker or Zevra. Direct your written request to Zevra Therapeutics, Inc., 1180 Celebration Blvd. Suite 103, Celebration, FL 34747, Attn: Corporate Secretary or contact Timothy Sangiovanni, Senior Vice President, Corporate Controller, at (321) 939-3416. Stockholders who currently receive multiple copies of the Notices of Internet Availability of Proxy Materials or other Annual Meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">51</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b><a id="othermatters" title="othermatters" href="#"></a>OTHER MATTERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 25%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors</p>
			</td>
			<td style="vertical-align: middle; width: 25%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 25%;">&#160;</td>
			<td style="vertical-align: middle; width: 25%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 25%; border-bottom: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ R. LaDuane Clifton</p>
			</td>
			<td style="vertical-align: middle; width: 25%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 25%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">R. LaDuane Clifton, MBA, CPA</p>
			</td>
			<td style="vertical-align: middle; width: 25%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 50%;">&#160;</td>
			<td style="vertical-align: middle; width: 25%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer, Secretary and Treasurer</p>
			</td>
			<td style="vertical-align: middle; width: 25%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">April 3, 2024</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;"><b>A copy of the Company</b>&#8217;<b>s Annual Report on Form 10-K for the fiscal year ended December 31, 2023,</b>&#160;<b>is available without charge upon written request to Zevra Therapeutics, Inc., 1180 Celebration Blvd., Suite 103, Celebration, FL, 34747 Attn: Corporate Secretary.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">52</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<div>&#160;</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ANNEX A</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><span style="text-decoration: underline; ">AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><a id="Amended_EIP" title="Amended EIP" href="#"></a>Zevra Therapeutics, Inc.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Amended and Restated 2014 Equity Incentive Plan</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Originally Adopted by the Board of Directors: November 7, 2014</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Originally Approved by the Stockholders: April 1, 2015</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Original Effective Date: April 15, 2015</b><br/>
<b>Amended and Restated by the Board of Directors: February 22, 2024</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Approved by the Stockholders: [_____], 2024</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>1. General.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Eligible Award Recipients.</b> Employees, Directors and Consultants are eligible to receive Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Available Awards.</b> The Plan provides for the grant of the following Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Stock Awards, (vii) Performance Cash Awards, and (viii) Other Stock Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Purpose.</b> This Plan, through the granting of Awards, is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and provide a means by which the eligible recipients may benefit from increases in value of the Common Stock. This Plan constitutes an amendment and restatement of the Company&#8217;s Amended and Restated 2014 Equity Incentive Plan, as it was amended and restated effective April 29, 2021 (the &#8220;<b><i>Existing Plan</i></b>&#8221;). In the event that the Company&#8217;s stockholders do not approve this Plan, Awards granted under the Existing Plan will continue to be subject to the terms and conditions of the Existing Plan as in effect immediately prior to the date this Plan is approved by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>2. Administration.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Administration by Board.</b> The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Powers of Board.</b> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i)</b> To determine: (A) who will be granted Awards; (B) when and how each Award will be granted; (C) what type of Award will be granted; (D) the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Award; (E) the number of shares of Common Stock subject to, or the cash value of, an Award; and (F) the Fair Market Value applicable to a Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii)</b> To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the extent it will deem necessary or expedient to make the Plan or Award fully effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii)</b> To settle all controversies regarding the Plan and Awards granted under it.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv)</b> To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or at which cash or shares of Common Stock may be issued).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(v)</b> To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under his or her then-outstanding Award without his or her written consent except as provided in subsection (viii) below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(vi)</b> To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or to bring the Plan or Awards granted under the Plan compliant with the requirements for Incentive Stock Options or exempt from or compliant with the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. If required by applicable law or listing requirements, and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A) materially increases the number of shares of Common Stock available for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Awards under the Plan, (C) materially increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which shares of Common Stock may be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Awards available for issuance under the Plan. Except as otherwise provided in the Plan or an Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Award without the Participant&#8217;s written consent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(vii)</b> To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of (A) Section 422 of the Code regarding &#8220;incentive stock options&#8221; or (B) Rule 16b-3.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(viii)</b> To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <i>provided however,</i> that a Participant&#8217;s rights under any Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and (B) such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Awards without the affected Participant&#8217;s consent (A) to maintain the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results in impairment of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code; (C) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; or (D) to comply with other applicable laws or listing requirements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ix)</b> Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(x)</b> To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(xi)</b> To effect, with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike price of any outstanding Stock Award; (B) the cancellation of any outstanding Stock Award and the grant in substitution therefor of a new (1) Option or SAR, (2) Restricted Stock Award, (3) Restricted Stock Unit Award, (4) Other Stock Award, (5) cash award and/or (6) award of other valuable consideration determined by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number of shares of Common Stock as the cancelled Stock Award and (y) granted under the Plan or another equity or compensatory plan of the Company; or (C) any other action that is treated as a repricing under generally accepted accounting principles.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Delegation to Committee.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i) General.</b> The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii) Rule 16b-3 Compliance.</b> To the extent an Award is intended to qualify for the exemption from Section 16(b) of the Exchange Act that is available under Rule 16b-3 of the Exchange Act, the Award will be granted by the Board or a Committee that consists solely of two or more Non-Employee Directors, as determined under Rule 16b-3(b)(3) of the Exchange Act and thereafter any action establishing or modifying the terms of the Award will be approved by the Board or a Committee, meeting such requirements to the extent necessary for such exemption to remain available.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d) Delegation to an Officer.</b> The Board may delegate to one (1) or more Officers the authority to do one or both of the following (i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii) determine the number of shares of Common Stock to be subject to such Stock Awards granted to such Employees; <i>provided, however</i>,<i> </i>that the Board resolutions regarding such delegation will specify the total number of shares of Common Stock that may be subject to the Stock Awards granted by such Officer and that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to determine the Fair Market Value pursuant to Section 13(x)(iii) below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(e) Effect of Board</b>&#8217;<b>s Decision.</b> All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>3. Shares Subject to the Plan.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 8pt; text-indent: 36pt; font-size: 10pt;">&#160;</p>

<div style="font-size: 10pt; text-align: justify;"><b>(a) Share Reserve. </b>Subject to Section 9(a) relating to Capitalization Adjustments, and the following sentence regarding the annual increase, the aggregate number of shares of Common Stock that may be issued pursuant to Stock Awards will not exceed (A) 14,985,108 shares of Common Stock, which amount is inclusive of the number of shares of Common Stock issued or transferred pursuant to Awards under the Existing Plan and (B) the number of shares, if any, subject to outstanding stock awards granted under the Existing Plan that, from and after the Amendment Date, (i) expire or terminate for any reason prior to exercise or settlement, (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares, or (iii) are reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a stock award (collectively the &#8220;<b style="font-size: 10pt;"><i>Share Reserve</i></b>&#8221;). In addition, the Share Reserve will automatically increase on January 1st of each year, for a period of not more than ten years, commencing on January 1, 2025, and ending on (and including) January 1, 2034, in an amount equal to 4.0% of the total number of shares of Capital Stock outstanding on December 31st of the preceding calendar year. Notwithstanding the foregoing, the Board may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence. For clarity, the Share Reserve is a limitation on the number of shares of Common Stock that may be issued under the Plan. Accordingly, this Section 3(a) does not limit the granting of Stock Awards except as provided in Section 7(a). Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Reversion of Shares to the Share Reserve. </b>If a Stock Award or any portion thereof (i) expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or (ii) is settled in cash (<i>i.e.</i>, the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased will revert to and again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become available for issuance under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Incentive Stock Option Limit. </b>Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 19,600,000&#160;shares of Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d) Non-Employee Director Compensation Limitation</b>. In addition, the maximum number of shares subject to awards granted during a single fiscal year to any non-employee director, taken together with any cash fees paid to such non-employee director during the fiscal year, shall not exceed $500,000&#160;in total value (calculating the value of any such awards based on the grant date fair value of such awards for financial reporting purposes and excluding, for this purpose, the value of any dividend equivalent payments paid pursuant to any award granted in a previous fiscal year). Consulting fees or other compensation the Company or any of its Subsidiaries may pay or provide to any non-employee director for services in addition to the services normally performed by a non-employee director shall not be included in calculating such limits. The Board may make exceptions to this limit for individual non-employee directors in extraordinary circumstances, as the Board may determine in its discretion, provided that the non-employee director receiving such additional compensation may not participate in the decision to award such compensation or in other contemporaneous compensation decisions involving non-employee directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(e) Source of Shares.</b> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>4. Eligibility.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Eligibility for Specific Stock Awards</b>. Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <i>provided, however</i>, that Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i) the stock underlying such Stock Awards is treated as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has determined that such Stock Awards comply with the distribution requirements of Section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Ten Percent Stockholders.</b> A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five years from the date of grant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>5. Provisions Relating to Options and Stock Appreciation Rights.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The provisions of separate Options or SARs need not be identical; <i>provided, however</i>, that each Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each of the following provisions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Term.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten years from the date of its grant or such shorter period specified in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Exercise Price.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair Market Value of the Common Stock subject to the Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Purchase Price for Options.</b> The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of payment are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i)</b> by cash, check, bank draft or money order payable to the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii)</b> pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii)</b> by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv)</b> if an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; <i>provided, however</i>, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are reduced to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(v)</b> in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d) Exercise and Payment of a SAR.</b> To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(e) Transferability of Options and SARs.</b> The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i) Restrictions on Transfer.</b> An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii) Domestic Relations Orders.</b> Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii) Beneficiary Designation.</b> Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, the executor or administrator of the Participant&#8217;s estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(f) Vesting Generally.</b> The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(g) Termination of Continuous Service.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date three months following the termination of the Participant&#8217;s Continuous Service (or such longer or shorter period specified in the applicable Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR will terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(h) Extension of Termination Date.</b> If the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a Participant&#8217;s Award Agreement, if the sale of any Common Stock received on exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of a period of months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(i) Disability of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date 12 months following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(j) Death of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within the period ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Award Agreement. If, after the Participant&#8217;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(k) Termination for Cause.</b> Except as explicitly provided otherwise in a Participant&#8217;s Award Agreement or other individual written agreement between the Company or any Affiliate and the Participant, if a Participant&#8217;s Continuous Service is terminated for Cause, the Option or SAR will terminate immediately upon such Participant&#8217;s termination of Continuous Service, and the Participant will be prohibited from exercising his or her Option or SAR from and after the date of such termination of Continuous Service.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(l) Non-Exempt Employees</b>. If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Award Agreement in another agreement between the Participant and the Company, or, if no such definition, in accordance with the Company's then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>6. Provisions of Stock Awards other than Options and SARs.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Restricted Stock Awards.</b> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common Stock may be (x) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse; or (y) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i) Consideration.</b> A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii) Vesting. </b>Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii) Termination of Participant</b>&#8217;<b>s Continuous Service.</b> If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv) Transferability.</b> Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(v) Dividends. </b>A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Restricted Stock Unit Awards. </b>Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i) Consideration.</b> At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii) Vesting. </b>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii) Payment</b>. A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv) Additional Restrictions. </b>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(v) Dividend Equivalents. </b>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the underlying Restricted Stock Unit Award Agreement to which they relate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(vi) Termination of Participant</b>&#8217;<b>s Continuous Service. </b>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination of Continuous Service.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Performance Awards</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i) Performance Stock Awards</b>. A Performance Stock Award is a Stock Award (covering a number of shares not in excess of that set forth in Section 3(d) above) that is payable (including that may be granted, may vest or may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may, but need not, require the Participant&#8217;s completion of a specified period of Continuous Service. The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Committee or the Board, in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii) Performance Cash Awards</b>. A Performance Cash Award is a cash award (for a dollar value not in excess of that set forth in Section 3(d) above) that is payable contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Cash Award may also require the completion of a specified period of Continuous Service. At the time of grant of a Performance Cash Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Committee or the Board, in its sole discretion. The Board may specify the form of payment of Performance Cash Awards, which may be cash or other property, or may provide for a Participant to have the option for his or her Performance Cash Award, or such portion thereof as the Board may specify, to be paid in whole or in part in cash or other property.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii) Board Discretion</b>. The Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d) Other Stock Awards</b>. Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>7. Covenants of the Company.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Availability of Shares.</b> The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Awards.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Securities Law Compliance.</b> The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; <i>provided, however</i>, that this undertaking will not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be in violation of any applicable securities law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) No Obligation to Notify or Minimize Taxes. </b>The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>8. Miscellaneous.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Use of Proceeds from Sales of Common Stock. </b>Proceeds from the sale of shares of Common Stock pursuant to Awards will constitute general funds of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Corporate Action Constituting Grant of Awards.</b> Corporate action constituting a grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Stockholder Rights.</b> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of shares under, the Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to such Award has been entered into the books and records of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d) No Employment or Other Service Rights.</b> Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(e) Change in Time Commitment.</b> In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In the event of any such reduction or extension, the Participant will have no right with respect to any portion of the Award that is so reduced or extended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(f) Incentive Stock Option Limitations.</b> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(g) Investment Assurances.</b> The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award, (i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(h) Withholding Obligations.</b> Unless prohibited by the terms of an Award Agreement, the Company or any subsidiary may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; <i>provided, however, </i>that no shares of Common Stock are withheld with a value exceeding the amount of tax required to be withheld by law based on the minimum statutory withholding rates (or such other rate, not to exceed the maximum statutory withholding rate, as may be determined by the Company after considering any accounting consequences or costs); (iii) withholding cash from an Award settled in cash; (iv) withholding payment from any amounts otherwise payable to the Participant; or (v) by such other method as may be set forth in the Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(i) Electronic Delivery</b>. Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at <span style="text-decoration: underline; ">www.sec.gov</span> (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(j) Deferrals.</b> To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(k) Compliance with Section 409A. </b>Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#8217;s &#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum on the day after such six month period elapses, with the balance paid thereafter on the original schedule.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(l) Clawback/Recovery</b>. All Awards (including, without limitation, any proceeds, gains or other economic benefit actually or constructively received by a Participant upon any receipt or exercise of the Award or upon the receipt or sale of any shares of Common Stock underlying the Award) granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law (including, without limitation, the Company&#8217;s Policy for Recovery of Erroneously Awarded Compensation). In addition, the Board may impose such other clawback, recovery or recoupment provisions, including in an Award Agreement, as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>9. Adjustments upon Changes in Common Stock; Other Corporate Events.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) Capitalization Adjustments</b>. In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), (iii) the class(es) and maximum number of securities that may be awarded to any person pursuant to Sections 3(d), and (iv) the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) Dissolution or Liquidation</b>. Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service; <i>provided, however</i>, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the dissolution or liquidation is completed but contingent on its completion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c) Corporate Transaction.</b> The following provisions will apply to Stock Awards in the event of a Corporate Transaction unless otherwise provided in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Corporate Transaction, then, notwithstanding any other provision of the Plan, the Board will take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Corporate Transaction:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i)</b> arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii)</b> arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii)</b> accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date prior to the effective time of such Corporate Transaction as the Board will determine (or, if the Board will not determine such a date, to the date that is five days prior to the effective date of the Corporate Transaction), with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the Corporate Transaction;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv)</b> arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(v)</b> cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(vi)</b> make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Corporate Transaction, over (B) any exercise price payable by such holder in connection with such exercise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d) Change in Control.</b> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>10. Plan Term; Earlier Termination or Suspension of the Plan.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier of (i) the date the Plan (as amended and restated) is adopted by the Board or (ii) the date the Plan (as amended and restated) is approved by the stockholders of the Company. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. For the avoidance of doubt, any Awards granted prior to the Amendment Date shall remain subject to the terms of the Award Agreement governing such Award, and the effectiveness of this Plan shall not constitute an amendment of such Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>11. Effective Date of the Plan.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The Plan, as amended and restated, shall become effective on the Amendment Date. In the event that the Company&#8217;s shareholders do not approve this Plan, Awards granted under the Existing Plan will continue to be subject to the terms and conditions of the Existing Plan as in effect immediately prior to the date this Plan is approved by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>12. Choice of Law.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">The law of the State of Delaware will govern all questions concerning the construction, validity and interpretation of the Plan, without regard to that state&#8217;s conflict of laws rules.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>13. Definitions. </b>As used in the Plan, the following definitions will apply to the capitalized terms indicated below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(a) </b>&#8220;<b><i>Affiliate</i></b>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(b) </b>&#8220;<b><i>Amendment Date</i></b>&#8221; means the date on which the Plan, as amended and restated, is approved by the Board, subject to approval of this Plan by the Company&#8217;s stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(c)</b>&#8220;<b><i> Award</i></b>&#8221; means a Stock Award or a Performance Cash Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(d)</b>&#8220;<b><i> Award Agreement</i></b>&#8221; means a written or electronic agreement between the Company and a Participant evidencing the terms and conditions of an Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(e)</b>&#8220;<b><i> Board</i></b>&#8221; means the Board of Directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(f)</b>&#8220;<b><i> Capital Stock</i></b>&#8221; means each and every class of common stock of the Company, regardless of the number of votes per share.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(g)</b> &#8220;<b><i>Capitalization Adjustment</i></b>&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Amendment Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(h)</b>&#8220;<b><i> Cause</i></b>&#8221;<b><i> </i></b>will have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term shall mean, with respect to a Participant, the occurrence of any of the following events that has a material negative impact on the business or reputation of the Company: (i) such Participant&#8217;s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (ii) such Participant&#8217;s intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty owed to the Company; (iii) such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s confidential information or trade secrets; or (iv) such Participant&#8217;s gross misconduct. The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause shall be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant shall have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(i)</b>&#8220;<b><i> Change in Control</i></b>&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i)</b> any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C) solely because the level of Ownership held by any Exchange Act Person (the &#8220;<b><i>Subject Person</i></b>&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii)</b> there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; <i>provided, however</i>, that a merger, consolidation or similar transaction will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are owned by the IPO Entities;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii)</b> there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; <i>provided, however</i>, that a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the acquiring Entity or its parent are owned by the IPO Entities; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv)</b> individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;<b><i>Incumbent Board</i></b>&#8221;) cease for any reason to constitute at least a majority of the members of the Board; <i>provided, however</i>, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">Notwithstanding the foregoing definition or any other provision of this Plan, the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing definition with respect to Awards subject to such agreement; <i>provided, however</i>, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition will apply.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(j)</b>&#8220;<b><i> Code</i></b>&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(k) </b>&#8220;<b><i>Committee</i></b>&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section 2(c).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(l) </b>&#8220;<b><i>Common Stock</i></b>&#8221; means, as of the Amendment Date, the common stock of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(m) </b>&#8220;<b><i>Company</i></b>&#8221; means Zevra Therapeutics, Inc., a Delaware corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(n)</b>&#8220;<b><i> Consultant</i></b>&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan.<b><i> </i></b>Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(o)</b>&#8220;<b><i> Continuous Service</i></b>&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service ; <i>provided, however</i>,<i> </i>that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(p)</b>&#8220;<b><i> Corporate Transaction</i></b>&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i)</b> a sale<b> </b>or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii)</b> a sale or other disposition of at least 50% of the outstanding securities of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii)</b> a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iv)</b> a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(q)</b>&#8220;<b><i> Director</i></b>&#8221; means a member of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(r)</b>&#8220;<b><i> Disability</i></b>&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(s)</b>&#8220;<b><i> Employee</i></b>&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(t)</b>&#8220;<b><i> Entity</i></b>&#8221; means a corporation, partnership, limited liability company or other entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(u)</b>&#8220;<b><i> Exchange Act</i></b>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(v)</b>&#8220;<b><i> Exchange Act Person</i></b>&#8221;<b><i> </i></b>means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Amendment Date, is the Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(w)</b>&#8220;<b><i> Fair Market Value</i></b>&#8221; means, as of any date, the value of the Common Stock determined as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(i)</b> If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(ii)</b> Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:72pt;"><b>(iii)</b> In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(x)</b>&#8220;<b><i> Incentive Stock Option</i></b>&#8221; means an option granted pursuant to Section 5 of the Plan that is intended to be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(y)</b>&#8220;<b><i> Non-Employee Director</i></b>&#8221;<b> </b>means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;<b><i>Regulation S-K</i></b>&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or (ii) is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(z)</b>&#8220;<b><i> Nonstatutory Stock Option</i></b>&#8221; means any Option granted pursuant to Section 5 of the Plan that does not qualify as an Incentive Stock Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(aa)</b>&#8220;<b><i> Officer</i></b>&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(bb)</b>&#8220;<b><i> Option</i></b>&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(cc)</b>&#8220;<b><i> Option Agreement</i></b>&#8221; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(dd)</b>&#8220;<b><i> Optionholder</i></b>&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(ee)</b>&#8220;<b><i> Other Stock Award</i></b>&#8221; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section 6(d).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(ff)</b>&#8220;<b><i> Other Stock Award Agreement</i></b>&#8221;<b><i> </i></b>means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(gg)</b>&#8220;<b><i> Own,</i></b>&#8221;<b><i> </i></b>&#8220;<b><i>Owned,</i></b>&#8221;<b><i> </i></b>&#8220;<b><i>Owner,</i></b>&#8221;<b><i> </i></b>&#8220;<b><i>Ownership</i></b>&#8221;<b> </b>means a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(hh)</b>&#8220;<b><i> Participant</i></b>&#8221; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(ii)</b>&#8220;<b><i> Performance Cash Award</i></b>&#8221; means an award of cash granted pursuant to the terms and conditions of Section 6(c)(ii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(jj)</b>&#8220;<b><i> Performance Criteria</i></b>&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board: (i) earnings (including earnings per share and net earnings); (ii) earnings before interest, taxes and depreciation; (iii) earnings before interest, taxes, depreciation and amortization; (iv) earnings before interest, taxes, depreciation, amortization and legal settlements; (v) earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (vi) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (vii) earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (viii) total stockholder return; (ix) return on equity or average stockholder&#8217;s equity; (x) return on assets, investment, or capital employed; (xi) stock price; (xii) margin (including gross margin); (xiii) income (before or after taxes); (xiv) operating income; (xv) operating income after taxes; (xvi) pre-tax profit; (xvii) operating cash flow; (xviii) sales or revenue targets; (xix) increases in revenue or product revenue; (xx) expenses and cost reduction goals; (xxi) improvement in or attainment of working capital levels; (xxii) economic value added (or an equivalent metric); (xxiii) market share; (xxiv) cash flow; (xxv) cash flow per share; (xxvi) share price performance; (xxvii) debt reduction; (xxviii) implementation or completion of projects or processes; (xxix) customer satisfaction; (xxx) stockholders&#8217; equity; (xxxi) capital expenditures; (xxxii) debt levels; (xxxiii) operating profit or net operating profit; (xxxiv) workforce diversity; (xxxv) growth of net income or operating income; (xxxvi) billings; (xxxvii) bookings; (xxxviii) the number of customers, including but not limited to customers users; (xxxix) employee retention; (xl) pre-clinical development related compound goals; (xli) financing; (xlii) regulatory milestones, including approval of a compound; (xliii) stockholder liquidity; (xliv) corporate governance and compliance; (xlv) product commercialization; (xlvi) intellectual property; (xlvii) personnel matters; (xlviii) progress of internal research or clinical programs; (xlix) progress of partnered programs; (l) implementation or completion of projects and processes; (li) partner satisfaction; (lii) budget management; (liii) clinical achievements; (liv) completing phases of a clinical study (including the treatment phase); (lv) announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or generally; (lvi) timely completion of clinical trials; (lvii) submission of INDs and NDAs and other regulatory achievements; (lviii) partner or collaborator achievements; (lix) internal controls, including those related to the Sarbanes-Oxley Act of 2002; (lx) research progress, including the development of programs; (lxi) investor relations, analysts and communication; (lxii) manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities); (lxiii) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property; (lxiv) establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#8217;s products (including with group purchasing organizations, distributors and other vendors); (lxv) supply chain achievements (including establishing relationships with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#8217;s products); (lxvi) co-development, co-marketing, profit sharing, joint venture or other similar arrangements; and (lxvii) and other measures of performance selected by the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(kk)</b>&#8220;<b><i> Performance Goals</i></b>&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally accepted accounting principles; (4) to exclude the effects of any statutory adjustments to corporate tax rates; (5) to exclude the effects of any &#8220;extraordinary items&#8221; as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to expensed under generally accepted accounting principles; (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles, (12) to exclude the effects of the timing of acceptance for review and/or approval of submissions to the Food and Drug Administration or any other regulatory body and (13) to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(ll)</b>&#8220;<b><i> Performance Period</i></b>&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(mm)</b>&#8220;<b><i> Performance Stock Award</i></b>&#8221; means a Stock Award granted under the terms and conditions of Section 6(c)(i).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(nn)</b>&#8220;<b><i> Plan</i></b>&#8221; means this Amended and Restated Zevra Therapeutics, Inc. 2014 Equity Incentive Plan, as it may be amended and/or restated from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(oo)</b>&#8220;<b><i> Restricted Stock Award</i></b>&#8221; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(pp)</b>&#8220;<b><i> Restricted Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(qq)</b>&#8220;<b><i> Restricted Stock Unit Award</i></b>&#8221;<b><i> </i></b>means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(b).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(rr)</b>&#8220;<b><i> Restricted Stock Unit Award Agreement</i></b>&#8221;<b><i> </i></b>means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(ss)</b>&#8220;<b><i> Rule 16b-3</i></b>&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(tt)</b>&#8220;<b><i> Securities Act</i></b>&#8221; means the Securities Act of 1933, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(uu)</b>&#8220;<b><i> Stock Appreciation Right</i></b>&#8221; or &#8220;<b><i>SAR</i></b>&#8221;<b><i> </i></b>means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 5.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(vv)</b>&#8220;<b><i> Stock Appreciation Right Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(ww)</b>&#8220;<b><i> Stock Award</i></b>&#8221; means any right to receive Common Stock granted under the Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance Stock Award or any Other Stock Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(xx)</b>&#8220;<b><i> Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(yy)</b>&#8220;<b><i> Subsidiary</i></b>&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than 50%.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;"><b>(zz)</b>&#8220;<b><i> Ten Percent Stockholder</i></b>&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than ten percent of the total combined voting power of all classes of stock of the Company or any Affiliate.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;text-indent:36pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">A-20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<div style="text-align: center;"><img alt="yw0d_zeropage1.jpg" src="yw0d_zeropage1.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="display: inline-block; text-align: left;"><a href="#toc" style="font-weight: initial; font-style: initial; font-variant: initial; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Table of Contents</a></div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<div style="text-align: center;"><img alt="yw0d_zeropage2.jpg" src="yw0d_zeropage2.jpg"/></div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>zvra-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 02:55PM UTC 2024-04-03--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:zvra="http://www.kempharm.com/20231231" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.kempharm.com/20231231">
  <xsd:import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zvra-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zvra-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="zvra-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="zvra_CurrentCEOMember" name="CurrentCEOMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_FormerCEO1Member" name="FormerCEO1Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_FormerCEO2Member" name="FormerCEO2Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_FormerCEO3Member" name="FormerCEO3Member" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" name="NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" name="NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" name="NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" name="NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" name="NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" name="NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" name="NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" name="NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_NEOTotalAdjustmentsMember" name="NEOTotalAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" name="PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" name="PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" name="PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" name="PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" name="PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" name="PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" name="PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" name="PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
  <xsd:element abstract="true" id="zvra_PEOTotalAdjustmentsMember" name="PEOTotalAdjustmentsMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>zvra-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 02:55PM UTC 2024-04-03--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpAdjustmentsOnly" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:label="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:label="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:label="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:label="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:label="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:label="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:label="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:label="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOTotalAdjustmentsMember" xlink:label="zvra_PEOTotalAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOTotalAdjustmentsMember" xlink:label="zvra_NEOTotalAdjustmentsMember" xlink:type="locator"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="arc"/>
    <link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="arc"/>
    <link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="arc"/>
    <link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="arc"/>
    <link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="arc"/>
    <link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="arc"/>
    <link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="arc"/>
    <link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="arc"/>
    <link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="arc"/>
    <link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="arc"/>
    <link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="arc"/>
    <link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="arc"/>
    <link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="arc"/>
    <link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOTotalAdjustmentsMember" xlink:type="arc"/>
    <link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOTotalAdjustmentsMember" xlink:type="arc"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_CurrentCEOMember" xlink:label="zvra_CurrentCEOMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO1Member" xlink:label="zvra_FormerCEO1Member" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO2Member" xlink:label="zvra_FormerCEO2Member" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO3Member" xlink:label="zvra_FormerCEO3Member" xlink:type="locator"/>
    <link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_CurrentCEOMember" xlink:type="arc"/>
    <link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_FormerCEO1Member" xlink:type="arc"/>
    <link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_FormerCEO2Member" xlink:type="arc"/>
    <link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_FormerCEO3Member" xlink:type="arc"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>zvra-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 02:55PM UTC 2024-04-03--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</link:label>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:to="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</link:label>
    <link:label xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:to="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</link:label>
    <link:label xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:to="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</link:label>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:to="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:label="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</link:label>
    <link:label xlink:label="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:to="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</link:label>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:to="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</link:label>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:to="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:label="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</link:label>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:to="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:label="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</link:label>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:to="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:label="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</link:label>
    <link:label xlink:label="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:to="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:label="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</link:label>
    <link:label xlink:label="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:to="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:label="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</link:label>
    <link:label xlink:label="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:to="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:label="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</link:label>
    <link:label xlink:label="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:to="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOTotalAdjustmentsMember" xlink:label="zvra_NEOTotalAdjustmentsMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOTotalAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Total Adjustments [Member]</link:label>
    <link:label xlink:label="zvra_NEOTotalAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Total Adjustments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOTotalAdjustmentsMember" xlink:to="zvra_NEOTotalAdjustmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOTotalAdjustmentsMember" xlink:label="zvra_PEOTotalAdjustmentsMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOTotalAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Adjustments [Member]</link:label>
    <link:label xlink:label="zvra_PEOTotalAdjustmentsMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Total Adjustments</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOTotalAdjustmentsMember" xlink:to="zvra_PEOTotalAdjustmentsMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</link:label>
    <link:label xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">NEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:to="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</link:label>
    <link:label xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:to="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO2Member" xlink:label="zvra_FormerCEO2Member" xlink:type="locator"/>
    <link:label xlink:label="zvra_FormerCEO2Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former CEO 2 [Member]</link:label>
    <link:label xlink:label="zvra_FormerCEO2Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Former CEO 2</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_FormerCEO2Member" xlink:to="zvra_FormerCEO2Member-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:label="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</link:label>
    <link:label xlink:label="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">PEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:to="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO3Member" xlink:label="zvra_FormerCEO3Member" xlink:type="locator"/>
    <link:label xlink:label="zvra_FormerCEO3Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former CEO 3 [Member]</link:label>
    <link:label xlink:label="zvra_FormerCEO3Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Former CEO 3</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_FormerCEO3Member" xlink:to="zvra_FormerCEO3Member-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO1Member" xlink:label="zvra_FormerCEO1Member" xlink:type="locator"/>
    <link:label xlink:label="zvra_FormerCEO1Member-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former CEO 1 [Member]</link:label>
    <link:label xlink:label="zvra_FormerCEO1Member-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Former CEO 1</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_FormerCEO1Member" xlink:to="zvra_FormerCEO1Member-label" xlink:type="arc"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_CurrentCEOMember" xlink:label="zvra_CurrentCEOMember" xlink:type="locator"/>
    <link:label xlink:label="zvra_CurrentCEOMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current CEO [Member]</link:label>
    <link:label xlink:label="zvra_CurrentCEOMember-label" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current CEO</link:label>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="zvra_CurrentCEOMember" xlink:to="zvra_CurrentCEOMember-label" xlink:type="arc"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>zvra-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 02:55PM UTC 2024-04-03--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember" xlink:label="ecd_AllIndividualsMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_CurrentCEOMember" xlink:label="zvra_CurrentCEOMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO1Member" xlink:label="zvra_FormerCEO1Member" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO2Member" xlink:label="zvra_FormerCEO2Member" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_FormerCEO3Member" xlink:label="zvra_FormerCEO3Member" xlink:type="locator"/>
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:label="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:label="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:label="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:label="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:label="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:label="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:label="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:label="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:label="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:label="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:label="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:label="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_PEOTotalAdjustmentsMember" xlink:label="zvra_PEOTotalAdjustmentsMember" xlink:type="locator"/>
    <link:loc xlink:href="zvra-20231231.xsd#zvra_NEOTotalAdjustmentsMember" xlink:label="zvra_NEOTotalAdjustmentsMember" xlink:type="locator"/>
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_CurrentCEOMember" xlink:type="arc"/>
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_FormerCEO1Member" xlink:type="arc"/>
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_FormerCEO2Member" xlink:type="arc"/>
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="zvra_FormerCEO3Member" xlink:type="arc"/>
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="arc"/>
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember" xlink:type="arc"/>
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="arc"/>
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember" xlink:type="arc"/>
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="arc"/>
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember" xlink:type="arc"/>
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="arc"/>
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember" xlink:type="arc"/>
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="arc"/>
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember" xlink:type="arc"/>
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="arc"/>
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember" xlink:type="arc"/>
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="arc"/>
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember" xlink:type="arc"/>
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="arc"/>
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember" xlink:type="arc"/>
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_PEOTotalAdjustmentsMember" xlink:type="arc"/>
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="zvra_NEOTotalAdjustmentsMember" xlink:type="arc"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>proxy1pic.jpg
<TEXT>
begin 644 proxy1pic.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &8 ^@# 2(  A$! Q$!_\0
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M]0LX;NRE6:VF7?'(O1A2_:X/MAM1-']I">88MWS!<XSCTS0 [[/#_P \H_\
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MOL\/_/*/_OD4?9X?^>4?_?(J6B@"+[/#_P \H_\ OD4?9X?^>4?_ 'R*EHH
MB^SP_P#/*/\ [Y%'V>'_ )Y1_P#?(J6B@"+[/#_SRC_[Y%'V>'_GE'_WR*EH
MH B^SP_\\H_^^11]GA_YY1_]\BI:* *MW!$MK*1$@(0G(4>E%27O_'G/_N'^
M5% "VO\ Q[Q?[@_E4M16O_'O%_N#^52T %%%% !1110 4444 %%%% !1110
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M@+Y[%2#ZUM^'HKR#Q]J&8[NYM9O-=KB>.6,V_P PQ&"3L=3C@CD?C7?XI<4
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M<GPYIGV[S/M7V:/S?,^]NVC.??-:E&** "BBB@ HHHH **** "BBB@ HHHH
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MU-10!#_I'I%^9H_TCTB_,U-10!#_ *1Z1?F:/](](OS-344 0_Z1Z1?F:/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH11*+B[,&FMQ:***0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC3;.2YEMKB6-" 5@0R.<G'"CDUH55U"6:"V9[6V-S+E0(@X3() /)XX&3^%
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M10!#YC_\\F_[Z%'F/_SR;_OH5-10!#YC_P#/)O\ OH4>8_\ SR;_ +Z%344
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MNXEN(7>^DG%Y:W$DL+8*Q,CJ % '&,LI]<>HHKHY+"TM8KR:WMH8I94)D=$
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M45UFP4444 =G\+]8ET;5;N:&-)&>'80Q.!\PKTG_ (3R\_Y]+?\ ,UY'X/\
M^/R?_KG_ %%=94.E"3NT2X1>YV'_  GE[_SZ6_YFC_A/+W_GTM_S-<?12]A3
M[![./8[#_A/+W_GTM_S-'_">7O\ SZ6_YFN/HH^KT^PO9Q['L?AZ^?4])@NY
M45'DW95>@PQ']*TJPO __(L6?_ __0VK=KSI*TFD<TMPHHHJ1!1110 4444
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MCCE=&W,!SSR?ID\G%% %VU_X]XO]P?RJ6HK7_CWB_P!P?RJ6@ HHHH ****
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M0 0Z="<=Y!O/_CV:UX8(H4VPQHB^BC HO!=+A>)QQUWQ/>L!I^A"!/[UR_\
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M_.I]/D<ZA;9=CF5>_O2="W43IGI=%%%8&84444 %%%% !1110 4444 %%%%
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MC^6/ZUW6*7%'M7T20<W8XF/P5HI??>7=Q=OW,L_7\N:V;/1-!M% AM+08[L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 4]:_Y!%]_UP?_ -!-?)5?6NM?\@B^_P"N#_\ H)KY*KLPO4WH
M]0HHHKK-@HHHH Z#P?\ \?D__7/^HKK*Y/P?_P ?D_\ US_J*ZRF@"BBBF,*
M*** -FQ_X\X_Q_G4]06/_'G'^/\ .IZYWN9!1112 *L:=_R$+7_KJO\ .J]3
MV+!+ZW8]%D4_K2>S$STZBJ']K6?_ #U/_?)_PI?[6L_^>I_[Y/\ A7#9F%F7
MJ*H?VM9_\]3_ -\G_"C^UK/_ )ZG_OD_X46869?KS?XV_P#()TW_ *[M_P"@
MUW7]K6?_ #U/_?)_PKSSXR7L-SI>GB%MVV8D\$?PUK03]HBZ:?,CRBBBBO4.
ML**** "OH3X<_P#(EZ7_ -<S_P"A&OGNOH3X<_\ (EZ7_P!<S_Z$:Y,7\*,:
MVQTE<7\5(H'T6S>YN+&!(KM)!]N5FBD(#?*P4'.:[2N>\;:F^E:4D\>IV6FL
M90GG7<9D0\'C (YX_2N YBG\-YK>?1YFM3I!3SB/^)7$T<><#J&YW?\ UJZV
MN+^&-T;VRU6X,EO.9+UB;BVC=(YOD3YE#$_0XXR/Q/:4 %%%% !1110!#>_\
M><_^X?Y447O_ !YS_P"X?Y44 +:_\>\7^X/Y5EZ[JSV-W9VL"1M/<DE/-<(I
M"E=R@]V()P/8UJ6O_'O%_N#^59?B32I=7@6T,RI9RADN%*!F*E3@H2.&!QS]
M>^* )3J4D6KPV<UJ5CGW^7*'SG:,G([#WS56^\0I:7DB20-]DBG2VEGW?<=E
M##Y?3YE&?4]*5M)N;>]N+VVN_-G:+RXDF7(0 <*#U W<GC)_ 8BD\.BXDS=W
M;R12R1SSQ! !)*J!<Y[#Y0<>HZT 5T\6#?!$]E(EQ=)%):QF0?O%D)QDX^4C
M:2>OMFKZ:ZCZ,UZ('\Q9S:F'<,^;YOE8SZ;N_I5)?"B#[/))>RO<VJQ);2E!
M^[6/. 1WR&()_E4BZ#,(6L_M6VVW"X$FT;VN#-YI<]L @#'H2* (Y/%6U;E%
ML)&N;19GN8O, V+'MR0>^=P(Z=\XJ:T\2PW=W L,+&TGN&M8[C=]Z14+GY?3
MY6&?4=*BD\+*WGN+V99[E)8[F4(,R+)C( _AQM 'H/6I[/PW!:7D3PS.+2&X
M:ZBM\#"R,A4G/7&&8X]30!T%9'BRSNM0\.W]KIT@CNI(R(VW%>?3(Z9Z?C6O
M49@B)R8T)^E '$Q76NZYK&D*VBW6CP64WG7,LTRD.-I7RU"GY@<]3QQGK7<@
M^IJ/[/#_ ,\D_P"^12^1#_SR3_OD4 29%&14?D0_\\D_[Y%'D0_\\D_[Y% $
MF11D5'Y$/_/)/^^11Y$/_/)/^^10!)D49%1^1#_SR3_OD4>1#_SR3_OD4 .8
MC'6O#YN)G^IKVTP1 ?ZI/^^17B,O$KX_O&NS";LWH[L;1117:;A1110!T?@'
M_D8X_P#KF_\ *O4LUY7X#57\11A@"-C<$9[5ZAY$/_/)/^^17G8KXSFJ_$29
M%&14?D0_\\D_[Y%'D0_\\D_[Y%<YD29%&14?D0_\\D_[Y%'D0_\ /)/^^10!
M)D49%1^1#_SR3_OD4>1#_P \D_[Y% $F11D5'Y$/_/)/^^11Y$/_ #R3_OD4
M 29%&14?D0_\\D_[Y%'D0_\ /)/^^10!)D49%1^1#_SR3_OD4>1#_P \D_[Y
M% $F11D5'Y$/_/)/^^11Y$/_ #R3_OD4 29%&14?D0_\\D_[Y%'D0_\ /)/^
M^10!)D49%1^1#_SR3_OD4>1#_P \D_[Y% $F11D5'Y$/_/)/^^11Y$/_ #R3
M_OD4 29%&14?D0_\\D_[Y%'D0_\ /)/^^10!)D49%1^1#_SR3_OD4>1#_P \
MD_[Y% $F11D5'Y$/_/)/^^11Y$/_ #R3_OD4 29%&14?D0_\\D_[Y%'D0_\
M/)/^^10!)D49%1^1#_SR3_OD4>1#_P \D_[Y% $F11D5'Y$/_/)/^^11Y$/_
M #R3_OD4 29%&14?D0_\\D_[Y%'D0_\ /)/^^10!)D49%1^1#_SR3_OD4>1#
M_P \D_[Y% $F11D5'Y$/_/)/^^11Y$/_ #R3_OD4 29%&14?D0_\\D_[Y%'D
M0_\ /)/^^10!)D49%1^1#_SR3_OD4>1#_P \D_[Y% $F11D5'Y$/_/)/^^11
MY$/_ #R3_OD4 29%&14?D0_\\D_[Y%'D0_\ /)/^^10!)D49%1^1#_SR3_OD
M4>1#_P \D_[Y% $F11D5'Y$/_/)/^^11Y$/_ #R3_OD4 29%&14?D0_\\D_[
MY%'D0_\ /)/^^10!)D49%1^1#_SR3_OD4>1#_P \D_[Y% $F11D5'Y$/_/)/
M^^11Y$/_ #R3_OD4 29%&14?D0_\\D_[Y%'D0_\ /)/^^10!)D49%1^1#_SR
M3_OD4>1#_P \D_[Y% %;6B/[(O>1_J'_ /037R77UCK$$0TB]Q&G^H?^$?W3
M7R=79A>IO1ZA11176;!1110!T'@__C\G_P"N?]1765R?@_\ X_)_^N?]1764
MT 4444QA1110!LV/_'G'^/\ .IZ@L?\ CSC_ !_G4]<[W,@HHHI %/@_UZ?[
MPIE/@_UR?[PH VJ***Q("BBB@ KC_B3_ ,@^T_ZZG^5=A7'_ !*_Y!UI_P!=
M3_*M*?Q(J.YY_11178;A1110 5]"?#D_\49I?_7,_P#H1KY[KZ ^'<,;>#=,
M+1H3Y9Y*C^\:Y,7\*,:VQU&12'!ZX-,\B'_GDG_?(H\B'_GDG_?(K@.8?P.F
M*7-1^1#_ ,\D_P"^13DC1/N*%^@Q0!7U2[6PTZYNWCDD6"-I"D8RS #. /6L
M8Z_)!H)U*=+-TRS*T=THC9>2NUCU;'&/6M^X5GA98W,;$8#@ [?P-8%MX?=+
M&9))XO/NG\VXQ;JT9;:%.U3TZ=>N<YS0 \^(?G5A9RBW#PQ2NS -&\N-H*^V
M],_7OBI=0US[)>S0K:O)';B)IY-X&P2,0,#OC&3[>O2H8O#4<(CBCNYOLH:%
MWB8 EVB"A26Z_P "9^E27&A&>[>5KV7$RQ+<)L&)/+8E<>F<X/MZ4 ,AUHWF
M8FM7BBN(9I()"X.]4(!R.V=P(Z\>G2BEAT7[$IE:ZDF2"&6.!&4#8KD$C(ZX
MP /;\Z* -JU_X]XO]P?RJ6HK7_CWB_W!_*I: "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH 1NE>'3?ZY_\ >->XMTKPZ;_7/_O&NS";LWH=1E%%
M%=IN%%%% '1^ ?\ D8XO^N;_ ,J]2KRSP#_R,<7_ %S?^5>IUYV*^,YJOQ!1
M117.9!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 4]:_Y!%]_P!<'_\ 037R
M57UKK7_((OO^N#_^@FODJNS"]3>CU"BBBNLV"BBB@#H/!_\ Q^3_ /7/^HKK
M*Y/P?_Q^3_\ 7/\ J*ZRF@"BBBF,**** -FQ_P"/./\ '^=3U!8_\><?X_SJ
M>N=[F04444@"GP?ZY/\ >%,I\'^N3_>% &U1116) 4444 %<?\2O^0=:?]=3
M_*NPKC_B5_R#[3_KJ?Y5I3^)%1W//Z***[#<**** "OH3X<_\B7I?_7,_P#H
M1KY[KZ$^'/\ R)>E_P#7,_\ H1KDQ?PHQK;'24445P',%%%% !1110 4444
M0WO_ !YS_P"X?Y447O\ QYS_ .X?Y44 +:_\>\7^X/Y5+45K_P >\7^X/Y5+
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-TKPZ;_ %S_ .\:
M]Q;I7ATW^N?_ 'C79A-V;T.HRBBBNTW"BBB@#HO /_(QQ?\ 7-_Y5ZG7EO@'
M_D8XO^N;_P J]2KSL5\9S5?B"BBBN<R"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I,TM9/BHE?#]\02#Y?4
M'%-*[L-*[L:V:,UX?]HF_P">LG_?1H^T3?\ /63_ +Z-=?U-]S;V+[GN&:,U
MX?\ :)O^>LG_ 'T:/M$W_/63_OHT?4WW#V+[GN&:,UX?]HF_YZR?]]&NX^&L
MCR#4-[LW,>,G/]ZHJ8=TX\UR94N57.XHHHKF,@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** *>M?\@B^_P"N#_\ H)KY*KZU
MUK_D$7W_ %P?_P!!-?)5=F%ZF]'J%%%%=9L%%%% '0>#_P#C\G_ZY_U%=97)
M^#_^/R?_ *Y_U%=930!1113&%%%% &S8_P#'G'^/\ZGJ"Q_X\X_Q_G4]<[W,
M@HHHI %/@_UR?[PIE/@_UR?[PH VJ***Q("BBB@ KC_B5_R#K3_KJ?Y5V%<?
M\2O^0?:?]=3_ "K2G\2*CN>?T445V&X4444 %?0GPY_Y$O2_^N9_]"-?/=?0
MGPY_Y$O2_P#KF?\ T(UR8OX48UMCI****X#F"BBB@"OJ5Y%I]A<7EP2(8(VD
M<@9. ,GBLI=;N5TO[7-HUX'W-^Y1XF.P<A\[\=,<9SFM>]C>6UECA,:R,I"F
M1-Z_B,C(_&N3C\.:E_8K6T5S96QN)1)/;I WDA-H!B4;\@$CD@\Y/ S0!J?\
M)+;&:$1P7+VTGE!K@!0D;28V!LG/.Y>@XW#-3:AKL-G?_9C;W$H01F:6,+MA
M#L57=D@GD'H#@<FJ3Z%=R766N;9;6:6">>-(2&,D>W 0[L!3L7J">#1=Z+?7
M%X\AN[<0W*Q"Z7R#D^6Q/R?-QD'!SG&* )XM<BOFFMQ;7$0>*1X99 NV94.U
MBN"2.2.H&0<T5!9Z/=6C;[FZAEM[6"6*V1(BK;7(/SG)R0% X [FB@#H+7_C
MWB_W!_*J.L:LFGRP0K!-<W$OS".%=Q" J&?Z#</<YJ]:_P#'O%_N#^58?BS3
M;O4Q!!:1VXW!D-RQ826I*G$B$$=QC'&<CL* -./5+>35Y-.42_:$B\XDH0I7
M('![]1TJO<Z]:6VHBTE68?O%B:;9^[20KN"$]B01VQR.:IW%GJ4.MOJ4,<$Z
M1V;0)'YA$DC?>!Z!1EACK[U5N- O;V5TNY+<6US/'=7 CSOWK&JE5SQMR@.3
MSC(QWH NQ^*[!T)V7*N0C0Q-'AYU<D(4&>0<'KC&,G JXNMVK:2=0 E\H-Y9
M39\_F;]FS'][=\OUKG5\,7YDLKF6>V-WIZ0QVZJ&".$W9+]P6#=LX([U832-
M1%F]B/LX_>?;C,V<-.;CS=@&<[0!C)]0?44 79/%EA';F1HKK<GF&:(1Y> )
MC>7&>@R.F<YXS5B#Q#8SZ@MK%YC!W,2SA?W32!=Q0-GK@$^G!&<C%8<GAK4"
MUW<1W%L+J^CFBN,AML8?:%*=R5"]\9]NE6=-\-S6-W;QK+$VG6UV]Y$.?,+,
MA7:>V 68Y[\#'>@#JZ**B:W1B2=^3Z.1_6@"6BH?LT?^W_W\;_&C[-'_ +?_
M '\;_&@":BH?LT?^W_W\;_&C[-'_ +?_ '\;_&@":BH?LT?^W_W\;_&C[-'_
M +?_ '\;_&@":BH?LT?^W_W\;_&C[-'_ +?_ '\;_&@"5NE>'3?ZY_\ >->V
M&WC _C_[[;_&O$YO]<_^\:[,)NS>CU&4445VFX4444 ='X!_Y&.+_KF_\J]2
MKROP(H?Q#&#G&Q^AQVKT[[-'_M_]_&_QKSL5\9S5?B)J*A^S1_[?_?QO\:/L
MT?\ M_\ ?QO\:YS(FHJ'[-'_ +?_ '\;_&C[-'_M_P#?QO\ &@":BH?LT?\
MM_\ ?QO\:/LT?^W_ -_&_P : )J*A^S1_P"W_P!_&_QH^S1_[?\ W\;_ !H
MFHS4/V:/_;_[^-_C1]GC_P!O_OXW^- $V:*^?+CQCX@2YE5=3F 5R ,+Z_2F
M?\)IXA_Z"<O_ 'RO^%=7U27<V]BSZ%HKYZ_X33Q#_P!!.7_OE?\ "C_A-/$/
M_03E_P"^5_PH^J3[A[%GT+1G'6OGK_A-/$/_ $$Y?^^5_P *ZSX9Z_JFL>(V
MMM1O99H1 S[3@<@KSQ]:F6&E%7;$Z32N>M45#]GC_P!O_OXW^-'V:/\ V_\
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MQKSSF)J,U#]FC_V_^_C?XT^.-8\[=W/JQ/\ .@!]%%% !1110!#>_P#'G/\
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M579A>IO1ZA11176;!1110!T'@_\ X_)_^N?]1765R?@__C\G_P"N?]1764T
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MY+_A0!-14/E/_P ]G_)?\*/*?_GL_P"2_P"% $K=*\.F_P!<_P#O&O;/*?\
MY[/^2_X5A-X.TIF),<F3R?WAK>A55-NYI3FH[GEM%>H?\(;I/_/.3_OX:/\
MA#=)_P"><G_?PUT_6H&GMD>7T5ZA_P (;I/_ #SD_P"_AH_X0W2?^><G_?PT
M?6H![9'(^ ?^1BC_ .N;_P J]3K#T_PU8Z?<B>T$B2@$ [L]?K6MY3_\]G_)
M?\*Y*U15)71E.7,[HFHJ'RG_ .>S_DO^%'E/_P ]G_)?\*R()J*A\I_^>S_D
MO^%'E/\ \]G_ "7_  H FHJ'RG_Y[/\ DO\ A1Y3_P#/9_R7_"@":BH?*?\
MY[/^2_X4>4__ #V?\E_PH FH/2H?*?\ Y[/^2_X4>4__ #V?\E_PH ^8[O\
MX^Y_^NC?SJ+%>[O\._#SNS-;2DL23^^;_&F_\*X\._\ /M+_ -_F_P :]!8J
M!TJM$\*P?2C!]*]U_P"%<>'?^?:7_O\ -_C1_P *X\._\^TO_?YO\:?UN _;
M1/"L'TKN?@[_ ,C:_P#U[/\ S6N\_P"%<>'?^?:7_O\ -_C5_1?!^E:->&YT
MY)(IBI3=YA;@^QSZ5%3$QE%Q1,JL6K'1"EJ'RG_Y[/\ DO\ A1Y3_P#/9_R7
M_"N$YR:BH?*?_GL_Y+_A1Y3_ //9_P E_P * )J*A\I_^>S_ )+_ (4>4_\
MSV?\E_PH FHJ'RG_ .>S_DO^%'E/_P ]G_)?\* )J*A\I_\ GL_Y+_A1Y3_\
M]G_)?\* )J*A\I_^>S_DO^%'E/\ \]G_ "7_  H FK(\5\>'K[_KF:T?*?\
MY[/^2_X5#=V*WEN\%Q([12###@9'X"G%V:8T[.YXM17J'_"&Z3_SSD_[^&C_
M (0W2?\ GG)_W\-=_P!:@;^V1Y?17J'_  AND_\ /.3_ +^&C_A#=)_YYR?]
M_#1]:@'MD>7UW7PQ^[J'UC_]FK6_X0W2?^><G_?PUH:7HEMI?F?8C)'YF-W.
M[.,^OUK*M7C.%D3*HI*QJ"EJ'RG_ .>S_DO^%'E/_P ]G_)?\*Y#$FHJ'RG_
M .>S_DO^%'E/_P ]G_)?\* )J*A\I_\ GL_Y+_A1Y3_\]G_)?\* )J*A\I_^
M>S_DO^%'E/\ \]G_ "7_  H FHJ'RG_Y[/\ DO\ A1Y3_P#/9_R7_"@#G_B/
M_P B7J?^XO\ Z$*^?NM?2^I:9%J=C+:7KO);RC#KPN><]1S7._\ "N/#O_/M
M+_W^;_&NJA6C35F;4ZBBM3PK!]*,'TKW7_A7'AW_ )]I?^_S?XT?\*X\._\
M/M+_ -_F_P :W^MP-/;1/"L'TI*]V_X5QX=_Y]I?^_S?XT?\*X\._P#/M+_W
M^;_&E];@'MHF'\#_ /CSU7_KHG\C7IU8NA>'+'0DE32Q)"LI!?+;LX^N:U/*
M?_GL_P"2_P"%<=62E-M'/.7,[HFHJ'RG_P">S_DO^%'E/_SV?\E_PK,DFHJ'
MRG_Y[/\ DO\ A1Y3_P#/9_R7_"@":BH?*?\ Y[/^2_X4>4__ #V?\E_PH AU
MG_D$7W_7!_\ T$U\E=:^N)K;SH7BEE<HZE6& ,@]>U<A_P *O\,?\^<O_?\
M?_&MZ-54[W-(343YVHKZ)_X5?X8_Y\Y?^_[_ .-'_"K_  Q_SYR_]_W_ ,:W
M^LQ-/:Q/G:BOHG_A5_AC_GSE_P"_[_XT?\*O\,?\^<O_ '_?_&CZS$/:Q/%O
M!W_'Y/\ ]<_ZUUE>BV7P[\/V3L]M;2HS#!/G,<_F:M_\(;I/_/.3_OX:I8J
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MX=_Y]I?^_P W^-'_  KCP[_S[2_]_F_QH^MP#VT3PG!KZ$^'/_(EZ7_US/\
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M_L>)O$,VIS".0M!%%&"O*%&<Y!]]X_*@!VEZS;:G)MMDE.(4E8LN F[.$/\
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MH7=(C<A1Y:NZAE4\[LD%>V/F%1Z_#/K%O%;:=<0")@LLPEB9DGC/1=PQP3U
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M$ DD= ,CD^M %^BHYYEAA:5]VQ1D[5+'\AR:CENXHKB"%V_>3DA!CK@9/Z4
M6**** "BBB@ HHHH **** "BBB@ HHHH **** (;W_CSG_W#_*BB]_X\Y_\
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M87R"C8XX.XAO?'K5O4-!;4/$#W,\K"Q:UCA:)"!YA61FPW&=O(Z$=\UT5&*
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MW.DZ@[1".2TAA)@7=@M*RH&SQQS'G/\ MFM'6M-N=1GTJ2.9[8P2M)*T3#<
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M>4KVP0HK*<NTX42% .GW#G\*2Y\7:;! DI\UA(D31XVJ',BLP7+$ $*I)R0
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M"07<-N)I-K+('V],-D??[]O?BDN/!]A<P2QS37+-,7,LF5#/O55;HN!PJ\@
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>proxy2pic.jpg
<TEXT>
begin 644 proxy2pic.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" &* ^@# 2(  A$! Q$!_\0
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M?9X?^>4?_?(J6B@"+[/#_P \H_\ OD4?9X?^>4?_ 'R*EHH B^SP_P#/*/\
M[Y%'V>'_ )Y1_P#?(J6B@"+[/#_SRC_[Y%'V>'_GE'_WR*EHH B^SP_\\H_^
M^11]GA_YY1_]\BI:* (OL\/_ #RC_P"^11]GA_YY1_\ ?(JCKFO:9H4*2ZO>
MPVJ.<)O/+'V Y-6M-O[;4[&*[L)DGMI1E)$.0><?S% $GV>'_GE'_P!\BC[/
M#_SRC_[Y%2T4 1?9X?\ GE'_ -\BC[/#_P \H_\ OD5+10!%]GA_YY1_]\BC
M[/#_ ,\H_P#OD5+10!%]GA_YY1_]\BC[/#_SRC_[Y%,N+N"W>))YHXWF;9&K
ML 7;T'J:BL-3MK^2Z2UD+M:S&"7*$;7 !(Y'/4=* +'V>'_GE'_WR*/L\/\
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M?9X?^>4?_?(J6B@"+[/#_P \H_\ OD4?9X?^>4?_ 'R*EHH B^SP_P#/*/\
M[Y%'V>'_ )Y1_P#?(J6B@"+[/#_SRC_[Y%'V>'_GE'_WR*EHH B^SP_\\H_^
M^11]GA_YY1_]\BI:* (OL\/_ #RC_P"^11]GA_YY1_\ ?(J6B@"+[/#_ ,\H
M_P#OD4?9X?\ GE'_ -\BI:* (OL\/_/*/_OD4?9X?^>4?_?(J6B@"+[/#_SR
MC_[Y%'V>'_GE'_WR*EHH B^SP_\ /*/_ +Y%'V>'_GE'_P!\BI:* (OL\/\
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M_GK'_P!\'_&C$W_/6/\ [X/^- $U%0XF_P">L?\ WP?\:,3?\]8_^^#_ (T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZG\:<5)/4FK4HR@U%:_\$TJ***T.,**** (;W_CSG_W#_*BB]_X\Y_\ </\
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MUH\B/^[^M $M%1>1'_=_6CR(_P"[^M $M%1>1'_=_6CR(_[OZT 2T5%Y$?\
M=_6CR(_[OZT 2T5%Y$?]W]:/(C_N_K0!+147D1_W?UH\B/\ N_K0!+147D1_
MW?UH\B/^[^M $M%1>1'_ '?UH\B/^[^M $M%1>1'_=_6CR(_[OZT 2T5%Y$?
M]W]:/(C_ +OZT 2T5%Y$?]W]:/(C_N_K0!+147D1_P!W]:/(C_N_K0!+147D
M1_W?UH\B/^[^M $M%1>1'_=_6CR(_P"[^M $M%1>1'_=_6CR(_[OZT 2T5%Y
M$?\ =_6CR(_[OZT 2T5%Y$?]W]:/(C_N_K0!+147D1_W?UH\B/\ N_K0!+14
M7D1_W?UH\B/^[^M $M%1>1'_ '?UH\B/^[^M $M%1>1'_=_6CR(_[OZT 2T5
M%Y$?]W]:/(C_ +OZT 2T5%Y$?]W]:/(C_N_K0!+147D1_P!W]:/(C_N_K0!+
M1FHO(C_N_K4%^BPV5Q(@PR1LP^H% %S-&:^</^%D^)?^?J'_ +\)_A1_PLKQ
M+_S]0_\ ?A/\*Z/JTS3V3/H_-&:^</\ A97B7_GZA_[\)_A1_P +*\2_\_4/
M_?A/\*/JTQ^R9]'YHS7SA_PLGQ+_ ,_4/_?A?\*^A;6-9;6%W&69 Q^N*SJ4
MW3W(E!QW+5%1>1'_ '?UH\B/^[^M9DDM%1>1'_=_6CR(_P"[^M $M%1>1'_=
M_6CR(_[OZT 2T5%Y$?\ =_6CR(_[OZT 2T5%Y$?]W]:/(C_N_K0!+147D1_W
M?UH\B/\ N_K0!+147D1_W?UH\B/^[^M $M%1>1'_ '?UH\B/^[^M $M%1>1'
M_=_6CR(_[OZT 2T5%Y$?]W]:/(C_ +OZT 2T5%Y$?]W]:/(C_N_K0!+FC.:C
M\B/^[^M2#@4 )1FJ-[J=M92*ES*L>8WER>@1,;F)[ 9'YU2A\2Z>UF+F61K>
M-IC HF0JS-G ('7!'/T-*ZO8M4YR5TC;S2YK+FUNPAU!+&2X"W+,$"[3C<1D
M+G& 2 3C.:2\UNQL[Q+2XN%2=MOR[2<;CA<D# R<@9ZFCF7</9S[&KFDSBL5
M?$^E,)<7:_NP&(*,"06V@KQ\W/'&>:GCUFRDTU[]9U-HF0SE2-I!P01UR#QC
MKFCF0.E-;IFGFBL-_%&DI;B9[K:A+ YC;<NW&[<N,C&1G(&,BI6\0Z<+PVRS
MAYL<*BD[CMW;0<8+;><9SBCF7<?L:G\K-C-%5K*ZCO;2&YMVW12H)$;U!&15
MD4S-JVC"BBB@"&]_X\Y_]P_RHHO?^/.?_</\J* %M?\ CWB_W!_*LGQG=06W
MAK4//OHK RPO%'/(^T*[*0O/7KZ5K6O_ ![Q?[@_E7-^/-#OM:BTTZ8;(RVE
MSYY2\4M&_P I'('7KF@#B_!_A%8?$.E:IHUK82:>,3-?1W)DQ^Y\MXPIZG?E
MMW;)'M7KHK@_!FA^)]#O9$N)-&&F7%P]Q+';HX92PZ)V R!7>"@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JIJ-
MC;ZA;O!>0I+$PY5A_G%6Z*+VV#T."DT_5O"4AET@O?Z5G+VK'+Q^I7_ZWY5T
MV@:_8ZU;^9:2?O /GB;AT^H_K6L17+:_X4CNI_MVDRFPU)>1)'PKG_: K3F4
M]);EW4MSJJ*XW2?%4MI=#3O$T(M+KHL^/W<GOGM]>GTKL%;<H(((/0BIE%QW
M)::W'4445(@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *JZI_P @V[_ZXO\ R-6JJZI_R#;O_KB_\C36X'R11117JH[0HHHI
M@%?75A_QXV__ %S7^5?(M?75A_QXV_\ US7^5<F*Z&%;H3T445QF(4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',:S9R3>(
M(I&MQ<V\EA/;F-^$+%D."<' 8 ]NU9MOI6K-X<GMXX.)I4>&"YNB[0(-I*ER
MN3R#QSC/6NWVBEVBH<+NYT1Q,HI*VUOP.-N='U!M0F8Q0_99KR"_=_,)=/+1
M,H!CDY0<^AIMQIVIZE++/]EAACU&.V:022?/;E&RRXQSQTZ<YKM-M&T4O9HI
M8J:V2_K^D>?'PSJS1Z9N2U5M*BCCB E)^T;948D\?+Q&,=>35G^R]1-I=6/V
M>/S[FY.HLP<B-&$R,D6<<DA3D]O3D5W&T4;10J:6PY8R<MU_7_#G R:!JXN[
MV_2&U,UXD\9A:4XB#K$JG..?]5D_7VHT[PQ>:9]DMW,;V-E=F^\\,3(V(2NW
M;CKD^O05WV*"H-'LD'UVI:VAD>$X)+?PYIT<Z&.18%W(>JDC./PZ5L"DQ2]*
MM*RL<TY<TG)]0HHHIDD-[_QYS_[A_E11>_\ 'G/_ +A_E10 MK_Q[Q?[@_E5
M?66C72[PSRRQ1"%R\D.=ZK@Y*XYSZ58M?^/>+_<'\JY#XCQ2RK8B*#Q!-C?G
M^R)0A'W?O^OM^- '.:'J7C4W/_$H@N-0TE%RK:U&MO*WLK Y.?4CZUZC9/)+
M:0O/%Y,S(&>/=NV,1R,]\'O7F?A2WN$\0V;/9^,XU#-EK^X#0#Y3]X9_R<5Z
MD* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH HZMI5IJMJ;>^A61#TSU7W![&N0:+6/!S;H2^I:*#DH
M?]9"/\_A]*[VD89ZU<9N.CV*4K:&?HNLV6L6PFL9@X_B7HR'T(K1S7(:UX4*
MW7]H^'YOL-\.2HXCD^H[?R_G3M$\6;KD:=KL7V'45X^;A)/H?\BFX)J\!N-]
M4=;11169 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 55U3_D&W?\ UQ?^1JU575/^0;=_]<7_ )&FMP/DBBBBO51VA1113 *^C[7Q
MOIR6L*&&YRJ '"CT^M?.%>E1_P"K7Z"HG3C4W)E%2W/2O^$YTW_GC=?]\C_&
MC_A.=-_YXW7_ 'R/\:\WHJ/JT"?91/2/^$YTW_GC=?\ ?(_QH_X3G3?^>-U_
MWR/\:\WHH^K0#V43W&WE$\$<JYVNH89]ZDJKI7_(-M?^N2_R%6J\Y[G,PHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!I<#K1O&.]<SK]S=
M?VTEK:3K;,-/N)DDD/R"0%%4L.X&3^=8UO<W,'A^\2.\NX;NSO%,QD>.7<79
M6(5@/NG<3T!&>W%0YVT.F&&<DG?<] W"DWBN2O;JYLO%-O+=7$S6-U,EO#'%
M*NU7\LD[TQDCC.0>..U5-;U.Y.JW<EMJ31K:BU,$$979-YCD'/'S9Z#!XQ1[
M1#CA92:2?2YW.X>]&X5Y?_;.HK'IV-4F;^TH(I+DDKFU+31I\O'R\,Z\YY7/
M7-:T>KW2>&K]3?%I8KYK6*Y)7?Y0F5"_3!VAB,XQQS251,N>"E'J=UN%)O%>
M:3:E?+<:A8MJ\\5M9K=21W6Y=SF-(B QQ@A3(X/K@9Z4[2]6U*]N;*6ZN98Y
M[F]-G-9 A0D?D%]P&,@YPV<]#255#>!DE>YZ5NI:R/"L\ESX=T^:=R\K0KN<
M_P 1QU_'K6N*T3NKG'.+A)Q?0****9)#>_\ 'G/_ +A_E11>_P#'G/\ [A_E
M10 MK_Q[Q?[@_E537XKF?1-0BL'\N[>W=87!QM<J<'/;FK=K_P >\7^X/Y56
MUSRSI%Z)X1/%Y+[HF<('&TY!8\#/K0!YIX?\+ZAIGB[3)5M;ORE*S2W$UZ9%
M4&#:\97=RWF9(/(P:]9%>2:#H"P^*]#O++PM!H<2M(7FDODF\Y2APJ*">>^1
MV]J]:7I0!4UB2YATRXDL(A+=*F8TQG)^F1GZ9%<AJOBE]-\.CR;Z"?4AO)-S
M$82H3!8,A.2WS*/^! ]*[2_MDO+26WD+!9%VY1BI'N".AJC'H.G#3&L9(!-"
MX(D,A+-(3U);J2?6@"+5;JZDNK*UTZ>&)KA))?.=/,&U0N, $=2P_ &L&#Q/
M?2VD>I'R!;+)!%+;A#N8R1HQ96SV,@XQT%=#+H5I=&4W?FREY/,4B5D\OY0F
MU2I&%P!D=^<U(N@Z:MW'<+; 21XV@,P08&T'9G;D#@'&<4 9?AW5;VZO%@OW
MA?SK&*]0QKMV;B04/)SCC!^M9R^(-26.Q)DMS_:<4<D/[HC[.6D12#S\WRR#
MTY'O6_%X>LK95%F)+<!T9MLC,2J$E4R2<(#_  C _.E3PYI2I,HM3B4 ',CG
M: VX!.?D /.%QS0!S,OB;4]NIQQM;";2H9II7,9Q<!&(4 9^7(4YZ\]*[N%M
M\2N 0&&<&LN3PWI3QQ1M:Y6/<!^\;YPQRP<Y^<$C)W9R>M:X&!Q0 QI%5L'.
M?8$TGG)_M?\ ?)J2B@"/SD_VO^^31YR?[7_?)J2B@"/SD_VO^^31YR?[7_?)
MJ2B@"/SD_P!K_ODT><G^U_WR:DHH C\Y/]K_ +Y-'G)_M?\ ?)J2B@"/SD_V
MO^^31YR?[7_?)J2B@"/SD_VO^^31YR?[7_?)J2B@"/SD_P!K_ODT><G^U_WR
M:DHH C\Y/]K_ +Y-'G)_M?\ ?)J2B@"/SD_VO^^31YR?[7_?)J2B@"/SD_VO
M^^31YR?[7_?)J2B@"/SD_P!K_ODUF:YI=AK5L8;V(M_=<*0R>X.*UZ,4TVM4
M!Y_'=ZMX1?9="34M&!XE /F1#W]OT^E=AINK6>HVPGLYA+&?[H.1['T-7FC5
ME*L 01@@]ZX[5/"T]C>'4/"\OV:XZO;D_NY/;V_STK2\9[Z,NZEON=?YR?[7
M_?)H\Y/]K_ODUS?A_P 5Q7TWV+4HS8ZFO#12<!S_ +)_I73]JSE%Q=F2TUN,
M\Y/]K_ODT><G^U_WR:DHI"(_.3_:_P"^31YR?[7_ 'R:DHH C\Y/]K_ODT><
MG^U_WR:DHH C\Y/]K_ODT><G^U_WR:DHH C\Y/\ :_[Y-'G)_M?]\FI** (_
M.3_:_P"^31YR?[7_ 'R:DHH C\Y/]K_ODT><G^U_WR:DHH C\Y/]K_ODT><G
M^U_WR:DHH C\Y/\ :_[Y-'G)_M?]\FI** (_.3_:_P"^31YR?[7_ 'R:DHH
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MY/\ :_[Y-244 1^<G^U_WR:/.3_:_P"^34E% $?G)_M?]\FCSD_VO^^34E%
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M5A>'?$MGK2E8R8;I.)+>3AE]?J*W:S:<79DM-;A1112$%%%% !1110 4444
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MSQN?^^1_C5^QGV*Y)=CILS_W(_\ OL_X49G_ +D?_?9_PKF?^$YT[_GC<_\
M?(_QH_X3G3O^>-U_WR/\:/8S[!R2['3YG_N1_P#?9_PHS/\ W(_^^S_A5;1]
M2BU6S6YMPZHQ(PXP>#5ZH::T9&Q%F?\ N1_]]G_"C,_]R/\ [[/^%2T4@(LS
M_P!R/_OL_P"%&9_[D?\ WV?\*EHH BS/_<C_ .^S_A1F?^Y'_P!]G_"I:* (
MLS_W(_\ OL_X49G_ +D?_?9_PJ6B@"+,_P#<C_[[/^%&9_[D?_?9_P *EHH
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M%F?^Y'_WV?\ "C,_]R/_ +[/^%2T4 19G_N1_P#?9_PHS/\ W(_^^S_A4M%
M$69_[D?_ 'V?\*,S_P!R/_OL_P"%2T4 19G_ +D?_?9_PHS/_<C_ .^S_A4M
M% $69_[D?_?9_P *JZF9O[-N\I'_ *IOXSZ?2K]5=4_Y!MW_ -<7_D::W ^2
M****]5':%%%%, KTJ/\ U:_05YK7I4?^K7Z"F@'4444QA1110!O1_P"K7Z"G
M4V/_ %:_04ZN8R"BBB@ KT323-_9=KM5"/*7&6([?2O.Z])T?_D%6G_7)?Y5
MA7V1G4)\S_W(_P#OL_X49G_N1_\ ?9_PJ6BN8R(LS_W(_P#OL_X49G_N1_\
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MD?B__D9+[_>'_H(KURO(_%__ ",E]_O#_P!!%=.$^)FM'<QZ***] Z0HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD/YLFT-M7:<G!!!X]C5JU_X]XO\ <'\JJZ\UHFBW[:DNZR$#^>!W3:=W3VH
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MI:K/93++&>N.H]B.QI2@UJMA.-B[1114$A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !575/\ D&W?_7%_Y&K55=4_
MY!MW_P!<7_D::W ^2****]5':%%%%, KTJ/[B_05YK7I4?W%^@IH!U%%%,84
M444 ;T?^K7Z"G4V/_5K]!3JYC(**** "O2='/_$JM/\ KDO\J\VK<MY'$$>'
M;[H[^U958\R1$U<[G-&:XKS9/[[_ /?5'FR?WW_[ZK'V7F1R':YHKBO-D_OO
M_P!]4>;)_P ]'_[Z-+V?F'(>8_$C_D=M4_WD_P#0%KFJVO&1+>);TDDDLO7_
M '16+7J0^%(ZX[!1115# U[W\*_^1'L/K)_Z,:O!#7O?PK_Y$>P^LG_HQJY<
M7\",JWPG6T445YYRA1110!CZAI#7&K0WL4IB9;>6W8K]X!BI!''4%?UJC#X7
M<64D<NJWAN;@[KF=5C!F^4+C!4@# [#/O7345/*MS55YQ5DSFD\)6L$Z26LL
MZ11F.1;;>/+:1$"(S<;N %[]@:/^$6$LD,MW?7,DVR%;D*5"7+1G()&,CGT(
MSWKI:*.1#^L5>YRR^#+01[3=WC>6JI;$LN;95<. G'J%ZYX %._X1;]R]J;R
M8VCAI'.1YCSLX?S2<8RI48 &.?85T]%')$?UFKU9RTW@ZVE1C]LO5N)/,$UP
MKKOF60*&!^7 &$7& ,8XJ6'PK;6ET+BT9PL;F>&U+ 0K+LV;NF>GOCG.*Z2B
MCDB'UFK:SD4-#L3IVD6=FS!VAB5&;IN..3^)J_1132LK&,FY-MF1XNN'M/#U
MY<1WMO8F-0WGW$?F(@R,Y7OD<#W(KBOAW<Q:QXCN=2?7K:_NH[;[/Y%O9M;8
M7?G<P;EN>/;FNZ\1:6NL:;]D:3R_WL4H;;N&4=7 ([@[<5B^'?"LNEZY<ZA<
M7_VA29A;Q+"$$2RR>8V3DECG'IBF(Z:]_P"/.?\ W#_*BB]_X\Y_]P_RHH 6
MU_X]XO\ <'\JJ>(&@71-0-Y(T5L+=_-=1DJNTY('/.*MVO\ Q[Q?[@_E5+Q(
M)#H&I"WQYQMI F4W\[3CY<'/TP<T >4:#HL6JW>F)"WCFW@0$VMS-(JQPJ5/
M(/\ ""../6O8[.'[/:Q0F227RT";Y#EFP.I/<UY3\/@L5_I,+OXS6=$VM'=Q
MLMJ"$.0>/NCM^%>N"@"GK$7GZ9<1_9TNMR8\EVVA_;.#BN;72M7DT:.T=4DM
MII&:6&>Y9G2$@8AWE23SG)/(''O78=:* .>N$U&XU"*ZMK2)3:F2!4FE*B16
M5"6!"G&&7'N,FLNW\*WL-FNG>9 UJTL$LD^XAQY<:*0JX[E <YZ'I7:!0.E+
M0!R6EZ?J.F7-I//!%+(MM!IZK#(2-JDEI&)' QT'KQGFJZ^'-2:+3MWV8-ID
M4<4($K'SMLB,2WR_+D1CUP3[<]J0#UH Q0!PLGA74C_:DB-:^;JD,T,REVVP
M;W)!7CYL G/3D5V\*>5$J DA0 ,T^B@"-XMS9WNOL#3?(/\ SUE_/_ZU344
M0^0?^>LOY_\ UJ/(/_/67\__ *U344 0^0?^>LOY_P#UJ/(/_/67\_\ ZU34
M4 0^0?\ GK+^?_UJ/(/_ #UE_/\ ^M4U% $/DG_GK)^?_P!:O)_%HV^(KT9)
M^8<GZ"O7:\C\7_\ (R7W^\/_ $$5TX3XF:T=S'HHHKT#I"BBB@#TWP'$6\.Q
M'>Z_._ /O71>0?\ GK+^?_UJPO '_(N0_P"^_P#.NCKR:GQLXY?$R'R#_P ]
M9?S_ /K4>0?^>LOY_P#UJFHJ"2'R#_SUE_/_ .M1Y!_YZR_G_P#6J:B@"'R#
M_P ]9?S_ /K4>0?^>LOY_P#UJFHH A\@_P#/67\__K4>0?\ GK+^?_UJFHH
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MJ/[B_04T ZBBBF,**** -Z/_ %:_04ZFQ_ZM?H*=7,9!1110 #K6S;_ZB/\
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MPHHHJ"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MITKL8W$D:NOW6&10 ZBHWFC0X>1%/H33?M,/_/6/_OH4 345#]IA_P">L?\
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MZN889#<$A9'"D_*OK7HD<D<B[HV5AZ@YKRWX:>'M-UO09I]1@,LRSE _F,I
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M#_D7(?\ ??\ G71UY-3XV<<OB84445!(4444 %%%% !1110!XQ\:?^1CL_\
MKU'_ *$U>?5Z%\:?^1BL_P#KU'_H35Y[7JT/X:.RG\*"BBBM2PKU7X(?ZO6/
MK%_[-7E5>J_!#_5ZQ]8O_9JPQ/\ #9G5^%GJ8HH%%>8<@4444 %%%% !1110
M 4444 %%%% 'C.O?\AR__P"N[_SJA5_7O^0Y?_\ 7=_YU0KUX?"CMCL%%%%4
M,*]A\+_\B]I__7%?Y5X]7L/A?_D7M/\ ^N*_RKDQ?PHQK;&I1117"<X4444
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M>IY%17?_ /"K=7_Y^;3\V_PH_P"%6ZO_ ,_-I^;?X5W>WI]SH]I'N<!17?\
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M ]14U% $+6L+B(-#$1$<IE =GT]*F%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:"S#"9]MN<<9Q[T:O);GQ+*FLO/':?9D%IM9U4N6;?C;_'PF.^.E=7M%&T4
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MWG.:T]!OM1EOX([Z19(Y[/[1Q%M\M@X&W\B.OH?I72;11M% 'GHU35K2]O\
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M ;=Q )&0<9S@<9- &S1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHS7,_:)O^>TG_?1H^T3?\]I/^^C0!TV:,US/VB;_ )[2?]]&C[1-_P ]I/\
MOHT =-FC-<S]HF_Y[2?]]&C[1-_SVD_[Z- '39HS7,_:)O\ GM)_WT:/M$W_
M #VD_P"^C0!TV:,US/VB;_GM)_WT:/M$W_/:3_OHT =-FC-<S]HF_P">TG_?
M1H^T3?\ /:3_ +Z- '39HS7,_:)O^>TG_?1H^T3?\]I/^^C0!TV:,US/VB;_
M )[2?]]&C[1-_P ]I/\ OHT =-FC-<S]HF_Y[2?]]&C[1-_SVD_[Z- '39HS
M7,_:)O\ GM)_WT:/M$W_ #VD_P"^C0!TV:,US/VB;_GM)_WT:/M$W_/:3_OH
MT =-FC-<S]HF_P">TG_?1H^T3?\ /:3_ +Z- '39HS7,_:)O^>TG_?1H^T3?
M\]I/^^C0!TV:,US/VB;_ )[2?]]&C[1-_P ]I/\ OHT =-FC-<S]HF_Y[2?]
M]&C[1-_SVD_[Z- '39HS7,_:)O\ GM)_WT:/M$W_ #VD_P"^C0!TV:,US/VB
M;_GM)_WT:/M$W_/:3_OHT =-FC-<S]HF_P">TG_?1H^T3?\ /:3_ +Z- '39
MHS7,_:)O^>TG_?1H^T3?\]I/^^C0!TV:,US/VB;_ )[2?]]&C[1-_P ]I/\
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MHS7,_:)O^>TG_?1H^T3?\]I/^^C0!TV:,US/VB;_ )[2?]]&C[1-_P ]I/\
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:T =!><VDW^X?Y45SSSRE&!ED(P>K&B@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>yw0d_zeropage1.jpg
<TEXT>
begin 644 yw0d_zeropage1.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" 4. ^@# 2(  A$! Q$!_\0
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M\&M:E;64M_+Y-LLSA?,?&<#^63QD@=2 =<'(R*^$XXM?_:$^+)=C);:<AY8
MLEE:@\#KC>?U8GH!Q]P:+IT&D:19:=9AUMK2%8(@[EV"J,#).2>!0!<HHHH
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MW$@%] @P()6.!( .BL< ^C'WX]?_ &;/B9:>,_"-OI$_EP:UI,"0RPCCS8E
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MPY\3SP:+I:2II5TZ.EI&"I$+$$$#@T <!_PU3X(_Z!?B3_P&A_\ CU;^K?M
M>%=+\*:!X@N+#6VLM::X6W1((C(ODN$;>#( ,D\8)_"N9_9'T+2=2^%<L^HZ
M78W<PU&91)/;I(V L?&2.E<[^V1!9:4W@!(+:*"SAGNV,,,850,P$X4<<\T
M=3_PU3X(_P"@7XD_\!H?_CU>D?"WXDZ/\2=/O;S0K:_@BM)1"XO(T1B2,\;6
M;BO)_P#A>?P?_P"A;D_\%,'_ ,57M?@&[T75?#=IJ_ARQBL[#4$$R*D"Q$CD
M#<%XSQ0!T=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX1\C#?*2< \\$G\:\HUKX%:/J&N37EKJ%S86DS;I+6!1QZ[7SD#H1D'! [
M>G^'M9LO$.B6>K:5*9;&\C$L+E"I93T.#R*J>$O%.D^++&YN]#N&G@MKE[21
MFC9,2)C<,,!GJ.: -6S@-O;10M+),8T">9(<NV!C)/J:XWXB?"_PW\0;BRF\
M207$KV:LD7E3M'@,03G'7H*[6:1887DD.$12S'V%>2_\-%?#;_H,W'_@#-_\
M30!5_P"&:_AW_P ^5_\ ^!CT?\,U_#O_ )\K_P#\#'KT?P1XOT;QMHQU7P[<
MO<V0E:$NT31G> "1A@#W%7_$6M6/AW0[S5]6E,5C:1^9,ZH7*K]!R: /*?\
MAFOX=_\ /E?_ /@8]=#X%^#7A'P/KHU?0+>ZCO1&T0:6X9QM;&>#]*RX_P!H
M?X;/(J?VY*NXXW-93 #Z_+7I^E:C9ZMI\-]IEU#=V<Z[XYH6#*X]010!;KR;
M7?@!X%US6K_5-0M+UKN]G>YF9;IE!=V+-@=N37K-<MXB\?>'/#OB32M!U>_\
MC5-495MH?+9MVYMHR0,+EN.: .!_X9K^'?\ SY7_ /X&/1_PS7\._P#GRO\
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M=/F;.=WZ4 >DT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ#(Q7@_A#X=?%OPCX>M=$T/Q=X>AT^UW^4CVA<C<Y<\E,GEC0![3X5OKS4M
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M$8@/T!.2NX#ZYK%\-_"3P;I6@6%A<^&M%O;BW@2.2YGLHY'E<#YF+$9))R:
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MXYX4^'_Q>\*^'[31=&\7>'HK"U#+$C6A<@%BQY*9/)- 'MGA^ZN;[1+&[O[
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M=1_Z^;?_ -&"O9*X3XU>#+OQ]X!NM!TZY@MKB:6*023YV@*V3T!- '=UX/\
MM1237LO@?PY/+);Z+K&K+%?3*P7"AD &3Q_&QY[J#7O%<C\4/ NG_$'PO)H^
MHN\+JXFMKE!EH)0" P'<<D$=P>QP0 :)\)>'SX<.A'2+#^R-FS[+Y"^6!ZX]
M>^>N>>M:FF6-KIFGV]EI\$5O:6Z".**-<*BC@ "O$QX.^-7]FKHG_";:*-.P
M8FU$1.;TQGC^YC=CONW9/WL\U[%X9TR71M"LM/N+^YU&6VB$9NKG;YDF.[8
M_P ?4DY- '"?M!>!]2\=>"H;30W@_M"SNTO(X)\;)]JL-A)XYW=^.,'UKCHO
MB9'::YHUM\5_A[_8=Q'.J6NJ-&L]O'-V*MM^3_@+-CKTY'J'Q*\-ZWXCTF!/
M#/B*XT+4;687$<L:ADE(!PD@ZE>>G(]0:\YU;X;?$/QQ/IEC\0]?T,Z!97"W
M+1:7$XEN64$ L64;3@D<'')XX% 'NBG(I:11A<4M !1110 4444 4=;TBPUW
M39=/UBTAO+&7;YD$R!D?!##(/H0#^%<O_P *H\!G_F4=%_\  1:[:B@#B?\
MA5'@+_H4=$_\!%H_X51X"_Z%'1/_  $6NVHH XG_ (51X#_Z%'1?_ 1:["RM
M8;&S@M+2)(K>"-8HHT&%15&  .P %344 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVV'!Q)CY3O"]"#^% 'T!17F]]\:/!%CX3L]?DU5S8WCR1VRB!_-E9.&PA&<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBX&>N1G!KW']G?6?$NK^$+Y?%R:E]IM;YX;:;4;8P3RP;5*EE/4Y)&<GZG%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ?'Y-LK*3Y:;MVSKRN><'(K?U_0M-\0:9)IVL6<5W92%2T4@XR#D'U!!'44
M?/WA^YU[4VTW0M2U76]._P"*KNK"18M4:6>*'[#YODFXZN%9CACR..A (O72
M^+[KQQK=MX>NM6NY/#]U86MKYNJA(/)$<;.+B-B#,T@9\N<G.,'BO8-(\"^&
M]'6W&F:3;VPM[EKR(1Y 69H_++]>I3@TNI^!_#>J:_;ZWJ&D6L^JV[(\=RR_
M,&3E2<=2.V>E '1KRH^E+0.!10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[XSWQT[5S;>#_$>HZ@FHZHNF0W+>%[K19([>9W43/(A5@2H.W"9)Z@G&#UH
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MZC!(!ZK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN+;RY0PFC4J&92.H&Y?SKRWX;P7DWP[U2UL;;1Y_%=EK%\H2]4BT6[$S;VC
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$!20?7;D>Q% 'D'PU^*#'QWXL\4^*-8\1C3K/SIX-/<Y@V,X1(2F[:)1N3
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MUET>,13RN $9WDD8!><G"A23_M#T->T4 %%%% !1110 4444 %%%% !1110
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MR@E>Q)X&:]"Q1@>E 'D'PX3Q%(_A^]U>?6?.,EO;W$,Y<1^6=*BD=F0\ _:
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M  ?A4^*  '(R*\=^'W_)Q/Q4_P"N6F_^B!7L5>._#[_DXGXJ?]<M-_\ 1 H
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MJY_]%F@"3X0_\DI\'?\ 8'M/_1*UUU<C\(?^24^#O^P/:?\ HE:ZZ@ HHHH
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MVR;O;:0: /I&9HXHV>4A44$LS'  '4FDMQ"\2O!L,;#<I7H1ZC%?.?C_ .+
M\3Z7-H,>C1W6F7GA@ZO?21W#*\!\LN$! [-Y:Y/][IVK/T+XP7WAG0/!_ACP
M=X62^GFTI;M8I[PECEG.Q. 6.%)P.3G 7B@#Z<$\(G\@.OG8W;,\XSC./3-/
M>-'^^H..F:^9[[QC9:5\=(]?U[1)]/U"/PY]LN4-WDQ_N2YBV[1EL_+R1SCC
M-;G@KX[ZKJGB+1K/Q'X7&E:?KD4CZ;=+,7$A&< \<@D8SQU!Q@T >^[!Z4T1
M(&+!0&/4XYKYP\)?M#Z[J>H:#)JOA.*WT35K_P#L]+V&=CB3*@X!';>IYQGG
M'0U;TSX[>)KF75=0D\(0MX9TNYF@N[^*X.4**2!@_P 1^4#ME@,\T ?0OEIN
MW;1NZ9[TGE("2%&3U/K7SYX7_:!U.]U""#7O#$6FP:C8SWNFS"ZW"3RU=@K9
M ^\4*]CG'&"*K^#/V@];U75?#IUGPK#::)K5[]@AO89RW[W(7&,=BR]<<9QG
M% 'T8R*PPP!'3!H6-5&%  ]J^<YOVCKU+U]23PMO\&)J7]G'4Q<?,6QG(&,9
MV_-CTXS5R/XT>-=6\9>(M%\*^"[?5(M(OGM'G6=AA?-9$9O3.PGVP>PH ]\C
MEADD>-&5GC.'4')4D9P?3@@T]HD;[R@_49KY(^#7Q!UWP;X/\=:Q>>'_ +3I
M<%]+<RS_ &@ B\=X8Q >IP ^XM@]*]K^#?Q \0^.([J?6O#<>F6*PQS6UY%<
M>9'/NS\H.,$C'.#D'@@&@#T[  Q2+&BYPH&>OO7B'C?XTZSIWC75M#\(^$I-
M>31HT>_D21@PSMR%55)XW =SD$XP,UF^+OC]JMAJVIP:!X2:]M-&ABDU62:?
M:;9VP&3Y<C*L2I/JK<8&: /H#RDW9V+G&,XIVT5\]>*?C]JL&J01^%O#<6I6
M3Z.FLN\TQ1XHMI9]P''RXP<'KTS5GX>?'?5O$OBSP]I^J^%X].TW7EE-G=)<
MF0L8]P/89&Y&7MC(/U /8]0\2Z+I_B"RT6\OHHM6OE+6]L<EY ,Y(QVX/Y&M
M9DC9AN4$]B>U?-VG:':?%GX\^.IM3DF;1M)L_P"QXS&0K*YRC;20>XG/?[PK
MA?A]\,=*\3_$KQ=!X7:X_P"$<TFTN+*&YN&60S7$D3Q @X (R7<8[*OK0!]F
MD*!GWKA-.^'T-O\ %:_\<W6H27-Q/:BT@MFC 6W7"C(.><X/I]XU\KZ3J,_C
M/P7\.OAZS2>;'K<\=S&02T<:E2&(]EFE]<;.HZ5D>+(/#4?BOXEW>I:M?V'B
M*TUFX.D0VRG9*?/?=N8+\N!C'S+^/2@#[Z?:1\PSGM2(B!<(H ]!Q7QW\=O$
M.L7_ ,&_AUI.K+/+JUW"VH7.]29"L2;5=N^2KEB3Z$G%?3/PCUS_ (2/X:>'
M=4+;I)K-%E.,9D0;'_\ 'E:@#K$14&$4*/84ZBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *\?UWX<W.H:?XTN9(IYM2O+JXDTR%KK$*"2)$+A<[0
MQ&X$MR!Z9KV"B@#PS4? &N'5M>O(X+J:YN;J5O.W6;1SVDMS%(41)(RQE2--
MJ^:2JE..HQ6L/A[XB@@TF*TL8[34AIT]E/?SR0R);AOM/EM&%&])5:5?F3"E
M78'H,>^44 >1Z+X)O[3X7^)=*M;>[M=0U&$@6UU);E&<0(A"^2JJJMMVY(R?
MO'DXK$UGP)K>I6EP+70+2SBO!>006GG1@:;),T&RZ&WY=RB-R=GS D8SDFO=
MZ* .#^('A=_$-];3+907/V>RF2)I-N8YC-;NI7/0XC;D>GO7!)\.M<_LC48I
M]-MI)T2T23]ZA_M62*_\]YFSP"4R!OYR[#@#)]YHH \K^*O@W6/$;Z--H4<=
MJ\=I/%,-ZKY;@)-;\CJ%GAC''8DU2;X?WG_"%ZM;'3[>36KC3+:".9V5G,N"
M9AO)R 79CUP<U[#10!X1K7P[U.\L5M)-+F%DNH:J\T5C+:H\ZW,I>&<&564%
M$)CY ==V5X&#TGQ,\(ZKKEW9K8VZ7R&P>R2:>15:RF,L3?:N>I"H>5^;( '4
MD>IT4 >+:YX2U_4[?4K:3189((;J2> O<QL+M6U1+K: ?NYB4CYL<D@\<D?P
M;K,FM:K)8:)#96=U?65X6FEB>4M'>P2OY;K\PC$<;$HW1L!>*]IHH ^?[7X?
M:]_8UM!)HJV8M5T^.[CM)+8OJ9A6Y627#J8]Q::*3$@YV=0<$=QKGA.X/@_P
M396=@]^-%N[::2VO)8VD,:1.A!8@(S#</0';QVKTBB@#Q+7/AUJ$JQ2V5@J9
MN5GOH[;R!)=J)[A@#Y@,;$"9'^<8.W&0<$=)K/A>Z@\%^#K"UTQM7BTB:)I]
M.OIHF:6,6\D85G("$HSHW3G9Q7I-% '@,?PQU.5HQK%EJ%VJZ9!#&MG=VT2Q
M[;#[/);EF4R<MO(VMY9,@)QM.4O?"&N6=CINH:II>GFQTV(/<VI-O"LT27AD
MQ(!B(/LQ(Q'RE@?6O?Z* /&/"_A:YO=-T'6;;2+6"YCM;![0RJ%-OM-P77H&
M"XE48P,@].*R?"?P^U_3];TW4=1TF.0Q:A%-*&^RJ8R;1XGE18PJ!5E*L !O
MPJGDCCWVB@#P30OAWJVE:78/=:-+JMU;W4'VZRNIK4P7PCAN(S*F$7^.97S+
MESM /(R=?QSX/\0:I\*_#OA^SM(Y)[?3?L]U&I@+I,+4HFUI05"[\ABN'P?E
M/6O9** /(/$O@.\O;&6:*P1[EM6AN)Q"(#-<VRVJ1%-TJE#B0!]KC!\OC!P:
MP8_AUK7]JHMUI]S=:9%I\MBJ_:+9)'@-DL2QF54#M+OW@LQV8V8&,X]]HH X
MOX96FKZ5HMOIFJZ7#:K&)G$L7E)P93L#I'\ID*_,S*-N2>YKM*** "BBB@ H
MHHH **** "BBB@ HHHH **** "O'?A]_R<3\5/\ KEIO_H@5[%7F/C#X'^#?
M%OB.\US68+U[^ZV>:T=RR*=J!!@#V44 =%)X,BN?B3'XMOKIKA[6R^R6-J4P
MML6)\R0'/+,#CITSUXQU;#*D>M>,_P##-GP]_P"?;4?_  ,:C_AFSX>_\^VH
M_P#@8U '4>"OA]+X,\5:K=:'JOE^&]0)F;16@RD$Y/+Q/GY1_LXQCZ#%WXS?
M\DE\8?\ 8*N?_19KBO\ AFSX>_\ /MJ/_@8U'_#-GP]_Y]=1_P# QJ .Y^$/
M_)*?!W_8'M/_ $2M==5'0M+MM#T6PTJP#+:64"6\(9MQ"(H49/?@5>H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?#F^UFQN+Z>];S@T<=RK21IL3Y?F.U6<,A)R!@=ZSOAC'XY\"?\ "5ZYX?\
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M_P#P:3__ !-'_"GOBG_T,D?_ (-)_P#XF@#[6HKXI_X4]\4_^ADC_P#!I/\
M_$T?\*>^*?\ T,D?_@TG_P#B: /M:BOBG_A3WQ3_ .ADC_\ !I/_ /$T?\*>
M^*?_ $,D?_@TG_\ B: /M:BOBG_A3WQ3_P"ADC_\&D__ ,31_P *>^*?_0R1
M_P#@TG_^)H ^UJ*^*?\ A3WQ3_Z&2/\ \&D__P 31_PI[XI_]#)'_P"#2?\
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M_P"ADC_\&D__ ,31_P *>^*?_0R1_P#@TG_^)H ^UJ*^*?\ A3WQ3_Z&2/\
M\&D__P 31_PI[XI_]#)'_P"#2?\ ^)H ^UJ*^*?^%/?%/_H9(_\ P:3_ /Q-
M'_"GOBG_ -#)'_X-)_\ XF@#[6HKXI_X4]\4_P#H9(__  :3_P#Q-'_"GOBG
M_P!#)'_X-)__ (F@#[6HKXI_X4]\4_\ H9(__!I/_P#$T?\ "GOBG_T,D?\
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M_P!#+'_X-)__ (F@#[6HKXI_X4_\4O\ H98__!I/_P#$T?\ "G_BE_T,L?\
MX-)__B: /M:BOBG_ (4_\4O^AEC_ /!I/_\ $T?\*?\ BE_T,L?_ (-)_P#X
MF@#[6HKXI_X4_P#%+_H98_\ P:3_ /Q-'_"G_BE_T,L?_@TG_P#B: /M:BOB
MG_A3_P 4O^AEC_\ !I/_ /$T?\*?^*7_ $,L?_@TG_\ B: /M:BOBG_A3_Q2
M_P"AEC_\&D__ ,31_P *?^*7_0RQ_P#@TG_^)H ^UJ*^*?\ A3_Q2_Z&6/\
M\&D__P 31_PI_P"*7_0RQ_\ @TG_ /B: /M:BOBG_A3_ ,4O^AEC_P#!I/\
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M_P"ADC_\&D__ ,31_P *>^*?_0R1_P#@TG_^)H ^UJ*^*?\ A3WQ3_Z&2/\
M\&D__P 31_PI[XI_]#)'_P"#2?\ ^)H ^UJ*^*?^%/?%/_H9(_\ P:3_ /Q-
M?0W[//AO7_"_@N\LO%-Z+V]DOWF203M-B,QQ@#+ 'JK<>] 'J%%%% !1110
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M2'P]_P"A>_\ )VX_^.4?\*0^'O\ T+W_ ).W'_QRO1Z* /./^%(?#W_H7O\
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MD/A[_P!"]_Y.W'_QRO1Z* /./^%(?#W_ *%[_P G;C_XY1_PI#X>_P#0O?\
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M2*5"K(0.00>0:ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KE/BIX>E\4^ M6TNU;;=R1B2 YQF1&#J/Q*XS[UU=% '+?#7Q5
M#XM\+6MXIV7T2^3>P-P\,R\,K#J.>1[5U->>^)OA],_B"3Q'X,U5M"UR3_CX
M 3?;W?\ UT3U_P!KGUQGFJ\5_P#%6!3'/HWA>[=3CSH;J2-6'T;)_E]* /2J
M*\X_M7XH?]"YX=_\#W_PH_M7XH?]"YX=_P# ]_\ "@#T>BO./[5^*'_0N>'?
M_ ]_\*/[5^*'_0N>'?\ P/?_  H ]'HKSC^U?BA_T+GAW_P/?_"C^U?BA_T+
MGAW_ ,#W_P * /1Z*\X_M7XH?]"YX=_\#W_PH_M7XH?]"YX=_P# ]_\ "@#T
M>BO./[5^*'_0N>'?_ ]_\*/[5^*'_0N>'?\ P/?_  H ]'HKSC^U?BA_T+GA
MW_P/?_"C^U?BA_T+GAW_ ,#W_P * /1Z*\X_M7XH?]"YX=_\#W_PH_M7XH?]
M"YX=_P# ]_\ "@#T>BO./[5^*'_0N>'?_ ]_\*/[5^*'_0N>'?\ P/?_  H
M]'HKSC^U?BA_T+GAW_P/?_"C^U?BA_T+GAW_ ,#W_P * /1Z*\X_M7XH?]"Y
MX=_\#W_PH_M7XH?]"YX=_P# ]_\ "@#T>BO./[5^*'_0N>'?_ ]_\*/[5^*'
M_0N>'?\ P/?_  H ]'HKSC^U?BA_T+GAW_P/?_"FOJ'Q4F7RX=%\+VSL<>;-
M=R2*OX*,T =/X_\ %-GX/\,7>J7CC>J[+>'(W32D?*BCOSU] ":SOA!X?N/#
MG@+3[74 PU&?==W>XDD2R'<0<]P" ?<&LSP]\/;J;7+?7_'>K?VYJ]OS;0K'
MLM;4^J)W;@?,0/ID CT:@ HHHH **** "BBB@ HHHH *Z#P__P >;_\ 70_R
M%<_70>'_ /CS?_?/\A0!IT444 %%%% !1110 5YY\=?!6H^/_ K:+H]Q;6UT
M;F.;S+AF5,+G(RH)SSZ5Z'10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#
M>A?]_I__ (W7V;10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__
M (W7V;10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7V;10
M!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7V;10!\9?\,L>
M-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7V;10!\9?\,L>-?\ H-Z%
M_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7V;10!\9?\,L>-?\ H-Z%_P!_I_\
MXW1_PRQXU_Z#>A?]_I__ (W7V;10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQX
MU_Z#>A?]_I__ (W7V;10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]
M_I__ (W7V;10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7
MV;10!\9?\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7V;10!\9?
M\,L>-?\ H-Z%_P!_I_\ XW1_PRQXU_Z#>A?]_I__ (W7V;10!\9?\,L>-?\
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MH>XA1L/(BGKAF H ^-_^&6/&O_0;T+_O]/\ _&Z/^&6/&O\ T&]"_P"_T_\
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M(R/F'-#74"MAI4!SC!84 ?''_#+'C7_H-Z%_W^G_ /C='_#+'C7_ *#>A?\
M?Z?_ .-U]E1S)(2(V5L#)P<XJ*.]MI8S)'/$T88H6#@C<#@C/KD4 ?'7_#+'
MC7_H-Z%_W^G_ /C='_#+'C7_ *#>A?\ ?Z?_ .-U]CM<PKC,J $9!+#FI/,7
MR]^1MQG- 'QI_P ,L>-?^@WH7_?Z?_XW1_PRQXU_Z#>A?]_I_P#XW7V-]KM_
M^>T7_?8J6.1)%W1LK#ID'- 'QI_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z
M%_W^G_\ C=?9M% 'QE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\
MC=?9M% 'QE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% '
MQE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_PRQXU
M_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_PRQXU_P"@WH7_
M '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_PRQXU_P"@WH7_ '^G_P#C
M='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7
M_H-Z%_W^G_\ C=?9M% 'QE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^
MG_\ C=?9M% 'QE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9
MM% 'QE_PRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_P
MRQXU_P"@WH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_PRQXU_P"@
MWH7_ '^G_P#C='_#+'C7_H-Z%_W^G_\ C=?9M% 'QE_PRQXU_P"@WH7_ '^G
M_P#C=?0'[/\ X!U3X=>#;S2-:NK2ZN)K][I7MF9E"F.-0/F4'.4/;O7IM% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %87C?PS8^+_"^H:)JB;K:[B*9QDHW5
M7'NIP1]*W:* /AKX/_!Z_P!3^+]YH_B*U_T#0)O,O\@[9><QH#Z/PWNN:^C_
M (]*%_X5P!_T.6G?^U*]1BMH(IYIHH8TFF(,KJH#/@8&3WP.*IZUH>FZW]@_
MM6U2Y^PW4=];;B1Y<R9VN,'J,G\Z /"?V2O"L4/AG_A)+C2+&&XG22&VU"*>
M1IIT\YQ()$)V+@H@&!R!S7COBC3M3L;[Q=H48:"S\()?36I0 'R[N6*,+@#H
M8W)^F>G?[8\/:'IOAW1X-+T6U2TT^'<8X4)(7<Q8]23R6)_&J[>%]$>]U:[?
M3+9[C5HEAOF=-WVA%7:%8'@C!Q0!\>Z_X7\,I:^-H=& O-+TRXT9M/D\]G5#
M<*HN""#@EMH!],#&,5:^*'AZ/2_$7C+0?"T!M@FN^'X+*)';*.UG<;<,23]X
M^M?4EE\-_"%CH4VC6FA6D6FS3+<20KN^>12"K$YR<$#'-6KSP1X<O=6FU2ZT
MJ&2_FNK>]DF+-EIK=2L+]<94,0/KS0!\7Z3J(\3*DWB6P^T6-YJFM:C):)="
MV$MR;:%L*Q^ZRD@KG/)Q@]#[+X\O(-8_96T*6TM)(;:1[."*WN[CS3L68(H>
M0!<Y"CD <'BO7K_X:>#=0LI[2\\/V<MO->27[H01^_< .X(.03M&0,#@<5JZ
MOX3T+5_#L>@ZAID$NCQA%2T *(H3[H 7& ,4 ?&EGX5N_P"PH)]+O/[-O[[Q
M+/X1O(HY#)#'%-M(C1LG<BD,<]3N]N?5_P!J*%O"_A3P$GAZ'RO[)O0]M&HS
ML$,>X?D%R:]IM? ?ABTTO3M.M=&M8;+3[Q-0MHD! CN%SMDZY+#/?-7_ !#X
M;TCQ$+8:S91W7V9F>'?GY"RE2??@D<T ?$,VO:EJ7P[\7P+;3R:IXEUV"<V\
M8+NR%'G. .2,[/PK1^)6M_\ "1:+::D79Y9/ MG'*S9R9(]31'//^TK5];:9
M\./">FZG9ZC:Z+;K?VG^IFRQ*_NUCSC./N*HZ=JK-\*? [VIMSX=M?(-O]EV
M!G \KSO.V_>Z>9\W_P!:@#IK36--EG@LXM0LWNW3<D"S*78#J0N<D5\H>,K'
M3M"^('CA[^&SU:75[?6)+#4[6]8R6<HM)#);S1AL?*I"@$<9SST7Z'\,?"[P
MQX6\4)K>@61LI%M'M5MT;,8W,&9^<G<=H'7&.U6Y?AKX.EU:_P!3?P]8F^OX
MY(KB7:0761=LG&< L"02,$Y//)H ^3[>?3O-CU#Q#:W5]>:;:>'H; 0:@+22
MUB:U5RZ9#;@7V@@+D;\@CK5[P7?W\'[0$%M=$KHQ\3ZC<PNYPJR*'$G/T,><
M^@KZBN/AMX/N+W2[NX\/V4EQID,5O:.ZD^7''PBXSAL=LYHO_AWX;N;.XBBT
M]+:>2:YN4N8B?,BGG39)*I.1N(QP01P.* .,_:(ET[6_AWHY2:WO--NM;LXV
MDBE#1NAD*M\RGZC@UX$^FQ:IX@T;0-)M[#5=%MO$&MPZ=!?7+QVS0B*!]OFJ
M=V ?F!!Y./6OK)/A_P"'I/ ^G>%-0LA?:191QHD<['+%!PQ*XYY)/0<]*KW_
M ,+?!5_I.G:9=>';-[#3]_V6$;E6/>07/!Y)*C).>E '@?CCP_X5\'>/?%>H
M:;I\4*:?X;CO[!DGD(2[DE,:2 [B3RR\=*Y'P/-;ZWIW@GP5XQ>>UT2RUB_%
MU'+^YQF!9(-V>5)=I0,]03CV^L+SX;^$;R%8;G18)(EM8;$*7<#R(F#1H?FY
M"D _A2ZQ\./".LRZA)JFA6ES)?R1S7+/NR[QJ51NO! )'&.#S0!\L^+U^QV?
MC*U\$SQ:KX970+&.2]O)B9A")/EV84 D-\N"!@"O3OVJ=0N1\,- T/3H9+B[
MU2:,^3$A=GCBCWMA1SP=A^F:];;X>^%#:WEL-$M5M[NVCLYXUW*KPQG*)@'@
M ^E:EWX<TB\U/3=0NK&*6\TU'CM)6R3$KKM8 =.0,<T ?$?Q%\2:IK%Q+XCL
M<2PWGAVSLM3X/\8*L?8"6+KZX'.:ZVS@MK;XFV6J6LKQ:[_PENFV2F.4AFM)
M(!YPV]U^Z"?]KWKZ3M/ACX-L]/N[&VT&VCM+J$6\T09R'C#EPO7^\2:L67P]
M\)V7B+^W;?0[1=7[7+ LRG &1DD X &1S0!\X?M61HWQ,D9].2[V^'( )WD9
M!9%KQU$_R]<%@N#Q\^>U:W@/P/9:Q\6/$]MXELM.U>"U\FTFO9[J2.X9S:JI
MV(& 8/SDGD9XKZ#USP;X?UV\N;K5M,ANKBYL_P"SYG<M\\ ?S-G!Z;N?7-9L
M/PP\&PZ[;ZS'H4 U2!D>.Y+N65D "GENP _*@#YV\!Z5I.B^'_AIJL445K->
M>*)5NIWD(#"-IDCSDX& <<8KS;5%0>"_#<TNF+J"P^'[M@QE:/[*S:E*BS#'
MWB"P&WI\W/2OMJZ^'OA2Z\-QZ#<Z):RZ1%*T\=NVXA)"Q8L#G()+'OW(Z4?\
M*\\)_9TMQH5H(4L6TU4 ( MRVXIC/=OFSUSSF@#XRU*35-*\?W>GM<&^LI=0
MTNWN[H$E9)D",CY]2%DQGL37T-^T5X2T/5=9\"7^H6"3W=YKUGI4\A=QOM6\
MUC'@' &23D<^]>A0_#7PA!#+%'H=N$EE@F<%W.7@!$39)ZJ"1^/-;VLZ)IVM
M-8'5+5+@V%TE[;;B1Y<R9VN,'J,GK0!\G:.FI6VO:99QVMFGAV'XASK#()&,
MWFC(V%>FT+CG.<UWO[(NA6UKX4_M9[#3H+RZB*1W,%R[SSQB5]WFQD[5P0H&
M!R.M>Q+X'\.*8RNE0CR]1;5E^9N+INLO7J?R]JK>$_AUX3\(ZC)?^'-%M["[
MDB,#R1LY)0D,5Y)[JOY4 ?&;27NCZQ?7^GHEK+=_VW$MQ:RLTMP%5MRRKN^1
M4&65@.2.^,KJZ_X;\/PZ'XM&C1+=6-CH.FW\,PD?$-U*8E9@-Y&75F)!''3C
M'/UKI?PV\':5J-Y?V7A^Q2[O%D2>1E,A=7SO'S$C#9.<=0<4EA\-/!UAH.HZ
M-9Z#:0Z;J!4W<*EOWVTY7+9S@'H,^OJ: /G3XF^!/#WAGX@:;#X>TE;<#P[>
M:DB)-(?])BBD:-\ELY#*IZXXKB]6@L=,\&7]OX>?,&H>$M/O=22.0NOVS[?"
M,GDX;!/';/2OM:Z\,Z-=:Y::Q<6$4FI6D+6\,[9)2-@0RXS@@Y/4=ZP[7X6^
M"K33-1T^U\/6<5IJ!0W,:[AYFQMRC.<@!@#@8% 'B/[+^OZCXH^*GB+5]81E
MNI])@0D@@-Y92,L,^K(Q/OD5PVK>&_$4^J>/_$_AZR2SM]*U76%NM56Y/F3(
MWR^2(P0?E#%MW^WWVX/UWX?\'Z'X?O9+S2K"."[D1HFE#,24:1I"O)Z;F)JU
MI_AS2-/M-2M;2PA2VU*>6YO(B-RSR2\2%@<_>[CI0!\8:Q9V6GZ=>:3X=C%W
MI-U9Z)=W-L'.QKI\94MD[2X8DX]?]FM;1?"FD:MX(\%ZA?V<++J7C46:6BW$
MK_8[)RVZU.2,?,A;/7Y@<Y)KZ>T_X9>#=.TV2PLM M(;62XCNG12WS2Q\HQ.
M<_+S@9QR?4U;B\">&8B#'I,*[=2_M=0&; N_^>H&< \_3VH ^8I--TN^\=_\
M(]KLA@\+3>+-9^T1F8QQ[HK:'R=S9]20.>YKSC4-0UQ-#L=0MVDGB_X1P6%Z
M6/2W>>6.//\ L@K%CW"U]O:G\.?"6J6MW;:AH5K<0W5XVH3!]V6G88:3.<@D
M#!Q@5)-\/_"L\,\4FAVABGLX["2, A3 AW(F <  @$8YS0!Y9\9?^1#^%W_8
M3LO_ $G>O+/V6KW4)?B/X<LKY3]E@T^\ELW;O&[88#VWH_XDU]::KX7T75K+
M3K34;".>WTZ1);5&+ 1,JE5(P>P)'-5M$\$>&]#ETZ72=)M[:33H9(+5T+9B
MCD8NZY)Y!8D\YZG% 'S]\5O!?A^W^*'C1X=.17/@R\UK/F.?],:9U:7KU()X
MZ>U>=:L^IR>$M0&KPVL6/!VEI:B!RV^#[=#L9\]&/.0*^SM4\*:)JFH7=]J&
MGQ3W5W8-ID\C%LO;,Q8QG!Z$DGUK-NOAQX1N[4V]QHEN\)LHM.*%GQ]GC<.D
M?7H& /KQ0!Y_K>B6^@?LU^);."PT[3Y?LD\EQ;Z?<//"KD_PNY).5"FO#O&>
ME2>$-/\ AQJN@Z7I]GK@>YOY(["Y>=91&D#J6W$X)7=E1CJ17UQI?@/PSI?A
MJ]\/Z?I$$&C7K,]Q:JS;9"P ).3GHJ]^U9^D?"KP1H]]:W>F^'K6"XM7:2%P
MSG8Q&"<%L=!B@#Y8^'6F^'/$-KH=EX^U.:QT>R\/2W-JPF,0BD.I2!G4\C<1
M\IX.1_N@CKK_ %(VGP.^+JZ;=B26;Q5=H'\P;WA>2!6;'?*Y!QZGTKWJX^%?
M@BYL=-LY_#EE);Z<&%JC;OW89RY&<Y(W$G!R.30WPK\$MK-SJK^';-[^Z:5Y
MI7+-YAE#"3()QR&;MWH ^6]?\/Z;'J_BG3O#UY87GAK0]0MKRUTJ\O62.\#6
MKM<+$^>77;V/0?0'9\#:+H7BKX@7-U'HUF^B6VE6$D8U"^D%Q:$6QV"/! D.
M] #GC & ,XKZ(;X3>!'TB/3&\,V'V*.8SJF&!#D8)W9W= .,XX'I1>?"?P->
M7\-[/X<LS<PK&D;*64((P @ ! X"CMVH ^?_ -FB"WL/%G@J329'6ZU/2+Y]
M7B0EE(2YD6)V'0'Y5';H/[W-G6=%M[SQK\8-5N;#3I/L=M>K%=RW+K<12-9L
M J1@[64@G.>:^B/"7@+POX0N)I_#>BVMA/,NR22/)8KG.,DDXR!Q["J.J_"S
MP5JVL7.J:CX?MI]0N2QFF9W!?*[3T;'3B@#X[\/Z=J^N6.M66IH1>:+X22\L
M'QN80K<172$'UV2LHQT'';%;R:3<>*[SP=K=]IMA>W7BC5-9O3;7]PT4+1JL
M2JK.N& 4H^.F2!V-?75KX+\.VEP)[?2;=)1IRZ3GDYM!C$1!/(X'7GCK5#5?
MAGX.U;2]+TW4-!M9K'3$=+.$LP6$-C=C![[1U]* /&)Y(?#L?QPMM!E%HMM8
M6$5DL4F66-;,J-ASDX7OU'7->/\ B^SL-,MVTOPPOVO1KF+1[J:/S\AKEHGX
M)ZJ6#,3TQZ#@#[!7X4^!UU&&^_X1RS:ZAC2)'8LP")&(U4@G! 0!>1TIUK\+
M?!5IIK:?;>'K2.T:X2[9%+<RH"$8G.3C<V!G')H ^9H/AWJ5AXL\+Z'XETG3
M)8[@7EXFF7E^_E6=NSI\@E0Y++\Q')!)YKZ]T9]--D+329X)+>SQ;;(90_E;
M0 $."<$#'7FLCQ=X!\,>,+BWG\2Z1!J$MNA2)I&8;5)R1P15[PSX7T7PO#<Q
M:!I\5DES,9YA&2=[D8).2?2@#XX^.'P@O=,^*UG8^&[0M8^(9MUFJC"12$_O
M$..BKG=GLI_V37V!X!\,6?@[PCINA:>H$-I$%9^\CGEW/NS$GVSCH*VIK2WF
MF@EFAC>6!B\3LH)C8@J2I['!(^A-34 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"WQAT)_ .GZUXFU.&&\ED:WFCA@?_6CDJJX)("LA)Y'(YR<4 >[?VO;>K?\
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M)OM(TO2H;:XU2\D5Y%G#%8H2=N< CDG..?X3[4 >Z_VO;>K?]\T?VO;>K?\
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M#<3TZ#+87FI='L[F:WNIX8-7GA?Q1ILJ2WL!$[H$N,NX&>>1GFOL&B@#YO\
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M<KD9]JO>!S<VGQK5/#>EZM'IUQ=7,E[;ZE9@+:YW9DCDZKD;?0]%);-?25%
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M"WDDL<1P[PIQ[<CVYKU/]I.VGN?A;;16T$LTHO(6*1H6.-C]A]:]@HH ^?\
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MN+:W,R3&2WV[LKG Y!'>NMJ.YGCMK>6>=UCAB0N[MT50,DF@#YY_X91\+?\
M0=UO\XO_ (BC_AE'PM_T'=;_ #B_^(KWCPYK=AXCT6VU72)O/L;@$Q2;&7<
MQ4\, 1R#60OCK17U74=/C:^>73VD2ZE2PG:"%D3S&5I=FP';@XW9.0!U% '#
M?#KX!Z%X%\0'5M.U34[B8PM!LG,>W#$'/"@YXKTW^Q8?^>C_ *5;TV_@U"QM
M;NW;]U<Q+/'G@E6 (./H15?6]:L]&M$N;V3;$UQ#:@@9_>2R+&@_[Z<?0<T
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MMK*#]AN#:SDC&V0*K$?3YAS]: &_V+#_ ,]'_2C^Q8?^>C_I6DTL:D!G4$]
M30LL;@%75@W0@YS0!F_V+#_ST?\ 2C^Q8?\ GH_Z5JT4 97]BP_\]'_2C^Q8
M?^>C_I6K10!E?V+#_P ]'_2C^Q8?^>C_ *5JT4 97]BP_P#/1_TH_L6'_GH_
MZ5JT4 97]BP_\]'_ $H_L6'_ )Z/^E:M% &5_8L/_/1_TH_L6'_GH_Z5JT4
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M%A_YZ/\ I6K10!E?V+#_ ,]'_2C^Q8?^>C_I6K10!E?V+#_ST?\ 2C^Q8?\
MGH_Z5JT4 97]BP_\]'_2C^Q8?^>C_I6K10!E?V+#_P ]'_2C^Q8?^>C_ *5J
MT4 97]BP_P#/1_TH_L6'_GH_Z5JT4 97]BP_\]'_ $H_L6'_ )Z/^E:M% &5
M_8L/_/1_TH_L6'_GH_Z5JT4 97]BP_\ /1_TH_L6'_GH_P"E:M% &5_8L/\
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M110 4444 %!HHH X7X6SSV.B66BWFFZC;W"K<W32RVY6( W4F$+'^,@A@O\
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M:,2B(R+YA!8)GD@8R<?B/SH26.1F".K%3M8 Y*G&<'TX(_.@!]%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK7256TNQM]+TVTL+&/R[2UA2"%-Q;:B@*HR>3@ =:LT %%%% !1110 4444
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MH \)_:BADOKCP!IBW=U:0ZAK*VLSVTFQ]CE5.#Z\\9S4W_#.&@_]#7XQ_P#
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MB2YN)K]+1DN[P,@5HY&)&U5.<H._K7UM8_\ 'G#_ +B_RKPC]M/_ ))9I?\
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M4H(Y%(!5R<Y<=O6OL"Q_X\X?]Q?Y5/@>E &.E !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !575M0MM)TN\U'4)?)L[.%[B>3:6V1HI9C@ DX / YJU7+?%?_ ));XQ_[
M UY_Z(>@#E/^&@/AG_T,P_\  &Y_^-T?\- _#+_H9E_\ ;G_ .-UE?L]^$/#
M6I?!WPW=ZCX>T>[NY8Y3)-/91R.^)G RQ7)X %>B?\(%X/\ ^A4T#_P70_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(  ]:^<K?P9KGA+P9\-]?2T\3:M+I=X+F_TEF,LENKH%(BBP" NWA?5CZD@
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M#5N4\(Z&M_9Q6-VMC )K6(82!_+7<BC)P%.0.3TH V**** "BBB@ K+\5?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% $-Y:P7MK);7D,<]O(-KQ2J&5QZ$'@BL3_A!_"?_ $+&A?\
M@OB_^)KH:* .>_X0?PG_ -"QH7_@OB_^)K;LK2WL;6.VLH(K>VC&U(HD"(@]
M !P*FHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRB/>N6'&<Y)Z;6[C% 'M=%?/4_Q]M;F\T_6+-+Z/18[>[-W8&")GE>,Q@%9
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M*-)E9I(CTD4 Y*_[72O"_ >IW^M^(?#FIZOJ]T;R/2-9M@IDB*S^3=QJH.$
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ME.?G/7KCC(XK';5=2+:]K\>MW5OJ][X;T*?;&8PH:65U=E0J?N\D=0#*V<Y
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MVEL93#:3,&"NS'Y0-F"W(R1R,U]<5XG\5/'?CC3_ (K:9X/\"VND3RWFFB\
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M2]OX.1V/H7PYUBX:"6RUG4X+B66ZD&G&6[@EN)X5C0L&\K"LRL6S@<*5SZT
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MI);EXI%(5#GA H$>W:6R>V,?Q%KWBBTL]3U"W\4Z@@\G7;N* 10%(S8WFR)
M3&24*O\ ,"<G YQQ0!]#T5X=>>,-9L/%VI_8]4EU&5-1O[9=')BPD45EYR,!
M@.#Y@ R6QAL=ZK:1KOB;4M%TA9/$%PL&HZC8QK>12VLEPHEAD:9,(I55R%*A
MER <=A@ ]ZJ.YN(K:$RW$B11@@%G8*!DX')]R!7B&C^*]9%]X+N=:UJ>2SN$
M%G+'9M"))+DSR1J\\14L8W50-R$;6#'CJ..U7Q;?^)K/6K:?5-1329X=-U2W
M:>XMFDA#:@L9SY: (,%3L;)4H">IH ^G8+NWGFGAAFC>: A945@6C)&0&'8D
M$'GL:GKQ35-<O;;Q9>Z6NMOIVF7&MQ6LVJJT*O'&NE),HW.I7+NOWB#QP,9%
M9+^+_$MY9V&KC5[BU:WTC2KQ[9(8Q#=O->R0N[*R;@'C ("D8W#N : /H&JT
M6H6<M_-9174#WD"AI8%D!>,'H67J >V:\Q^+WB;4M(U58;;5CH\%OHMYJ<,@
M$9%W<Q-&$@(8$E<.<JN"<C!XJ_\ #"Q;_A,/'6ISR70N+B^MPT$Q4^5FRMI-
MN0H/R[]HSV4<9R2 >@)>6\F-DT;9D:(8<'+C.5^HP>/8U8KP'2]+DGM=*LK?
M7]02X?QOJ2-,K1-+!B._Y *8!<#)R/XB1CC"Z'XT\4ZO<^'@+[RY_P"S=,NV
M1I+:&.],TKK.6#?,Q*IA1'MPYZ8(H ]]HHHH **** "J6N6;:CHNH62,$:YM
MY(0S= 64C)_.KM>'?$?QWX[MOBU%X/\  MKHT[R:>MX/MR,#U;=\VX#' XH
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MD<L&^TQ%$#D+Y;$;<C:<A>1QGJ*\2_LI8M+TW[7'J%_X.EU=I;[3X=%O;8P
M6;!<1,S2-'YP1R1P)#GWJ'0=+>]^'[K=?;(;6X\.Z (YDT^:[25HS*[1M'&"
MSH?E5P.S\]: /<HVT:;7;FQ6VMVU&&-+N7, R%EWQAMV.21"RGOA1GC%66T3
M2G96;3;)F6(0*3 I(C!!"#C[H(! Z<"O"['2[V2UUJ^TOPS<:-XDO?"$$=F%
MMY<QS(;A'192/E?:(,!F#?<ZX-6],\)6^K-H%I/%<7WA^?69I9+0Z7=6"6J_
MV?(I&V5BVPR!3G(!=V'.: /;TTZRCN!.EI;K.&9A((P&RV-QSUR<#/K@>E9F
MBQ:!/)?6^E65FAT^]VS+';! EQY:MN' RVV1?F'KC->&_P!D>)4T7Q9-;RWD
M>OF"[2[M(],ND^T*UT"KI<;BDC"$,L809"OM[5W/P\L;6R\(^.!IFGW6GZ9+
M?W$MI#<6TEN3']EA&520!@NX-CCMCM0!Z3#I6G03PSPV-I'-"ICCD2%0R*3D
MA3C@$DG JJTFCR>*%@:&W;6TM3,LAAS(L.[;P^.F<\9KP'PE%-!H^GZAING:
MJF@P/H<\R+93EFG17^T2QQXW.,&++(I#8&"<57O-+OI;.SFCT;5QJTEC-_9D
MGV*<&"Y;4I'0N0!Y9V'=EBORYYYY /?=-U31+_?I5C!YEL7N;:1%M&$ :-@L
MJ,=NT<OC!^]\V,X-7;'P_HVGL&L-)T^U8.) 8+9$(8 J&X'7#,,^C'UKQN32
MM?6XUQ]+M+R&]:#Q+]FD$;)^\DGMC#M;C!;:Q4YYQD=*[/PP]K8?#K6'\*Z'
M?K)%!+*MC>PSPFXG\D$A5DPP#,-IQC+;CWR0#N&TO3V)W65J<L[G,2\EQAST
MZL.OKWJ*'1-)@BMHX=,L8X[5_,@58$ B?^\HQ\I]Q7SEX?TW5%M=3M[S3KU_
M"[:U8SW=O;:3=VZ2PM:L)@L#9E91*(]P^;)&[ !KKH[>7_A(M5FM],UM-1?3
MXD\-3307++:I]D8%)7)VK^\'S*YR25/.-P /8K_2--U"9)K_ $^TNI8U9$>:
M%7*J1@@$C@$=:F>SM7LC9O;0M:%/+,!0%"N,;=O3&.U> Z-9W5KH;SV>EZW#
MI-M=:)<SPS6LYE-S'-NO)$B8;V&-A8@'<0Q&:SH_#][?M>:L-)U1;J"(W-@[
M6\L4D;MK5S)D*0"&\IP<$9VMZ&@#W5=2T2YOVO(K7[1>6UW_ &8T\=HSR128
M!*[@N0@W#+?=]ZT(M"TB&25XM+L$>9Q)(RVZ NP;<&)QR0P#9]1FO)-/T..S
MU;4$L-(N(+D^,8;F9UM)$5X""5??MVLH)?)!.,\XR*Y/2_#FIZ/X3MHK72M3
MCM;O1]+DU>!(IF>;%Y_I"[1R7\G(*CG9QC&!0![=XZ\+:)K/ARYM]406U@A>
MYN&@BCW%2"9.2C$;@3DKACZ\U+87NA>,+&VC?37NK1H4NX5O]/=4VL752/,7
M&[Y3QUVL#T89X;P'96-]\(/%%E8V<C6$EWJL=O:O"P;9YLFQ"C#<#T&TC/:L
M*?PF_P!FT[38]'N4T]K+PY'+%'"ZJ,7EPTX..A ?<WINR<9H ]G'AS1!<07
MT?3A/ %6*06R;HPOW0IQD8[8Z5?L[:WL[:.WLX8H+>,;4BB0*JCT ' KPS5O
M 5H_BR=8]'NOL1UVWL<()?+:P&E("IP<&/S$4$]"R@') KI+^WUEOV?='@CB
MOFU$:?IZWD(5_M#1CROM"X'S;MF\$?>ZCK0!UNK#PS9^(K&SO-*MI=5U<3;&
M33_-9U4*)&D<*=J_.@)8@'(%3W.K>'] BU"P80VD&FV']H7$,<!"16Y+_-A1
M@_ZM^!SQTY%>7^!?#:S>/M&U*71KE-+@.J'3&N[=U>V@#VODJ0P!C&XW)16
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MP99)3;H7<,,,"<9.1P<]135N-,M-;BTV-(HK^[MWN J1XWQQ&-"20,?+YB
M^O'2O"/#^D:[+<>$DU62_L9(M,TP6,SZ7<W312I*YG1F1@(2R[%<R#!0@#[I
MK=^%>G3Q_$9+R_TV_BUG[+JL>J7DUM,D4K&]A, 61QM8>4/EVD_*H';@ ]97
MPYHB)<*FCZ:JW VS 6R 2#.<-QR,\\]^:L1:5IT,=O'#8VB1V[F2!5A4")CG
M+*,<$[FY'J?6O)8=+O9/BMJMSJ\L\6V\=XU_LJXGCNK#[(%\HSAO*5-Q9MA7
M=YBYYW8KB]+TC6H?#DD-]INI1VTFIVDDXNK*:Z_XE @=;:%HXR&?RWQOC!W
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M)+*6622W@;3)[ 6P\I042.9BVW<"V>F6:O*/!^BOJWAW2X+#3+_^P;B+P_\
M:XY+>>,37 =OM$JYQE?+V;G7Y2-N#@4 ?35%>&MH]Q9>/UMK?3;]9H-3ACMY
MDAF-JFC+9!6B+X*$;]XV9W%]IQC%<QI-IJ?AWPIK&NW&G:K#>:1?6>IZ7'=
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MI/\ T%+'_P "$_QKQG]FQUD\8?%=XV5T;7G964Y!!DFP0: /=Z*** "BBB@
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MWPE\)^/-8BU/Q'9SSW<4"VRM'</& @9F P#ZN:[VB@#QS_AF_P"''_0,N_\
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M5R!]X\=37744 %%%% !1110 4444 %%%% !1110 48SUHHH 3 ]!2XHHH 3
M]!2XHHH 3:/0?E2XHHH *8D4:,[)&BEVW.0N-QP!D^IP /PI]% "  = *7%%
M% !BC ]!110 8'H*9)#'* )8T<*P8;E!P1T/U%/HH 3 ]!2XHHH ,4F .PI:
M* # ]**** "C%%% !28'H*6B@ P/048'I110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %& .@HHH ,#T%&!Z444 &!Z"C%%% !TZ4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&)'(#&*6U^TK,1S\H0,/JI%1>'_AE%I,PF;5'FF_M"XU!BMLD2EYK80,H5>
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M1=%\3_#*31M(T[3WD\10*[6MLD18!TX)4#- 'T+1110 4444 %%%% !1110
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MRUSA-WSEB#U(Q0!#J'BN^OO%D&EP0)');ZLMK"PGD17+:9+<#S OWEW<8/'
M/4"N>\._$#Q!H_@7PXVJ06U]=ZCHL<]C,9'+W%R98HUCD)[MY\9)'HV,XKO=
M#^'VDZ/=0W,4VH7-S%=B]$UW=-,YD%NUN"2>2/+<C'TK-D^'-I;R^#[:R8OI
MN@7;W2+=2M+(H\IECC0G^$,5/7C8.O4 &KXZU*[TV^\*&VE*K/J;QSJ.!*@L
MKJ3:?;<BG\!7&Z7\4M9ETNW_ +0TK3H]3U"/2WL%BGD:$B^\P+YAVY&WRG)
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5X@M]2NX;SQ#-96^H$YAA/RJD(],8!P.S9K:L/CCI=W=D'1M2@L94N&L[R4
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MQC@M?#.D:Y9^'=3O+&_ADE:1"JK 8V*LK'GD$'TXQCO@ ]N_MMO^> _[[_\
MK4?VVW_/ ?\ ??\ ]:OF&/XL:D/B=?W\=AJUWH$>B_:HK%<*(HRD<IG8#C&.
M,G.-W7%=/)\<=/C@L9#H]V?M6F2:DH\U?E5'D3;]?W1.?>@#W?\ MMO^> _[
M[_\ K4?VVW_/ ?\ ??\ ]:O!F^-GEVMDTOA#6DNKX[[6V(&Z>()N,B\<C!'U
MY]*6;XYZ=*VDQ:+H6IZK<W]L;DP6^"\>&92F.2Q&QCQVP?H >\?VVW_/ ?\
M??\ ]:C^VV_YX#_OO_ZU<=K_ (FTGP[IT%[K]VFG03,(U,W]\@G;\N>< _E5
M'P_X]\+^(M0%AHNLVUY=E2XBCW9('4\B@#O_ .VV_P"> _[Z_P#K4?VVW_/
M?]]__6KY[^*!\76/Q"T"RTKQC<65EX@G>**%;1&%H$1,\DY?)8GMBL;P#\3M
M0TOQIK6E>)CJ&IQ7.LC3(;XX6*!MS(J[>@SC/'H3S0!]._VVW_/#_P >_P#K
M4?VVW_/ ?]]__6KYL\+_ !5;0O#MM]JBUGQ%J&I:G=1V\;;0ZJFSY!C.>6&
M.N3TX%>J:]XOAT+P%)XGU*QNX(XX(YFM' $JLY550CH#N8 ^G- '?_VVW_/
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MHR0#C@5T@^*UEYBJ=-N,'Q#_ ,(^3Y@XDX_>?[O/3K0![!_;;?\ / ?]]_\
MUJ/[;;_G@/\ OK_ZU?.FM?&>YUCPCKUQX;T'6(DAA?R=3"J8X\,%W-Z'#9QR
M?RS77_"_7]0U?X40WU]!>07D%LR">Z.YK@K&")@3U!)_0T >N?VVW_/ ?]]_
M_6H_MMO^> _[[_\ K5\V?"CXOQV_A^QL/%L.HB?[-=7:ZG<'<MT$=W8*3UP
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M[$4EW <&-0-VP'LS'I[*:S=+^,MCHBV>EZC8:W<PVGDVU_J=R 3;S.,E)?\
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MNM2MWN?LT(!>-5D:,@ 9W',;].P'KP >[?VVW_/ ?]]__6H_MMO^> _[[_\
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M^_\ ZU8]% &Q_;;?\\!_WW_]:C^VV_YX#_OO_P"M6/10!L?VVW_/ ?\ ??\
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M=6L@P\,\(='&<\J>#0!\I?!_PWJ^KV_A/6K6TS8VUWJC3N7"X\V)47 )RPW
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M[[Q?<ZU?1^)M*T^STU8(FMI+:7>S2%074_,> =W8?4]:](_L0?\ /<_]\_\
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MZ38R1W^IG^TY'F5FBME"!2I#=>93WZ#@9KWBMO\ L0?\]S_WS_\ 7H_L0?\
M/<_]\_\ UZ ,2BMO^Q!_SW/_ 'S_ /7H_L0?\]S_ -\__7H Q**V_P"Q!_SW
M/_?/_P!>C^Q!_P ]S_WS_P#7H Q**V_[$'_/<_\ ?/\ ]>C^Q!_SW/\ WS_]
M>@#$HK;_ +$'_/<_]\__ %Z/[$'_ #W/_?/_ ->@#$HK;_L0?\]S_P!\_P#U
MZ/[$'_/<_P#?/_UZ ,2BMO\ L0?\]S_WS_\ 7H_L0?\ /<_]\_\ UZ ,2BMO
M^Q!_SW/_ 'S_ /7H_L0?\]S_ -\__7H Q**V_P"Q!_SW/_?/_P!>C^Q!_P ]
MS_WS_P#7H Q**V_[$'_/<_\ ?/\ ]>C^Q!_SW/\ WS_]>@#$HK;_ +$'_/<_
M]\__ %Z/[$'_ #W/_?/_ ->@#$HK;_L0?\]S_P!\_P#UZ/[$'_/<_P#?/_UZ
M ,2BMO\ L0?\]S_WS_\ 7H_L0?\ /<_]\_\ UZ ,2BMO^Q!_SW/_ 'S_ /7H
M_L0?\]S_ -\__7H Q**V_P"Q!_SW/_?/_P!>C^Q!_P ]S_WS_P#7H Q**V_[
M$'_/<_\ ?/\ ]>C^Q!_SW/\ WS_]>@#$KH/#_P#QYO\ ]=#_ "%1?V(/^>Y_
M[Y_^O5^PM1:0F,,6RV[.,4 6:*** "BBB@ HHHH *BO)3!:3S 9,:,X'K@9J
M6H;R(SV<\*D R1L@)[9&* /&_#OQ<U/4+*SDNK#3/,O8+*ZB^R732>2L]W%;
MLDH(!5P)=P[':?2O0+?QWHUQ=7UM;?;9Y;596Q'9RMYXB<1R>3A?WFUR%.W.
M":Q-(^'2Z9\-]*\/6XL8K^WDL);FYBBVB<V]Q'*Q.!DDA" 3W-8,WPFO5T_5
M+*VGTW:\LDEI<.9_.=)+E9Y()2'P(V *';RPP3@CD [&/XBZ)+;Z:\$>HRRW
MTTT"6\=E(TT;0N$E\Q ,KL8@'/J.HK1TGQAI.K:U/IEG).UQ%YN&>!TCE\IQ
M'+Y;D;7V.0K8)P37F]K\)M7M?#L6G6EUI%K<)JMQJ$-Y DHEL1(ZD"!L]E!4
MJV0PQD\5U'@GP'+X<UZYN)/L$]LLES):7'[W[2HGE\UD;+%, G' ^;:I."#D
M MZWX\LXK7Q MAYZ3Z0I\RYFLY6M@XVY7<,!B-Z_*"#SQG!INJ_$[P_I=]?6
MMT;W_0UG:6=+5S"3"F^55?&UF4=0#UX['&'KWPYU75-7\27,5[I]E;ZG:/;F
M*V611<N70I+.I)7>BJ5W*,MNYP.*YG7_  %K>H>(]3T"R:$Z5=KJEZMVUM*H
MA>[CV[&<G:Q#%N$R<#)V\ @'KN@>*=-URPO;RV::"*QE:&Y6[A>!X650YW*X
M!'RLK<]C6,OQ-\-_8EO)I[BVMC*L3/<VSP^7O1GC=@P!".JG:V,$\=>*N)X5
M:6/QC!=S#R-?F+CR\AHT-I% 1GUS&QX]17$2?":[O_!\GAW49M,MX+I[>*]N
M;)9?-GMX%RG^L+88R8/' 7(&<T =M_PG>E+=Z-!-#J$']K+&;:66TD6(LZ%U
M1GQM#E5;Y<Y&.<5A:O\ $^T%II=SHMEJ5W#=W\%MO:PF4212 D219 W@@<$9
M%<[J7PHUO6O$NEZKK5]I=P\-Q:3SR 2B0"*+RY(HQG:J.<R= 0S'G&*W+/P5
MXF@\+:+I4FHZ/(VAW%H;$B"11)' "N93N/S,".%& 5ZG/ !HV?Q%L86UH:R#
M;_89+YTV*2&@M2@=L_WOG4X]ZV_$7BZQT#0X]6U"WU V;1^:Y@M7F,*!=Q:3
M:#M '4GTKS_QAX N[@Z5:KNG^V>)YKJX:%"52RF1VE20XX!"A>V25 YQ6W\7
MO -[XWMK:&SN+18H[:Y@:&[\S8'E50DP"$?.F#C.1AS0!T^E^+=.U77;K2[!
M;N:2U \V<6[_ &<,51]OFXV[MLB'&>A]CBI;^/-&G\3R:"OVM;])I+<%K601
M/(D8D9%DQM+;#NP#G K#\*^!=4T?Q;::HUU8P6T-@MI.EFKJU^RI&J-,&)7*
M;&PPY(.#@<4W4_A]J%Y>74T&I1VK3:G=WR2Q@[XA-8-;+C_:5B&],"@"_)\4
M-!CBD+PZL)TNELVM3I\PG\QHFF3]WMW8*(QSCC'.*6S^*/AN]LY;BUDOI I@
M\J,64HDN?.W^48E*Y<-Y<G(_N,3@#-<IX%^%&H^']>BU&>?3(U6]M[IH;02D
M?N[2X@;E\DEFG#<GL::/A'J"Z=IJ_;K)[K3[73HXE?S!'(]M]I#!MI#!66YX
M(Y!7I0!UUY\0=.6:"XM9%?28]-?5KRXV,3'#DJBA<;@[,&X(X\M@1GI=L_%G
MGZYI-NUG<P6FJPS>1]IA:&:.:(Y9'1N<,N2I _@/4,*YT^";S3YXH["PTF6"
M^T@Z;>6[HQM8V5WE7Y6;<8V,LRGDD%D.",X/"O@K5M.U/PY#J<R7%KHHN[E)
M=Y<+),62.",L2^R.,L-S<G*X.,@ '67?BW3[/Q):Z+=1WL5S=96"5K9Q!(X0
MR%!)C:6VJ3U[$=>*Q+7XI^'KK3X[N%=3(F-N8H382B659PWE.B;<LK%'&X9&
M5/;FL/5/AKJ%S\2(O$K75G+!#?"[1G\PW"Q_9S%Y(YV!0WS# '4Y]^4TGP1X
MIAT7P?JTT5J=8AM])L8(/(E46T,*R.WV@9R&S(%)'3;P.<4 >IM\1?#RQZ<_
MVB<I?1B566WD(@0OY>Z;C]T-_P GS8Y!]"07WQ#T6QN=7@O$U"WDTRW>[D\V
MSD02Q*VQGC) W@-@<=<@C(.:XVT^$EQ;2:5)))IE[_HQM]1BN%F$9+7#SL\0
M5Q_%(X ;T4]JHQ?!W5?MNN3S:AI[R7^G7=@)\2F64RSI*DDN21D!=N%XZ8]@
M#T;2?'&G:IK$>F6]IJR731^8XFL)8Q""7V^82O[LL(V(W8SQW(%47\?VEEX[
MO/#VIQRPJ)+>&VN!"[1M)*C-M>0#:I., 'KBEU/PGJ%Y\1=.U^">SM+:V4K*
M\"NMQ<Q[&'D2<[&0.P<$C(Q@8^]5?7O MQJNM:A=FYA6&ZOK"YV_,&"0 AAD
M=SGB@"ROQ,\//I\UY&]\\4;6X519R[YDG?9#)&NW=(CL" 5!SBK>G^/=%O-2
MBL,W=O<.O_+S;/$B2>4)C$SD;1((SN*$Y SGH<<CH/POO-.TFTLI)-+\VRN-
M.$5U$LOF306LZR8DW,0&(7@+@ LW8\76^&:R^)M9N+H65QI>I2S7):0R_:8)
M)(!"P3YMF,9.<9PQ7&,&@#5C^)WAZ73FO(O[0=1+#$L(L9A+)YV?*=(RNYE?
M:<$#M73>'=:LO$.BVVJ:7(9+2X4E&92IX)!!!Y!!!!'M7G.D?#;5X9M.N-3U
M*QEN+!M.MXA!$R*;:T+D$Y).]C(3Z#@<UU?@?1-8\/VRZ?<SV$NFHLTB^6CB
M7SI+B20Y).-FQU&,9R#SC% "^(/%L.A>(S::CMBL(]-DU"2<!F8%940*% )8
MG?P!R3@#K69=_$;3(VMKM9GBL$MKZ>\@FM)%N(S;*C.NTXVL V2"#G(QZUDZ
MU\/O$/B.74GU[5M/D?[*;:PEB@8$XNEG1I@"!QY4:X7K\QJMJ'PPU?4H-2GO
M-2LCJ.I0:FMP41A$DEU!##&$[[56%<D\DY- &MJWQ.M5&DMI-G?SF?5UTRZA
MDLY4EAS&9/N, 02NPC(Z$]P172>)O&6D>&[FW@U62='F4RDQ0/*(8P0#)(5!
MV)EE&XX'/L2.=U7P/JDVKW.I6-W9"9M;MM5B28-MVQVBV[(<=S@L"/:G?$'P
M+?\ B+5)[K3+VTM?M^EOHU\9XF=OL[N&+1X(&X N.?[P/;! -"]^)/ARREGA
MN+ITGA2[=HO+.[_1G". /4D@J/X@0126OQ*\.SSZC&\UU;BPBN)I9+BUD1&2
MWD\N8HQ&'VM@';G[P'7(')ZQ\(9KWQ9=:M'?P)#+JEG=I$4Y2WC0B>+./^6C
M-DCH<#-7=0^%T^I:2VGW-_%'&]OK$+/&K94WEVEQ&<9&=H3!&1GZ4 ;Q^)&B
MF:S@C@U62]N9I(!:+82^=&Z"-F$B$90!98VR<## YK9\,^)[+Q)]K.G1WGE6
M\AC\Z:V>..7#,I,;$8<95@<=,<]1GEO#O@6\T_7])U>X72X)[?[5]I2S\TB4
MRK"JMF0DD@1<DXXP.U7_  %X3U#P_K6N7MW<6<=M?LC)8V"NL"R N7FVN3L=
M]RY5>/ER<DYH H:G\3[*.'3;K3K+4KFTGU+[ [?89295\J9]\("_O/FAV\=,
MY.!6J/B-X<;^RS'=321:A%#/'-';R-'&DS[(C*VW$>Y\J-V.01V-<YH?PYU6
MS\0PZA/>:?!:1ZHM^+"R618 1!<1NZJQ.QW,RDJ/E^3N35"T^%&J6VG6VG1:
MG9):75E:66JMY3M(RV\SR PDG WARAR., CF@#IO$OQ$LK+0VN=-5IKJ0W"P
MI*A"GR+J.VE)^CR#'K3X_'D-[\0+'P[IL,TD)%VMQ=/"ZH9(-@*1N?E8AF8-
MC.",5S-Y\,M=NI)H)-1TPV$9O3:XB<2_Z3?0W3>9R0<>65&,=OPU?#/@+5='
M\86UY)>V$FCV<VHS6T:(XG_TN19"'))!VD$9'44 =0OC'26\2/HBR3&]5S#N
M\A_*:41^:8A)C:7$?S;<YQ]#68GQ*T)H+IC'J:7%O<);&S>PF6Y=W0N@6+;N
M.45FZ<!3G&*QI/AM/_PDFM7D5Q:);ZA)-=PW)\TW5G<20>5F/Y]F!RV<9Y*X
MQS7.>&_A#K.AWKZK:W6C1ZI%<6EQ!&JS-"S10S0R;R6W9<3;LY/(H ['2?B3
M8W7C&[T:YBN((VF@ALIFMI565I;99PKL5 1R"V$.#\O/) KH+KQ58P^)!H(C
MO)+_ ,E9G,5L[Q0JV_:9' PN?+?&3V]Q7-+X%U.363J-[?V<DSZM9ZE(8XF0
M-Y-J(7 4DXRPR!D\=ZM^(?"&HZEX\TK6[2XLK**SXEFB5Q<SQ[7!@?G8T9+!
MN1D$<<\T 1:;\2=,%GX?COGFN+W4X+.1I;.SD\B-KH@1;B<^6&.<!CGCZ9U?
M!OCO1O%TCQZ2UTLBP)<A;FV>$O$Y(5UW ;ERK#([CT()\RE\!ZUX=OO#=C8>
M5>QW+:*E^4@E/E_V>REI!)G8BE0,!N21@ Y)'6>&_ ^N>&X+"73+W37OK71K
M;2P;A':,E)B[M@$'E&('/7&>* '_ !,^(DO@B^=);))K8V:7,3[R&9A<QQ2K
MC'15F5N#GKQBJEK\5H8=85-7MW@TR03F.XAADE"JMX]M&TA PBD*"2<<MCL:
MV/B+X!3QEJ6CSS3(D-G'=PS1L,^:D\.P#WPX1L?[/J!6''\+KN'PY;Z;#>6P
M:/0(=*9B&(:991(\GKM)S[\T =3=_$+0;6YU2&6:?.G0SS2N('\M_(7=,D;X
MVNZ C*@YY/HV+6B>--(UC3=1O;9[B*+3N;I;FW>&2(;!(&*, V"A##CI[Y%<
M5<?"RX:3Q1'&^FO#J<=^UI<RB4SP2W2%2#\Q3:-S<@9(QZ9KJM'\+W>G7/B6
M;S;24ZHD(B26,NBF.W6+YUXW*2N< ]#0!77Q[97"Z1>*TMCIUR+B27[?9R1.
M8XHO,+J3@!<8;=\P(R!SG$,?Q3T%[;S1;ZP'-S':+ =.E$S2/$\J83&X@HA.
M<8]<<XYN'X3ZA-H?]FW^I6T=L?MRQV\ D>*SCGM_*6.'<=VU6R^"0/F(&!4/
M@;POKVH:U_:.KK#;_8=5MY%/V>2$7"0V4EN2BO\ -@M*""0,[3CC!(!TJ?$S
M2O,>[2>2\TV9;/[&EG9RO,[SK(R@CJ<B/IM!7!S5F[^*/ANWM-/N4DN[B&]A
M6X5K>UD?RHV?RU:7 _=Y?*_-CD'T-<[X9^%VH:1_9?FW]K)]CFL)&VAOF%NL
MX;'U\T8^AKG_ !+X UO1[>SATIH;V74(X=.N8TMI6V*EXUP) X.U%"NP)?'W
M>-Q.* /7/%OBNP\*VT5QJL=Z;9C\\UO:R3)"N0"TC*"%'S#KSUP#@X=HGBBQ
MUG6-1TZQCO&>Q<QRSM;.L#.I 95D(VE@2,C.?3(%<;\8_AUJ'CMHQ:75DL/V
M*:V\N\\PB*1F4K,@4X+?*5.X'@\=P=?PYX2U'3/'FJ:V]Q96]E=1&-K6R5U%
MP^X%9I58E1(JC;N7[VXDXZ4 1>,OB-::'9Z_%#:7QU33]/N+V!)K.1(KCR@
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MM)%+.VXJX#[=@RPR.2-O<9KTQ-VQ=^-V.<=,T +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 48'I110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]@Z1MS_=^A&)_P *LNF\,C3)=762X;0;S2IKF1&<R37$BR-,<G/W@Q(Z\]:
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M6&\6YQ@N=YVH%+#"Y88S@XN^,/@W=Z];W<::EIS"XFU"0)>6C3+#]ID5UDC
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M5Z__ / '_P"V5[C10!X=_P *K^)/_17K_P#\ ?\ [91_PJOXD_\ 17K_ /\
M '_[97N-% 'AW_"J_B3_ -%>O_\ P!_^V4?\*K^)/_17K_\ \ ?_ +97N-%
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MZ*]?_P#@#_\ ;*]QHH \._X57\2?^BO7_P#X _\ VRC_ (57\2?^BO7_ /X
M_P#VRO<:* /#O^%5_$G_ **]?_\ @#_]LH_X57\2?^BO7_\ X __ &RO<:*
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M_A5?Q)_Z*]?_ /@#_P#;*/\ A5?Q)_Z*]?\ _@#_ /;*]QHH \._X57\2?\
MHKU__P" /_VRC_A5?Q)_Z*]?_P#@#_\ ;*]QHH \._X57\2?^BO7_P#X _\
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M(>$3\6('XU@? [PQ/X>\#PSZL"VO:M(VI:C(P^8S2\[3Z;1@8]<^M<U\1/\
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MKZ&H \*_:U_Y%GPE_P!C!!_Z!)7NM>%?M:_\BSX2_P"Q@@_] DKW6@ HHHH
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MYS*2T:]% (P!ZX S@9S@5L?\*7^'?_0J:?\ DW^-'_"E_AW_ -"II_Y-_C0
MW_A=7PZ_Z&JQ_)__ (FC_A=7PZ_Z&JQ_)_\ XFG?\*7^'?\ T*FG_DW^-'_"
ME_AW_P!"II_Y-_C0 W_A=7PZ_P"AJL?R?_XFC_A=7PZ_Z&JQ_)__ (FG?\*7
M^'?_ $*FG_DW^-'_  I?X=_]"II_Y-_C0 W_ (75\.O^AJL?R?\ ^)H_X75\
M.O\ H:K'\G_^)IW_  I?X=_]"II_Y-_C1_PI?X=_]"II_P"3?XT -_X75\.O
M^AJL?R?_ .)H_P"%U?#K_H:K'\G_ /B:=_PI?X=_]"II_P"3?XT?\*7^'?\
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M:/\ A2_P[_Z%33_R;_&@!O\ PNKX=?\ 0U6/Y/\ _$T?\+J^'7_0U6/Y/_\
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M_H5-/_)O\:/^%+_#O_H5-/\ R;_&@!O_  NKX=?]#58_D_\ \31_PNKX=?\
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M:/\ A2_P[_Z%33_R;_&@!O\ PNKX=?\ 0U6/Y/\ _$T?\+J^'7_0U6/Y/_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%<_X\\5V'@GPQ=:]JZSM96Q
M02"! S_,X48!([L.] '045X3_P -0^!/^>&M_P#@*G_Q='_#4/@3_GAK?_@*
MG_Q= 'NU%>4>!/CKX5\;^)K;0M&BU1;VX5V0SP*J852QR0Y[#TKU>@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH *XCXS^$KSQS\.]2\/Z;-!!=731%9)R0@V2JYS@$]%/:NWHH ^,O\
MAE/Q=_T&M!_[[F_^-T?\,I^+O^@UH/\ WW-_\;K[-HH ^:?@O\ O$7@3XA:?
MK^I:EI5Q:VZ2JT=NTA<[XV48R@'4^M?2U%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !@>E'3I110 4444 '6BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "O&/VB_A3J_Q./A_P#L:]L;7^SOM'F?:BXW
M>9Y6,;5/3RS^8KV>B@"&QB-O96\+$%HXU0D="0,5-110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45C>)=2N+%;
M&WL/(^VW\YMH#/GRPPC>0EL<XVQMT[XK TWQ9J.H^1-9VD+1WFDKJ=G;MO61
M\A#L+D;"3OQA2=ORD\,* .XHK@KGQQ):V-K?RVZM97R^=:,,J3$5D96.><L%
MB., CS,=13+CQI?12RI'%:R>:)TMB-PP]O=1VTN_GH7E!4#L#DT >@45E>&-
M4;5]+-Q*@26.XGM9 OW2\4K1,5]B4)'L:U: "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *.K:
M7;ZK;K%=&9=CAT>&9HG1AW#*01P2#@\@D=":K67AW3K+4%O+=)A*D7DQJT[M
M'&F%!"(3M7A%Z#M[G.O10!B-X6T=[*QM)+-9(+*V%I KL3MB!C(7WYBC.3S\
MM,N?"FE7#7AE2X_THY8"X<!"65CY8SA,LJL=N,D9-;U% %73+"#3+)+6T5EA
M0DC>Y=B2222S$DDDDDDYR:M444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>yw0d_zeropage2.jpg
<TEXT>
begin 644 yw0d_zeropage2.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" 4. ^@# 2(  A$! Q$!_\0
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M2!G<3NY;(X.!G KY@\.3:?I'_"J-6UK3C=62B\$B"!9#.5GDVH V%)RXP"<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG<-AU*D_Z/#V- '.:?\ M'ZI+\*M3U2Y73%\407\5M#"(G\MXW7=NV[L\!)
M3G^[ZC/K%Y\9_"6B'2++Q%J\4&J75K!/,D43ND1D4'YB 0O7.#SC![BOB&W\
M&:K-I,NH"WE$*6\EP,I@D)+%&PP<'@S1GC/!^N/0_&GAFYD\>26^J:?X@,&J
M6EB]J--MUE\]1#&K9!/)7:QQV*\XSD 'U/J/QA\%Z;XJ;P[>:U$FI(XB?]VW
ME*Y&=I?&T'H.O!X->2R_M#3W'A_QI=:5/9G4;&[\S3(I;638]EYL<8=N?OG>
M."1]*\ENO E[IGCF]\,:S;^)KIYM11X#:6V];J,%_P!^03\Q"LW3CE\D8-;G
MBS9:Z1\5O#T7AZ>*Z.L27<-VMKM5+?[7$$B4XS@YW # P 10!]$I\;O!]IK*
M:#K&JI;ZY%*+2Z5;>00).#M8!R,;0V>3VZU:A^-/@J?Q4GAVWU1YM3>Z%FJQ
MV\A0REMN ^,=>,YQ^%?.OC/2/.C^(-S]@\RZ7QC#Y4ODY<(6FSM.,XZ9QQ6=
MX4EETGQYX1\*:KI,UCK-CXK-S))(@&^.1H@,'J?N9!'!&"": /K;QY\0?#W@
M.VM9O$U]]F%TY2%%C:1G( +$*N3@9&3[CUKRKQU\=))O$OA?2?AY?Z/.-5P)
M9[Z&5D1G8+&IV\J2=P(P2#C.!5;]H^VGTSQUX/\ %5SHLNL:%81S1W444/FJ
M"?NAP1@ EAC/H>^*XWX1>%)]/\5?":35-+$3WCZG=L)(>0GE?N2^1_L[ESTR
M"* /6/CE\3==\):UH&A>%;6P.HZD'E,^HL$@VKP$#%E&XGU(Q\HYW<<E>?&W
M7]"^('A;1_&\=GI-N+4S:REO$9&65UE$2 Y; _U+?+W)&<9%;/[4US8KI6F6
M6M^%KO5-/F\W9J=LX$EG.4(0+CU(!(;"D+QN(X\7TC3/$>F^)?AYJ7B'PY=Z
ML;G3)K2VMY44F9F,Z0JY;A0HEA.7Z*!C[O !]/Z%\8/!6M^)'T'3-9CEOD\S
M&8V6)]@);;(1M(P"<YQ@$UQ7C?\ :#\/_P#"&ZU<>"M2AGUNT6,Q1W-O(BLK
M2JC,NX#=@-G'XXQFO M-\*:UXGA\.^$=)\.7>G:]HK7O]HWIAVB0LV]"TG'/
MRE!N..F#@\:TFL&X^"=_X9/@J^M]7TJU2"ZU.2V"LF;Y7$1R P!R3CKE3Q@$
M@ ](\9?'AH?AC877A:_CN-?CDM+34IWM<K&\D+NQ3C86W1GH"!SQ7IQ^-?@8
M>%5\0G6/^)<US]D&()#)YN-V-F,].<]/>OD:=[^R^&)\(W^GRQWD.MVNJ1D1
M']Y%+;-UP.<#RSS_ 'P.V*Z37M*DTGQ-<:Z^A/>:#H_C6^^TVL<!(\IGA*@(
M,#;B,@9.W.T<@XH ]H\3?&2.X\6^ T\+:C:-X>U6:1KVX:/YU6,C<C;ON8!R
M>,]"#BFVGQUTS7OB5I]CHM]"/"\%A/>7]S+ Z.&C5SCYA]T *W SGO7SU#X5
MUB2T\.QPZ/+;/K-QJ5Q96H#?(DD4<<:Y;L2IP2>1@YYJ2STO4/$TEIHFC:%=
MZ;JMCH,]K<Q& QM/-'(\C=!DLR_+AN<\'CF@#ZIL/CEX$OM(U+48-78P:?L,
MZFW=9 KN$!"$98;F )'3(SC(JF?VA/AX+5)SK,FUW:,)]EEWC 4Y(VY ^;@]
M\'T-?+%EHA?P;XHN8K/Q$UW!IMM:RO=VN(ED%S#NB!!R-NT;0>2-V0N.>M^+
MVCP6UIX)ET?P_J4&L_V)9B&>VLEDMKV1@-\;KCEP#S]XMN"D8P2 ?6>L^,-'
MT;PG_P ))J-WY6D>4DPF,;997QMPF-V3D<8SS7D/Q&_:)T:T\)QW7@:^MKO5
M9;@1B.[MI0J(.68CCU&.>Y]*E^/6D^(?$WP"TAQ93#5H1:7E]96\3!O]61(@
M09.%=\X/0+UXKQGQ!:GQ%I7BOQ3:>&9=.TW4-;T^.R1X &PB2B7  XR=K-CC
M)QDXH ^EX_$7B[6/A)INL^%4TK4/$5U'')]UDMW!;YBH<J0,>N#7"_#'XXWD
MVBZ_J_Q'FT^TTVSNHK*UGL(7=9Y2)"ZK@MNP%0Y&!@]>:Z;]HK69O"?PEN;7
M0+1HY+Z1=.B6UB $*.K,Y '0;58<=V%?.&L:C#J?PY\-Z-X6TCQ!!'X>E^WZ
MG*;=%,CN5!F4@E@5;A?0$9Z9H ^I]'^,W@O5KVRM;+5B[W<4LR.UNZ1JL2,\
MFYF  *JI)S[>HK.E^/G@.&.Q>34;D_;8S+ %LI267>T?0+UW(PQ[5\Q^)/ L
MUM\+;;Q1I7_"0#=JLD?DW]ML<I(G^N3:2-K;5!..3QDA<GU7P9X2_L?Q_8:<
M+)+JXL_ JR1F2%9%6\,P?*Y7&0[''&<=>] 'KG@_XP>#?%^O#1M#U0S7[AFC
MCDA>/S-O+!2P&3C)QZ GM7!?&;XB?$?P;XQ@M=(L-';1=2N([739)UW222%$
MW!L.,?.Q'('%>2? 5;R;XW^$Y=1_MF344:]^VF^B*K'(8)>%).>>^X YKV/]
MIR"6;6OAL8HW<1ZTK-M4G W1\GTH C\.?&HZ1XVU;0?B-/!87<264,$=M;LZ
M^>T>Z?++NX#,H'.,#ZFNZ?XO^#$\7'PT=6_XFHF^SE/(DV^;G&S=C&<\=<5\
MW?'&PFEUOXE2QVDC2'6-*$;>42<?9KC< <=,A<_05B6/@K4(_'UQX<UC_A*4
MOQJ9N(;JU@$B%23MNG).<]"6!/!/.5P0#Z0A_:%^'LJ2LNK7 $2;V_T&8\9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBOOSQR8U.>2?49.?4Z,4 >.>,_V??#'BWQ3J&O:CJ>N0WEZP:1;>:)4&%"C
M,9/0#O3-1_9S\%7^K6E],VIKY,<4<L"3*L=R8P%W2?+G+ ?-M*YZC!)KV:B@
M#Q#6_P!FSPEJ^N:CJDVJ:]#+?7$ES)'!-"J*SL6(4>4<*,X ]*ZCXG?#&U\8
M3VNJ6][=66MZ;;3II[Q2*D0E=<*S_(6X.#E2#7H]% 'G?P]^'5MH7PJC\(:O
MLN//@FBOGA<XE:0G<0V%/0@#(Z 5SNB?L\>%-)34T34=<N4U"P?3Y!<7$9V(
MQ5@RX0892BD9R/4&O9J* .4^&O@;3?A]X=.CZ--=36YF:<O<E2Y9@!R551T
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M5YS\5/@!-';Z1:^ ;/4KV>2+[)>W=QJ,4:)&KHR-*A +]3]S&/+4X)Z_4E%
M'D)^!?AS4=*OH-7N+VXN+^UL89I8W51&]M"(DDB^4X) .<EAR:J3_LY>$)M#
M.G/?:WN>Z^V37GGQF>9\, '8QD$#<W;J3ZU[310!XO=_LY^#[C2;:T^U:S'<
MPS2SR:@DZ?:;AI  PD8H01@#  '?^\<U=>_9]TZ30;2QT'7-2L[FUL9-/CGN
M-LJF&29Y9 RJ%))\QEX(&#T->Y44 >?R?#'1[SP[X1TB[>98?#<T%S (-BK-
M)&,?."#D,<DXP3D\UR=I^SEX6M;9XX=4UN)Y+1[*22*2)2\;R%SG]WU.=O\
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M?>NOHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSJ%KK$-U=K#I+7&8)@(HL>7$6P-GFDD8(X7I@DLUR[\1^%OA/;:]:^/-;O\
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M'P9XTTKQ@=5.B2R31:==&SED9-JLX )V]R.>O'MZUTX.>E>!_LEG_B1^+_\
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MBE6('_/09' )] L/VA=(N?&T>BG2+R/2YKPV$.JB0/'),,# 4#[N2.03PRG
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC<".%#XY.'4>Y[CX@>(];UO]G*37+&UMQ>7VFK-=*KE5AC9<NR'.<CMR?QH
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MYDE"Q[3C!W$XP<C'U%>=_$/XSZ!X=\%W6K^'M0TK6;U9%ABMX[M2"Y/4[<G
M'..^.W8 X+PY\ O$5KJVDV^LZ[8W?AS0I9[C38$C(D\R0Y&[ &/F56/+=,#(
M->E_!GP1??#_ .'[Z+JEQ;W%P)I9M]N6*;6 P/F .>*ZG1?&/A_7+S[)H^M:
M=>W/E^=Y4$ZNVS.-V >F2/SJO?>//"MF]S%>^(-*A>VG%O.KW*J8Y"&(0\\$
M[6X/]TT ?+/P+^%FO>,-#TK4;Z:"WT#3[JYGM(I%9)))GC0;P=O*;XXN_P#"
MP]:]/U#X,^($^'W@BRTG5;.'Q-X6N)KB&8EOL\A>0R?W<YR$'(QC<#7JR^._
M"D5Y<Z</$&E"ZLUD\^ 7*;H1$"9-PSQM"G/I@U!)\2_!L;1*_BC15:95>,&[
M3YP>A'/.: /#9OV>O%>HZ7!IVK>([*2UDNKC4[S;YA>2[D7:IR5^885<D@$;
MWZ\5E_$SP#J]U-\+/"NNSP7>LI+)8RW-LK,AL@T>UG+;<,J[QC^+'7/%?2<'
MC;PU<20QV^O:9*TUT;*/9<*V^<8S&,'EOF''N*?K'BWP_HVI6]CJ^LZ?97MP
M%,4$]PJ.^3@$ GH3Q0!D_%OPE=>,_AQJOAW3I8;>XO!"$DG)V+LE1SG )Z*1
MTKR;QA\!]?UN#Q&EMJ>F1G4[VPN8]YD^58()HV#87J3(I&/0U[/-X^\+0ZN=
M+E\0Z4FHB7R#;-<J)/,SC;MSG.>,54U7XC>'K?0#J.FZOI5]),)4L81>QH+N
M9!_JE<G .2HYZ;AF@#Q'1OV=_$6E^--,OTU;2YM-L-7345DD#?:ID$BL0[A.
M3A!P3C<S$8R:)/V>?%$^BW>F3:]IC6]K?F]TM&B)3+']X905/4;>/F&4QC!)
MKUKPM\6-!O\ PIHNJ^(]0TK0[O4H6G2TFOD8A!(R @\9SM]!@Y'4&H_"WQ3M
M=1OO&"ZXNG:38:!>K:"[;4$=9MQ8*3TV$[5X/<D=5- ' 6'P1\1"]\%WUY=>
M'(KC1]6;4;M+&R%LK(9(6"+L0!B!$W) Z@<CFK7Q.^"VN>*/$7B;5]-OM-C:
M^NK"[M8KA2PS;P-&RR#:1R6R.H..:]7N/B#X3M=/L[^Z\1:5%97F\6\[7*!)
MMA ;:<\X)&?K45W\2/!UI';R7'B;1XX[F+SH&:[0"1-Q7<.>1E6'U!':@#Q_
M0?@9XFT^STP2ZKHZ7EMXA76F>"-@@4*HPJ;0 <@D+PN..*TOAK\'O$FC?$]?
M%WB;4],DDBAD7;IL7E?:G=<%I5"*/XF)[E@IKU>Q\=>&;_5(=-LM>TNXU"=%
MDBMXKE6=U*;P0,\Y4Y^E-T?Q[X6UN_2QT?Q!I5[>N"R00W*L[ #)( .> /TH
M XOQI\*9O%7C;7M2N[J!--U+0/[*51N,L4PF259,< JI0'&[DCTKS^V^ /BF
M_LKL^)-<TRZO+?25TC2=BN%A0-P6(4'A"P'#$[N>@KW6T\=^%[QKX6GB#2IC
M8QM+=".Y1C"BG#,V#PH/4UQGC/XW^&]'ET2/1]4TG4Q>ZC#:W,B7:E;2!F^>
M5L=@/4@=_:@#OO#6DRZ5X3TK2IW5I;2QBM7=.5++&%)&><<5\ZZ1^S[XPM;.
MSTZ;7=-.FZ?JR7]O#\W(_C8GR\[B%0 9P,-[5] +XZ\,-J5OIPU_2Q?7"HT,
M!NDWR!P&3 SGY@01ZY&.M6?$7BO0_#0@.OZM8:<)R1']IG6/?C&<9/.,B@#Y
MXU;]G77KC4-1U6UU#13J#ZI+?017$)DBDC<D[)-R'D''&".6KUKP9X)U;0/A
M??Z&[:/%K=S%./M&G6WV6$NZE49@@&6 V_,%'0>F3TE[XY\,V%_!97WB#2K>
M[F17CBDND5F5OND<]#V-5KCXD>#K6]N+.Y\3Z-#=6[LDL4EVBLC+G<I!/48-
M 'C.G_L\W^D1^$+G2+S3[?5]/EE;5;EGD872,PVK&"N!A-Z]!U[]:JC]GOQ#
M]GT",:KI6=/T>\TV3)D^9YGNF4CY>@%PN<\\'BO7O''Q#T^P^&&M^*/#U_9:
M@EK$R02PRK)'YQ(50<'L64[>I_&O)K[X\^+O">DZ8_B/P>MV;R&*6*^28P13
MF2,2;478PRH<*<,>1VSB@"XGP$UM])DLY=3TY6;PV-'#KO;]\+L3AONCY"%
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M";R2" XQD9SR"*]%HH ^;IO@9XQUO7+!O%_BNVU&PT[SUMKG86NV#Y*[R1R
MV#M+' R%(SFJ.E_ GQUINDZ++9^(-)@UG0KF5K#;&3'Y3DD@L4SG=T!!&&/3
M'/T_10!\QV'[.^O^&[?1M6\)^(+6W\66SRFYN)8SY1$BE?DR&Y4%ARO.<\8
MJ#Q-^SUXN\0Z[/K6H>)+"753;6X2X&^,F>-8E9FPAXPKX(P2=I..17U'10!\
MU:G\"?%6J6&I?;-5T@WU]KD>KR,K2;<!) P^X.27';UJ;1?@+KMIXLL8KO6K
M:3PAI^JMJUM" 3<%R1A6X 'W$R0<=2!7T?10!\L:+^SSXOT"SLKK1->TF#7(
M)KA6E,;,AAEB5.I7.X?/P5Q\V014TO[.WB"UTK06TR_T*75+2UEM+I+ZW\^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%1W#F."
M1UZJI(H DHKP+P)XK^,GC;PO::]HZ>!TLKHN(UN5N5<;79#D D=5/>N@_P"+
MZ?\ 5/O_ ":H ]=HKR+_ (OI_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\
MB^G_ %3[_P FJ/\ B^G_ %3[_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\
M5/O_ ":H ]=HKR+_ (OI_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_
M %3[_P FJ/\ B^G_ %3[_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_
M ":H ]=HKR+_ (OI_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_ %3[
M_P FJ/\ B^G_ %3[_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_ ":H
M ]=HKR+_ (OI_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_ %3[_P F
MJ/\ B^G_ %3[_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_ ":H ]=H
MKR+_ (OI_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_ %3[_P FJ/\
MB^G_ %3[_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_ ":H ]=HKR+_
M (OI_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_ %3[_P FJ/\ B^G_
M %3[_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_ ":H ]=HKR+_ (OI
M_P!4^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_ %3[_P FJ/\ B^G_ %3[
M_P FJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_ ":H ]=HKR+_ (OI_P!4
M^_\ )JC_ (OI_P!4^_\ )J@#UVBO(O\ B^G_ %3[_P FJ/\ B^G_ %3[_P F
MJ /7:*\B_P"+Z?\ 5/O_ ":H_P"+Z?\ 5/O_ ":H ]=HKR+_ (OI_P!4^_\
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M^_\ )J@#UVBO(O\ B^G_ %3[_P FJ/\ B^G_ %3[_P FJ /7:*\B_P"+Z?\
M5/O_ ":H_P"+Z?\ 5/O_ ":H ]=HKR+_ (OI_P!4^_\ )JC_ (OI_P!4^_\
M)J@#UVBO(O\ B^G_ %3[_P FJ/\ B^G_ %3[_P FJ /7:*\B_P"+Z?\ 5/O_
M ":H_P"+Z?\ 5/O_ ":H ]=HKP[Q%XD^+WA6TM]1U]?!3Z>;N"WE%HMPTF))
M%3C<0/XJ]QH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYN+Z\>RMPL+ 2,B*S-D@87Y@,GJ<X! S7S6_Q(\07?Q6L-3T76_$<NBW.N)
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MSDXR"!4GA/Q5JEU\6)+1]:N=(L]5U8W=X;.:2#SI""1&2A!VL3M SQNSG.,
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M44 %%%% !1110 4444 %%%9^O:SI^@Z3=:EK%U':6-NF^2:0\*/YD]  .22
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M ./6;_<;^52U%=_\>LW^XW\J /+/V6/^2&^'O]ZY_P#2B2O6"0.M>3_LL?\
M)#?#W^]<_P#I1)7H_B+48]'T+4=3N,B"SMI;F0XS\J*6/'?@&@#Q;XK:IJGQ
M(\:'X9>%K@V]A %GUS44W$1IC_4\<'.1QGD\<!6K8\9:M8_ [PEH-EX5\-?V
M@+N\2R$$<FV:=RK$$L%)=R<=N^ *3]F#1);;P)+XAU$B35O$5S)?7$I.6*[B
M$!/_ 'TW_ ZSOVBKZ2/QU\(]/"H89_$$<[,?O!HY(5 'MB5L_04 ;/AGX[^#
M]3OFL=5EN_#NHJVQH-6A\D Y.<MRHQC^(CK]:]5@N(+F!)8)HYH7 971@RL/
M4$=J\T\=:IX'UKQO9>!?%^DK<7]Y;F>UFN(5$9+;AL20'<K':<8P.,9S@5R5
M]\,_%?PX=]2^$^KSW-DI+SZ!J+>9'(!R?+/'/08^5N/O'I0![)XL\-:3XKT.
MXTO6[..ZM)5("L/F0XX9#_"P[$5X]\-]2U3X7^.(?ASXENFN]'OPTNA:E,6!
M/0?9R3\O ' '0D#^,8[SX2?$JP^(>EW#P6TMCJED_EWUC-DO Q)QS@9!VGL"
M"""*Y_\ :@T-M1^&LNJV:R+JFAS1W]M+$/G3# .?H =Q_P!T&@#U^BLCPCJW
M]O>&-)U;"K]NLX;K"@@?.@;C/3K6O0 4444 %%%% !1110 4444 %%%% !11
M10 4449H **** "BBB@ K,\3:'I_B70;W1]9MUN;"[39+&>,\@@@CH00"#V(
M%:>:* /&--_9V\%V&FZM:0MJK-J$?DFXDG1I(8]ROB/Y-HY0#)!.">>:N:M\
M"?#6J6>IV]Q>:RB:A]C\TI-%E?LL1BCVYC.,@G=G//3%>MT4 >+R_L[^#SXJ
MCUZVFU>UN([E+M8(9HQ"'4ANAC)P2,XSW.,# %GPG\!?#/A?5])U'3[S6GGT
MVXDN(5FGB*LSJ%.[$8.,*.A'UKU^B@#S+XB_!GPUX^UVVU;6FU%;J%%B86]P
M%61 20K!E.!R?N[3SUJM<? CP1<^(Y-6GTZ5P]J+3[&7'V=0$$8=5QN5@H !
M! '4 'FO5LXZT4 ?/VO? "RT7X=^)-+\%/?W>JZN+:'=?W*!%1+B-R?E51@
M$]">,#K@ZEK^SAX+C\,/I4W]IM-)*L[WHN!YRL!@*OR[-O+<%2>3[8]MHH X
MG0?ASHF@_#Z]\'Z8D\.F7EO+!/*'!GD,J;'<MC&['M@8 Q@8KF+7X#>&K6SM
M[:*^UDI!I<^D*6FBR8999)6)_=_>S*V#TP!QWKUVB@#PJ^_9D\$7:6JK/K5N
M88A$TD-Q&#,1GYG!C(W=!P ..F>3I_\ #/WA7[%+;_:M8R]]'?K,)HA)'(H(
MPI$?"G/(YY ]*]BHH \M\&_ _P )^$O&O_"2Z1_:*7*^9Y5L\X,$.\8.T!0Q
MP"0 S$<^H!$OQ0^#7ASXBZO:ZEK,NI6]W;P_9P]G,B[TR6 8.C="6QC'WCG/
M&/3:,T >-?\ #/OA;R]3C-[K>W4+"WTZ4^?%\L<+0E2O[OAO]'3.<CEN!D8Z
M[7_AUI>N_#>U\%WEQ?)I=O!!;K+&Z"8K#MV9)4KD[1GY:[?K10!YB?@WH!UB
M74OM>K>?+K<>OL/-CV_:$+$+C9G9\YR.OO7G'BG]G**?5?#^FZ)/=G01<W-W
MJ=S=7$?FIO\ (&V/"=2(SC*D#!R>F?I7..M% 'B^J_LZ>#=1L=*M5GUFS_L^
MW:V66WN5#S(SLQW[D(SN=S\H7[Q[8Q-KG[/O@[64T<7DFK9TRVCM%9+A5-Q'
M']T2?+C/NH7K]*]BHH \=\2?L_>$M?U[4M6NIM7BGOD6-D@N%5(L!1E04)SA
M<?,6'S'CICT_PWI%OH&A6&DV1D-K8VZ6\1E.6*HH R>YXK3HH ** <]** "B
MBB@ HHHH **** "BBC.>E !1110 4444 %%%% !1110 4444 174\5K;R3W$
MB10QJ7>1V"JBCDDD]!7S[HEK=_'GQ0^KZUYD/P^TNY9+"Q 9/[1=3CS7SCCU
M].5Z[B>O_::UR[TGX67=KIP8WNL3QZ7"J1[V<R9+*!ZE58?CQSBN\\&^'[;P
MOX5TO1K,#RK&!8MP&-S ?,WU)R?QH UK>VM[6WC@MH8X8(UVI'&NU5'H . *
MJZUK.FZ)8O>:O?VMC:IP9;B58U]ADGJ>PKS/XG?%&ZT_Q"G@WP-8'5/&,VT[
M77]Q:*PSND.0<[2#CH <D]CCZ1\$X=1F77/BQKEUXBU+;O>)IC%:0<9( !'R
M@YZ;5_V: %\1?M$:%$+Q/"6DZKXEFM8VEDDMH62"-5Y9F<@L% R<[<<=<<U=
MUOPA8?&OX;:/KDENFD^()8%N;2[B)+0O_=+8!9<CZCJ*M:+KWA_QS\*_%UEX
M"T][6R@MKK3H ULL$4KF%L%,?PG<"<X/.2!FK_[-5U)>?!+PS)-M++'+$,#'
MRI,ZC\<** (/@9XWO-<LK_PYXH3[/XJT!EMKM68YN$QA9_F&3NQSCCD'@,!7
MJE>&?$6T;PK\=O!/BFS'E0:S(=&O]O1V;"Q;AG)))'/;RQFO<E^Z* /-_P!H
M#_DGZ_\ 83L/_2F.O2:\V_: _P"2?K_V$[#_ -*8Z])H **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP&4B3&>I\T\>W6@#E9/BQKFA:/XP'B2VTJ75-%FL8XYK8R1VS"[4,I<'<P"
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MA!N"JFV/ ' "9XZUWOASP]9:1X1LO#ZQK+8VUHMH4D4'S%"[6W< '=SGCG-
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MDH7\2F/QK#UWP==7?B1M9T769=(NKBW2UO-EM%-YT:,60C>#M<;G /(P1D'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>GRZ:UY>WEZEG*A1X8Y;B1T5EQ\IVL..U $Q^(WA8ZCK&GQZS:OJ&DPO-=P
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M:=N;5Y$NUE$2QSS"-?F13RWS!<=\$\4R]^(&@IX@O_#EKJEHWB.W@>46D@<
M$)OY8+CH02!DXR<<5Y?X8TO7]3^'.K:KK>E7T.OW^I:7%)!)$_F-%:R6Z;PF
M!A25FD^Z -QZ@9JS]GO=.^(6JVWA;3-973=2N+R?4[;4-/;[/'+Y)'VJVGZ9
MD)"[1G.3PHQ0!Z+-X^T71O#NAW_BG6-,L9-2AB9"KL(Y&95)*;@&V?,#E@,
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M:\ \7:'JGP=\4ZCXT\'V9OO"]^WF:UI2\&$Y)\Z,]E&X\=!D_P /*^_T'D4
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MW&",%0S+_P".\\_6O3?!_@W0O!VF_8?#NGPV4).79!EY3SR['ECR>O3M@<4
M9/PD\"V_@/PRMD&^T:G<G[1J-XS%VN)R!N.XC.WT'X]22>WHHH \V_: _P"2
M?K_V$[#_ -*8Z])KS;]H#_DGZ_\ 83L/_2F.O2: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_B* /9MP]:-P]:\9_P"&?-!_Z&;QE_X,A_\ $4?\,^:#_P!#-XR_\&0_^(H
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M/$44$.L0-<V\,JS"$RNL;D$$!U! =<@':V1P.*\S_P"&?-!_Z&;QE_X,A_\
M$4?\,^:#_P!#-XR_\&0_^(H ]DCVJN./RI<K_D5XU_PSYH/_ $,WC+_P9#_X
MBC_AGS0?^AF\9?\ @R'_ ,10!ZO?:=:WMQ937,0DDLYC<0')&R38R;A_P&1Q
MSZU=4@+C@?2O&_\ AGS0?^AF\9?^#(?_ !%'_#/F@_\ 0S>,O_!D/_B* /9?
ME]ORH&P9P ,]>*\:_P"&?-!_Z&;QE_X,A_\ $4?\,^:#_P!#-XR_\&0_^(H
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M\&0_^(H ]FW#UHW#UKQG_AGS0?\ H9O&7_@R'_Q%'_#/F@_]#-XR_P#!D/\
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M_9^\.I<V\LNO>*K@0RI,L<]^KH65@PR"GJ*]DH **** "BBB@ HHHH ****
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MI&-H4#G.>M>K_LE^']/M?",6M_V?80:C=1/$MS#=.\TT7FMGS(S\J8*J!CJ
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M6]"?E^[[4 ?)E]8:7>>/;G0M;NGM/#LWBO6O/ E*J#'&GEGKRP)P.YW$#K7
MR:KJ]I9K/:2O+%+HOV&Z,AW!H&D:-1] 0F/3:O;BON;4?A3X,U*SU"UOM%2:
M&_OFU*XW32;FN&^\X;=E<^BD#VIT_P +?!L_VSS=$B*WEE'I\R++(J&!"I1
MH;"X**05 /'6@#R7]J+_ )!OP_/;SY/_ $4M>6_LX2:DGQ9\%V>H+(+9(;RX
MM"^?FC>*0';DXV[T;H.N[O7UYXI\#^'O%46GQZ]8&Z2P8M;#SI$\LD8/W6&>
M!WS572/AOX4T?4-'O=-TH0W>D0O;V4OGR,8HW+EE.6.[_6/][.-QQB@#YQ^*
MG@OP^GQ.^("+IJ!(/#$NK1CS'^6[:5<R=>OS'CISTKA_&TFI2:9!_:UO;0E?
M!6G+;_9Y2^^#[3;[&;(&&/<#(]Z^S=6\!>'-7U34M1U#3S+>:C8G3;J3SY%\
MRW)!V8# #D#D 'WK,U3X2^"M4BCCOM&,J1Z?%I:#[5,N+:)E9(^''0JISUXY
M- '%Z[X>T_PW^SEXIM;+3]/TZ26VFFN8-/NGN(1(<+D.YSDHJ9'%>":]HDGA
MRQ^&NL>&=)T^#7VMY-3=;6Y>X\]88HI@\@8C:V!(2J^X'.*^N])^&_A72/">
MH>&M.TLPZ)?NTES;?:)6\QF55)W%BPX11P1TK*T#X+> - U2'4=+\/K%=Q!U
M5GNII5PZE&!5W*D%6(P1WH ^4_A;IV@^(6MK3XA7SZ7H]CHLDMC.D^P@F](,
MBGD!MQ9,$'(&<=#761ZD8/@#\2H["^:Y6X\32(UP\@65X6> &3 QNW< @#^(
M\8!KZ$;X.> WL=,LY/#\,EOIKE[5'FE;9EBQ!);+*22=K9'M35^#7@)=<GU<
MZ CZA<-*TKO<S,KF4,'RA?;R&;C'&>,4 ?)WB#P_:W&L>(M*\.ZI97&BZ-?1
MW5KH\]YY?VP-"3,4YR641 $9!&<#D@'H_A5IVA^(_&VJZEINF6=QIEA!8/#)
MJFH2I<6;) ,^7C E(="#G"_*N.#BOHR;X*_#Z70X-(?PY!]A@F:= )I1)O88
M),@;>1@#@MC@<<"H=5^!WP[U6]:ZO?#J-,51/W=W/&H5%"J JN ,*H' [4 >
M"?LT"+3_ (@>$!ICE6U+1;MM21&W!V6YG"%ASM("1XZ?J<RV'A^QO]8^-6J7
M]A822V4NK&VNGN76>.39+A5C'RLI!;)/.>U?27@OX<>%/!,LTWAC2(K&>8;7
MF\QY9"O'R[G+$+E0< XR*RKOX,> KO6K[5KC0R^H7K3-<2_;)QO,H82<!\#(
M9N@XSQB@#XR\,Z5?Z[I_B*.^W?:](\/K>6OF=HQ<0R#G!/\ JY'Q]5'3BNLM
MM(N?$EQX+UO5K+3[^^\4:MJUW)!=SO!"ZJL0"LZC<@#*^!D]O6OK6S^&WA.R
M,AM=*$9DTLZ,Y$\N6M#_ ,LS\WL/F^]QUJEJ_P (O!&L:+I&DZCHIFL-)61+
M*+[7.ODAR"PR'!.2HZD]* /*;J2T\-Z1\:;71IXK.*WMK.&T"2\J@LU4!222
M>#UY->':E86EI/IFF:##_:FG7S:-<WMM]HV*;QX'S"&S_%O?YAPI)'&,5]@1
M_!?P"FJ0:A_PCZ/=01QQ(9+F9UVH@C4%&<JPVJ!R#GOFIK#X0^!M/LX[6ST)
M(H8[V/4 !<2[C/&&",6W9(7>V%)QSTH ^8H/A[J6E>,O"&A>)M*TYC>->W:Z
M9<WS+#;Q$<(94).1M9A@D$D9/)K[$T";2'TM;'0[BTN+2P LS';RB40E% \M
MN3@@;>#SR*Q?&OPU\*>-[NVN?%&EF^GMT,<3?:)8]JDY(PC#//K5[P7X)\/>
M"K2>V\,:<EC#/)YLJK([EFP%SEB3T'3IU/<T ?''Q>^$.HZ5\7+?1= MGDM-
M>D,VG]EC!.73/HG7V4KWK[*\">&+/P=X5L-#TX'R+2/;YC?>D8G+.WN22?QK
M7GLK:>Z@N9H8WGM]WDR,H+1[A@[3VR.*L4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445B^*O%.B^%+**[\0
MZA!86TLGE)),2 S8)QP/0$_A0!M45Y]_PN;X>?\ 0UZ=^;?X4O\ PN;X>?\
M0V:=^;?X4 >@45Y__P +F^'G_0V:=^;?X4?\+F^'G_0V:=^;?X4 >@45Y_\
M\+F^'G_0V:=^;?X4?\+F^'G_ $-FG?FW^% 'H%%>?_\ "YOAY_T-FG?FW^%'
M_"YOAY_T-FG?FW^% 'H%%>?_ /"YOAY_T-FG?FW^%'_"YOAY_P!#9IWYM_A0
M!Z!17G__  N;X>?]#9IWYM_A1_PN;X>?]#9IWYM_A0!Z!17G_P#PN;X>?]#9
MIWYM_A1_PN;X>?\ 0V:=^;?X4 >@45Y__P +F^'G_0V:=^;?X4?\+F^'G_0V
M:=^;?X4 >@45Y_\ \+F^'G_0V:=^;?X4?\+F^'G_ $-FG?FW^% 'H%%>?_\
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MPN;X>?\ 0V:=^;?X4 >@45Y__P +F^'G_0V:=^;?X4?\+F^'G_0V:=^;?X4
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M#NVL/0]B:[JLOQ#_ ,>D?^^* / ?^&>_!7KJG_@0/_B:/^&>_!/KJG_@2/\
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M-L?,^VZA9VWEJ6?SIU38 ,Y.3P,4 >6_\,]^"?75/_ D?_$T?\,]^"?75/\
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MSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\
M$UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_
M ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)
M]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_
M10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1
M_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_
M\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y
M!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$
MT?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_
M\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PS
MWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\
M#/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K
M]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]
M=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@
MGUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% '
MD'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\
M"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3
M_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#
M/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\
M31_PSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "
M1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_PSWX)]=4_\"1_\37K]% 'D'_#/?@G
MUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\ $UZ_10!Y!_PSWX)]=4_\"1_\31_P
MSWX)]=4_\"1_\37K]% 'D'_#/?@GUU3_ ,"1_P#$T?\ #/?@GUU3_P "1_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "MOPW_J9OJ/ZUB5M^&_]3-]1_6@#8HHH)P,T
M %<GXX^(7AGP-]B_X2K4OL'VS?\ 9_W$LN_9MW?<4XQN7KZULWVOZ/I]P8+_
M %6PM9P ?+GN$1L'H<$YKY;_ &T=5T[53X._LN_M+SR_MF_[/,LFW/D8SM)Q
MT/Y4 ?6RG<H/3-+6&OBSPZ%'_$_TGZ?;(_\ XJM>TN8+RW2>TFCG@<922-@R
ML/4$<&@"6BBB@ HHHH **** "BBB@ KC?BAXLT;PAH]K>>(+LVMM-.(4<1,^
M7VDXPH/8&NRKD_B-X"T;X@Z3;:=X@^T_9[>?[0GD2;#NVE>3@\88T >7?\+P
M\ ?]!QO_  "N/_B*/^%X> /^@XW_ (!7'_Q%7O\ AF3P!_U%_P#P+'_Q-'_#
M,G@#_J+_ /@6/_B: */_  O#P!_T'&_\ KC_ .(H_P"%X> /^@XW_@%<?_$5
M>_X9D\ ?]1?_ ,"Q_P#$T?\ #,G@#_J+_P#@6/\ XF@"C_PO#P!_T'&_\ KC
M_P"(H_X7AX _Z#C?^ 5Q_P#$5>_X9D\ ?]1?_P "Q_\ $T?\,R> /^HO_P"!
M8_\ B: */_"\/ '_ $'&_P# *X_^(H_X7AX _P"@XW_@%<?_ !%7O^&9/ '_
M %%__ L?_$T?\,R> /\ J+_^!8_^)H H_P#"\/ '_0<;_P  KC_XBC_A>'@#
M_H.-_P" 5Q_\15[_ (9D\ ?]1?\ \"Q_\31_PS)X _ZB_P#X%C_XF@"C_P +
MP\ ?]!QO_ *X_P#B*/\ A>'@#_H.-_X!7'_Q%7O^&9/ '_47_P# L?\ Q-'_
M  S)X _ZB_\ X%C_ .)H H_\+P\ ?]!QO_ *X_\ B*IR_%SX8RZE%J$M_ ]_
M$ACCN&TZ8R(IZ@-Y>0#WK:_X9D\ ?]1?_P "Q_\ $T?\,R> /^HO_P"!8_\
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M !%7O^&9/ '_ %%__ L?_$T?\,R> /\ J+_^!8_^)H H_P#"\/ '_0<;_P
MKC_XBC_A>'@#_H.-_P" 5Q_\15[_ (9D\ ?]1?\ \"Q_\31_PS)X _ZB_P#X
M%C_XF@"C_P +P\ ?]!QO_ *X_P#B*/\ A>'@#_H.-_X!7'_Q%7O^&9/ '_47
M_P# L?\ Q-'_  S)X _ZB_\ X%C_ .)H H_\+P\ ?]!QO_ *X_\ B*/^%X>
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M_P +P\ ?]!QO_ *X_P#B*/\ A>'@#_H.-_X!7'_Q%7O^&9/ '_47_P# L?\
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MH_X7AX _Z#C?^ 5Q_P#$5>_X9D\ ?]1?_P "Q_\ $T?\,R> /^HO_P"!8_\
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M)X _ZB__ (%C_P")H H_\+P\ ?\ 0<;_ , KC_XBC_A>'@#_ *#C?^ 5Q_\
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M_P#B*/\ A>'@#_H.-_X!7'_Q%7O^&9/ '_47_P# L?\ Q-'_  S)X _ZB_\
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MO?/ OAZ/PIX2TS0X9GGCL81$LKJ%9@#U(%;<?W!GTIU !1110 4444 %%%%
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M(L&[;D;5W+@#'-;UOXCUFW\>?&IH=2NHI;:SNGB9)"#&R7"*A!'.54D#T!H
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M\07/P'UW1=7T;R/$<6I?;M-C>9,MB.-6 920-RAQ@D#(4G& 1F:M\*_&NC^
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MS\5/B;JWA[1O%>@W%LNCR/'-J<L(BWHSJ'<O]V0@(,;,YQGG.:VU\&^,]/\
MCQXDCM=#N?[&\1M-97%^83)$EG,P9V5P0JOM7'/<]"< _65% 'Q)_P ()\4+
M31[OX96VB.^E2ZC]J?4%C(@?Y0 ?-/R[.%;'WLC'7BNF\0^"O'/PN\=6VO\
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MJ_@[X;6^F^( T=ZT\D_V<R!Q K$80$<=BW4\L>:]-HH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6&&!&,?,"=V/O9.<U,W@?PNVGI8/X;T1K%)#,EN;&+RUD(P7"[<!B !G&>*
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M=AXX;/0<U[I^QM_R2:[_ .PK-_Z+BKU36_ _AG7(+"'5M"TZZAL,?94>!<1
M8^4#'W>!\O0X''%:6CZ)INAVK6NBZ?9Z=:LQD,-I"L*%C@%MJ@#. .?:@#X-
M\4WFD?V=XYL)1&=>E\2>9:_N2TGE!I@^'QP,E>,C/X5M_$+PAJ1^,\_@^S61
M+77[ZVO@%&XC<K;I,9)&TR39SC[N>!7U[)\.O"+ZQ#JI\-Z0NH12&59TM44[
MR<[S@89L\[CD@\CFL&3X<W5W\;$\;ZA?PR6EI9_9K&T16#QDK@ECT(^>3ICJ
M/2@ ^/MO':_!#Q-#;J$ACLU1$48"J'4 #VQ7R+H-G96VN>"'^&-]<7_BVYB?
M[;#<PAH[6<I@[=T8&T R'/S8VYSQ7WUJ=A:ZG8RV>H6L%W:2C$D$\8=''H5(
M(-9FD>$/#NBW9NM&T#2-/N2I4RVMG'$Y!ZC*J#B@#X/BNM)E^%NG:%:0 >-O
M^$@+KMB*2K$8P@4R$ ?ZS&!G@@GBH/'FKW'B:\\0:OKFH"VU9]1$8THVP#E0
M"I)=0 "@55YY;\#7W=;^!/"]MX@_MRWT#3(M6R6%RD"A@Q.2W3[Q)/S=?>JU
MQ\-O!UUJMQJ5UX8T>XO;GF:2:T23>2<EB",;B>IQF@#P3P?I%IJ_C_XPQW.G
MP7TT=CNMUD@$K+(8VQL!!^;..G->:^"M4T>ZOOA!I]DJ)K-EK[?;R(-K,KW,
M)B)?'S#&X#G(P>!QG[@L= TNPO+F\L=.LK:\N@!/<0P(DDN.FY@,M^-9-G\/
MO"5GJ9U&W\-:,E\9EN!/]C0LD@((9#CY3D9RN.>>M 'F'[9$,C_#72Y5C=XH
M=6B>4@9"J8I1D_B0/QKPWQ5+X?U_Q)\2M6\*V4/]A1:+ ;9EMO*6*3SK520I
M V,2).<#(SZU]PZE86VIV<MI?V\-S:2KMEAF0.CKZ%2""*Q-+\#>&=*T2?2+
M'0=-CTRX.9[8P*R3$'(+@@[L=LYQ@4 9?P3LK:U^%/A9K:WAA,^G6\TOEQA=
M[F)<LV.IX')YXKXPT+Q/8:7\.OB)H4[.VHZU=6B6T:H3\L<KN[$XQQ@#'4[A
MCH:_0&SM(+*SBM+.&*"VA01QQ1($1%'   X 'H*P;?P)X4MKN.ZMO#&A0W<;
MB1)X[")9%;.=P8+D'/.: /D#7K&?3=9\4V5Y&T=S;>"+*&5""-K*EF".?I5[
MXL>'Q:? ?X;ZEI>GPP6S1!KZ>*,#=*Z HTF!EC_K,$YQDC^+GZ\O/"N@WMW=
M7=[HNEW%U=1^3<336D;O-'Q\KL1EE^5>#QP/2I[C0-)N=#71Y]+L)-*551;-
M[=#  IRH"8VX&!CCB@#X&U;2Y7\/>*M0L=<TW5/+NK8WW]FQ/;IL.\;PIC16
M3>5'RCJ,XQAJ]3\<:Q\,]>^%OC >!=)BM]5@M;&5Y3:,A5!-"F%9NA&[:Q&-
MW)RPYKZ8TCP;X>T?1Y]*TW1=.M].N%*SVZVZE)@>/GR/GXX^;/%1:-X%\-:-
MI-WIFFZ'IT%A=\7,(A#+./1\YW=3UZ=J /D'^W/!Z^,OAKJU]IP/ANSTZ"TU
M&4616.6[2/+L0 #)M:2,MP<X_B'7$5(;CP09[:W*:;<^+U, *;5*>6WRXQC@
M$<=J^TY/AYX5D\.QZ$_A_3#I,;^:EL(0%63^^#UW8XSG..,XJ]_PB'A\Z79Z
M:^B:7)86;;[:W>U1HX6Y^95(P#R>>O)H ^6/VD-+\+:3XTDNO#^IZ=IVNV%K
M$TVE&P!AESN^[A2F\AERC* 5(.>M>^>%]5/B3X%17]S:6]L;C1I UO"@$2A8
MV7"KV7 X'8<5TOB'P/X9\2745SKVA:;?W,14K-- K/@9PI;&2O)^4Y'M6ZUI
M ;/[((8A;;/+\D*-FS&-N.F,<8H ^$;C3XX/@[X UF>P,FEKK%RNI/'A#(-Z
M[%8XR?E64 D'&3ZX-;Q5);ZI>_$O5?#6/^$98VZH(HC%&6:>,QX0@8P$EXP#
MS[U]PR^$= D\/RZ'_8NFKH\F2UDELB0Y)SG:  #GG(YSSUJ"R\#>%[+16TBW
M\/Z4NF.P>2U:U1DD8=&8$?,1ZG)XH C^'6F6&E>#]'_LVQM;0364#R>1$L>]
MO+'S' Y-?&/Q$L=6\?\ BSXB^*]+AM[G3=.F5)I<@GRE81HT>,@_+%DG/W<F
MON^"VC@@CAA1(X8U"HB#"J!T 'H*R;'PEX?L+*[M+'0M)MK6\7;=0PVD:)..
M>'4##=3USUH ^4DU"T\9_$3PK=WL$-TLW@R03++&K*98X;A6..0,.I([BN:\
M(PPW4?PHANH8YH9+F^5XY%#*P\P<$'@U]GVO@WPW9R126?A_1X)(HVAC:*RC
M0I&V=R#"\*=S9'0[CZTL'@WPW;_8_(\/Z/$;,LUMLLHE\DMRQ3"_+D]<8S0!
M\)>"=031+?P3K=V&^Q6/B.:6:3!( "VC'H">@)P <XK0G\2W2>$->MM+;9I6
MM>)&:>\:(,JHN'C&&&023N'0_(:^T[KX?^%+O16TF;PWI TYI?/-O%:I&@DQ
MC> H&&QQD<XXZ47'P_\ "D^CRZ6WAS1TT^5Q))!%:)&K.!@/\H'S $C/7!-
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MTDO[Q(UE !XC+/P>>!Z\5V5KK>FW6F-J-MJ%G-8(&+W,<RM$NW[V6!QQWYH
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M](L-*O=!U:Q@;1M0TF;Q?IL;?V;9BWLYE,=KN"Q!F&.H/S$$Y/>N?U"SN/\
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M8 BD@9$9R=HSCKCH:I>--+>TUKQ5IFBPZ;9>'[/Q-ILL]O<0XT^!6M.6E1<
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MRE8Y)$#HN0I#$J0?ESC(SC-5HOB9X0EU32=.768Q>ZK%'-9QO#(GFK)]SDJ
M"W8$@YXQ7!^'M'U>[\'Z1J>IZ1>6VIZMXJBU:[LGB9GMD\S:N_O@(B')"XSC
M Q4/BI/$NH>/I+6\MO$36L&N:;-9):VBM8-:++&7DDD"D[E8,2-P(R#C:"0
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M2\/7L&D^+M8\7V'AKQ!H.E1Z3=7VNQ7ULT:SW.\./*5V :3"RDLORX*C@G(
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MFDZA-;6*:)=Q1VUJ7-P()W,D<70%E0YVC/0#'-023^)OL/BK5=$T?7[2VO\
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M">-D+(TAVN 1RI'((ZT ;FG?$'PIJ>IZGI]AK-M<7>FQ--=)&&;:B_>*G&'
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MJ;IJX$%TEK+;&U42HSHS*V"V-O[MQUSD=.E02?M)>!TALY,ZHPN(S(VVV5C
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MF_$ELOSG<!M7#GYN2><<*:U+K]H#P3;>&;?6'N;MO.G>W^Q+"/M,;+R=RY
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M[P.>*XK4O#'BZ'Q)INL1^%;VZB\*+I]I.DELS-=O']XCC]Z@92@*YP@C[<T
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M00RV]P( ]N@?:W))'/EG(X(R5]P.G^.OBK6/"WPDFUC1;K[/J&8$$QC5L!V
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MC/05WEGJWB+2_P!H2V7Q1KNM6^G76J-'9&WF,EK.F_:L.-P '*JV,E3D%?0
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MF)P>.3P:[']G^XL%^#OA:*SE8'[*<I,R[_,WMOP!VW;L>V,T >CLV*3>,_\
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M^^"",<>E4K']GCP19Z7JEE&-39=0B2&25[A3)&BR+)M0[<#+*N<@].U>PT4
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MW-<[X?\ @A9>'O'WAW5M/OYGT;1;:18+*Y_>,9W:0F3.,#AQT .47GBO9J*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*V&R%P<=,]#@T ?26EZG9:MIUM?Z;<QW-G<H)(98SE74C((JT'4]/I7QE<^
MVTOQ-XTTPZ[J8?PCH45_:/!)Y:M.L"L3MYPI);H<\]:PM @L[)]#B_X2V[6W
M\0:'>W6K_O&/V>6)96C;L20T$?'4^6<'#B@#['^('C'3_!'ABXUS5(;J>VA9
M$,=L@:1BS # ) [YZ]JW;*Y2XM8)5#KYJ!PLBE7 ([@\@\\U\$Z'J%Y??"_Q
MCK5WKM[-JUNUC911-</N2 N/FZX/^K5?4;3GKS+#J?BK4O%ESJ>F7ER^JV6H
M16]O+)JL4"!5^5(?*<@L6V+T/.T@@DDT ?>PE4D@'D=?:E\Q>/?I7R+\%C=Z
M;\=X8O$>HW&JWNIBYDMM1L=06:TN<(Y.\+U  ?@GY3CY>A%7]J/59M1^(=]:
MZ>MW#)H-E$TS_;PB?.5(=(N"6'G;3C)Y[ <@'V)O&<9]Z!(IZ&OCF\TV\UN]
M\<^(GUK5DU#P]I6F7UH(YB5:1[5&9G!!S]T^G4DUI_LMCQ%!XU@DC$G]C7^G
MF6\6?4(YV=QG;,$!#)EAMY!ZGD\8 /K/S%R!GD]!ZTC.-O%?%/[1VJZA<?$_
M7;O39KRWCT4VL)=[\ )(R$@Q1<'!!Y SC#$\-@+I^MW+^)M0LY=4F$LGCZT"
M1&X(8P[[@-A<_=R4![<B@#Z-?XQ>&AX6\0>((S>RZ;HUV+.5DA&Z60XQL!(X
MRP&3M_+FO1HY/EW-P/K7P5I^DZ;;_"CQU=_VE/\ VG%>K9QV;7 (>$3PEI?+
MQDL&VC=T^;'>K;7-]I.KZUX%_MK4[?PW_P )/;6<]V;@((HR\RN6/'+ !R<8
MS'D]J /NTN!UKEM%\;:=K'C;6_#5K!>B\TE8VGF>/$+;P" K9Z\]"!T.,X-?
M(=@U_K.I6'@Z35]0N/#2^*&TZUO4G),L+G:P5^58;0C8 Q^\)Z-6AX@M-)\/
M>+O'VEZMJ^MKINDVD'V)(;[;+/<;(U522#G<79FP. "0,#% 'VHTBJ"6.,<G
M-4];U6UT;2+W4K]VCM+.![B9@I)"(I9C@=>!TKXBU?3]9LO!G@K2;K5)]236
MI+J_EM8-36+!:*(1HTC@J& YVD=6(')JA=WFOZS#IVC>+]1G6RL-!O9[-XK\
M2I<[$E="65F5OF01X'.$ H ^R=+^(6CW_P -?^$V"7<.D>3).4D0&4*CLAX!
M(ZJ>_P"5:_A'Q%:>)O#.GZW9++%:WL8EC6<!7 )XR 2,_B:^?K728M5_8TM3
M-+<1_9+>>Z3R7V[V6>4 -QRO/(]A7E5K#!<VGAS1)O$%[::4N@W&JG%\H47@
M5V"X_AYCCPIR>XQG- 'W?O'O^5&\>_Y5\_Z VL^+OV3Y6N);I]46RF:&56<2
MR^1(63!'))$84>O?->#_ -MZQXCTJ76+W6;[2["6ZTO0972=W1(A"?,?'?F!
M)" >K'KG- 'V?X\\<Z1X+M].EU8W#'4+E+2WC@CW,[L?<@ #KR?SKJ2ZCK^%
M? .OQO+<S>'I-1NYM"T/Q(;#3Y6FW;89&96PW3@0(1C !=CCYN+-U-KEUXXU
M>7PKJEWJ#Z+>Q6^FZA)JL2((58QQC#$"0OLC&01G!R#NH ^]MPI"Z@$DXQUK
MP7]I&_N;/4?AJPN'MM^KI]H"2%%QF/(//3K7C32Q>(WT6QU77I[72+_Q-K$4
MMTMS\OE>7:E<$G!!S@#I\W'6@#[?\Q1WH,BCJ<5\#Z;J=WXHL=-TKQ#XDO([
M'3M&O;NTS<A/,GC>1HURWWN44 <G"@#&*75K_5/%&AVM_JVJ7YGTWPRMVA$I
M!E>/4# A;)Y.U@=W4D T ?>^]: ZD @Y!&017A/CB36]>_9NT.2SUN.SU6\M
M+-Y);B[$#7;% 3$KDCYV/.,\XP>M>)>$M;CLM2^&ZB]U2QBM]>GCU!+^\S'%
ML-KD _*!&%[,."6Z]2 ?<>]0,GZ5R=AX\TJ^^(^I>#($NO[4T^U6[GD* 1!3
ML(4'.2V)%/3'OD8KY"\.WC^)T\#^'/$_B"ZTW0&L;R\>Z-QL"S++<%79F.&V
MF*/ ZC) (S4/Q&TJ*V\;^,9M+UB\N/[&T?3Y[2^2?<UR"ME#N9AU!64GCVH
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M='\,^!H/%.HK=MIUQ'')$D,>96$@RHP2,'![GBNKL[N.ZLX+E RI+&L@##D
MC(S7Y^>)KB37]%UO4M9UJXDO].^P6MG:O+\K1F(AL+WQY:GCG.2<YS7O_P"T
M:TI\'?#ZVANKFW6YO88)&@E*-M:, \CZT ?11D4+N)P,9SVKGM;\6Z?I/B?0
M-"N/M#7VM-,+;8F5 B0NY8DC'&!W.2.,9-?'4,TTSZ5X+U/6K^W\,GQ-?6LD
MK7&"(T6!5!)XP-Q(7&,L>.14/A73[+Q!?^!)/%7B._BM)[C4+)[U[M8?)BA1
M7CVNP^4EI""23D848P* /L3QEXYT?PIJ6@Z?J33F\UJ[6SM(X8]VYBR*23P
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M)(V\]>O!P2*Z3XR_$^[^'=YX=M;#06UNZUEY8XHDN#&P9#& J@(VXL9!Q[4
M;$OPE\$2P7,+:%$L-S:1V4J)+(@:&-U=5X;CYD4Y')(Y)R:["6Q@FLFLY8U>
MU:,Q-&W(9,8P<]1CCFOGB7]I=K6_6+4O"4UM%;RQP:B?MF)+9V+941LBLQ4+
MS]WY@1G&"=75OC__ &5\03H&H>'6AL1=M;_;?MJLY0?\M?*"YVG((R>1GN"
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M8DD^8W'O[5X]XA\8^*8OCAX^BBM+VYMK/19X5ABU 1?8+?RXF^TQG!^8X5L
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M1$#;O+X&)%(.#GGIB@#VK2/!/A_2)]2ET_3HXVU*"*VNP[-(LT<:>6BLK$C
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M0Q^3' B_*J=,8[^^>M<O#\*O!D'A6Z\-Q:+&-%N;@74MN9I3F4!1N#%MP.%
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MG_:7UA+6.;_A ',,EJ;U7742P$'F&,R'$7"[P1D]Z /99/A;X.?Q?_PD[:+
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MX&+'+%#D! 2>GW3]  >NGX%_#PZ5!I[>'HC#"[2*_GRB0L0 27#9/W1P>!V
MJWJWP<\":K8:=9WGAZV\C3XS%;B)Y(RJ$Y()5@6R<G+$G))ZDUQ^A_'=-8M;
MRXM]$PEOX<EUT[KH\O')Y;0_<Z;@?G_\=K+\4?M#R:!)I+S^&%>TO;&TO7==
M30.@G3>56/;EMO(R<=L[0RY /2[SX3>";N;4)9M"BW:A;1VER$EDC5X8S&40
M*K *!Y,?0#[ON:<_PK\'2:]=:S)HZ-?W-N;65C+)M:,QF-AMW8Y0X)Q[]<FO
MF:[\<^+99/BM>ZA#JEI,BVZ,\&J;7TLBXQ'$C '*DL<[<9 ;/WLUW,?[0?\
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M6M<^$WQ+\3VNIZYXBMK9]=ECM;*"TAGC7]U&REY&.[:"=@/WN2S< 8%?6M%
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MFCW#DJ7SM &0 @;DYS5NS^%7Q+7P[H>A:AI]K/I^BZRD]KY5Q$#Y6YVED)+
ME267 /S=>*^MJ* /EC1O@[X_MM3TKP]<R6+>$=%U1M6MKD2+YDQR"J8ZYX/4
M ?.WS$;<7OA-\+O%WA_5_ 4VK:4L,6EWNI2W;"XB;RUE@1(SA6YRRGIDCOBO
MIFB@#P;X\_"?4_'GCGPK>Z?;PO81AK?49&=8S'"KAQSG<V=S@!1QU[UY=%\
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MDA+*I(.2@4J6!Y#9Z-72?$CP/X\M?BDWB_X>?V?-+?626$WVIP#;<C,F#PP
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MP595+*2,D@<%%."1D9Y['URB@#YG\$_"#Q3HGB+P1K&HV\4]Z-2O-1U=HY4
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M0QPXXSMR,@\U]0Z&M\NBV"ZNT;:D+>,731_=,NT;R/;=FKM% !1110 4444
M%%%% !6-XQTRTUGPQJ>GZC'YMI<6[I(FXKN&/4<BMFC&>M 'YX^'K/0K[PYX
M6L=IDU"[\0+#J*#>,P'8(QG[HSNDZ'/Y"K.I6\XMM/T,W%K;Z GB#488%OYI
M%MD=5A&7*'<,!EY[;CZM7V[#\/?!\$RRP^&-'CD659U9;1 1(#D/TZC/6IKC
MP/X6N+![*?P]I4EH]PUVT+6J%#,PP9,8^\1QGK0!\<>!?">GZY\3O 7AW7=0
MM=?TJ>QN!NM+B78%4W+! 2$=<,N<8'7N#6;X7TK5&\3S:AH^O:18^(;;5I8[
M:.\NI_ML[J.(PH!#*WW>>6/RYY K[>LO!_ARPO;"\LM"TVWNK",PVLL5LBM
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M>)OB!X>T'PU_;,VJZ;)!+$[V>+M,7;*/NHPSGG )&<9H ZW.>E%<C\-_%O\
MPE?@'3?$UY#%8B[CDE>/S,K$JNPY8X[+DGCO4]CX_P#"=]:WES:^)-&DM[,@
M7,HO8PL62%!8YP 20 >A/0T =/17,0>/O"4^G27\?B71C8QS?9VN&O8U02<_
M+N)QDA21Z@9&1S4H\;>&FT&XUM-<TQ](MV*2W<=TC1HW'RD@_>Y'R]3D8ZT
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MY2H F#U&.F#FN4\<?#_2?$W@_4-!ABATR.\\L//:P*'"K*DA Z==F/;.><4
M?#GC Z9/:ZU+X2BGC\/^?IJ[2&"B46TN<YZG<)<$\GYCWJQJ\,SWVH:EH$:1
M^ _^$A_=-<1,;56R3'YB %RHCSD $X.,9(!^Q?'_ ,*M*\7>$]/\/(YTO3[:
M\2[D-K"H>;:CK@G@!B7R6(/3ISD=Q#I-@NG_ &'[%;?8_P#GAY2B,\Y^[C%
M'P#=/]A\-:=ICWFDRZ;+<7UU!JHM9I45_*"F!%DC&,E8SD*2/,0Y7!KO?@1X
M<TKQ=XL\.V/B*S2_M(_#=PZ12LV%;[=*H(P1T#G'IG(Y K[ FT/2IK2*UFTV
MRDMHFWQPO I1#G.0N,#D9X[U-;:;96LBO;6EO"ZJ5#1QA2%)SCCMGG% 'A?[
M4#6%MJ7P]?Q DC>&H]3=K]=KM'M 3&X+U.W?@=2-V.]>$^%M(BU.#PM!J%I(
M^B3W^LS6<4I8!U2VA8$<Y(#(/8E2.>:^[;^QM=1MGM[^VANK=QAHID#JP]P>
M#3/[,L=L*_8[?;"&$8\L80'KCTSWH ^?_A%*\G[)NMAG9@EAJ:KDY"C9(<?K
M7D/C+PS8Z-X!^%^NV&G6<,=VC?VA=7*/) \FX,GG*,DC!DZ#) P.@ ^X(["T
MBMFMXK6!+=@08EC 4YZ\=.:9<:787-@;&XL[:6R*[3;O$&C(]-I&,4 ? NL:
M%?>'/ .@Z_I^I07\-[-?:;Y]N) $B9 NSYU5OFW7!P%QR<G+8J/Q9X6?P_XG
MU+0=<N='TZX2VLQ'-/'.1S'&<QF)""W7>Q')#X)/7[_;3+!H(X&LK9H8CE(S
M$I5#Z@8XIEYI&G7LT<UY86MQ+']QY8E=EZ]"1[G\Z /BOPCX9\/:CI_Q8N?'
M<JK=Z7=1)'J-CO<13/+.K,B9&]&8#@CIZ'D<AYJ_\(C<V<$>CSV=EJ]G]HU&
M.&<)<@QS*F_[I"*%?.$#'=GKU_0==.LE\_;:0#[1_KL1@>;U^]_>ZGKZFH8]
M%TN.TDM8].LTMI,;XEA4(V.F1C!H \)_90A&F^%_%-W_ &KIMQHOVXR1_95E
M5(&5,R']ZBMMV^7C.> <X.<_/5I_96F?\)%9:']FUJTN-.F>*^:"6.XL5RIP
MX("Y.T+D9^_P1DK7Z!V=C:V4/E6=M#;Q==D2!%_(57CT32XFN&CTZS1K@YG*
MP*#*>/O<<]!U]!0!\"ZL=$ATC7/[9MY#K,^D:.='D97P,10^<01\O*AAD^A
MYJ7Q%IMY=>.M=L]2U.QTN_EU&"2UDO$F:9D.[RO*>)&VIL9"0<'A,9((K[TF
MT/2IY(I)]-LI'B3RHV>!243.=H)' R!Q4DFE:?+=17,MC;/<Q#;'*T2ET'7
M.,CH.E 'B?PE9M6_:$^).KV$Q.EQ+#9R $[9)U"KD=CCRI!G.<,,=37O-8/@
MWPAH?@W2SI_ANP2SM2YD8!F9G8]V9B23VY/0 =JWJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNO\ GX>C[==?\_#T =717*?;KK_GX>C[==?\_#T =717*?;KK_GX>C[==?\
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M/[4N;DP<W3<$*<MD<[CGG[YH Y?PK\7_ !1J/@]&N/"-YXBE>2:VGN+%610
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M>"HO 7A<:3'=-=O)*;B68KMW.0!PO.  H'6NPH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"NBT+_CQ'^^:YVNBT+_CQ'^^: -&BBB@ HHHH **** "L;Q5X9TCQ7IJV'B"
MRCO;-9!*(G) W#.#P0>YK9K)\6ZJVA>&-7U98Q*;"SFNA$3C?L0MC/;I0!QW
M_"D/AU_T*UG_ -]R?_%4?\*0^'7_ $*UG_WW)_\ %5XYJ'C7XJZ;\*)_%]YK
ME@]AJ$,4UK)%;H)K:1YP/+ *X*[-W)R<D?4]1J'[2%M9Z!8Z@_AB\%Q)<SVU
MQ;R7D:"%H=F\ D9<XE0XVCJ?0T >F^'_ (7>#?#NHB_T30K:SO I02H[YVGJ
M.6KJO[.M?^>0_P"^C_C7@EC^TQIDNJ3"[T&[M]$#7"0:F)BRSM$A95"E%PS#
M;QG(+KGKFFI^TK"FB7UWJ'A:YM+J)[5;>V:[!\Y9T>17+% $78@(/.=XQQDT
M >^_V=:_\\A_WT?\:/[.M?\ GD/^^C_C7G<OQ>TE/A+%XY6"=XY1Y<=EN D:
MXW;?*S]<G./N@G':O+M6^-7BGQ-XS\)Z5X7TW4-&=KY[74[:1(Y6>2-T,L8)
M7.$3))X/S=!B@#Z5_LZU_P">0_[Z/^-']G6O_/(?]]'_ !KQCXZ?%:^\#>-/
M".FV$\:6L\@FU-&1&9H#(BC:2?E.%EYX'OQ6)K?QXND^)D-I:V=S;^&=-DU"
M.\?".]\]O;LQ"Y'R@-C^+G*DXY% 'T%_9UK_ ,\A_P!]'_&C^SK7_GD/^^C_
M (U\S>'_ -H3Q!)JVKSW7AZ:]CNKBQMM,TI)U1XC,DC#Y]F7+83J/3\=^V_:
M:T@ZE<VU_H5]9QPPR$L\R[S,B[FB*$#;R" 2<DC&,] #WK^SK7_GD/\ OH_X
MT?V=:_\ /(?]]'_&O A^TI$]OHY3PAJ;W6H,Y$*7"D% V,Q-C]X>"-N%Y&.>
MM>VZ]XHT;PXMO_;NHPV7V@MY7FY^?;C../<?G0!H?V=:_P#/(?\ ?1_QH_LZ
MU_YY#_OH_P"-8>O>(X9/A]J_B#P]=QSI#87-Q;SJ-R%XT;G!ZX9?TKC?"OCK
M4[JXT*WO-4TG4K6YD=9]2M(C$GR6S2E>79=RE1N(.,-@!<4 >G?V=:_\\A_W
MT?\ &C^SK7_GD/\ OH_XURNF^/+75-.OKJPL;Z6>W2*5+4F-9)X96Q%*I+A
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M?]]'_&K=% %3^SK7_GD/^^C_ (T?V=:_\\A_WT?\:MT4 5/[.M?^>0_[Z/\
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M6^P3R7,:I\N.F-N3QWX'%4O^%(^.?^BR^(?^^)O_ )(H_P"%(^.?^BR^(?\
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M]9TXZ=:ATOX>V%AXKO=62'3#%<R33%3IR?:3)+GS";@DL5)9N !@''2O/?\
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MBR^(?^^)O_DBC_A2/CG_ *++XA_[XF_^2* /?J*\!_X4CXY_Z++XA_[XF_\
MDBC_ (4CXY_Z++XA_P"^)O\ Y(H ]^HKP'_A2/CG_HLOB'_OB;_Y(H_X4CXY
M_P"BR^(?^^)O_DB@#WZBO ?^%(^.?^BR^(?^^)O_ )(H_P"%(^.?^BR^(?\
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MI'QS_P!%E\0_]\3?_)% ':K\,;<VY@DN;=8'TR2Q>*TL5MD$C3"82(J$!0K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5X%X,_Y/$\>?\ 8'A_] M*]]KP+P9_R>)X\_[ \/\ Z!:4 >^U
M\_\ C+_D\;P)_P!@:3_T"\KZ KY_\9?\GC>!/^P-)_Z!>4 ?0%%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,_Q#_R
M=1_Z]I/_ $ UY!^Q_P#\D@3_ *_Y_P#V6O7_ !#_ ,@'4?\ KVD_] ->0?L?
M_P#)($_Z_P"?_P!EH ]OHHHH **** "BBB@ KYY_;8_Y)WHO_857_P!$R5]#
M5\]?MK#/P\T7/3^U%[_],9* /?-,_P"0;:_]<D_D*LUY)8_'WX:Q65O')XE
M=(U5A]AN3@@?]<ZG_P"&@?AE_P!#,/\ P!N?_C= 'JE%>5_\- _#+_H9A_X
MW/\ \;H_X:!^&7_0S#_P!N?_ (W0!ZI17E?_  T#\,O^AF'_ ( W/_QNC_AH
M'X9?]#,/_ &Y_P#C= 'JE%>5_P##0/PR_P"AF'_@#<__ !NC_AH'X9?]#,/_
M  !N?_C= 'JE%>5_\- _#+_H9A_X W/_ ,;H_P"&@?AE_P!#,/\ P!N?_C=
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M#+_H9A_X W/_ ,;H_P"&@?AE_P!#,/\ P!N?_C= 'JE%>5_\- _#+_H9A_X
MW/\ \;H_X:!^&7_0S#_P!N?_ (W0!ZI17E?_  T#\,O^AF'_ ( W/_QNC_AH
M'X9?]#,/_ &Y_P#C= 'JE%>5_P##0/PR_P"AF'_@#<__ !NC_AH'X9?]#,/_
M  !N?_C= 'JE%>5_\- _#+_H9A_X W/_ ,;H_P"&@?AE_P!#,/\ P!N?_C=
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M#+_H9A_X W/_ ,;H_P"&@?AE_P!#,/\ P!N?_C= 'JE%>5_\- _#+_H9A_X
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MX W/_P ;H_X:!^&7_0S#_P  ;G_XW0!ZI17E?_#0/PR_Z&8?^ -S_P#&Z/\
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MX W/_P ;H_X:!^&7_0S#_P  ;G_XW0!ZI17E?_#0/PR_Z&8?^ -S_P#&Z/\
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MX W/_P ;H_X:!^&7_0S#_P  ;G_XW0!ZI17E?_#0/PR_Z&8?^ -S_P#&Z/\
MAH'X9?\ 0S#_ , ;G_XW0!Z)XA_Y .H_]>TG_H!KR#]C_P#Y) G_ %_S_P#L
MM:&L?'KX;7.DWL$'B0-+) Z(OV*Y&25( YCJA^Q__P DA3_K_G_]EH ]NHHH
MH **** "BBB@ K-US0M*UZWC@UO3;+48(W\Q([NW295;&-P# @'!//O6E10!
MRG_"M_!'_0G>'/\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'
M_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\
MP60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?
M\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\
M0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P
M60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=
M710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"
MM_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>
M&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?
M_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\
M$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&
M_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_
M !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!
MRG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'
M_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\
MP60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?
M\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\
M0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P
M60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=
M710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"
MM_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>
M&_\ P60?_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?
M_$T?\*W\$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\
M$?\ 0G>&_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$T?\*W\$?\ 0G>&
M_P#P60?_ !-=710!RG_"M_!'_0G>&_\ P60?_$UH:)X2\/:%=M<Z)H6DZ;<,
MAC:6SLXX79"0=I*@'&0#CV%;=% !6'K/A'P[KMTMSKF@Z3J5RB"-9KRSCF<*
M"2%!8$@9)./<UN44 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'
M_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4
M <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P
M1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_
M ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-
M'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_
M $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\
M\%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 3
M75T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_
MPK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)
MWAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D
M'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M
M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)W
MAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'
M_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4
M <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P
M1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_
M ,%D'_Q-'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-
M'_"M_!'_ $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_
M $)WAO\ \%D'_P 375T4 <I_PK?P1_T)WAO_ ,%D'_Q-'_"M_!'_ $)WAO\
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M\$?$;2/$&I:GI4]M9>=OCMVD+MOA=!C* =7!ZU]-444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Y+\=OA-)\4FT39K"Z9_9OG];;SO,\SR_
M]I<8\OWZUZU10 D?W!]*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140145918362784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Zevra Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001434647<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140145909472896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Pay Versus Performance </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">In accordance with the SEC&#8217;s disclosure requirements regarding pay versus performance, or PVP, this section presents the SEC-defined &#8220;Compensation Actually Paid,&#8221; or CAP. Also required by the SEC, this section compares CAP to various measures used to gauge our performance. CAP is a supplemental measure to be viewed alongside performance measures as an addition to the philosophy and strategy of compensation-setting discussed elsewhere in the overview of the executive compensation program, not in replacement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Pay Versus Performance Table </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The following table sets forth information concerning the compensation of our named executive officers for each of the fiscal years ended December 31, 2023, 2022 and 2021, and our financial performance for each such fiscal year:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto; text-align: center;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;">
			<p style="text-indent: 0pt; margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Value of Initial Fixed $100 </b></p>

			<p style="text-indent: 0pt; margin: 0pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Investment Based on:</b></p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td colspan="2" style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Year</b></p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Current PEO</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Current PEO</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Travis Mickle, Ph.D.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(2)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Travis Mickle, Ph.D.</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(2)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Richard W. Pascoe</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(3)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Richard W. Pascoe</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(3)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Christal M.M. Mickle</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(4)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Christal M.M. Mickle</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(4)</b></p>
			</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Summary</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Table Total for</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-PEO NEOs</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(5)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Average</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Actually Paid to</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Non-PEO NEOs</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)(5)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Total</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shareholder</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Return</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
			<td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Net Income</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>($)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2023</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">3,445,231</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">4,975,770</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">3,593,438</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">4,385,998</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4,122,558</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">3,308,589</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1,669,956</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2,211,127</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">2,039,861</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">2,724,999</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">58.48</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">(46,049,000)</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2022</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2,400,356</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1,349,703</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1,199,492</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1,106,040</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">40.98</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">(41,543,000)</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2021</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8212;</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2,657,059</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2,808,110</p>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto; text-align: right;">&#8212;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">953,616</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">989,957</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">77.77</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
			<td style="vertical-align: bottom; width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">(8,555,000)</p>
			</td>
			<td style="vertical-align: bottom; width: auto;">&#160;</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(1) Mr. McFarlane became our Chief Executive Officer on October 10, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(2) Dr. Travis Mickle served as the Company&#8217;s Chief Executive Officer in 2021, 2022 and from January 1, 2023 until January 6, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(3) Mr. Pascoe served as the Company&#8217;s Chief Executive Officer from January 6, 2023, until June 1, 2023. As noted below, Mr. Pascoe also served as a non-PEO NEO during 2022 and 2021, and his compensation for those years is reflected in the columns entitled &#8220;Average Summary Compensation Table Total for Non-PEO NEOs&#8221; and &#8220;Average Compensation Actually Paid to Non-PEO NEOs.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(4) Ms. Christal Mickle served as the Company&#8217;s Interim Chief Executive Officer from June 1, 2023, until October 10, 2023.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">(5) Amounts represent the average compensation actually paid to our remaining named executive officers for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Year</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-PEO NEOs</b></p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">R. LaDuane Clifton, MBA, CPA and Joshua Schafer</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2022</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe and R. LaDuane Clifton, MBA, CPA</p>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2021</p>
			</td>
			<td style="vertical-align: top; width: auto; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Richard W. Pascoe, Sven Guenther, Ph.D. and R. LaDuane Clifton, MBA, CPA</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">
<div>
<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="20" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 13%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 28%; border-bottom: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Adjustments</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"><b>Current PEO</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="3" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>Travis C. Mickle, Ph.D.</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="3" rowspan="1" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"><b>Richard W. Pascoe</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="4" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%; text-align: center;"><b style="font-size: 10pt; text-align: center;">Christal M.M. Mickle</b></td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="4" rowspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Average</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-PEO</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>NEOs</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Deduction for Amounts Reported under the </b>&#8220;<b>Stock Awards</b>&#8221; <b>and </b>&#8220;<b>Option Awards</b>&#8221; <b>Columns in the Summary Compensation Table for Applicable FY</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(2,941,461</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(2,558,873</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(3,469,457</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(1,047,596</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(1,327,110</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">4,472,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">3,589,040</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">1,590,000</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">2,013,274</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">2,814,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">&#8212;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">&#8212;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">13,320</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">11,795</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date </b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(237,607</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(158,512</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(14,553</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">(11,821</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">)</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited</b> <b>during Applicable FY, determined as of Prior FY End</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date </b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>TOTAL ADJUSTMENTS</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">1,530,539</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">792,560</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"><b>&#160;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;">(813,969</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;">)</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">541,171</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;">&#160;</td>
			<td colspan="2" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;">686,138</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;">&#160;</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 2,039,861<span></span>
</td>
<td class="nump">$ 1,199,492<span></span>
</td>
<td class="nump">$ 953,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 2,724,999<span></span>
</td>
<td class="nump">1,106,040<span></span>
</td>
<td class="nump">989,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"><b><i>Relationship Between Financial Performance Measures</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;">The graphs below compare the compensation actually paid to our PEOs and the average of the compensation actually paid to our remaining named executive officers, with (i) our cumulative TSR, and (ii) our net income, in each case, for the fiscal years ended December 31, 2023, 2022&#160;and 2021.&#160;TSR amounts reported in the graph assume an initial fixed investment of $100.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;">
<div><img alt="proxy1pic.jpg" src="proxy1pic.jpg"/></div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text">
<div style="text-align: center;"><img alt="proxy2pic.jpg" src="proxy2pic.jpg"/></div>

<div style="text-align: center;">&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 58.48<span></span>
</td>
<td class="nump">40.98<span></span>
</td>
<td class="nump">77.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(46,049,000)<span></span>
</td>
<td class="num">(41,543,000)<span></span>
</td>
<td class="num">(8,555,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember', window );">NEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,327,110)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember', window );">NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">2,013,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember', window );">NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember', window );">NEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">11,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember', window );">NEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(11,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember', window );">NEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember', window );">NEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember', window );">NEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=zvra_NEOTotalAdjustmentsMember', window );">NEO Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">686,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">3,445,231<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">4,975,770<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,941,461)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,472,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_CurrentCEOMember', window );">Current CEO [Member] | PEO Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,530,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">3,593,438<span></span>
</td>
<td class="nump">2,400,356<span></span>
</td>
<td class="nump">2,657,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">4,385,998<span></span>
</td>
<td class="nump">1,349,703<span></span>
</td>
<td class="nump">2,808,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(2,558,873)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">3,589,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(237,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO1Member', window );">Former CEO 1 [Member] | PEO Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">792,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">4,122,558<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">3,308,589<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,469,457)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">2,814,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(158,512)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO2Member', window );">Former CEO 2 [Member] | PEO Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(813,969)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">1,669,956<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">2,211,127<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Deduction For Amounts Reported under The "Stock Awards" And "Option Awards" Columns In The Summary Compensation Table For Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(1,047,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">1,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">13,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(14,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=zvra_FormerCEO3Member', window );">Former CEO 3 [Member] | PEO Total Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 541,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_NEOTotalAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_NEOTotalAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=zvra_CurrentCEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=zvra_CurrentCEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=zvra_PEOTotalAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=zvra_PEOTotalAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=zvra_FormerCEO1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=zvra_FormerCEO1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=zvra_FormerCEO2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=zvra_FormerCEO2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=zvra_FormerCEO3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=zvra_FormerCEO3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>60</ContextCount>
  <ElementCount>15</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>22</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="zvra20240303_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="zvra20240303_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>zvra-20231231.xsd</File>
    <File>zvra-20231231_def.xml</File>
    <File>zvra-20231231_lab.xml</File>
    <File>zvra-20231231_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="zvra20240303_def14a.htm">zvra20240303_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>proxy1pic.jpg</File>
    <File>proxy2pic.jpg</File>
    <File>yw0d_zeropage1.jpg</File>
    <File>yw0d_zeropage2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="82">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "zvra20240303_def14a.htm": {
   "nsprefix": "zvra",
   "nsuri": "http://www.kempharm.com/20231231",
   "dts": {
    "schema": {
     "local": [
      "zvra-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "zvra-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "zvra-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "zvra-20231231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "zvra20240303_def14a.htm"
     ]
    }
   },
   "keyStandard": 15,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 22,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 60,
   "entityCount": 1,
   "segmentCount": 22,
   "elementCount": 271,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2023": 82,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://fasb.org/us-gaap/2023": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d_2023-01-01_2023-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zvra20240303_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-01-01_2023-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zvra20240303_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "d_2023-01-01_2023-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zvra20240303_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2023-01-01_2023-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "zvra20240303_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r99",
      "r115",
      "r143"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r92"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "zvra_CurrentCEOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "CurrentCEOMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current CEO [Member]",
        "documentation": "Current CEO"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r119"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92",
      "r136"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r96",
      "r112",
      "r140"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r144"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r103"
     ]
    },
    "zvra_FormerCEO1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "FormerCEO1Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former CEO 1 [Member]",
        "documentation": "Former CEO 1"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_FormerCEO2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "FormerCEO2Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former CEO 2 [Member]",
        "documentation": "Former CEO 2"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_FormerCEO3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "FormerCEO3Member",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former CEO 3 [Member]",
        "documentation": "Former CEO 3"
       }
      }
     },
     "auth_ref": []
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r79",
      "r92"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r100",
      "r116",
      "r135",
      "r144",
      "r148",
      "r156"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r160"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "zvra_NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Deduction For Amounts Reported under The \"Stock Awards\" And \"Option Awards\" Columns In The Summary Compensation Table For Applicable FY [Member]",
        "documentation": "NEO Deduction For Amounts Reported under The \"Stock Awards\" And \"Option Awards\" Columns In The Summary Compensation Table For Applicable FY"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]",
        "documentation": "NEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]",
        "documentation": "NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]",
        "documentation": "NEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]",
        "documentation": "NEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]",
        "documentation": "NEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]",
        "documentation": "NEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]",
        "documentation": "NEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_NEOTotalAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "NEOTotalAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEO Total Adjustments [Member]",
        "documentation": "NEO Total Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r174"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r107",
      "r108"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r100",
      "r116",
      "r135",
      "r144"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r98",
      "r114",
      "r142"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101",
      "r117",
      "r145"
     ]
    },
    "zvra_PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Deduction For Amounts Reported under The \"Stock Awards\" And \"Option Awards\" Columns In The Summary Compensation Table For Applicable FY [Member]",
        "documentation": "PEO Deduction For Amounts Reported under The \"Stock Awards\" And \"Option Awards\" Columns In The Summary Compensation Table For Applicable FY"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End [Member]",
        "documentation": "PEO Deduction Of ASC 718 Fair Value Of Awards Granted During Prior FY That Were Forfeited During Applicable FY, Determined As Of Prior FY End"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End [Member]",
        "documentation": "PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Remain Unvested As Of Applicable FY End, Determined As Of Applicable FY End"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date [Member]",
        "documentation": "PEO Increase Based On ASC 718 Fair Value Of Awards Granted During Applicable FY That Vested During Applicable FY, Determined As Of Vesting Date"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date [Member]",
        "documentation": "PEO Increase Based On Dividends Or Other Earnings Paid During Applicable FY Prior To Vesting Date"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY [Member]",
        "documentation": "PEO Increase Based On Incremental Fair Value Of Options/SARs Modified During Applicable FY"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date [Member]",
        "documentation": "PEO Increase / Deduction For Awards Granted During Prior FY That Vested During Applicable FY, Determined Based on Change In ASC 718 Fair Value From Prior FY End To Vesting Date"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End [Member]",
        "documentation": "PEO Increase / Deduction For Awards Granted During Prior FY That Were Outstanding And Unvested As Of Applicable FY End, Determined Based On Changes In ASC 718 Fair Value From Prior FY End To Applicable FY End"
       }
      }
     },
     "auth_ref": []
    },
    "zvra_PEOTotalAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.kempharm.com/20231231",
     "localname": "PEOTotalAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Adjustments [Member]",
        "documentation": "PEO Total Adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r93",
      "r109",
      "r137"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r94",
      "r110",
      "r138"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r95",
      "r111",
      "r139"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r102",
      "r118",
      "r146"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r97",
      "r113",
      "r141"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001437749-24-010874-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-24-010874-xbrl.zip
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M*PF;&.?,Y3_O;"=MGFP\Z!+LS@ ,I LF=%H.Q[5?'&HNE05\<?G G5_#W7B
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MRG7#3/3@^XDXCD29;KK$RIH4?G^VD&F' (C2?$HM-6J2FAB"5IG-;(S9\3X
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MAF7\N[;+E8*T;YLOHVM6;)]'U:?<F+O*?I5"_<ITC2SVQG6R@1#(0\4"P')
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M=4=2#9L]X=[ =?# @C2<T="5+,S=_:GW[,J7@\;861S62*R%@F=].;'Q@39
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MZ0KQJG'?HGKQ/+9KZ68)!+^BN(/GRTVRD@_")ZTMBDT(M^$;?KC+P-,N)V6
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MU_+WG_)X#95I,^)T88#H1Z)4XJQ[VT['->1.*^?D/H8&,[)V+TD]B(G\MG)
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MZYAN72YCF=.E]U//8J.E(JHC&$SC]S; &^=?]S>\=3D/>J4;-ATU"XKHZ.%
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M@K R&5% 9(GT;(-Y%0Z,I70('HSI]L.!/$5YH;MG:#"7[C,X<)2YCWUY].D
M#FPHC<BA/!.& _'%,/"5*?\'A)6_O80#YZ,<N$C8H>#5W(0$.*!1F]":8NE7
M("9YYDO]G7[<[&\ Y\,YI!;-YJ*'VPU\N]AU=CH_Z3?MHEWZAR"23CC05\V[
M;_K.?/%32\>[GZ.../_@,-N4[M;CGUS*_Q0H*S,1_8_[T]P@_:F#1S]'C(8
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MN"EDCPFW\4@]MC&\4,X-0LW"1VMUF?SG_2/,ILVHTEY7?*=@O5O3T6;5'/(
MY0B97]71.:W9T0VOIVH:*GE+IR>X% H'@B!!P\WG[XBTRI])1!*&YZ:+5*5U
M?)EV.<Q-(^1*FI+*(Z#J)X[=U'E<%_]-2]@:69UJN2XK@.;9FPX_:9_SRG9S
MVJ,<WK$",&J:Z[')&PD&6._G";:W!Z1W^LVQ/N^<J8Q$H\:.^SLPCEHH ?FW
M&LE><_(:8#T-6$CQ;=8PC5$-Q>8ULY,8DR2(?-W@Z&CX9<DHB5^^FU[-?=)[
MI_N4>0-&LBPX3SFJS#YD^+ZA+"E(HC\BN 0_ O=D"1368'VJDKSQ*:7Y9%]B
M+Z;&=:>(X<LSQ2AEO*X+5,)'*65F!3[L7D%VFNR8G,@V3E^F;QSL>S@3M-WA
M@N'4"8#ME^^;+;/KB+V:BZIX>G^DB,SF%9@7U[!"/\+TWJ2 *UC'EX.S)@>S
M5T16.A-?D[(R;.O.@WLH$E'""$^7[G5/@$_!)/[)B#UID9:/&FA[Y\ZG$(JS
MQ:M.T+?X"U_K '?[$4'O0]^*(+02E4!,EF[.5SMUE:N,L;=7>1K[I:"E]#?K
M0O<)[O&U:=U"E5"LL-BJ>QKT=!P9MXIJVA+G^9C<I6#!*7(MER/5MJ^^];/;
M0\_3GZ,BF=N >4>RH[7#7=P30$:W]$EP<DTULP#])WECV<<C\S&O9-I?_UT;
MJ1A%?P< O\($W<83SE!1W'Z4@&?JBMD)&AV/2!0SW*(*\C_4=MOR=]VW*_9,
M9>T*85%V NQ:+>6%"$*_ATYW#$V;/L#DA@8HB)1)/19*<T:Q#6P/JF-]_S*X
M&5^^^U%;%&@@Q2W&BK6$W$N%WR $6.3^9JTY(H=ZL\#7O6606+ISOU[I[1)9
MH0^;Q$<K5"3J4!N)_C)R)Y5!1<L$&RFZM"J&IQ;9\XVO!)X?]5FA27VG2<2R
MOZ0VW(MXJH5,WO'I-H%%I2JHAV0QZ=GGQ@Z\@<S)1'V"M&0/#%8$F'X3@,!N
M!"D(X5!I6O^.]=>)OUQ_K?@U+K?^X7K -7WAQY _'^K1T[W4Q185)SB0( \'
MDCB<CV7S7+#;$LX(<A&I_0CXNXR.JTX:2ETT'^TEC5:"!IN;"4U>KO\#ZK$Z
MU6_OKV:+$M0:CDWWHX]T/4G7CX)S=2\X;!<4CLW["IKZ%5-P,>A[>9!QWR#<
M4RL!@DE6,402<%L>@4=_N8C<9K]S=F<.X14=88:9RE>N,!&$>SI"N,DXN0(=
M4@P^_5_*XAC'I)@(S%F7@>B(!U->'-U\AL@RH*ZR<""?_C(G[,%N"M$4T>?,
M96\J[6+RRD,]J(*\%C5/W!/_]&Y8B6RI92X]#.\5^):Q;7""C >X*ARFEC=)
M%YY:KE_#P_,.*:EAVL>X83H<@;%'='??3XHC9MID4 I:>J?XJ:J^J&I9@O5!
MQ\)4$U$J>&]C07/DX0=/\+&I\N"E-MIYG,,M\2L./_#[_#Z(^Y@VF&S5B*BY
M+>1DF/IXB71-1W\QO2:AY1YG,71JUMD40\RFLOUAKQN2#MZ>&4R<MF$C -Q5
MT2P;[5"41ZNC29(0XKO=E1Y<<G]P ,9Q$V_6[CZQ"=IK=Y]HO1![D9?3XL_!
MO%81[6*6?1X"KO,/C](R?%<AZRL$!EPHWM"FL/V"/!=*&W'R[< (WTR> L93
MD_DM+LT!PP1YCVZV/CG!SUU"DP)W[/)V+\1GJO%KO.L4=&%ESA%*)#,3W1R/
M#.W/<*VUK'?%^D^/QLJX@\T[H5=T@J=B[X31+EU.HPV/(V[!#,;>05TE@I2G
MMYS2\EG-W[W%GAEE,#QVVKN,]*G<RR7=7\O00MCP5Y@YS;%;-);NT^*%'-/?
MZSDV*2V/J'S]"_Y?>U\=%=>6]-M(T 0"@2!I(- $A^!N(<&#!M<$".[>$" D
M@>#N$-S=W2$T[MIH8XU#<.=U<N_<N3/??&_>S'OOGV_-'V>M7J?//N?4KMI5
MOZI=I^I!O! ,X3Q,*2V<UZ_.*) -?L[MJ.=6=MY# 4TAIY1'0[J'ON46X>[D
ME46;SFXLWI@'5\XB]#[3T3%5$R-'@?(W0@'-.9S2EK4$0W&JFXTY#Y5A5*>_
M1H?^_K,B-Y$3BV."+4NOK:D-^HE^HY\>$DJ1)0(DYH;>C&AT_/%3B5(JXB_.
MYV$H\4\_UOWV\ ZP05568-$E<LB.T$R-+9<8A5I[7]M#?/[8L:GX9SLV"*%O
M/(KZ>=O7(PF#XT[:[IA*+!3&!A'&AJVO7EL;[G9?;\5>4T^RF<:2%NU_,['
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M$]A!1K7 ;['*=P<MUX%0KQL[_34](;T.F-<%4>4=X'*YI;>.S0N+K:@L3YQ
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MWWF<3;?,?0"V Z;O$+_9$5"6,T0-!EV8E]<3L--UK(RY:-6((Z][])XZC\Q
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M[\R]-5,U,S]FSE2=5?5TU=YKU=K]K/6N]WV>O3&_,6L V0ME-64 =-?X0?P
M@%D$% $<['LX][!Q<.[AX.+BX!&0$1#@XQ-0D9 2D=%2T='14M'0,# _8&5@
MY&"BH6'C9^/@XG[(^Y">]='C1SR/'_ \Y/G')"!<7%P"/ )* @)*'@8:!I[_
MVPW3!9#CW2,!;X-![  6.0A,#L+T :P  +H'^H\&_&<#88'O_B\N'CX!X=V
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M7$N,G9=J%;GV]Y_N?"&1?&@!XJ">\C- 9*U(H *_03P7=AX]:#^N>9)OUOI
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MD$9E#) J!L5FL@SWL[E9;I>@/J4&J"_KD8&W+ZICY/:%O#! 84:GFL-=B<
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M+/&'A\WH.&);U'&/_]ONEM&4(@?^DX47GV-<Z*.RB.X2(N_E%LRY_SJ7N,C
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M.\<A%D>J\>1(.:"94>5Z,TAVOR#(?>I_6#%>OO*IN3G]ORN6D80-?0*_P=R
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M_)_Q5=CIV!;1QJ=X2+Q%D?%-^RE6[>0P3=G,G(T,?O_.1I]H1PJ6!@4/<2*
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M1QSU+4 CSI3C+E[76NN5!$5:)MRJ9IIC"U_&!"5\>3+&1WKNAZHOM0_ ;L$
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MQEJ6S=.]^8RS8> X,-P4CQNA$DE2*1CMH6[\BICTSZ'"GQ,R+W_X('3/*/!
MP>$>!N@3_.3IE< Y-\]0]&6$,::B\*4]'L=$J.ES70ZX',A.5F .+?-M-WS;
M:%N7U;[NV(J@]4)Y]7'WX"^'G;L3^1*9_=/.X&C 09T=N[X^EDV!N@7[N:('
MB3PX2.+@K9_4W>/KU4UA<^5,LBR-/\,A6_6V NQ1FYMT?XD?OA_;H7?Y<RBL
MY*_HC&CMG718>3!;%+6^[DS6,V&J)-(<F] 2!F!)>HRZLY#>Y*#O$C7%HH-G
M_#>CI46Y3&PO<0++6.@SK&])\6Y*@+?X_EG^SE4>*M?#H]30V/3WX,\_+Q 1
MB?B@[. 8.*\7;XY4L(DQC!7?884;P312J@([G4Y[H^V;V6P1_M?ZO;9>;P.C
MW6 7$V7.VOS"W48&,-EV8#?/<4VJ+XI5L ^YGD>"8\K=Q-:(_$^,7N=?BZ$8
M+OJ$[=][\)@G:@A]OY^M0^(3)'8(_OT8^D$3IS.VC<.QS(^R>5KTNI69[TU&
MSZR@*'U4V E<*&%3SL58?LP7:?+R6FYU= T#1$Y !/M:2%(S*@S;=#(J"[@N
M.3A&0=F0!#H!1=:O+J1Y5^(#+&13?OHPNSIB@X>O<]F_'41IQ;2J\BH<A8"V
M..(4JJ1@U=VDA!!<(\F.C*NPE3RR(K>5%Y5_L1XO/OL6DP"5R"-Y<CX/AXU%
M8P#S]QA@4GC^*V1SC)@2;M,7S4RQPD?X;N*!4L@LMBW5PG,]1Y/':IRW7!TE
MJ)0U8HYUE@3'DKW-;4/#,8&W^U/8CMWZWIPLCP?*Q7ON5FD(OJS2/UW<MY":
M#VIH"M<E!@]8Z@W^B=LM[*P$_-+6*TA)NQ'@KHSPY-3"OJ,R=:98@,4W:,PP
M $?-= DN R;R^#X>9:!<ZH!\VQ] -9W<8K(;Z$0&BH5:):J,?^ <WY;QT9U>
M8;W);J,N@.006X/*QLR21J.FUCT@Y,'#R#JA[HWW\1T.W]M0-GG+:.70@=H'
MW7/FZE'2W7]9OY2\@$MTG^WS@+=R_^"L[)F@0LL==(L&6ZQ3J),=;U9;/DMN
M?8J,<#WMJH*>S_^LE\6;K.X8Q5WLK-,AK?.V_'6,+G\]NNRYE?5QU&>\US3\
MBK9WL!X/+2O@N2HY]#!'?NOO&-!%!^8^*>_@@N"JH2+SH,4.L1Y,0K^XXU[:
MX&VOD2=\45'F2)!GP86/RLEGGF<@G&(^G';#?J_A-;@6/.K,,+!04+ITLR+
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M/ME*Y0MT"URV,]@MNL9"GO,REQ@%*OXZWO@,2:5Z/1+[&4:&Y<W&&R03]/U
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MCM\8VG5/E7Y]KTKGR5AXU\]X.=+BR/KX_NI.-?%#9B_R*0_=^6,/8=2V\;Q
MPX?VFGJ^WO%L'YNHK/,L?.=C[!VQHRKBHD*@^@5FRN0TJSD1>Z^LZ>M-O<8:
M@XS-E+2O$W6KZFT[.%_U4[/2,?EL56Z4/\$$3:7"2X<X$CH=WG5URGV83H1@
MF[A2F'BV-<)B#GP8 0Q?#DU65%/JO,XI,\;(%5G!^H,$N13[:+Q#2H]B3?V
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M&'#D!#^/)'A%7$H;^$-4<,!#'U.:@NM;U(=H ;\_UHI6CT+;O:PC78)QYH;
M?JB/M%A_^_:@VTLQZ<BGQR000[.I.+:Y"MNLRAK2B*Q$$#F.L!JN\LT;'(N>
ME,?1P4['E;L_UH!V/*%'ING5;C?3_,*(E.UUS*]<U;^&.["X-OAOZ*&W!;YY
MY,%B^P^F6*7OP7S/%)X0Z\3.<[T^[3.BGG9^6*(#>W_@FU!H@K1]N2VT"8AW
M'.OL!\J/DMFHBOV1\(B+%/>E7;?-OI7-E;Z0JK!%?>3;-</QJ!84L>@@LV.<
MS!" 9ALQ$402;#*%FZ;=+YY9_TIO@XSS'_/(5M"I\(G"X6+7@-I;%HP#PM5#
M'#<(YD#Q3,TV9U$BG'U4>33#$GP=M1[?PDSG5%R!?MUWPU2 "5>;JEOY.(QF
MCAD V40R8TLNW72. [JTZ<CB1,:^8>X!R/.H5$2H.6JE/=O;TS&GOLA.L*TB
MF;S4YDF4\HG"I"[#.Z_=,8#3+VE""3:'O-T+DGP^N8+::!O4\@A=X;3GZ58)
M'DO+1MIED0F*-=7.&3%8.@O<N6),YJKS8_TRKD"A;3+$3J/6IK*1%E;P"TVP
M*@]^362A.B]1DE<?>2[?8%S-7$/XQGR9!+X6DTL8E; RB:L3VBJ=CTF53U*>
M/PR<"QB-9)9/EGMA_Q#3W J+-2'\<@DW[X_-3B%^O,2Y'Z((]YAX?:&;_Y09
MN27=H/+R@)\ZQL0W@HX>T)\+PAGS>)]^-I 6NGM&I.KB=HGK^@QL4>]K#:T9
MDPS&E>C&,4][5ZY>3CM:3!S=73;]:[]L<YK5P&/CZ9D@4K$HTA\JB,?]RZ6]
MZ?%/&L+E%^*Z$MOPXZS?8=RZ%.=_@Z,2_Q_#U:[74.&R>Y54@)&,GE)S]LRW
MP&#WDJ>@VSP.]U?D7!BQ$@LOYA;KG/W)A#[@I ==H"3!2(09N <\FO:._(;1
M&<@@1I58/8327Q%<:MGVMN5*TZS@$X:".'O)8!S6MO[_7.5#=_.E 8WG[SQ&
MJX2J"-_JF"W-KPXT5G8RG'XEHRP)6,GL;F-">(4[(%:#O>BG[2 M=55AHDG^
M=1>;25&-S!'7.NK0LO^SPB]VG5[(T*);'YYD,UQCK#MA$[&"(V&3E6EK/7XC
MB9@@57%=$T]7_Q@UN -3A6?^]-MD[A&PSS5]#OV5.!"5OC^_DT62289H[_B>
M!Y%"@A]9D^GN1.89[J+W\H=R/!%SO84R9FM%U$?$)'8&+:C97XS$MC?\%J2@
M*?6\]DPZJZVO#43/9; D*@W.)=)TU.4!D,L  1)JY;*=I.;Y:)/\>T"W>(Y*
M@;ZO^_;3Q32%[/&I/S.7<N7J8ZOU]/> @%9P\0JD0E>=6'>G.2HO.YU;B>M8
M4];3_@@K[8R 7-CY7]6 X'&M!EX(#//S8=5 =%%3"L+W+ 616J)ZM?=VAI@,
M^U@'<W >^Y%[$&)3,B3LK#X7>%I!?B,U7ZMD],:.ITR?V7R\\U;!?9VIS/D1
MSGP8X,234@U==QPF:$RQ)\::F;<7^C>2;[COV.,L1?;5[Y;FZ(2?,@.L91Z\
MJ(L:ZW5&4HC_ERFN&W'B CIV)PQWXIH*GQV7.#D 6P[+%QKGJ5[P689!M00C
M;-B.INQ-_= 0Z-3Q0K>_TC@Y^,A,Q9O-A V^<;-(9P)O2FZGWX/"L:"'9-TJ
M^?O3,/W%/OY]+A?;K^:*,40;(;,O!JF/C>X!#]\C37FHIP-:3G;^;ZA:)BA_
M96GXNI/]1()%02SC>0<[XD9V;>+YOZN@[ (0VE"=,GP-RG68@C 1?L;2K"!C
MTIVV75$PW9;QP#%&*@A;GWY&'M)3:+Q[JK;CA<'"BJH7])5J=!P3Z=MHZI\>
MV1$.IXZ&CX,#SB$>C&CV;A5G2K&5HVS!N- 7_\(YV4.4QRF9&=HX9@JS2+"\
M@U)RQ7X3>2)JH3;'9VU2XYNXY1<_IA 1BB_M"TB+Z"(LLJFV,\*_H-J;5RD$
M;H$?)K]/(Z(0CX_**'(2VFN?QVZ.V/DFC0-L'6H=?0?*'\QF@G;OOJH(<083
MJ'CR7%LK-RCWSC/"B,PI7)YN?M+U7&MT\!U<B<U(&-B1)I90 2&6EI0/<O0V
M4>([88]V')U,T_VV)=_MGSIME[F?O\!:\^)'28>GJD /!")?TYY!:\6?LL7
MF17FK>T[_6B/_1C]2#YCH/D>7R8%29YAOBC^K065Z*W(%NK]BPP$?8\U>"MR
M[">5J_/]@<'W@#"!"7I(3?<)=U4.4!9_CFL33 &_MHE?+$8JP=:>Y2;]\UGW
MC=B(,+T1PWA6[,"@P4?E3G]JKU54'37;+2E0ZANR@H51KQI/[@'"#&UC[G4O
ML$Z', Y(,U1%H-/U(;DST/U-12)8PLK;7+><.:V5/U'KU"<W@EAA'9HGY V
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MQ'.@I1O7>6]SY#B:1K(D2_Q+U4:$DZ8WP2RF#[F^EAG<7%Y%%M#RY:1,1<'
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M!Q&=I*@/:]+?")SH<IO7K>(ANW*(W:?(FRC&I:5%KY<9R;IQ7QPL#<U)!0!
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M0G7T]=O<'7J\N"Z*R9(%PI"H;U]F0+*C8#+[$1D,\.+22Q,OHJR=,V/2V/O
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M9EY36=_1^"Q[_-R'\?:SM\8U>=VL+A@9>J.J$=2Q3VJ# 7)TFG?_IW<R1G7
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M#,%03>?7<6F@E_A"9V'T1QRR6M _X-797D:/KG92U$R5)QP#U.Y\-%5SX<8
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MRQQ/T?;O@16J#ZO3?M8\$1:[8[MKH(MZ]9HO)AA&$1*77RE_XUJ=[53]G\W
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MZZ_%_WSW +GX:G8S]3TP/)1Y#WB#[WAA9P%95P%G3:DIBFR#G6&$[TO5G00
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M$VNC+"FV<UKL%21.X"Y5 ,F4'W77SM;0KBDW.K\FLTPY(5/M<$VP-&9QI;$
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M;SND3H7MYM4CSZO13&%>F"-K9P@J-'2=&KV,[7F"\EM&X)FO?<P0FKU>J30
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MZW64%4P\7+TK4>O4QOQDOB-[B3<QE?X1DR.SDRCG<8I7%4MAP12Y1UI:)5M
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M>-1AZ(B,NDIOV]=3V@V51Z-_G$^N8O;36T _H'+8Z*>F&33)*M/:IM#>86S
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MR?RW0$]!VNP"3YO_37"GL\S0F#S8!2^8;D"U!)DE/2/O>DT@^4F*@D]KR!!
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MF$>)XO>G_*?:&*_K%^?.*%.8%SVG2."]F2X.V"2S%Y7#?/3K+!-FY@D,$S+
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M*[T29/HZ%;1XD=7N"2]3A<O36X- [N@X[JP6[>U?  T\FOHM)]U9 2S;A9,
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M"CXS>T7CDE_L3P<P@R"AU6Q#$IS:RTNCWE^A'!8X:R#K)R=YYD.P"YN(/H0
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MKB=P!?/TOC!E.S@P&.T:I-3C?(I<M4KSF<DN5/1S .4+DDSH)=+.?R97C\/
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M>ZEL#BE<W)%@0"PE^F. G\D"Y&1D2+WFU!Q;&>S'.3!_]2>OEJ/2CQ^GFJ^
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M'^[;>M3C15%(Z'%_[V*T #F2N/?JUBKS:I+C7V46#D&J.V <N&2'Z7#J@(7
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M2;X[;?$S^\)=@@XLK-F6D8VT3H'IY_1EDE6@RU/)TU$,8!2S*XT!Q$>OCC#
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M*N0U @(:Z"&9/6ZB]FQKC]).0,P-5W[$8F#A?'T(2VC^CJQ"3$%KA;X1V75
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M"?O[D+,]U;=0C(0/H;BAN[^F;7U@\=->^_E##;\(X^;K(*0T?48^NK'(4R$
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M91\H(K.LB27S.Y6GO@FBS*T]O/D!<?)4LLX../@Q)5C+$,SU$+'&KX"$GX9
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M?2U]<'P(,Z_V0YX5ID$N>K0523HP-Q8PVX&L0=Q+":N.3?O;U\-<@=,:&!E
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MSNF.6+=XK?JVV"?LE"S&<-:?DKM^BMM.*J"<K"$L399C)6_-+QRP.A+B]&+
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MEM,. =/J/&,CSK@=5"4PZ\-7P?@CW'J'\V]]J/?>7]'5WL=+TJ;K"/X,SHG
MZ/>D2T]P GYC/DG*Y/@&"!!"@Z?)]:N!=AF2B@TA@@GEU\_Y*Y9/QHR6,7+3
MYA'QG(*$ "E5LA*].@^WS#X[XLB,QWTC$_G-@,'>3/,_?NR;:#GPJ\'W5?C
M#ZX?7'\?E[HO94\.)0T>+GZ(5!9R7,<K[^V+@8_BUTKT%B(_<<1$[(HH6=[G
M]X542=?/)<K3?&"?.>]P:H@K;QBX5'P()"!9JX[E7':*-_4IOHT]+/4L3X2\
MW,1&R@&_&9A&]%[<D@Q%C][ CEC>)OTC^G]P?0]<ZI<H91E4+0HRI=^YRT^W
MV_-P.2[B?:TL]:6;J>MG=]!]5Z//>KKI?7K_V)*^A\$&%Z-Q2,O HC>_PE.E
MO<HX'GT< A@:L-%;KXQ\^_OB%)A+$$T7K#BXW 1V9VZD)6NP\AEM@NCG.@,^
MS?$QUIG!^0^ULKOMPW>-Z^PA\))MV";,X,Q5"HB@*MB.]5>R6.?.(R^RFO"?
ME/0^=$T77[7M4R]I]3L- :&SQ,]!5('',;J=[+TER"HJ/MA&_<E(]#%,F_.J
MW:Y=*:Q_V?7Y+\A"R5TK+DD@?JR[41<N\7HJ9ZL.-<=Y"16Y'MZZFIA.@6L]
M#+>N^PJWM\E\C#1]\G3#-O*&9:?_'@HO4CX813U%%J K%KH4/?98 :LY'VD[
M1[K&3H*%,)^5]<RTZ=Y!]1B'3+/3>XJ+0ZYA%*@'G@-W36[Y;S^0]M]C:7'0
MG7X6%0(!(PROZ>[%&GV;JX<H$HPZ.:P6L<H9! &:_$/BF/+D>XBELU6,XU?[
MP65NJX(I1^;:&A&P^8/?.0C NJ!H6]2^6I"PF+$E]V1>Q.S@$ 1H1%3W_L^J
M_(U0]Z98,?*Z"5F07LWV!5.#P2;=%02;>_RT&)?6I!*PJ5G,M3@7ZS4!OWT0
M8,L"7V>)72@A6)=@J6'J/!!0< ]&VZ+[];=[AO\M2."0"%WG \-]UQC>NMBS
MR#_.**A4J#'/>.GX5^!4=N[HY@# <M->@9.1"!K(B-\BTS+38'H_8DD[F8YC
MG#B0Q3Q(@( +R0NA=Q3A*P?I4YF;]],T'Y7LF2_F9#/LP28B\Q[!C@>=./E@
MW#?I_G!O.'JL80U>GR1)&L.'G3FFK,I*SYK1MRT*_BSJ,8P'UK-64CAA QLZ
MK]7%<62W J'S+O4J;(:/X6L.,'5=V-7TJ+G1GIE'3;9GKYTE:IW6VI[S'&!J
M-YX"OHU@2::8-UAABEEF(YR[2FMB.B@Q8ZAL]4QP:]>[4QL#IK1/4Z.!@4BJ
M#UFL-W*\Z,44[D@U]ER%5>A6O%L,YMIT8-N)$/X^M!0^+HF'E/\D=9JR))-J
MAK<5&<I5%7]95_#U,-/KO[J#J-6&/MC,249LO *G3YO,*'\<*_Y,?3C&"P&5
M;/1'6AHB( LX&876IK]]!0%3>RMM?ZNF1)OB46NJ;2')*_.,.C%%^\KL%7[2
M$%W?G>A \[4$I[C[*O[Z9J9_ ]C:$!RXR9F:O7_Z&Q;]1E][SY>VVL4U-6PP
M;F4*\51Y69FARKP+!.QM^QDW=Y4Q"C6BJWNKI%=+("#*H=9Z]2=-AGHZ5V9_
M-8']/1"';=B"S:H=B+EC;/30A&IB%7R5459'NZ>!_;=A-'YEW_I-+TKP$Q&E
M;/^UJ][JS#NR2I!',N\T;F!]Y9%IKV4=1LB][,84>KV=34RP(3G(1?@^,7>G
M1J,V!!"=QD@5-6)@>X_M&@(">/4964.>M$@//(]80I&?T_EP>-PZ_V'&K(UK
M\!>! (Y<0A^-\Q*"T720#X.U,Q1/"#AE$CG):$C.']LD'4FY  &,GGCJ8A<$
M[(< 80!%E<,&62\KF]$-(*"NXQNRQ6_E$00]ZC$(2#4VH"92'9EPF_34WL35
MA=LDN\F&E*T0L%G/ZX-4;8J."U&O]2ZGK[[5E06^LH3/BM$=6"W@ =.LOU+
MT_%+C=2#8!"X?,@) F+ <#CI!9W1?+5G9]+/TP\#8Q0K:R[<E',!-1D"0I[3
M!4WQV'7AEZ#4?_CSE[)@;3S%"P).9B2OJ5#:F4&"IY\:0\^<QB60OC]R$T_F
M)EF&>[9;$\9HVQ/ R;$)#4Z&33VD63HF%][,2/ )B$U$SS8):V_2'5#9I)_C
M-T1>?XBA6X^\((L0]F=BG7Q:5W&9K=E.20X#^V4/+)6%YRT%W(^:@96X?'M;
M_EG"!_XO-V#^41;W)5/]**GCN)U4R;[E:L$Z@7BOKQSLH7R<<74=!3,GF!"!
M/H*_"E]Q\,\1R>0^'DF-EF>'@/XC<!J+J:N/<';Z=&_"F41DYG1[7O6S0G9"
MB-K>"'^3HE; ;R0577:2%#F_C\PS49?P2,U/"8\21<K=>,^C%,&$/?_-J&GO
M4Q=$RUOUR"G+VN)[O;R^L@C9/Q3[H $X,&I8H^_4G?]Z ?3#XA\6?Q<6'Z\<
M3\JUS;_;67.BNSCQ445!>>$87_/3HR/L36WERLO/W,7Y2;! JI2O[%B0AXN5
M.M&,FHD.:)'3;)3JWCX]Q<QH1%R:+\"V42S,S61NSK97%LRQW.)Q*?YF6IJI
M,B$@!>MO&UF@PPPP],&#+-FBKVO+61PB;4"UCQ#P'7CB7^_>_[#XA\7?I\4P
M."V#O@=M7%^SK5/&3S7/TGJD\>6I8XT[77_F?K=MDFL.H;8>6D53Y_0[<69'
M$G\7GOGAC>&[)5/, ;]+G_L#_Q]@BIAHX^]'2^$%+5;SBTIB"S1W!S CWA/.
M,$E4<BTSM1M=X84 SE/C!FN$/ @8/P22/4"\(867CG8!*=N3J5: ;PG_1W$6
MRBS!6H22,'2R(ZU'8)5@];!M2\ZUBP7-7+XPW16?WV4E\/M#.2(4SN<ACVED
M-!@_!\HG;YQJ7;K;LA-<\55QD%'XVCBK(?:1K\7[$EHB5JE4BTNIC\7^UXOD
M_PYO^7D3") \9@T!=X<@0%<":X'=1\O!308Q&NW%(7#ZM <3298A*5ZY<9 Q
M#;EU(&9CV^@A/ANC->RT1Q P6>:8O/+N,P2<KKZS^/O&B&$?UKZK."RWTE(D
M;(UXKM$%%;Y4>@-H!NX8:)I.I< .4;2)\KRSXFKDD<@PO\>27:WQ4;;,;'HF
M<2IW*@N^'-F^<$*1ZVB]UY6C%4F-;WUH(^GA_*TUR3=E+LB;V(4'(Q[G2Q,F
M]9.%:Z3/-KV5O"/OPNW?7ZK:F.>5=+!K[!+I S:C[JUD57'<B-D#?ZOM]]?;
MMSK4;FSDF1(:,:B5;0F^+7EJVS)B*RH+M^@T5MOXL?66P';ZJ11W*X=ERRV*
M?_HH;-IPUOS9Q9M3 '\SA8T8%TA ;9E68PO>T^-:I?EB4#9Q.J/6-,Y<0@2\
M;:+[RF8KU\VF_+)QN; [J7YRG4A/2Z_2JJB,UVA1OP[OZ*) =<JUY%/U@#WU
M8D5/!B62]!6_[E8&IELXCPW"G:.;4J*JLHRZXB^)N0^]SK%XUHL;1XBB+]17
M&7OE3R>,3%BT.&1I<Y='3C9%B?'KMVOO?N"QTJHR(1[@0#0(922.Y7F+CH7B
M ?WLSRGVFG7L+7$7V-?\%P<KY7?X'28%8901\V*\6J$<\X$"7G$Z5DPS?)5B
MKYNG(XJ9ND=/NKEF!MC'"<0=T931YGJR:SBSVY.?N H!W"NX'8/6:+TK]\YK
M-_[TOG3=D",@NW&_W^L/1YEN%]SU1ZX<]^4JR[%PK#C?^SRK97)PZ,SU*/)3
MIJEC,>U<GT/)VZA[B*A=ELUD(7%?.+_6WF%'8;_W6[2<4XA"%T&^G-;*I&U&
M#Y4TQ)O':0BCKN,()V3>C**SSV.K/A5] +9G<AX ^#R8Q8!%2^4/%.;ZG6A<
M[6K%2P4=E$1XO$!GMFG9XSN4_IU<FM0&F,]4UJ^6P_]@,,-,R2"FV+*MT$5\
M3\?R1EXJ-3&W/\U//,CEIZ/8>(0KEMLQ@5$%[(7W6S0D9J_!7;_<;?2(\?:M
M>N VJ*]T_\&Z\&ID"'P+59G,7!>>-ZLR6"=XAB_(+KW@$/+R!"8\PGL%FXAP
M@@5:P/'R%&W<*[<2Z<AY>+$W#AD%1\5_M'7KO@R^5/W@:\C6)VQ=AV#-2'3$
M$AD50Z[, 7:UI[OO!]![/-4\:4F9=OR?$CU1WDX'WKL/-4F&-]S$;]&<%"9)
MPP<<WAH/6+Y?SPS&ZPB_WD+<<?T!!+0)K^)8*,YM;^D"7<MB1_1"7.<>IJ-N
MO$W?7>!V%O"4>I7"6?%;SW^(ZDH4W2^-"*X5>=ATD29K3]?I2SK-[$=T\]W]
M#;1.Y):E^:LK0@#&F.Q%VUH,WUA T56TJ8K)8;@IY10(&','R14;1T*!M<QQ
MW!MY;C0O42 9.V,1%WO3Q2TZ5]NM4_#8A-VN=TS=ZWV=W7],5MO*]D),[<^K
MZV*._Z#L(-V <,0%JN'J)@@0,.<R)&(]MUCLG>PLI^*==$FAQ,! AFY3G10*
M8!HD4'8HCIT61WNVB6UCYE?^>YZ!V*+C+Y076(KXPB3FR[XD.NY86\*SCYZT
M%)UP17;52#.?)]L_SUKC-1\\V3'J))T],%2Z$K6T<T[N3*T^]9K.T%(,?CNP
M<"!_^^=&'HO^P;$6MSP[OQK/YSNR%?BC8B.\6UB#)X!()3$MQ8F&^ Z]0]K\
M+Y,<G\D&#_^T^M5H2 ^7%/B156..ZSS@P\H?2P@W*KDC,ZP;L"^"Z&N^A=9)
MUNU0L+8QC)ISN?2[/)[\9\*!F4&KFERW BNA>-L@;8Q]2$?0C7>:HCQ<L-U1
M[0EY=H01M19#RQ:/Q[I1W@JY^O.B3H$L>WE+T%I3QWR?SG9H[ HG(,7F7B(E
MB\QW%Y8*/)0N.&:S55%P[/%SU>/4XI;D[4ZFG&@[O<CEYW%;"&].FINMV1X]
M5Y@K5MXLI%RM!9ATR>SNDHGN[3"_=O+LZ,?^:!W)(AX=R6@=U>;<B__HTO/W
M!1P:^#=02P,$%     @ Z8&#6$#H@L+O)0( ?YD" !(   !Y=S!D7WIE<F]P
M86=E,BYJ<&?LNU54','W[SMD<'>WX.Z>P8,'=R<!@KL-,+@%@@0(D$!P"^X:
MW-TE##I(L" 3 @Q^^9USKCS<AW/NP_^L=5>JU^>INKOJNVOOJKW7ZG[Z^;0%
MP%=55%$$("$A 4:>+\#3*D >@(J,@HJ"C(J*@HJ&AHJ.B8^)B8&!28R+AXU/
M1DQ.3D9,2DI)PTQ'2<5(34I*ST7/R,+*SL%.0<?-Q\W&Q\S&SO:?ER"AH:%A
MHF,286(2L5&24K+]+[>G'@ !.@HN\ "(Q !X08 $)$!Z&@#0 0!(*$C_K0'^
M1T-Z 7R>+QHZ!B;6\PU-^( 72$#@"V0@"@HR\G-OT',_ )D A? EORPJD?9;
M- 8/8H&PY'QT1KFZ7A*=V7,FP7>>X1B8I&3D%)3,+*QL[!Q"PB*B8N(2\J\5
M%)64551U]?0-#(V,3:QM;-_;V3LX>GG[^/J!_0,B(J.B8S[$QJ6D?DY+S_CR
M-;.@L*BXI/1[67E]0V-3<TMK6WM?_\#@T/#(Z-C<_,+BTO+/%2AL>V=W[]?^
MP>$1_,_%W\NK:\3-[7]T(0& 2/]G^W_51?"LZP4R,A 9[3^ZD%[X_><& F24
ME_RHA++::&\]B!@$PM")Y9+SZWHQ& 5USDG>><YBDC()P9CA_Y'VWY3]SPD+
M__^D[/\2]G_K@@*P@4C/BP<D $@#;DOBV/)>_.,?__C'/_[QCW_\XQ__^,<_
M_O&/?_SC'_\_!8\1T0)G'93"7J@.J8?0L106KD"+%X<*N3;,K+U(H*UHR8E*
M%E[Q5CEJ)@\%O&H5".L^/\KLINILU/RRT5]\IF\9.$F0615PP@>PM[Y9O:_M
MMD\B,G(,(7$&<6__N.N4[C.!L/MX-L]F!)89V?#2B/6@?8,,MU:+FL!YDF#J
MFL.CMD[25TIQC<K1<;V8+Z+D4(:94!ZV]NF.'@8! =/QCV*(CTK-YM9JYWKS
M8/.JJFHRK;9<JQ!Q68 5P2>-.20F@M0%@]R/4N*K#EV\YSDQA2O%.TXOH&HQ
M*>8EBZZ8SLC8]W>FOGCONIJVM#<.9\ 1_1NDB#0_?Q=8+I[Q('MM- N+4RRQ
MZAA,90@T5[1_6H**162<61,-LBL!I_9UO5S8;DRYMEQXV5'[I3V5*ZK0=HT,
MR7!?0VP8)D-G<V\$_WI.%U9SN1?F:ALZE-QWTOA*,.IXN4TZZCW";WLZQA6"
MEP>.L%S@;DPZ,?I2I,O_!#!*:%;070/>$ICQGBA=9?NZH2"DU1+%FV@T=2X6
MF75&*BA/QG>XR*[C-9!@IO.Y*+/C)6U;-2C''@J@3,VXHG#[%5G%1!67Q0P'
M0!I72M!I?MTJ,=(5S?"@)="TUT5H@W4^A?.S@-S@%(T\,9/'P]Y;A/X2(@K&
M'*GJ<P>D:'B<P68:N9-ZR+&C:8%T6W#"-C&,3,T1N1K-[<V)ICX-"VN*QVEC
M"J]>#C>P,1Z^IJQWZ*)H)!MW5\R'??W-O>JJ)WT5F12?T\/JO..>A]?,*\4.
MIIW<4LLE.JSK@'/-EF4P%6*7#3O'TP;B!RYI]DM_\+,0@.<F>G_EIF]N.G^
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M;0E]2SM<X,0*^ D);AK*9*:_%S3+J0J,-#G]($%".Y[_?AWXWXM09XS<*CY
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MY08\W#SX"^!9?-:7HQYN/.+;M ):M1NAPVJ]1SB  &"<K'TQV.96J?$7OXF
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MB_^&N3G?O@WGOWKD'@_BFVS))&JYJ6@5KLM(M0>/NJIQ7 1]<M'8,8HX[\(
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MBU>NJKI&S1];>FRSD(+7+)"XWZN.5^WRG$+$.G5*^UP/R*N48,('_KT<%4=
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MIA87,[09XN[8TC8$J,NEN$C2#/Y3/62BOVLP'@HN*'X'<#MX93C1-\URSA@
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M$('02) A>I3CA2WM?)[BVY:OWP='20FTE+65O79"?(X&;$T02GW>W@0FIHA
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M !=T.9E'WKAS*$M_!5ZDKVE?CR-G7)G5H^DE>(D;F<!U'$UVV>\%!FWTWA/
M'@>GD2:\[K#)@?XP@W)J8T7UU<T,-G).+KKK$\"#''!YR\[0*]9\=1TN\,/X
M99=3??C12PP:,;1M2;'YCO^'-3+%_\/R*B=>V_H&1GE0K-$8-AMG8C4L<=B
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MQMU$G= 4Q8X#H?-IU??"C3#3/P-G=EXP6:<ZR#XS.^Y:.M.[G6.R&X?F(P6
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M.C7XYR\I2QDRE0.W!NS]I'S!0[V>7]G%L="1FB'VR\QI9W9T +Q!#DUTW$<
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M8'YC5]\I]6&:?L;#V S"^V_$G8;*W8O^,HI$<FS BGN(S" #RN8F\N)%360
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M[]VL<T-;#9Y:";^1L43%KF OKZ(U5.I]5JW6(+J$GG"?O\Z'9U.M2[#KI.^
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M)?JX8>2 AMM,P&&B$@2BR%7"_PM[;QT5Y_?T"39I'$+C;@F:8,$A> @6@H8
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ME$:Y&QO>66JOON_K29&"9.3S05F!=D@YN*,#\2+4.Q#%W?3@';O5]2.A( X
M6>K8,F-B'KNK26 H!EB,CMT 17U$O8U(K5; ^:5_:B^\ID;5E\#WL5MU(MS*
M>D=R_)?#<L-QI"DU"K>@S,R!WK"U98:/>F!KT8X&^G0?[D*+%:$D22OM634$
M(T'3RY$:'5@H>\TZ6<88UC!?P*,@(6$?B>!1BQT*8Y)C&@!H!Q+Q:NJL7);<
M857/:Y[&J'_9VUMSDP?;@RPT-3@N[_7\DXV_C^EIPIG5%7PCU=J[B>7COKS8
MY<TT>Z&"%SK=X5_-U3..^Q-.BQ'DC$LL5!%?9 LN_?0I57*YM@TBG1M9P%:L
M)->C!1Q_6*6[*TA;[9BM%8X]A:-JF,Z&U>+TR]AGQ')'<CM(5@)5,%/5[L\7
ME^%N9O1W\1X43B97IM.T18I?DB6;=)+Q*BP#?0-_2/1N7OJA3[G=GLSH7(-3
MB=8C;Y.+?FMW9JP!<??[:-B+ )G83>0DS?([:%#86#BBY7/.4KFA*L<)83E;
M0HODJ,?57'"I@YO=<7F7M9/L'M@IX<*,WXH8Z*(,L>@>VBD&0+TWMF A&\9Z
MC0TFY +,:_B6[]0R?BUCZ199V&I+COG.5][^#&"9/H2R43?=Y'W _>I)T=?T
M;$5J5,34P>97'*8\I +W>9",PW0MC [RZE8HPU<G6?,K9Y7*HA7+GE;\B<L*
M4M:L;?>)- VRMX>9<,8&AAQ+<:S9COV9HE4_POGFT??(C\_+\D'A!=EZ4U/J
MHT)T3HN'X.K7<^,M1Z18VU71N60Z33; 7)^EDV-T:N\5NY@I]^WP&YGJA/B2
M]TNJ'+SD/O'?TIHEEKOS6!.[/L*Z)P-(T33*[:VMWY"8!PZ?5Y\8V5E^%I)X
M-, 418<=&F,L$&:*5X=<+<A?LK7-,LW?XY@QL_U47XS/DRD.[F)C!29HE>>#
M\F0Y(#3RR..^C$;D:@K?'(APM.+E]U%^W2UZC;J(E23E"14)1+$+?3\LNQCM
M?#3?VZ2L;KQ&;&AJ3U@'[H>WQKK(K;"Y GR9_X[Z]XJ'U;_#:.!%6?]8J>RU
M==1UYT$1L*<M?2E-ET[.=?B2N'X<M#%U+B,K %)D*BD\X!AFGRK_6-TB;[[P
M%N]+A?Q%/HCH)AVJ%+B1%[MX6U[9[%<NXA&?S:OP>R)?3I"+G5]+1NV\QJ#/
ME![%8!\@@3(-+>ZE*OE2YD"V8L]B]W?G'>/ $-O#)!V3'$:+&O<@T.PJ!=H=
M7DMH[[;_G"\ZY,IPD29C]".Q$U=F/;]7$.@U24B#QS'1[I5G0K&5G37UO&ZN
M0W;SRD)?G?KMMR]]R-701 5Y%B)('8.&I+-('DFJY]=761HC/77.[YSIU[BX
M?I ?)PG.EP*9O$/:F?(=3*F0L$J_TJ[1"G2?X6=R.ZUD6YW$A3'5VT=M;#ED
M8VX\>WZ!H;<X3=/LT^L3%@E3ZO4P2[4M[.&@,*G[:7?_X%[O+.UNI-\)DA:T
MIS3>:Q/;CS1BZ4S:0(:4:!I/Y&4<76OC_<R8HS?9273VX'/>.Y26$H\YKY4F
M>%4F.)#[[F#D@8O4ESZ2AJZ?%?L7Z0XR1;6\NKN='UJ%F+KS[>A%6>1?6$S;
M7VS MF<"*-'"NC]F^,#U>ED,U]LS->(:G-O-X'9XDY7[;A'(WN,.0 1ED%N2
M7B%_W)2NLW?Z>.1Q03#A)_F";\W<150 U%R0=,9%X1T@"=Q[NC2>>@=0XO,!
M_X%S%N510VELRGA#%AZU-]<+Y&6)Q\A[;2*<SYQ#:X[.SW=BH"#X,952Z6"M
M(4/1MX]SO6/)TG7*H)4/N7C061,V>&>XB+^B2L>T1\'#U62BI07UG:$![N46
M*TF+MAN+FS\(UP%NX Y+3"X1\@JJB0Z*+<E7E1;DKZ8]9=EJLS,0\CPX97[N
M/M4<R*!6KE:B<%,-=B(PP[$; 5_XJ!^''HI=T]7ATEX"V59AH[/M./!1,[V9
M!B9%+:%5>S$NC=;4\63HB)O"0E 7B?PFP/] 6 ^MOEZMRXV 3<:5,^=1IX<>
MON'G*[2R3(QD(BP?-Y44P>H_@#%/8\2O)2$E<R-:TV=['(U9#I]%KDN;PU1=
M6DAV)+G+D_LAG!V%:O 1EHC6P0B/+[+WP<_FS(J3LREBW/!CC/D)+IN#N>JK
MVF;&#5C;5  #VD 5F5L KY92?[:;<33U?LF_4/^4+DWO2W\L"9D*MD=5-7"]
M*4CDH2Z3BCKRJM^;U%/?K[SX_?-/YF^7RW$,X\A6@V3?H(U+;64?.3AH11F,
M%^]>/.=-^3V6^H<U>XHXQ@>KB?HUJ1NNZ\3\.^8B<S00]52*:+O%.)%"-=[E
M!"<-;A-$]TRPS1L0)!>%"G+8549+KHM_G^;=1&*$C/=J3&>9[8RM#;]CIX\\
M8?]2G7RH819J^L#$S?_]+OY5>.^KJ;;E7\/;VMTGX1<G=,V#= A*K!/O*&DY
M!]<J2.PKY%&YE6OA[OSDBM'NZ:I/H.-# F'*'8Y/+['HL&V *5B[MU1VBRQ1
M&*>*?2/G3!O7$D,%<^3/"GORXOYL=J"LZ3..1Q.A.0+#S>L;L+CL]=K>/0\)
MD4CD)LN'$.LO@"P=S@M:]B$&'UI@R.]UUZXR3[/@-9)SX[G6#N2^2+^.G+>W
MM#T5Y=.@BG7BI\%=A_+,!-<B^/5W@"AF4GJ+-"=UI38G-;(F/*N6G$<?QJ8>
MJ"3DE?]J9&;YWCDG*VJ?<4%-KF[%7^54D[LU!]E<X*>R8.%Y@E.G)7EHI@81
M@ ^&2U/P3D,L5&,&?"+FLW_Y6/(,CK2,D+9HNY (\3P]7A\,JCFO/#1"* J4
MF=:/N@HL<3'\*@C+P>L:LMZ5&*?-!\6U"Q>;';0&1GV%K5QTL/4>^#AL>\6]
M5V3=P;X#5":CSG6F8P[XZF/SR-]#!(QGJ^JOKX\I[1<;EI-,QI O]BM)"<>^
MN@&&T70R'0X'QG(1JQ1U0@PFW,J64V-QFUK\1A-W@!'A4S]0]K'K7+G]'0"_
MG:S*ME4YM6RWQ.$AAZ4Z-VS^^=]'0[Q"C!0I7\MEN('#SD7UR-5D5,F\<BZ/
M1/5A%;R>0.!IR*@>#GL*1,9'%+Z8%EY<=&6=F=][4UYJ)A;O[N=T$1\#9L;[
M]>@'QGAMF_$)NVN<P6\R# V2T#[)G@69^'5%@='U4<JVC4E9B"@.W?"WQ7PW
M$K_MDF]HQ74GV3$I8QF"QQ%2O\\!.'UM<:@(_/XFR_#5W[JNXZ\ ?V- D:WI
M:0@!?%M3SJGZ;?%X/Z]6J]%37C$460^==FIRPV?S)#4ZZ:QK"OEL57\^1P^I
M6/58=0#O+Z^3Z)<<E""^%@E6I_73H2HS>HPHLC3^Z+ &JE.<O7<X,4CA7VAX
M42[)AM\K?35[C(/FZETEK,]=ZJ5W,^R5SG6LJ)-*=\09,TR=\-B;N13!0@WV
M'X<]3TA#N:TI3?#EJFOX*HKE+5A@;TW+1L\OO+JLK6LG@,?*X4'T>Q6G@T_X
MV):VQ5>3HT>D_%+4, ZF?CQV1_DM6;2K?OZKK^/RZ_TB2*:7V&*^_R]03/3_
M[TU?(*;]32%:=YBGDW2?U-!8G>M3RFM5XM]<C/=)/UR>0<\@+[!G&^US!U T
M_?*W":U[GX_\G[?6_[K5QLO7,0V\W_ZRX3LW#[.\M]?@*AA^<&3>F9C=6G9@
M., 7A^H^\T*VP)@#)Q9* YQN*0/_H?^'_A_Z?^C_H?^'_G\H_?R_Z*DF(5K]
M5Z#8#\T9O5E?8 5,;3AI!>R'7!)C*@T \/]+Q:G_NQD0H;R[?0T21'C4F<"'
M+#81ZYJPU]DDAU4RH(\.K56=I'> P:+ XQ@ D@5MTXGCNY^')I5#9\G!<S$4
M!Q6!ZZIW@ V'^8.=3BJH#:HILJ8F_C@4-FZ>\9#80)Q4@UXMQ#5"FEQ^G!)K
MZ@[0*X/FFM>[ W0EWP'Z)N\ Q)?K>29O[@ /5.X %";>(5#KK+R@^G%22.:?
M,^\VDE\_7CV6QP[7"]DIP-*"'4D9:-U\M32BHO%:*ME^M%UCE@-M/QTO!O@8
M8(370OP]M3 $+!@-%N1X ,'YK!R2/1 ENO_#7DQ;%37JX\0P(+1_4L8S73;.
MI+*CTUUEET$^RD@?_ZGN18C:6RY][E+T9^"__M+?6ON/Z$4"_Q.)Y\OM6AN_
ME$<\=[HI7G\?XK3]3C T="(W,@8A*P#I-4/ZAW^9CSSCG+4 B]9\5F*KP@]B
M^F5PE&"<NG>>3PRZUQ[VU;WVR/\+[:5,!4A!*H[5VV=9>KZ+98(9CEKCK4[2
M-0'$F+*M2"9-UP%WT]%U.4IC2*+\-*??$LTL9UW$QO8B@=[GV!J?U^DZ>6:O
M /#._YBG[1T@P@^I55-^!PAFNP-$U^HTSYXM.>S^J1$EDJBUW.);]7S'4*K$
MQ56&V0-[^HL-_KIV+K!QVBJW.2W5^PT8T]0"4F)M=?X[NBA]?["H5.6JYE[Q
M6Y&Q"']1/4Q[,P670/H$_RHFU^G5P,-<S\-ZOWDW<)HR?%]R4QLO+?#?G7[3
MZ@^!-F5+? -YGF!/YS4O0W:2TKAS1@^VT[(_GOY2VNF&?T2)I,H?<5BJVAAP
M*TNP,C]/_*6-E_[?6%6F9:+J0()/9D9_%1HS3C, 5S8R#N.><M&Y*OVC7#TN
MQ2E[I\I3RZ;M"W> =,WAR@4?G9]C[HM!PH'_GC:KUT#HVCZ:.P!50S7NL5:X
M"(.A]!!_&JTP2RJ+F,O"\C*Q!7*GL6FV_B![KZKZ^)"C/0S(2_:K^K%-R18>
M&RH?Q/N?,?QZ2W?<+=M:>HN=>,O9H7YMK'GM6G?M7[H$P.[>$<@,<9%]OU-M
MD@]B_??H&F'LZ*O3G@!>9$FJ@QU8VJB_*\(@Z<MDHB -3^+EN-FK0V?1CJ>S
M,<O[7L^^!?)&\Y.I.B+ 7#60?H!/Y'_=A"Z]+]*]K(].]E=79Y41(G78\H(Y
M1](>Y7P[,=MDHNW?1R@\(+^%\OJT\5+^&S/<J03PP?NO#G1PIHV7] ^'?SC\
MP^$?#O]P^+\XX-]S\ WL/GY@>XO[8Z9@XG:Z;F]R\W1SU2T_. 'W^5R\$P1\
M\WI-Y\86^#&&.__!?ZW5813O ,SWX\%X=/^?:VX@$#D*/4 9V<$XH093[31%
M0Z.E>]6P*R7)M\[2O4=ZT*\WA4K^5&<W#ETB9J&FPA/'1\<>>;2+2R8K*3:9
M3M'>/]DW<RXE,1TX !<YIMKUU(TV._'&# K;*XTJ_6]&1J_8'KU^-##U-JC;
M-9?D!4(V)[SV(ACYWCOWY;#'0V6QZ 5-*AOBWY)TB\P %8E?D2VUWBA0CP#5
M^Q7;Q>WL#=M ^-/Z^,+FMD_U'\V^7'Q[2H#-ALT:1RK;LGMXR[!_F4=X#B)&
MQ_:Q.,^ V85C(W4/@$>@($VZB'4?B>L5B7P0/BP'_>,U.@]! 'R:[$3,?3!D
MT!)K.X1XFEQVG'-^/MN,; J7%D8&C)MUINKEO9FOGL(.D9RD)-UXH?(S"2]=
M2/.H&2%9^V;J%C12BF&?DW["7."\&%'\7(MC+?U%4"T#SOD Z?E1WV4Y]!TR
MW00,=XZ'SW1$7ANKZ6R^A[W4]"$N<@]28%Q/DC\7P4*L 147,([3!3$#Q^HQ
M#CZ*1LM2-$_-^0DX#%C3]!E]_0RF[P"DDDB6:+D_#.YW@,*L]E[X': GD7S/
M5/8'RB!&]-KIQ1%'LM5; ;9G@I_GM\V%@U2<9P]RV::7])%'Y:7L,8D^=GRM
M;<3A_.%N*@AY%E&TU*V&67_>^57@&3</R;QB;+?13L^*\>M<K[;9=(;8^,/P
MORL*VG@*C2]*YSHRE-!O_$JA;'/2S(M?VI;-M';XNN(.-2TDV&J1;QK,P@V\
MFV0!R:(\'LST"92?',%KCI9<X-)E&7];X%;VR,5<GEYG9U-[ZVPM/_:(6X)8
MB3H-<9O/F/(S9<$]D\'(/V\VQ/N=R*?[E+<"9BUHOWR%JAY2M>RP!Y+%49QC
M'":= X@@/]1F&_#;&38@?^K5=_233>W8,N4E!X>:V;U8:WSI_WC<1S\9%W<
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M7#ZL%,$I$N,2=*)S:+\-T]1:C,HLAJ5T:86AFI\ZQ2\#H/S.A"K-YV>WZT^
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MK0YYD]?W%ZKB9MX\L]CW;LCPQ3H_/ JM2-<7.X#/,R\=!*H\E&6S\PZD.,*
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M_4Y1^4A5I[Y&4U5&>"I(ACKF] X0+<O77(>6*T?G]1K(ON_\F' T91/[I<8
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M[<\+WB/&DZ-VXP7/970:]E&2_+"L6V!?Y\3U,"*!8!,M[?FB>H>_Z=: "H+
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M]B?QJWIBPP;(J)#C^EK'*YR77F,>B<1#0VY 9#1!#I\$Z6(K]IR_*K@OCU2
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M1\OC;F]M;VK%P\3FG!B(UD:HWD?G*$43X([EPACB_LH"?(.[(X,)[!ZVXKF
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MB:[&YZ @ZJ-..@1+;IT-?\29AP\X(JX:!77M<=9]C/23J?_;JWQ\=OC=@E.
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M#8<,\]<'J33SNYJ>K;5.1OA-(WJ9:\FF[1G/1Q+;G4_?V5ISNK>A<OB.>?:
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M,JTFU06NSNXD52RPT;8XGK31?.PGM?4$3/0LQ.. 7V<'M(OZR,\<#)GU,'+
MA[PJL.0_=SD^V:MU!!38BM#L11;YJ23V"<Y:SH%"=Z@GN/0=&>9J6$";K [#
M4"C%.2I[B+Y-+B8L5/O)&QXOKN5=K8C>X5GRH5K6*?/[.V0%5ENIA4ZC-&&
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M4PS3YD,*6P*":S<WURV4*KL%XEJ#PZ_I2 B+>"VE"<X]3 ![U^=?GGCGKZY
MO4]C#=V@9=,/BWX!D7O-D=)?,VAH,,X^<N26L$%5)< 4M36HPV&#7D'$5L9M
M)U9,[?77EW0=)>D[BQSVC+8ZZM18NUB*W@%$W09MCUS)[V0HC^?71^Z3 @)N
MA3:.Q01-%3F[!'^"HY)*.?7?XY%'"/R^B=-':5(\1?]"^;JT-:(LENF [ L?
M!-J*]F7AHQ_<=8<)=K>IBXG4PY,O^4:83H4EPU='09T<JR9O9!>]_>F*A/X:
M*7"@!:4?+8,>N9 8(YU?9;FS@+X=(CRB=)E4<5D<&G_8E1EUK-KC2;]&=WAE
MR--,^V<5XF9K(=F7GE+KS)WN_?8/U\^N_KA!WPB/O&O<FC!6=-/M]U9E(RT4
MJ@VC-T_V#[5_&#&).?B5I;NZNM$"PKVI9G7?\*]CL^JGH1X%'@JCV4"IXCT>
MM:'-X17'N5JE4SO8"S!@$H?CE'<)F?[ 7^+#8-C""--0C[=&HH;+V#SAEM*$
M1_+8)V45!D38S\P!1CQ&VMYE/[I:=7-M_:6R%(WJ\AB6#5;-BA]ZD4F%0?G+
MX$1AU4<5Z G\M5,N]5G)!41)1_V"F.9>!R<'B#=ZO'L3B8KT"[ZA@2W 0+$;
M()HL -)=/WY<BLK][X1 >YK+<HO:ULJ'_XN:4@3)TXTZB6.LYJ4M8>:AO+99
MYJ[K5)\K\*DRF;+X@P]K75T^=D-$'C^^"63<4M)G&->+E&=D>P:0/QI"ZXG,
MG O?1FMT:Q3@R5CTK[W_4P%G^WCG;1?_B@9FK2R^@:W)$??$[PR9_2QMREL@
MFE[AG"O=ZH)UQ3_)4 .#R;=SHKQ L;K!""]SG-BGE[6S<=)%5,Y4ABM"?QJ<
MWG&H+AK]A$[\FFOY+OEC2^$98-#C4I8]$'#[Q-B[(+)-MGFLZ<,M^,("PCEL
M85H=417A]V9&[08L =BS108D@6:9G!@95OR8B"'<E?2%(:T9RKGI@FG(_O4Q
M8PIU0/D_8OFO]1E TJWD!9/PT-W68J1,M)1E!*JW0:)CUP[/-]L8K3#<98^N
MZ[)'>]$R1]KFZG[4;3P#K.X:-'FS;X )4N_7VS/I%L5H!F;-2'-C>FD'0Y3Y
M;);.6>;#07VM3.K)I#;!W:$7.^Y<[3@0-;HF1XR"A4<_V/=N<UL_@WGB.(^6
M+C@+YV[\LB\)J,O6@:?MR7@G0M('[!K?'5CM(MK+/W_FQ\#WL=&#^)@JZY92
M5(SR0;J;!;HG98LIZ]U![W?0M5X?)YK-H4VV-:&[8-"YY/\9(S!_PEBH$'"I
M1=QB[_@,>+&BW9@UXT&RO662S'*HU*IFE11:^$*=Q+O8W6X56]M"TB:-@$'#
M;%%:S LF8ZF1(F$"?O_[((=-V?/5I7O(//IE6EXJ-/>*&/-DY?ZI%A:;PVS^
M=O09<"KZ7GF<]?M<R($K0N6[>I1<IW/O#ZBIBZDVB=:3'Z)W#KI0N*1CKQ1C
MWT_/:#K#FJ:"4<LWL$U(C/LH]OLJ-@GL18^N$;$ZF_\,$(J.D"23OT&/X'G4
M6/9CP!E8";A_U>*F9-\62^K[(M$W$\PTG>(5)\,5GSDJ*] \)S*)7U(R#M,@
M-!D=I(N)7X;\UP%\EZ4Y$BL]5!@J?GW:^^;(,'<[ZG#A"LH'L>ML?COGMA7I
M_M/>JRNIJM+=9^%'S5\QZ/&0C3_?=7 >_)^/:%WB]6"+)^]28'-/K^)%KV/!
M/QF7_8IVN$T2QG<BB[OT<UZ$;IIDVVA-)<#?!&+W]-O??I@?BYOU3H7WL)*:
M>MH7HI+2TJ,"RW1<F"T[^I^B(\LWAI[M[3TQ/S9L$S[ 7645=,3Q7,I70FA$
M#K^D-)>X!$CR[/WFJ=TU'2"/!2XE<FSKM63[0#M.QL0I# T0F)W@^"NXBL%*
M7=W57UDD'QQTVQ9O()$N6GE)CCT:YNH[VP((!$<\29JALD>66YE!=SS7(EW\
M)B,$\3*I&4G(G)P4\%:5]\OR6C6'70^*XT[>VE_ R*M?11\1/B?+&<:#?Y@)
M1$]#&MD>^Y%)UCUT0[V8V?*Y&L&$07!AM,,[6IVVSRI4N1JD?>ZPJJD1965Q
M&M9:%[E841T+TP_W,4,ULK2,M&\I_@,9XTS-BKO+X!Y$4.WH.GL]\B#.;WI&
M0.LUGUPL65CR7EWH6?>J3:9X*Z-=U=VE8+M$(=IB1(J(Q.)\4=<GB3UT6BVY
M-/JP9'PHBX9OOW9G51.93\&P;?I(0*F[F0Y.!@1U;M2%2A)VX=%3Z5DX9^N,
M(GX]Z,<O[-6(.:6=S;S1_JGWKY30C:GFAQ".!=N^]M:L&45FD.KO>)+ >8]+
MZJ+O6>/48(H6:'VL1O&)@2&)2UO341:5F)AH4$BZ2NM+\=!=(%T>UCB-M$_^
M-1T380C#,P!7-$(8V&*:]\"9TSN5J1R_]\/>K8]SDLQHK\@539Y^%DXD@H.P
MR.^T_:WT9KE&08C9[AE@)HK _?/PX@8SH,X#+'F>*,U1?R*YE _YL+W6293#
M6\46,UNX%3K&0D+MBIDMP99^\;!2!;P<PH=M8CR(;TW:L)@I^I$C?W:H) _5
M3P!96<ML@)G0O:"G[%K(MG,;X;^]@QPMS.[SGF](UQ]\^F275,Y:#"9'ZP]1
M1FV+Q3QZA?YZMXSO499H*3H#M!6C&M6IV3*M'XLD77S<5&6=[_GC6\?[,/"2
MB72Z^@\$OIS.#NEO&\?JYKM)Y8IQ[2RH!<$Y"@7 %! =G+A'Q]^@3;T1_RP3
MGI:EV52/83)3[9L<=*<LI$96D<2PNN?D1>KW*YH93Q'V!^546!_C][H#I&@J
M++QIK5M0]!G (O4%2GDL26%G/[&+V2AR)'DXU*-[,DK[J^\G:O!6*?MC"O5!
MPM;\&S2CKS'[E\>; LM9A] H,V"*R\J*1U\3KP?K(B^H('%?TS/2\^'I(GDL
MZ3]ZVR!Z'1SF77,J]794[:_Z..N.[.'?SI3W=;5AMWS[JVN\8N^-\CD]B5@9
MO'UB1G01]?'KP\\ ^BL&*S^LI]D>4&_*Z(@[17>[SNLU!C28VHOTAD \\O 7
M=1"/6$@5JLAHZ6J6QN)H[C@;7V:DU,!+4G0)%XTO\]80Y[)V%B4O_*7;I125
M,KH%F7"3??'#R V>3JG-C]:>)AE!)/LK0O)ROC?LWY!P]W#'S7=VBZ3;.BX]
MKZ6T^864>72QR2AT_<_MV@?$QQ1&0C$LW&P0V1] "R!RTS0_33[=IX5055.6
M:=_]S1Q+AI3'X$\V90#;/Q;B2 W@KGKK4GA3Z9R(FX;>0FU)%-5+\(WA5QQ_
MGBCM+&7 E0R0&J(]7$\]5&)F=A*^.C_I!Y5X5++E8?9D<5RD,!83FR[HS[>A
M?L5X_>=CB%Q;JNYO#ZRK+E#!NV> CM*J *NY<-)$*/I=.6-[A>]Y[(U!IA,/
MSVDSV*JX-7H?Y!)O(R5XN+UWM) +., 9[M$4$6?N;)^O@6\/>)U,RTQY[)<M
MJ%(1@@X=7KD!VJ1M$8[KJ&H])&^$U=)!2T?&T/#]!WPO-R>1BF\FP8$2*9;?
M;<*D'&C.#9\!4%6E ,)%D^UXOA;,3)54Y6A1Y/"G! E=H['UVX0FHI[@%4T;
MQ/4\74FE2[9DS/Y,N5/EI">"A6SY@*>ZQ9/_O7S0Y5:$5'=(>WV^M#G,S7!0
M[F5WN$R)QEL7 7"Y$_('3<J=6VUWR24_FC:$3OP)'LJ(,YFP=R9-:.57/1GN
M?^#O9L)@3AJ)+F'=9D1%S=H4>]@AK8/S&14 ^[82_42!HM..O1F<">[BRJOT
M\!,OR_$OG:(4,;KC!DMG # J1=I@J:F7:\F"+K8+OE>AO(2ZIBXC6<:\D _/
M@)+A,=%RC/.^?Z;?_"8;T>AKCC]TT\G8Y6-7^0<Q[9H;M[:;7A9KL#4VMD:]
M01Z]SG@ NB9&WU"K4JITZF7M;>@+_J^II]T4R'!.2OW-?L+-D*[H #\UKQP]
M0GQ:IL5<^R:FL^!U$ZW9%E-;AA'[EV80P>R%@_CF@6UFDDU20,T^TO#+51$&
M,.")E-I71G:+#U^MSFR O?GKW]5WNOS4-NRS9O>7%OE;A%9(=#ERQ6HS,'.3
M*5VBQQL:!WW[3VJCAEGCX#('OB%3N]_%"]@EHF/=,GQQ0W<VK\7P" J"D@LD
M?>09 V';B5MLF>^6_8KPE<I-31PA87E^/A2G/*P3MPEU/_ : &_;<5@SBYSO
M 4S9,ER'LU_Z7K1@S?4U=G/XA<&K(<9&%@><O3/;MGB5W#5:5W<X[W'8O;:+
MBC._HW:%T?8*^5'1,"XF$E3V ]FVEAO'8*7K?9(AWI;?V+> MJR!")W&M$#,
M#&*&M\08D UG)A!'JOMY\K<ID]"6#%-0VED6&MO[R)<9_F\8[1$"[0TB\ZAF
M:(WD4VVH#V5]8#G$.0IKR<UM#M!CE#J!O^N]K[40/08(];_BPU,L!4X.;S&G
M'*NQKV!59%#J4/(QXQ$PWDT#7$X,;L4D>:Y[BWQN-#H^98B[HV-?Y%?BH?YX
M>GK!+<5,UP9^A(@B6[_<-/_9$FG]W1Q*WD;,+=:0VN?'--V2TR:8=5R. ; U
M7!#3^?L38J31;?W^30\1C;= 6JC+E.L3*;:F><OYR^/<D<V;- A;P,N?7 KN
M8([BN_57#-.S.,L1$IMR([(B30N@ @Q5-S(W]<FADYI9;D2[VL^9U6)YNGW7
M-P3#N^(COOYA(DB<A&X%.R>H$6@R6/SJ1%/KNKZM>8QCG%2E+6:P<I+^,D5@
M6ON?) MTY:'<'J&ZZ4SR)RS3#J7H5CALX6 62/U:;X\C75B*#/N'T57328E'
MB3J+/\I<JMP<HG-@5FU,#H$H,WI^K-@S;[K\'1T<=J@<U408KTL8R4)96X)B
MY6S%%F@GR_$]R5L5JFK*<8D_U:,^HQRQTCZU0$%3MJ6LF<.AE?,Z,P6&;E=>
M&]$F#2%*ZU6WU4_8,A+U6O_,:+ASX:LXXRCX;D^J?J;N]OZA]S@@!BJ=@JLO
M<8V14/$,P+^ZJ^N68U]:F,7.?%TZBO.%HMUT$SK7$^$M\P<CLP69&G_-1VPQ
M!#.Z:HDV0?3,-%JQ?_$3L*(2$#U@2V-7S"=Z^C;QJ(YDK*]\E%@1YF&O?;7@
MJXFO'?I^0WF:&^X94?$EMA^/W(&U8-C_<%$X/.;$AF$CP.3OWRO+-;Z?1J45
M"=SP/!H )UK>7BJWLM8 R@&5O7-J J)*,T)%G6M%ZS2T-BZR:@#WJ-ZA?=D^
MV-<2E])FB9 H^L)$YX H3^83KC 9X+GZUF+L>IB@*(/\RB7V]>3BU7L_.3%=
MW*NZPF? \).8WJZ;RH=HK9Z&N4)3%RE<^&:=_5<5NEB>[G]G3A60F42D6I?P
MO\'A@2$\;)22CY)AU5YV/E6;(I"-$5JJ-N\O[3K]47(!&P$RDK^QF&)D7W4C
M.6*5?P17.]&VY;RY.%Q@!2Z^7I)B,,IH0M=2^?5V9;B>;!-H.D0<7*Y ./+8
M/.3DFIG!>LF>_E$C?6:NBX,^WSJSOY<P=?"\VEPC]'5)Y7&;I7-7)S"#9XJ<
M$XT$"P (';=6JV6B!@9M#]^30]P64XD.U%@*^?&'WO+;ION,*@("=ZZD:0&(
MHGB3V?CK9,G9(9.I3K5%MQ#]<N.I<8S0W&.)S) P6Z64O<W;KPC_A/NW,[AP
M-^8HW))8SO2/K,GOJCBI 6C]& WUTG+X9#L*LF7U%EO'BJ:MRP>=P+F0T0@W
MU2@"K ]>8)$CULC_Y_\ID0$9H;N%*HD-\$MQ [?B?,YQ.843>7JLU"2_L9"0
M0L;EJ^G7G%D3&@]YU1IW;*9&"H,Y8L,1[A+]F/GH003+A45(H8'[E(+@<+NZ
M=4T'!R^&VN&JVB];*K@%';K#@-W]DQFT>N[?[B+$9$>]0LU%0XR<C4BQ>'@Y
M3T!@>;=!UC&K710:ZZ?'Z@@M;+/&HX3HH2V,]J40H;J[9F#!]8]BE?*AO]6?
M6N<4V1RF4C@1.9X9G'OHN.XO9  RB6;(\]@KML4B@T5-4)#KG.FFE.F$@02;
M_)\./$6R4J9L\;$9(?V?J!SH"S]-#BUS>X'@JA'Z9:]N08[<IM 9]0A\?\SH
M0@$SICA0J,7YP+UR>>4151:DL!96T>+2Q1&? \^<@G0][+ PC^,G[6)0$"=D
M#G?&I9:V=+<B7YH,U#DU&[/7_OR',>[&[ PU],P.(P%63]97NXYL@""YX5F2
M8T9RQ+>SKE]K)EME&33E"<&Q<;>?Z$_?)F?-B(LS7L\X]Y'U0<F[YE52^YI]
M\X)/-!(CV4'-9LEC",R/#PW#Z5P9HOEN]->U]4FMAB9Q@ZDOUXYN%C;--6V/
MR$E&S3=[T%/4:CQHCPS;#!'2HF(O,1&_*MUI6.S7A?Y^?^LI^P! ,6@1_R@F
M*AIFE$&TQ1EJNSD8M[301EHV4[)W]WO%[M!SR &A*C[:'4APG%NWL0>TLH6"
M=G,P+F'U_5[3-VZBG2[YP<+R%J!6V0[<\C2,MKW/D@QBI+WS1SCQBV\U$TC+
M#C\[ZKW=:_Z!QDP0>CLWUT*(U,]_:A<<OZ "RCF,4VIH6RCM2/U4J/KCZ]O,
M_I,V3YRDFV)"N!1,^[,?5ZBU"X_]FTS5%#4/+[IH,HXM3[S][)3JM.#_(#C#
MQ/@N]Q9E%4>2TZ!E21^*KH(VY<9/#FP--&:^5@.G+L-NT&4'Q&S">4N%]'N.
M9\#GMR[!V4NNP[C9 %$4=)"34S*EF[$W+XQ[3L22UDF.A'W.EVZ3V\SH:-F3
M?:0O761A?6)!K44+C<[8!H>-H9N,$V/AZOS+%ODB:!W_@<'Z#=RC/ELS,H-C
MTJQ5?=30_;^TTOT(ZH$9W#I#,!.-,!_Q,:VZ8C#^NFRM;%[%&.*#9E]&3K8C
M_C@!DB INGU7.GVX"$\][1DPJ E ^I?[>, 8!)].'A35!6:E/5E5'BJ^*9)4
MB\GQ/3;OD$XK_# ^_CU-V2$6U[+8^F\F9[>Z_ 62EM(*;-0J%\@NS'R'8AE-
M0+#8(_M-D"XPY7+8)*7 Y9=3FQJ>9#Q&L2-K&G=>W-3AU-B+0KS4GO0/2[*O
M@8H:B*VB^JV3CZ\S*T37G3+>L G2DRDOZ?8GT>\1D$9'FVDG@C1US0T>]%*U
M>K*VP".M)J7I2OA2T^Y9_,K3M,^ 2<W:HJ[,KZ^\WX2QFC-8OOO=\E?J/3(L
MIVZ]9:_3MS77*M<T8 "+E_D07Y3\0K8L."*8L';8T+_1##+6-"#X@C5=2_$-
M#2;3.Z[8?W06;^<$8Z*!N%C+R&DA=HVYMH2:<<1P<<<P]M&^$URN<%"4[121
MF#FC@0K4IR GM'YEU=O<SICX;(UG:TQLR.A%HM7IP-&.8N< QK>HXF? FF'&
M^K;E'T*,T((<7C+1Q&FN46I.''^A)/K?.&5.120A/)4HB]UA@]SIOAN>KN_[
M'5^%WXGN[C/WOWJ<C$SQ%EAN"1&#$?(-=WZ0+(P)9-C_NO;BK:VW9!01+NOO
M")>1$!5HK7VHRTC09Q.WJZSEPC<+?C9X\B/U;C_BI0=(I%55.# DN%*Z#<O_
M%+Y]L+W_3PTZ';8D\N+,ALS,F'J9(M4G,./P*QE35SNZVF._8$@H\NWDH*P,
MHC<FE.WC^K&+D)GZW-@T";51:PSU7=&KZW[Z78FZ*#X&E+4'15OLCV4WVQ5R
M =$JM5=U&KQ>;9Z C(X-P(R V<JP.!\SJ@CQ8!"GU=O=!*)"S"RG"?>::M"[
M,)X2?R4CGO+$EF!IAPLI+UDM@OJ(96,J\R8]**9KU"K^YE'"-IK%O00FLNS2
M>'\'A)1^\I)GC$=B@%L9<19!VO .F]8%/@LKD2&N#LWX;WA5+]@:&5( <A]=
M#%")4 :6!;6NQ99)5>8E?<;I=8XIY0'B",'JL4E1P)F2;8A*H9O82!C)TC.@
MR4]3>1D,C[4JAX@,_7!\5S_1?0%\#!5T&:N3QJ\U-3W2.R9Q@;@7A4+O:GXU
M_SX=64S/X67["NG\=B>8$;,9HZ,3U:^#,V?!N:25"0W5,XS!W+9ISCK2\__]
M0-) <SMB!;2$6<:TP(DN/[8MUQ*8>#/WI;<IIPD1&V*\57U%HBJ^DVL>H!JL
M_5FR,-6*8GIHY,>X$SKY5!.IN[[RW%(J!D9/(,<P$_9);EU)Y>N<7]O<+M!I
MD?]&L,6$Q:2VV,;P;/$$21Z\I@%!0ZB'#XO=7)1=T. */SIC$7P-AE6[5;N.
M!,J-4FS,%V( ^5F&9#O@)"PEKQ15HHPXR/1S":C9.&Y=-O0_-<H#EFYV7(AS
M\V,+C>ZH7A]<>1!.Y6+7A[J&:%1L'=,>9')?.&<Q.60IQ1YO\S;&$)#JT&?@
M;'"4<Q1U+/A]$3EAH-0D-LD"/H;_!:UXK:G>#"XUZ7>?NNV(8_I#UD8E +?:
M%,#J]XC"7+Y'I0HE&V=3:U!$!GP%KY@,3+-#M)0#(_[R]!+QE%-^3%O73&Y@
M$D4%RA+?^BA.YVUHG?\7^J10(Q?O;YCU)( PC+=IZNU=  7R+A_CB],&-@LK
MV'C17JQ:)26E=\D(F=U&A<A50-JB;(N4.YKCE5M\;NP_HUEGCO=RSLQ]9C?]
M<2C!T "0L7"SWWP4>MU2WK1IDJ<8B/^F_YNHAR[Q#^K'DVFW)\&U#93I &T^
M96 7\G4)8]&-<KX]1I]M??HDEC@80RK6*[<' ?[0U_RWZ!1T,LE5':K@.[[K
M8FQM^U5@.V95V=M;'!QTD8WRJH2<;-%TQXX>J-9>$S)>\^PF* ?;"'STG1&X
MB%CN+QP*=F@%R$99TJ/<NBU">/Y64]T@S+=MW_;_W5S=3"Z%WS7F[^9;%Y6C
M9H?N,QS=;"J5Q&X@JO=A%)'Y+&<A!%X@OQE^X,E(8&@"*N,6YE:Y7.OW#+C2
M)MWHY&S^6%Y;M'J@:D>&M3]FIQO J(:)D9 )M8\/QAG1)EFW4")9D!:W;UMH
M[1*="^"#B&,B]$5_'$$BI#2U1VECZH==Y/#!I1@4^TDK!K=-9C%DTI_L1&/8
ME8W0P2L17OK23+!G ,D&ZMB2"%7]8:'F,$_K::&-TI!0();_./:-&H &S68"
M"8:9PDYD%,)X@)9Z30MU[CLM\^=+N<*#'K+&__&&Z?-$8:O6:0RM-#C)\BY+
M6UI!ZTD<)?\+TERZZ:*X;E9NWC@GDB[S1RL=G-#@FXPJB?(&R)3KYQYL:W;D
M#JZYUY4DYW+2:G.K]GMV-7@5YHP$JJ&^P1A(3OP+W\Z!=JO6%3R\'-S*+2@O
M"8=CQ8N]44.Q3$)$ AE807Q?_+@F+;&=);_%?+UP)ET=EZ8L-,Y0SK;BHOEO
M1NN4@& E\L]-MF1V)%]QW*#%_Y1U[#$A]'ZZ-6SD3U8&VB5#,#,S%SR3T2,C
M?_^[NLO_A'$C;5N?F!=$&(BUVY%:F?1"*H0%"RIN@?1=K8+2B=\&D@=F O7&
MII6@SP"F;6,(JDJ.0:G<9!/E^6[EI5.S=-H4N^88A9$'X:TA#EN&P #%M,5Q
M+OPQ3!@YDPQ-]M!>7-"(5ITO[FX.;Y'""<C0?H71+_A+%O%W#9ZN'\(,'5VI
MX>;NEK.#$1.UYOB*<!V%:)8(/0-<S/+AZ;.Y91/\?$D[#/F>G!B+LI2H.FU:
MU.M)\\+)4S*M2U;3["T;@;'Q\?[#_5FM:QMU)#BV)9QD\T^0?:.;3Q7D<+HM
M*4.9B(B(?U6:_F4*JBY@AS*ORLF2L!;>TEX:]<=\LSU!PSYRZ<.9LGX\!P<W
M,3T__2Y'' ([NLIX"_ARZ#:(MYSA&1#'QW?8NV2Q[OI:S#CJR[Y5O/00=R!^
M9HS$@ 5 QF%05@)QGKC7G3J4F['54C@KYZH5*>9 WQ01Q%@@,/T2>#CDA6H
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MJ-U4>6*0F7'BF4KGSB"I8J0U2R$?7@Z9],!<>AD:VQ0I2MK6"D7;N*D!@<\
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M87^"48RN_9N]U1PK*1MY#_=_.Y<^=O(?M3BED8#*>-YN[VME#L,%)%3UYP.
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MX2&07:7/:71EP/%L2,#"]@QTR!FN)8%S69>AQ<FN8>-J(PJ]W+7AOJ67#O!
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M\5'&1.550POZF=D*"BXZJ7YFO?J+2_])5+],5H9X'._[OSF(#!X. %Z4=#X
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M'36(B_08%SGX6/MZ?)[<R<H<?Z6\ER+F R^G\&]],)#K1S@1L 5P60!4?([
M$.I8C^UH@X4-I^U?\W*O6:H/+>!D] !.*-][$_&! .^AANL>$;?/JG4JG<U!
MQLTGA#;B@5T#,D/*_9%C\@&ITW'+R7URKZR?Y?1[F4?.E3;1>_ATQHH2DC>[
M^Y[CY3IVO<5Z88+W?W:)8'"AV2L7IUHSD.8H*W.S+Y$UI,]+B7@  $\B+@T
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M]+F33B(P^_$ W];+B[>.NL7&!9P9BB!A36\X/@4K+.>UZ^0';;O Y_?/"T?
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MG&NNL$,&=3[25\F[-+/\F41,876"($P(Q>LH5B3!Q+<(79\DV&BR*N7YQ_V
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MU.%(0!4K\:\P4SKM$\G\P6?;>SHXXP MI#=,'ES]<0HK;%%SQI''W%B]95=
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MO=81X_KULF$R_(WSCI\S57&HP1-TIO$K^;('9?UI=QNHT_6KZI(G+HN3W50
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M:=X%:RM24:?4F1&!:0[FB.FL$->IJ+O\,I!=HS<<SVREQ\4\08,BD[HK=;N
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M'IFG9P9AO\.].F)8"S4I7TY0ALX19A]F1,1+<17SU(%0\8I-%/P54S=I2*"
MB)@^*#.%E>&':\]%'F%&U)]%SP<NN=F,?P"C.9XO7Q8K9D>)5 ?EJ(XT"0$[
M5Q70?P ZL%F?6N-<M=2;7WV6'K%L[9->09KEL5#QF^%A#/P<18!'O2[GI3&.
M1SQ<Y=01I'$6\P_@8/A]8#<XZ>Z\R4E\PM7D'^">.Q[S(?5V%Z)1T-&1^,R'
M&$[)JZ3T6O/OU:#;&[HW>82-43T1@_2TF?2:7;]4"-I,0])JLKI;"/A S;@)
MQGD]%V7_ (@<E)9_!I#XH/!4=GL)[R ^>P241C#YIZ)+6]D(<%A2Y02B0^G1
M*?YE0[)'I97 :;H7D5A*'\)U!!.Z+[%R@(4BBT.=9&TS)YY<SB\.!0R,&D?V
M*>P:V5F#*/=C$EQS.IY:09A,076!6SB:M&/&F<?YRPXKZ]4Y][=^VA>45B[@
MVT6&K?C(6[*<L"KUG_89,J7E=HBT.\JN6 $W+&[-UX*31:]=;-&[ANE4\MN3
M!W(IOT"$$7N+1FV.PNT*[M9D<T9J("Z*]=%?Y;QN!:[B=/()0(RX:8A#WI!K
ML8$]]6"V7=FZ?-*0'=MH>8WY:P"'.%LXUH<)P5 Y.EDCKF"4!A(#O+ZHV]11
M\SB^*%3>U-A9<RYZH^RZXKY*2W3Y 4JV\?\_5_X? BOD7H>@^''Z'X! F,=T
MOEX_RM@VL<<Z#A:!UD*)49\ VY?E]<,]DZ59.1Q21TH_%N(*0._?9HBF)+,Q
MN>R]N9"D8.F<!IF"^WI]^6(\$HM042-.<'+%='T_%I9J)3T=;#%6%U]BR?E#
MH5@)=</*PMJF))RX0\NDU[T*1\MW0ZOG<@S/4/DK4&VD4V.I3[$=N7<R=+(P
M\X!=P#\EX@1#B=4_BN5E@FLWP(W?6&(OM'CM&,YV@2-TG2/>\KLYS0\H\&(Z
MNV62MNWLM<\5V37>P:W#.$:UA>T,-(C)'3?U&V&PIMA0@WA]I72FN\%*ZCE^
M"S^O=T[E;#5Z!@#%8?9[VK%>O;1SP]DQT*;*'H\PVQ6]7K ;@\76"LOABC;>
M=%2.XQ!$],:RXG$,9)O\KBF$=&IAB\9ZC)6PYK[0VPKA2ZQZ76V2*S_CQ++L
M6F2HEODGT^RY17."NIO$#GJNA3[D6^?DCH_=CN/R+OS&:YMRJ+@! *&1WO^Z
M<MRW*$H>D\, (I3^]>?W:^*C3ZLWF?Z@/[:=3ND]$^+5;C,SA[*6=L1WX^==
MM>PLXZS9X4K\E_#?5=(U9EL>!(S+0[8>;0RU2CTS#'5% Q8Q+YJ[6=#/R#SA
M/.NKT';^^N=>/T9#?OE:S@3)RE8OJC?/>!JV,SE+& UMEG->BBJZA!]/-IT+
MYNK(? U1])/]FV*_@4@"1UTMZLXZ\9A-K%DWU$39SC.@5('4,4A&5I(1Z3?C
M_DQV^79ZKB;*-D7+T"$W:+%!WD?B7+WN?62IQX/ D&9LP>Q?.-SR,^\8A@4Z
M_TX2UH>1/&"LE/&FXQ<(9!["]W/X/2]?IEG3*K86OX7/^S@%0JIT-!8J,1CU
M+D2T^* U'R6J.?.7Q?F%O"?6(OF>.)4A!7<6O0"1"3Y:^*"_PVE\C=%#.5S6
M)@)."=W[2U-SF--< K]HP_-K<:K\"]]J28MD4^EM.\]1V7DJ*H"I5J'&)O#9
M0PB-V..8T$C9N+LS1^)^?6;!N=I+&WH#6GP$-GKH!R/#0]^/$H*HN#-IY;[S
MP]M0HTS=[P-T(\JZ.K28!&UCTA*4$RI[G4_"X*N?$KG;"@%[M]'HP*^(OX<U
M(Q.J)N;)R3<92?M*L[R56R'[6O49V-]LMY/(K.6Q&8.4L!@9>H.D9'N]SP]S
M:ZE7H<:*GLQV:6@_4_ *6-2.[H)Z6.PXJNUOFI3 7;\AMA8MC2T,2^0;4N1;
M9 I74 'MJNE4'16>B;\V[%WR21,KDJ Z96=<8T>NW5> '])*$N9[+5JT$-D9
MB ;L0>%-.*?'\*G4[_.5[I^]%:5,Z,6F/ZXF? 8 $/%M]"(MATKU3<[B^+['
M@(PV%?/\]XZ\[CG%+FD89P&6ZQ7VB#_7*^&%>4J)*. C,<.:</\[1]W:=P&?
M "8E\>( DM 8JZ"  >33@*WD&E@GF;V7BO/HD%E!\NZ(_"[Q:2RHPH%ALIT9
MA,X6B]/U2VB$'/X#6-R1-2W] ^Q'?,\7G @XX7\ZCC79)8APL5V\SZ^QHC%7
M?T_,,I[/*63W>448ABR4(P83\DE2_>(FU*<!&&!W-:1WM)2DY1:74%=]?)\W
M8:+:>)ASDUI>#-&4^%"1F_BSSNY,A9FB^J@%1Y%1==M,B$L[[GM"]X3F[AV;
MN$OAQDQK!^:.AL)VWK*/0JYA3*H38O <5SEZBCMMX;#&0L3EO5R2:'C!W%KU
MHD.]G]P[)[PY^$;P7.S2J1G)IB,SCR80[TV)D<HMZ_7MGP57-0.LCXUAP;0[
M0</2D3KB>YWPKIJ&.<><]<<5FG)O2MLBN:.^57H"P3N!H2]<5Y+^O\.)XKDM
MT([CWUWG 7,?B=3. D9:EVP^XUB4ENWL<"XS#1V;*6SSX2\=K*.A0%5+=@LN
M0UZQ#S\]W>)9@>RPD7W.$19,S5!6?,(@8#/+[_JHY<JMAF">I1>?#+H_Y+1[
M[*6[%BZ9+-'01$O:?8F"BYR^L!V^6%%ZVN-GQ]1DUQ%2Z'G'MP&%S^]%ZT!V
MG?[-"1B1";R3V;J=CHM8:*XC(V.?"I V8;E]CQQS]71N^\JS5<0K?Y2%D!/*
M_(/N5)'8/(M^1"/ $"U0%_3=;UN6X(K*#,HX'4'B%(4C3+$B,SMJS[_3XSX6
M#J[<@:Z[D:9IU?+*+?<'Z%M=V"B;OI6X7.2G_2&WLK5#[_>LOK%QUT3OSB8J
MAM-IIG\08A\>^-!&9'0AOJTN]]#'2V>G5MM<Q2J)V>"XX;N_<K[[Q1P&V42G
M6SY>O*#S.&8[OUJ1DYE^;",*WKN\VU@_\KW-")>F4(^;43>X.!9J3*;9,OC(
M8EFD]-H6O3?0&ELI<S.0=.T?P/ZPB9H/&I/XD&+],3A%D.GAB,L1NKLM#J-]
M&F721H'6=KF(1$/;P,\+E;Q"ASE<>R$&)]SZKUQ@02V2\CLVIP@EM<4#NNS8
MRN\RNMGU(DC/96(,T+ N^$*#E[W9]NG)#J'IH]UYH^"[5?<ISPM2- 1OA8>*
M1ZS[W>=UA8K)7[;[RHDI"'Y2&5<,2'N)1?*!W%XADCS3QW.[TFM29^ZO1]N-
M)R5K0Q*2W2Z=\)1K%)S86#0H_Z9GDS\)N[J#?>JB="=*]0+ZDI[UK, F6/7M
MA%>(,CJCJXYJH=W9FJ([3VS=:K_($-?;PBG/;K'A PEMK,A[ML_S7;9:D1(=
M7_L/7;E%W ":RQS:Y8E+VZ,)-N)]^)["I\*AL ULVP""F8G<S3:,N@9>*W.J
M].QXK\^LR=#D*;25II+_5]?V_!?_Q7_Q7_P7_T\X ZY$]_LVA<O0*@3F;8Q;
M>#AO?QO#N6E,@<1/:6-53X.R$??FJ&BA,5(9CKEU9?.R* 5RCCQTVHR<?X"M
MIOXUB<W*2R"1_5437LCTNS9**RL7?2&T6Q)%B..=S+TJ,N*;#-. 9:7#=5IJ
MT8K^V8Y%3-!K7_V9:Z/I>G#2L;:*D?[9MB'MR\0."FFMWWF$HU';CI<%[MS3
M4/N70@F-RWJB>OQ-!6A3=]2Y\$70.>(";7[:)/.(@K,P8S<D.$D3\*Q4-K*R
MH"X.?IFI6Y_2J"R>C>'D Q-Q\648OM7&<E=TTRI99:Y3]1@NP_GL!$ O92\9
MVLJTDQFH,VQR;JRZTV8#;<2U: 8X]P9)MG)]O_-<O+^79G!J_0?(C<@CK(K:
M8D/2\FNYXK=VM&HXY5A-UP]3LVWO6>1@L20/,1?7S^^T-X9L+5Q/-.4(I[Y\
M$5(5(T#)((\M&POP(M5_>75<?8/RE5GS_ >0!<K1F9*-^K<>/P;0QS>9!D[V
M36'I*[KE_L]'%?SOQ15#J[KV-P_^9R8 3X__AOEOF/^&^?\BS+&W<N)N/0%+
MFF._U=3S(\[\(-S_!40NE.-158CABB3B'^!-4L=*.\?5R#] D@;6P]?-?X I
MLR IA2O5WW6MJ#1O3^_/SJRS%RW5/-O:5%]_;FM_),;\*VFY&I<R?F^ RO5$
M,D\J252E.SN6'$X/)YG*K6HUQY4I?<3'Q\]1IT=1!6+?^[@BK@>UC[6A-"60
MXI"M5=FT/:6UNM"I,*>(PB]/9!MON>VG0=ZGB+BGID\OXBYDC QU\L'FR \"
M=&_/Y=H#6N[X_@%&/D8\=K _RG=H796I;B@@CI9/[][,_5_M7%=8DUVV_C!*
M$9 N(!&D*"I5I+> 2E,1$.DE*)T(2.\$48IT4$"I2E4Q@/02Z56J(""A!Q#I
M"2 $",G)W,PXCAZ]..>?<^;Q8MU\WWKV?O=Z5TW9$*_BZ364RX/E-(.DP"XB
ML*''302*-.KCBO*1UC-\6,47,_N/A#.F]GFUKTUGB3:9Y7-K\9Z4W=SZ"NSV
M-9I+C2"VS#QWE!EHW: C",2P!HNZ09P<TX.-N?@8;R"SV2>0WQN]Y.=,V^QG
M2Q=^>]CD6LKZRM*=9+[7"92S-(@/:FSK*:O"BA2CA<FOQQ91K3UII4OG7HYV
M@I55LO.F"W9*&BB6$WF![5:-YWBVF":S\QN;1@D+MRJ'(.7"3M?!$U*'SW59
MN54M9-;9@9(Q1:U$@-E!D4ZU"A.]$)[K<Z8B ]UJQ PP!S5:6ASCJI U2#(Q
M,S?4A,V\0OBOX]0D!'HN69V_)-OV6DGFY$6.8VK8^QFP)>>0.HK8!D7.3(V(
M@Z*'E4(>G\7]*,=?5K5I[<CN#U''AJ3H]467K_KZ&#TV+(%I.%Y1HNPZ7Z".
MR,@YMSKTJ ?P[EF/P7N]MC,X+IN[&HF"&0OU;%VY5##?DMH=V;1PVM)C8;]A
M(:)O6,1C@EH3%^#GYV:KT.+K/V+L_XJ^FT&0TE*W79"2[^N2P$=_"8S:OD)A
M3 &:HQ9':%9,MXOD;'1F?OW^!I4,KY]+0Z>$,>2^6$_.XC J.4)8F+-#"WS7
MHD-]+EJ;)QA_9"Q.UM4.%#X0> $WT/3!V2.UUJ0+UB,&B[169S$"J_<7@,D^
M]&,[QM8'2W *L_#CR^:*A ZL\ MG-\<S"2G!@MI9EMT,8AO,X/O\$H&0^Y*T
MEODHL^6+UVCS,B7"6\BNL:9HZ&N]PPO.SJ]73E83@='-)MFO83$2"I9&E76A
MO9,?%X?7?3@[^8YV,!_IG!;TGH[O/V0'BL4U\3N'3S%VWWC]0*O47IG+Q\LH
MB@['H(N[M5-/C[>=.4G7O'=UV=<#"?^$F3*IKI@TYU?B?8A_Z$2FQ0]ZG+1H
M7HN&/ZQ ;=>BTXV^:C"4C_&5,_CPTI>P7:WS<NNFCK__<=,P&G.30&UVQDRJ
MC;4BI1517595J[U2TD3UZ74M02F;^GX[, WNIV!!^$.Q(7@#V9BP )BM+2RO
MT4=>Z"YBL^P1]<-QJK;MCL[%FTM<+/X^N?:R!XDM23N^>9D>3@BO(\4\;!.F
M=:KC#(DZ"11\>Q%;0I;3*[XI#N:>[^2N!>2-V??Q-ITLI6XAW)8+1;<)J^T;
M];TYT==8FYJN:U0W@#?RR>]YV5$BJ^8D2?]:=;C9^LG:XF",\BQPTKGII*7V
M")+)\:4#*CTCWTT\QG_9$%]<D,$02M$MAU&06?*[.DLX[GU>A,S;U/["A,18
MY[FJI#NU7C+ />0T\-RCL.D?.>K_LWPI$\%AN=93%F!9_?6S+7!2>*M^>VOM
M6Z3>3#IOJZ_#)^_@]W)C$G%7>5R5QB\^:*2H1J1T8IU>HUA#)0*,+!E3J64*
M'UZ9#6P1BMI>5 )[X<_1A4&W!(R(P)0K''L+WA2'(U6&2^69!SO\1(#%7.:E
M]PBZ,!63!6>=A"71W7YYF7FX1,4I&&;/>4^^^.AT8<]X6EK\5P75%_OJ)D9?
MCLL^P-W!F&JX*92W(I/CGX>\&$4>4C5%WY)&R69>5N),)16#D$E:S%J6R);F
M450OYISR>;D%^R49AZ7Z4@1\(8X(U,7B1H(-"8,GK&IRFM:5:RL_@$SY3CQ]
M6M+[@=M:.Y>5IMF9O4.X>CG%(7"@..]1@-=+;^// TO\Y29^-K44O48?Y@P$
MM0^;A5/*+WBWLXN3K=>/#M=O=L"GU/!VA-YR(I!QF; 'F37W$FE=/:W(V#J;
M&.P5HS/?;EU%=6+6<TH 8IHVNQ;L@D+6ZN.&T)E,WGU-O@8A6Q.753WK_,QN
MH*[$Z/OPNHNU49G.,/%ET/7TWPE23/QF8;5MCR+\!M?.!R)P AL;D\E2A*2=
MU:)<K&!J2RKM.//Q0SQ["HCG+$IC]\9Q<V].O/Z92BQZ4?',97N8K9OS3+JD
MYB6Y]B:Y*85WM1>HXS>"/A&$77-FXY6XE.&VQD2@CU2/ KBPV?NR(P0?NOTO
M1"#:OX=D5113"Z,#"KECSIFR+5<0R>%X\:K&$">OF'KSPFBRT,,E!<C)?6<4
M3%TVL:><$!)@"Q;MN";?A>R.K,XZJS36<8K15;WM8C]H\AL:/ARDPXB ?-C!
M%KP-21DX$*]0%Z/;=")UPH%F[E+R466E3]V:L9.<E&,A<Y89Y:LU.Q'BSL>$
MZK?7LFF34=0^YDZ! 56]TCM<Z8#=SZ#?7I[D#=4*0]6'RRMX@1=I0WI:D4M2
MW-X?JAN70Z$#55-'<<NZ-57]B'4)3?Z;Y=7QPP%7!W@9_9-ZSIF;);LF<H1+
M-UL<:05\O;ZQ.N0;3Q+(PVV,W!HL*GPCZ)R;,<&3**01;97!;L)P-:=*"1&Z
MW_VF]L;T>6ML&=.X7?_BMH%!SRM5&_()- ^S_BT;&1<DN055K/=)7WIU"HUO
MK!&[L@S=G8.L9Q,DPF:@[/8$GKJ,X?ZK,6\CPVE2U:N#TK/LMM_N:JQ\<E)N
M8V.*],#*-J%F=8VV>F[(^;$["Q$&FB#"]H[98DC[S873+.$=H'EYC!VHXB=>
MM%DP]:C>LAI6@)"Z%=PK)"DW7 ISO]CYN0?L$C=I<W&3*_GD[JGH++],KLD>
M--TQ0T.[D0^IZ<:.<MJAS@+^'$*32E2;%W8\KR7RGZ7SU%:26_\[>O%O>2DT
M:%64+\=L5TIFNMQ^V5VQ_0CNYG;T1<0D>5R;69<TY-SA-% #_]M\4V\BH!FF
M5U>ZL<:W+WN=-TGT3:584\A\J+RDUTN*ET!< Z->,=G'GU%N98C+ZB4".GYR
M$$E[WIJ$H0Y3N@0)3Y>,E]2"5C$Q+JI%:#MQQ!UJ@2_S$52W,BLNMKTM  S/
M#.QWH@I=F8,H^+3)ZW]"=OJH_[6$@)OK/0-%/)4P.2I!1W!+Z82&"]_,U<IG
MI?:&'S>4V?RW6N6:X(PF-Y^:0!<K7TDNIS[*^_2();?&7//0;K5_Z"'N6F!'
M@>P4J/\GD5#UJ8[WDU:NJ=G8Z.2[%N=#[79M9^>>\=\IEA:< ?S!Y-86RC?)
MT&796/MD:/E UH $KWS2AXGKABWUU@:"K-WDFA,Z]U%LAX EI>?''GQC%ZZ_
MIRG8HR&DAW#T;,&!Y-X 6O,\AQ_Y_O6SM8XI/C9193G%TJ<M07;2N]$&6/Z6
M6C]'*5/">]-)8Q4!5)<H+6WGHV$9S]6[^*B&DXUN:84S/8#7U _SGVD.$: 7
M7S99KO4++[I"KW)OT9?!6""TD@B8AY.-&\ETH"Z6OTW3KWB&]A/2U4UZWYBA
M85&=,APHRI!%55^DL]_"SC[73U[T8R:&:LX>RO_SZG_OU28\9O+<$%YBQH_2
M7^P2S+?MQ;%4>VX]'DE7GV;_ZH:&/O!".>#UD\K'^A*OCX4T>R/<(1SVMBVR
M SG)KA.+A?0!X9*'W]1>J+J] 6@#AS/*+VUNIX7*+>/>(/G=?&#,CT^_:_%Z
M3M5B:'-'TO\Y?[=++?C8+L"E3 1^$NG>DKG[:CDGJLH'D?Q^ 4[+L/GKPI<N
M=KH 26??.TKS);S3NA3P"C*3CU?,5^6_5GO!M/4S5/29FXW7712%D0S[BF?<
M/5<E8*?HQ^FJ*,,?NJ\T=3HY_*Z@.#5"=N]T=:1FG=AN@7A<E1';N5BV6^,+
M,ES"LL-AP8%RYE '\^.8^?4PD;5ROUIUVKGEL_KZ@0DK*#+]FPF,E$?!7U%V
MH(F?1'Q)^3J[MY\2TD335J^RM-J*4="5*2$GCDY+&WZ^%_>XJ"</#TDV^.#!
M 5--,)&(V+.B8];I<F%D9V,D[X_1X@M0 =Q_'(/F+EGXRVE+3$3@KIFA1NZ8
MO;.OTRJ/E4DH*_GILV]6[MT#V/G>3J=%3'+*E<O2U(27U$XXRE0B*^UOJY99
M:Z^8H90>'K:^6R"IS+:L=%+K)TE1+F#61$Y!?XW*L5 E.KT25?B5MG/>I+#M
MGI'4[M/S^33TP8&F<PP&2 $T#$H_-KZK8VIBAJI/=H'=8^T.3Z2I/G\U[=5A
MBXPJZ5-!9*]^7 ,7AJ>.E^V667V$J@U;:+P(1@_SJ^.[<A(\'EP(6EBKS7.+
M85?O58$0CH/['4;B3.V-GQ0ZKVYU"%J&7A!T>U=[HS&MJSR40JCA9"1=2M!/
MRQ/K%>S$<.6LXYFFYALU)U2&4R6Z2ZI4[*S5],Z/WL5'/^%6WDU]A?JT!*\\
M-/DNN_E\KW#2J)=8X*9[H VVUW-:BH)B7MXR!?CPDRH[QXV+S>L\JPOSC12O
M*+!;H4>,2S&]H9+WMMQPMKAQ[YYR.T_2%)JE?"H\--HV=\F+]9)?N%F\KM4=
M*EXUSZZ \?=T0 8=^_-CM3_.Z0+Z6+!LX"MKBZ0=*2\O4+?W:I#E8;G@W4(J
M"J?/(."X?!RE/N_16?2-5/+,5Q/EB)W',-CV%[;#$*?*B=+N,-J.B=AW93-/
MMBSL0"4_.<&T$^&\L:'QU#CT2\T[I+ZF"[B0H R59(O*XZ[0W12W*%YM/$QB
MNJP^7'\GI>33^*)L81IMEQ%R)_!J.SB+2YJ7)2[M*<$IS5U:G.S3S\JW"Q>F
M=*N]7.-4Z4?^%*-5=&6PA.9FNPS/N61A0/7\^ 6:"^]CSM7 8PO+M5B^>'KZ
M:J(7=SR]2LS8K]Q>_1QL.&L-@<BQE11KCPH_G98$Y#)_3/8;D6/>+TB'I.M\
MW9@_8=1P9_,4[#$'U9/">>N-B:I&]E[*Q8]@-\7CN&<L4R$()X^":UV.6ON*
M[[]<:62>+&] A8(510<.97N.>TB3!ML7/TU1]^+\KU2DZHO)%Y#'DB=+S'=X
M'&RYJ8D^0DOS,7*XSK@]CF*D1#!C5TM&)S2\\AV2!E&[G0JE;44\FF#[LY%S
M-D?2P2R-C>WFSX"EGR2/ OL3KQU"YQ$#4)YSQ\43P[HD=:"N7@U390LUQ:O&
M3\AT?^@N#A/,?][\#[S1HCEW]&ZXH^G"H9SO)NILQ.+V7L5CGWSS5S"3#O-)
M/8K#V:]T@V7 3#WF1=0'A>43!LV$(P/"[@I7=VYD:*JK#AC?^'!1))&[\;P:
M^Z&@"SDX*K0,7L0ORPR'@D4R,'L.'^_CH+RM\D2C.@[,.@M\;92?94E]'=AC
MG#C_.=O-&<W!E[3G@])+Z>JFYB@I>=CK675J/O28--BFTC'P*.ZSGUTN:33N
M1+-LTDM*7G>)S]S%D6JC.FZ!$"D2#E]_5+_+$R0ZN'WW'9SJDUVE\4&UH01U
MY$B2G.?NP_@K08"6]IT^Q:I"MT8XN;\6>I77E @\#%D8*'1<NYM5G*Q=JK.@
MXL@<?\3N_N+;[-TZBWMJ/9V%1(# '!L#_U*""R/@4HE PED2 M[9S#W!.E*D
MU)TA G,1P!<^G )-YI%5))/0AM!\*=5L?01CT UPL6/0AJAGVM=.!=A%TIX>
M)ZE;C3G?O5S^,#6)FII:8LTQ66'J=#N1WQ7S=.QQ>R %R[7?V*L?]PRC@W1#
MI\,,ZS_R* 9$Z=<XR-;=35<_77<3!'HF#9DJM.G;=A]BU;.MQ]XT'56O=)I&
MH;5D/T]UQ6]F!#KF4Y1L\PU7XL]Q@8G !VLLW0%6B@CPZ1"!HVKMD"TC_\M$
MP%^3"'0RDV7.0$:)@,& !$*6L-,BF2QD__*365Q%JY2:PYL7%-+S5Z/VW7JD
M= [21?*Q^F]?&WE'O&<3SJW*H%P8?-B-$,&\Y8^3XQK\?&H1WA2/[3LX#J4G
M E-,\ T5+DR.OQL14$EN@>RT3.'CE<"K[2LC!5U9C7E<S*,^Y#-K^="5LMV3
M$<%WG)%D>J8O3]V3+LH37 UYER.ZGJ0E=,@Y?D?.PE+0[_'XR$,B\*O5.8?0
MCH(PQ9-#XD7B32*KUN5B(1.EOBP349M1P\+9,Y1%)LWO-\F<<W/B.UD36Y8P
M95>L1$=W2C-\ R7FB<!WJZE];SEM"FBNOV"85G_.X$SUX*RS)!6OM_C3+(W#
M,N>V0[B6>V]HW%&TR#G">^9S*H80 +F!&4[G+"(\R%ZY4V!W7,WZSF6U4W?;
MJRZH<HF>BY.<>]ST2V-QQF/V&Y+JZ#*F47EIO!<02"[;P00J_=/R5*<[[4WR
M#..HV-M@Z0]FUG)?<]$W%TP*E2?V$%XHI F0[ZAER' SL=(%UYD6;= ?N^<J
M:W#Q7WG_'@#@%7@*YXMZUP!?Y64D50F33PS; 2U/G8Y;[([+KO)R[O:Q27[&
M7*\?ZRHP63(W[4+0F@J8K)GE]3B:\VX>NTK.7<LH+;W0"__G0(W%W524(0)9
M76BN?;0S0?TYG3K6.;A^ACO5/+[H.A>J!K*M#!7P2MQ4G[35R?R:+KTX_&*
MP/G)T+MP1U_=O9FE^_'U6XN=VX_YJC>IJOC>WC2J BS [D4*_QHSWZ<(!8&F
MP*.QES\BRJF<S]36Q6KM4W=TO35]9FSPV,G;QF9!9C^;;4'"HR^L>(D@'&F8
MLNA?=,$ZB2+H8C&]!EU2R9R8VB-JQSFG3H*P_&^EAY7G.&?7IREFUJ>1%<'O
M3RKJVM]W<C379;>FVV_2OX,8_&C)RXJ4P^PI2"[H)!"VIM3@,(4WV%US_2N5
MNKWMW%6D<=,@*F!\IV&3"'QGM>SOMP>5#2AR=.9X>^Y?'US;BO2LIF(JL7,1
M=+OTNJO$BH;FC1>CB>MF%$!-_BFLR0!DW%_(-V25,GCMH6J!N$QU8C#SZ?QQ
M*M69"!:9VVE;H&XB\"O25+$4]U,-L"<GEI?DQ/>_K,S6EFV(69G86\4K/;XG
MD'2/CB)([29E:^J,0E%RD9J]1$C)DH!8^_G%^-3P[A*?*/.[ZW&@IJA""@I/
M,G#F[R2E+Q49AT,\;%+VT'+O)&C'QD9WCUQW=F_-%]SOQ5R3!H'(:N-HY50Q
MMVIN?3!K?=V-2AEM=M@1HFR).B,V?JTX0>JZ>M_-*K8BZ=]PDZ\:"O:PAE_Z
M;6 6DN(WO&!G2>#/6O^VM<04_H7)EWA63MX/BA#OU";?]8BO6O0FBWN&\>9K
M]D=+I4;'154]&P]=NI@)-=6F^)#8A+? 2.'Y"2QFDAR-EG[.]Y+U1\Z(HF58
M/WHT'M[:7N[?48N'2OO;D#J*6).#Y_Y2,T+4K;Y%8:M?:05Z;,M2E.Y_'*^^
M$[%$Q2-:W9>?"VB\\B?'JF#W;TW1%]D."4\G]6DGH<^X^WE9M/$=J3)=F)]V
M;V#1J[>E?NK$?UQVOLPSU&23QAG$^$I>\>8AMR&7QS'E1;^1N6^5'&1^I11!
MV!+&RWFHWPE/QW+7W;:EB@Z#HGO5<JU0A&ZZNRBY=@3J&<^N!YW88+=10_*]
MLVSX?!O62JWM:'?(+XL?62&>\MV0^7BTTR0WPQ#'P67P05'@)!%H1MHNZKTA
M@'#W\<HS)JN6;0P3S2_"K]R1XV8.CP>_<9B>BZ'@S]/BK/@EQ?Z?*!!6WJ67
MH?1V]:.K(@GU]A550J6!_L]FDYW$9'>]MWM]%LTE?L,8OE(12"IGM,*-/?2V
MM>2(L>%@3^GE6IJ2W5=GO "EVSL7'HS/1K1\)#"W!LS$KI37#"*L;KN"48L,
M*L[/LAB2#971*D>!@-8@05GP,=W?<+HM(;\&6W-DHH>01NIU&+O@0P8EGB=4
M/ S%8@\V50,)3?D+1]U"#I7A:6?<,:U1V".#R,ZY3:Z5$^Z>.E$T9&\OCM4R
MNFHI!\D7_$X'BA3"3![@!;):BR8%#;8]AUTNG[C<4Z(F?[&30]1?QN8^^0KM
M<Z\%!<$,*A]Y@S/%J"##L5MANH:'P:'75"O.0KU.A=(.1C'TNLK/_L[)M.AP
M/&9TAH,BB*^BRP[);WLX3(A X;5'W=.@VKGSGQ;2&]S9$:"<9W6GX X^7CS2
M=Y/.C#-?V5@+B()$NKY)" Y<XSNII27PZQPL9U=W(J2403&/)DG'1#FG9HQA
M6QTQ;W3'X$A?^J8:Y^Q& BO(2:.@CA[#5\,5GFI8.Z2RVIVU\K[ <?X<[!%W
M7/PF&+C=!D%M+_1!?N5H!B/^<BYN: $ARZL?CX2,NT3Z)0P3O#*=^ PVV@P/
MR]!(66#:8\AEAG$.IP=$W!<]F#?JF@^2\\7&Z!V%*D,_C<;MYL]I/9W&UWVN
M*OIEF:[$4C2_\@C@-RC6U+D=>1-9@_2$F;5>'UZEU-F,K:VJY,U(\T!<P=B?
MB&[M1.I'S.H%W#!, 26<Z%MI$VW$S0K53K&MF]O_AM=[[+$VC06<&1Z@%!;,
M/EZ95,E07O$,3(-MT-!+?++F)1=CFN9[MK/W769P7LG'-^N.'I<2E(7S5@DQ
M'*[F-_A/66$ZWC^]0WD*'..]F?G+4PW)B\R\VHJ6NAFZMBT7&;EH;@#S@_,P
M"[X(5*\4-=UHITCB2YE_@=,#IU"^'7*>J:\.'>A]/VPD&/8D?DQRCO&*Z2/0
M!;G[O +WVW7?_[(//OD:?Z%2\C.5L.,PQ2#?6V^$H/[HX6C1I^H1#X\<;?#/
M 4\[67;*:N/$9EXPFB_!A+.%\SESO>3U)XTU2R0B+307["YDO9K;H%J_O_#]
MVC]H\A'>)LV#=I))GO$.3%KV3@FO-.BMNS2JJ9SJS\_?DU:X)VN@80[Z#3[\
MOK),_SJM4M3K_%GM/V^U^#3;E-T%;=S%V50YZM1,G&D@-_R,Y&.GT=![5&V!
M'U;-I%9*"Y:,%YH^(H>=U];7"&-BSPKS[*$@)_+/?.@@A>!O?\]0YW-0 9E+
M_U*_S0(]8#H=0 N5)XQQ;=S8@NX?+2(\2@A2V+E.!.(<BPY<M>;.]^@/0N8X
M8$3 ]/'NT=)_W#C[5X@WZP/('%;>APA8>,.WJ*_NH# BY/!.M/<FH0%#!+X<
M?T*V7DX:;J+JY[!(*I*6/62+^OW>H3HX-AF?(74?LD++3[COH\2EI*/"#/R%
M0I:)YMH%EB!?5_D)0; .B"41V.4C 822P*Z4+Q-(=2ON6#9I/AN ?R%'/MB&
MD+*@4N97(@ A="EQ3GW[[]+OR*D++<J .\;N\ON*'(08$($KG4J<^WGP#LD1
M0C7_!HM-@7WF!FTYJ:AJX$.,_L'Y7R%(ZL;,#>\,TFQ;+ _9.Y+KM_H]?\ .
M:I<(M$$WO"</D[3$,_>.S >002&X+H(61T/F-OEC(J"$?$[W_&Q6!/!72A^6
M#A_DP;6W_3< $G-<;XD /H$$L8@$=]N8Q LI9#LH2&-E$<G#0.;*^URD>#ZE
MM4<$,HF ]7,ZYV]_MOX]0=#+!GW0BN*^YAY6!4@Y:_W!!5*(;7X;8CZG8]NG
M0M\:F;3S/U)RC]8+^^1T@Y+K:V\^$0B]C[,F I=%B4 #1R9!2HGSE8H/%"].
MURRRQQY& ,:) +8&,O,\D!W>WPW!D"\0@>A^BM<ZYJ2=:4&8+D+H;2(0) 7!
M.\7B[+A"H5L7Z?!DU41@UIULZ8E!(JG?5L*+$8$73^'3M'U$@".;<()B)OF
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MBB/(HG[S<"@,MPT'31AG)BDEC2F1L&U,:**P?Y-MHCKR'Q=C-E,L6ENRV?W
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M:KIPUUSHI)'S875BT*3$W^5H_ '5-B"O@X,3:Y9W_K WD$'JJ;$BU'&= ER
M;+0_4IG]>%3.F$)YACU(!GZ" 3"3;HB7EVO>3:Z4I<*UF@IK*GR8WF*5;8HH
MMPBH$.P,3IR1E.+@@USAYCIA%*[T?,;FGDQ\W:T ,V94F!2(N2PIT1+%7$;5
MSTABF9E 9)?66%]C_4)@/9AJP*QM#Y?*''/N_4;T<*JXRX5NJ$>MK+%$"<,3
M\+ 3T"J;3Z'SVT_.$;<I4W-]([GO84E+"'6V&L< ',7#=>2\])NJV9B?U79M
MB.(5/P#.!IU >8+H#4ZI*FG*+Q5GX7>AK?ER_/?D3F3?$57%+(5__J%R$.>>
MVA+ ^?R&&*R3RAUHZLQX0%1,PAJX:;_CZ J)SG%HOL(*1_(L&)^WKA5%$&A?
M>.(6#.7Q0PI<4_ *](E85^T6"+,)$H6\J@G9$85L1%IJ3XE ]A0ZSO)JUP-:
M'17ENK[^GK)TAGV9 LE)RH!OFYB$.9Y*PFQP2<=$O'_XTJ4ZR<M52=?J)*\Z
MR>NY)GG-J6DRU;+]*$3?BC4HB8<6N&%O8E@IU5Q>65Y7<6U>N[$$8G"V $F&
MU/&PI[17FF4(ZW')0P9?'E$3,VBS#-O5C;=)!6):F8[%8O M366?U= 1UEX8
M<G-T'BKTOT4-(-U*=_[__8)Z Y]T%> 2P)_1;5FP[9"8L2V.+Z,08- R0*&@
MS3_R6KA]CF,</':'I.9Q4^Q$W\7&^NIJZ[$7P[DTV')=G';%ZMK[C=65Z];U
M))$T3T/Q!\#E.>F&\S $U["-@7-/4"1DF#35PXD RBTO6A;_V[F-+&+_:,I$
M [O9!9BN$38Y\[IR5V>QF(0W75E5G;R&"8>V%8QY*'K\;G .#>%39IWQC89N
MO$6/@--Q%IWM:8J9)UPSZ;:L(C\=ICR:151GH/F@*V"6U[\S[^(9USA:5S7"
M9EGP'11$D6> Y)F!RB?L)#31+B:XU+J6@D![>"EOS\9)='>WV#Y&W_H5GH9^
M,7-_GJ=-J5_AQ"9@XHV8T0(+;PIW<8E8:PC=F&>CE.L^O<"\BUO[0J)OVOE!
M]A+*5"1-F#/RGA]&5W,VJGKV,G0]#[@ @')L,3U/^LAX$IPK\*!9>'4ES4*"
MIQ"'NDF]B>DR4R7R&M>6A4Q=H?WSY2H5W64!F0 :55Q7715=PG69[&2J_4>1
MS:4CE ='>>$J\'$EE(>O7>/<A^#^*V&NJ5&A-'+JB9:B7N&\9>2T_7 !/;MI
M#PXRL(V5, 50!K&2'I^3EQ?\U*FV2Y-1\1#9?.?131B!#<_-Z.(SHXN*[ '/
MN%,:19TB]!P1^K%2A'1II0[U.N++PRJD- J"E4$,:FQKY=WJZLJ;S;65=V_>
MK1NI!1=D_>%*BG607 U)0W_<UC,H64GCR)'?Z9J%?=*2;\7FSR;YCK1H'G^%
M3S7CN_17I.P6&_'F8E-WV,J+-&F;)MAL \@@.=YM;;ZGUCV%H#%#0P>.6VYG
MV+PO54V\-?$^GC0J](HJRZ2+Z):QC6&:CK=>O\8VARK$!HE1&%.[V02C&Z__
M]>6TK4,<MG#$- '%& LIH'$4^OTR#3X$E=NRZQ\@<OYW3>DUI2\.I>LXFZ-!
MNMV;M3UD34+N1'"EIJU!$N?D!YE8JL4O+GB:I,?=J#4Y.*8G_JA;%G B&?>[
MTUY8X!,JB,;*%O#:'I+Z'DX+A+<HKV#0TD1,QP]<8742TY@JXY5<HLMQ_N7,
M0+ZO1@EUFX2R1VA.$X)X"HRA!N,-*L#9J:2S5,AY8063G4J",D_Z--Y:.S!=
M;=DT--"BL-2[P#1BH!1(NB0#_?J,J=U1Q"L>7)IDD3MTC,^IPJMS,YO8)J'>
MNH1^NH)>[,_(R;[A _(>NB;ZDTS-U:!CHU.HZJHP_<C2Q W=W7M4IY8^5FKI
M>IU:6J>6/M?44AO+':&MA.PWX; NBI-E">L>@Y6)&7TZQX/M,_;_9V-L?&"#
M ];=@PY9NH<[F!$VY5WXZ ::J'[S5DG/+ZJ:Y]$,Y1C+7=&NZ)HBJF7*&ZC#
MIS\8/ITQ?8U,S!R=YCFN;) 4^R3DGNB>-5M+@^K8$(:GS0X=.F51Q?D"N![#
M09X?6==VXH/9B0Y^&_/D)B:$VXW-04YN/6 FV> 17.G0_0V>28C-\?9Y\V>X
M#PC)-_-P.G. X1]1_$V+1SO*T[03.?KCK&,;BGA*C?2(0FK%G@62J)+3KE@Z
M2Y.Q!$HR$*-MV<<BO*F1*]$]&'3>%?9(UJ,U?2!L/^G'BD!A=F*&889YATWS
M8$O?8.?I-D(\^L_)<L13G&KB5URGG:F)?0[Q7,L/U)=CWXC*K8$!_AF]ZQP!
MX[&IU T/?AO#=J0N*M;3U@"NC>N?22LO;(6R*S+,_0I1_\;V=H,!+='T"N09
MFK%_Z8/ES5T(B\V73%7N2,47_(7#V<UQPM=*=YU*BEVA7IK,#(02VL^ MLI[
MU7 Z8A2Z:+QTQG_B'"[3A<-]*^NW</&,9U!G/N92 S+"P_ZDM+'KGO&*D^[Z
M*B;O!,BJ,89%E+C /)Z04D7=S>M- GN1%S038R7)QA@=60[1T=6#0;B59,/)
MK@0$<-J16;QXY5RS+EYR%PIDF/-[KYB9;#_0=T6?K'W[AOOVP?WWP7@UEY]4
M$#-%W8CDF3$T@/1DR,J++ @.SM5BQCZSLR430N*@JTV2[B4J[.=>R@K_G]-K
M,V_6)%[&-VMB5>I-A5=V_D!>PHZZ!VHV]:JR*>M\R7/=(>C(BA;J.II1Y3_E
MEK)5!P8PPAUX2GK3^J>>RFN3UV8\PP_Y&;D(A/_E!Z5;^.5GB-EZU 8PY9ZX
ML!/#X?CA6 >'\$Z*8[>ILZH6KL3JHG N^%C XMS<V8C5-;YQTAOSO95T()0\
MTM.S4#W5I\!SPPP$,R=@(L85;VHX;FI7K<>I>81'#KRF9H2[N8V%CKKS%^TH
M;M3X%M'#&B9ZC?D@W&(K<&Q[,=%><3?5L^S+KO)B"_)35FIT>?Q]=I?;YR>I
M"C5 74.HA>Q9 \8K/]%.(=3I-%Z-Y#>E4_.!*?6'$8B09%G<'<58K32!6A,0
M]N9#T7  >,4W)VR56#VQPN(V+*]!;6#&8Y $:*(T*HH=*+[L:!9<G8%I:$;'
ML ;#K-M_1(KIQJ5)I89P.]%FDD)O(LMF;>4!]2?FO=<MXR<H4I4U9(5*OKPL
M;7;043N&3%<IRHD8&(4$K" O0Y;,FY^>H/EJ1MX!YU^@B,*1,VJJ=DS'9Y\=
MT[!SB_ 8Y$2WTQ?ND, (<-YG>W99&.=7K6D 1"QU(R*3'8 A[X$!BRE/]!5J
M1$BXP&NT*V-6&#J+W:;+U%II'$038'0&S5![I-;\^BWF%30#4C>!+OI/M=+!
MA 6*+AGQV'TV"S6#;(J]ZI<6E*JQ]#UMM_-&@/H*S ;!4;7WKVS!T*ICY8]Z
M60R;+RFE[-32'(@72UW>DGS4I0:OGNF05W_FVA:I_T4'7?+L"52B1H,(D-+Q
M&FV(&\>,.,U*AA07XU2/92%5J^/,!D6E959,^"G>QJD_U*/.\P<#N"A,C=2O
M'+Y:93AJ_U6N!,W(P4&]QQCP)@DN?H2@19ULXB:;;-3))G6RR;-.-MD%9M<5
M.OXSTO6PW).,VTJRDT/772Z+.*DS!.;WNU.ZL M#>+&Z!.W.M;!0G('NB/7(
M;O;WP$<UTIW-.7*ZBKACPG2600[]0M@T+Y$NOYA&E$V$8PRR=*:!U<"4EZ$W
MP,ZL=/MZ/%%=NW*?M2NFZO\BEJ@74WR:@K2IID;7-*WKJFK<7"3<Y&2Q&BMK
MK'P$K-3]VDTO.^OW-A5[A8@,9229%B^>S4RND;9&VH=%6FSJ(TFI!U2]BC&(
M%IHQ&;9UD:0YY*"7E_)WTX@<WKLV_^I,8:J#C,E::+7>K8I=T!5ZNOG@3I0%
MZI)2D,XR'RYOK:XWW"L:8O^@(=8WWFZ\K<M#&8GW9F5&UXI_S1%^!D>8/:&D
MU._+%JGR'09+37<P$WAJZ%PJ%0P:T\9]3>9VUD L1A@?ZV=QG&NT7"&1M\&)
MG&X9VCO"60[X(R>_)<6N%\\;;G55Q \&UPIQJ:$*JA(:J5B!1C^99+;(3O!R
MBN-GS=[*!\17/OGYH:D.ZX(BA4"MS,CG/*U"+I0N*O R+GP,X164;H3.>9V5
M X_%.]UYS,OBNW<<]XFXPIR6D.54I#M*YL4K3C8Q92)CR0+FI2(7L%"U>4[E
M#(0!55Q0JI)MF8U(N[:ZMGF3@=ABG,5)A@X*6-HI*+RBM2%7WNF<920.4))!
MJ4LQY</6Z+3[E!G1>K^^P>EU.OO*'2;L7FSK>-Q18;K##$,!-HOJ/,U$G>2Y
M:AM.@Z1[U]VUZFX<_U=^,L3W&,LX7YQ;1U)%!J\JC\%5+XRLT\G//:=-Q$V.
MV6EQX6$F#L)H'[:2X?Y;:P2DS88N(!+PH, W/3K^*4.^BGM-;7ZP#*Z!N<6*
M.\ER4JM=QS_*=(MKUS/R/"=#87U5>'*2Y$666!RI CEA]CE](0?UG"YWFWDB
M'</:]-/2@3]$*O\5P:VPK;DEU*VUU72(+\P7QI5'Q3UQ0F/J#G6;^UB^3@=U
MWM_D%=0N&P!+=S9@)[ 5;ML;ZKOSV!!^C]]0F9P/CS(IGF$("E*?"H',RZF'
M$E(ROM(YHH$?)RGEN'-HC&H(,0V*DCC-A,I+'U@?2;9)(*\ N?A]NBV,FVZ%
M!4^ [IQY*7N8@FLF)9K9E(-;2HSG)S\K*YC<Y#M,5TL&$W/(&!J[B/!3 ;S,
M<=UC,5WO)K:5#%R$+;82V]5&UY,DL\5-1=J>KB9S:ZCR@L@H;^]3F<EKKB,Z
M-:42K@<F49Q#IU?LA]BJ1O<.XOT2;["RIO7>$3:NT%@&3"GH"6C/Z@Y&N=.*
M4IF)]E\B25$^9)X-C5_A<08:B?#P5!J]<K(:O:B?Z8OY^BM4]09^X+0H$F>=
M79MD#R> E2JV%2+\9H__2O42GV+G6[?I]XB-'A/5;UY$E[JOX_,[7-LVQ:3,
M6<MV693>+[1I4WRA-V\J'\#&&C.K ;9CBRUTB836?=UTC&<'KSQ[%A'$F$F@
M*,/7VL3$Z@K"'/MK"W_][^>93CR-0&TN/\P25%6H8WF#N=7<?GGD!O!M$2&8
M\H!"E#AKRDDH71DUO0O,RRW75"+639=#ZBG$]&O>$!+M-Z<@C^=B4I$B=BC(
ML9V*/6<5YS;<,I?I-_=1X]/%M_G;F^*<<OBSD LY'3^(H;1\F'$9GYH&F>H<
MWL?)X=VL<WCK'-YGG<-;:AB'? F8F<<V)]?R*6Z/9FS$I1%KYX4<4(Y.)MD(
M[H'7<#P$.+\_RD;,]*^!FY ZX*6X_0K61_82/<F.5?PI_O\$HJ^W.!1F2,0"
M70E"D<F" +&QRD+@MAS8Y+6N]*(TC49 9N/O9#5[(K[HO5QM"/S?JP^B'.?E
MZRU[?/.WN5'1'\,S+8/*1&?;#>24]+ +.**V^?;M,R+'51%R*U7^-C<@?C]G
ML[[ZF(>SIY)^[(^1/&M(54$*#4=Q:IQ#: FV=?'WPL.KM?D(\.I8QL\F]V-1
M/TVE1.L+3NRQUM#.15^-+/.1A?,(Q!%H!8]U6E^,=V-&(LU?G+RJ:?L%@;VV
MBC'!]7?PQ^;FJ^E$JWF'_. BNO63T''>K0_/P3M.ZQ1;V+\4.T?-?AQD,5R1
M3DQP3G<#Y _&MY^[JW28F!L? .-* ];U\X'2>5B<G#ZZ%8V-O'!]N4U@PRRL
MJ0XJ#,#+@D/6-."2B=A%2UUTN]V\^\-4:ML#'-C#\T/CHM9RJ]##*_>B:>\]
M-O6B@ E>16D;&%PG=MI\<.;9=DV\F$)N3D'_4AS>3LFJO?OQW5WZ;&Z2X+FS
M]+DCK'^4*2[+:QDI%^*USU.C65L*N7XZW<U-)],Y+=VP=UL<HO25(UCL'W"N
M%WS5P<&)[DS*GW^\I]M-^Y,NQ>G,U79LVH*C>4DQDO^.8JVCE?0PV\<*K=A8
MY7W?[.CQ>9J:[AQ',H9Z $[*K?^60[%RU9-R!H 5R?K@VA<28["%PS-=WDCM
M70Z()=I-K_OC3O>>IZZQNGFH^D[=X#' 4G;N,RHZX&N*EZU7M8KS3%];JS@_
MF3#7ET*(GMOH8N.Z1J\]F?AZ4LB/-'M%.8!,#M.K;8U3*='],83EP\-^X307
M$V<N^)Z60PK7>LN]>&&*_I4IE:361I[I:VMMY">3VW*8]*XV<O_-WI<"A(OJ
M%:EUBUJWJ'6+)RWD:]WBQW4+N 8+WWY]\?[%31;Q[AK:FUMO,*-4P2;$:V*<
MG4INTII?;+]LO6)(S/KSW"7%VTQ'X]MGC$@K3<_2(])0>!6Z@& Q:U[NX\Y&
MG3/$JS1'K:$'<-D16-0JA&M9\87)5./?F7>Z@\9R=R[U*,C2(8O:\DXK!VQ-
M>W0?;NR:>R[U[+4G/'MM6B0^[S95SGRV1(\UCN)LY%;9+TLE;MOLO=SM!5N0
MJ+Y*$F1*5,P88$/%2XFYK+83NKW=:*W6*B@^SDRZT;62YB.< (XE24L6!O7]
MRE)B7#2]32-TV8; [":;)%=LHW*M50)K3^<W\7!FQ3>X7![X _RQT6J\VUQM
M;+S?X!/DU9DMN>NN,GR: JX\'V;:3>Y866NKC?=KFXVUC;?N<VV;DUO86Z6.
M,K:3$)]5<TE0^X^*.7_&J$HC'-14(/XH!":IU0?;V(?1?;I!>"/O5A>YD]K$
M2^31H4+RR?O2F(EN/364P:#4+FS&S/17NB$,+L=I3BB\67TS :&OJ>VZ"10<
M%D@"F_&>^A'I2Z;P=JYWX+9DR:T:O7]'./RQA,6F W'>5O@Y(;"MC>S3C).!
MCWTY,CTS7259D"9.WC"QERJ)OBR"ZZMR6M>8SD>(=H&/'83BB8&2@5VU_N..
MOVOD,S_<&ZUHPZ2K9,@126G[60(64XN<4.S#3L2[E=]8UP9=4J=BP *QB0II
MR#X.HT/:-\+&:795N;Q!]:)L8N^E] .JHX2W9#QD&P>9F'=*6A6?&"[M)FL8
MF<&55RZ,*Q\'WVNP%$!O5QEZC1N]DO?H;NY;&%V%O*F&?G>AX=3,=4P]KIY'
M]EB]#-[4O0SJ7@95+JDGU\M@1I$:')GO_?H"G2^M%X(4??M)GR5<!T Z.3T^
M.3YK'XC6TQ?/LZH'#SJ[Y]WC(W&\+_:ZI_#A^/3LZ>_V1LK(,8BVG0CU?W19
M^=P5&$1GI"NRB$>@K[*#[1GH$WL_DS2AMJ@AMJR<X+_&49+X-'T<Z QXWPH(
M3YQTSII?&J4@V$*JI7>[\NGIM"I__)#Z&M/K5R@1',YLU!1?)*B7?5]9*Y>7
MK>>+@IP-R%X)R-QA53VQGD'X:MI0!V-!^ZWR"C'1SOL%.C?G[V-](B +"Q<T
MT3H5+KTA\B:JEW:Y_5A)LP;L>(N?$V62PRHA J8(O (XRJ6R3<-XM5[>G7.0
MX0AW@ U_@4Y2@A^"$W/K VZCJ9]J \M)UD?G2$2CP+T,X&6+YN#&/T&'\P?^
M<K0J/[>GJLTY  9B'\DL[2.FV@/N3&459X8S>T$S-C)EHMN?)%MYY2%V]D(7
MC;F/#HN4<M"O<;IUI6;/NJ<_R,^E>C@[/]N9N#3K\6NK:V]OTB?Y@UFY>?:<
M!]ZH\?('0BD#CAL\]4VY?6WI@<5CJ*CP) 7\? @(DX@](&:*(J!]=*2 'O:;
MXK"_#_Q*AAQ(:0>70(9G0W_8$(?-O2:W*RL]O_QT"3@E1;LI]N4E\I.('O45
MC(V)V/._X]M.AO0PT\2FO.#2$_\9#4.QTP14](!Y[D79!5PGOC;%KL1=,X/<
MC6(U$5]EFN)L<>+&F@_8HMD BVR SRCL^8Y1*GXM<N<*6)526P$T<0XP<[J>
MV(-O$4#D0>2O<6KD2*>G8/=58E,4#C*[(G9+[']E+.,4A]K(&%9,M3Y4KV@?
MEG='U(DP6AJ%HIU=H ,1T&*=[C%=GKE9-A LFJC^I0KTVO.C[:D^A<KRO<+C
MCN$?R&GQ>0V#<VQQ4A@,K%P4/'8Y7-QDP/./1)S *WW/E#7O#GTU$!V; 7S,
M&<!-WE7W6NI5^0DFSAE>4=]^!FG.Q.=1,/D*7?]WSO^'OLOND;/UE KG,'V,
M\Q'K22(0X/#/.7+$ ZDVI', ?JN3I=$S-L*>)F#^4XB">KQB=U[RQ*NP#U]@
M\,XA $K$UKM'66?/# EKUN239A49VKD;P82!!;(6I2N<6/X^[!S,CU6>@>WZ
M36';O%YL/1/1J =VE!R=G/"NYZ;YCE^6^C42YN118 Q#4B-WW1/>5*0WK$JC
MG*8*J6D"8,(1%BDXUYZX&GF5L#[(A!%[R(H4-I8VGB0F'7@!ON0BBCS1EUGB
MA%,MN\K90\/X?MG]121(@0<B%^Y%R6N6J7TU*IX8"E72LQ"HW!E/1003*TLM
MH>NH-T,U,CJXYNO:SZP;BNNGVB>2>GP!@'*8;ZXL- 5J]( 40&54P8F7A]@1
M729<=06 ]-6EYGHN+'G?/54&9NV%>BPOU-O:"U5[H9Z%%VI6U.CH^+![U.F<
MB?WC4V'],.TS,,-W#]IG9Z2Q&I\,7=06YY]..YV5/SKM4P$8?R@ZOY]T3[M'
M'T7[''[KD++$S:5I3[WM]M'1Y_:!..QTSN&R9^G889^>OSUM^O#HK,??\KTD
M\U7E[U6@MAEI:*S\,DQ(*))L\XJ*@-'YM-(O$A]#<XXA4K22R/ 7ZYOLIKI4
MP/"E569Z?C0&K6(DL14"W*^+#O'5@=:[2;V0 DTDO&L(3&H%>.]5"I9!?"%#
M_S]Z A4J *.,#094ZON@K:BXM)CBIOIDGTQ5*!9GEL#CSJYDN.-':%C'<JS@
MXGZB]WVFQBFY/_ATUU9IC 4:!(D:^2N8^<?Q]@KSBF8V&,]$,-%F BP-E]\C
M$\_JY$-_C$\X)!,1K;LFV%IZX QJ*0TTSO*=D45-NR,S-*:&Z0!?4)4N)G:?
MN#6T--Q]-;!HHLG9:51* 2^ O]^!Z:W2*SR,M=75#5H\_MPHPI?,0QS/BDO#
M2<*2S(0<Q#1I FQE,.E/Z.3[]%I,F_L($G7,GL+<X:>?04%! ACOP>^+. HX
M\[,7P2-C=!* '$2WH1Z' :8O[!J4[''Q10[D:"$,NC&>4>LMM=6@<#)Z''!+
MW-5#?P(3M_@TJH0%+$2Y<M@G#XJVPQ.  CH[!5)HE"5Y=+0OL>LM3M*J(!6:
MTH,NT$N5(/HAXF.?>UC1:=2#QWU"??T+K#;3F:\G0S^0G@K&0U\VQ(D*PV02
M7,*:9.GQL#.#78<[[;P6Y#,/D]%>WZ,H!5#NZ;;Y9,8>@B48_4<"R0>!NN!9
MA&8S;0][%M.Q^.AU^:1T8S+]IITS7&/?OP3(J/ "M6A*<;%O/VGN-F%K"3S/
M?4''N1;V?J"0\IVELA+/CA"MKFO;I.BC,1Y=H"QJY1)24AK^BB2%,?S85TC)
MVM<,+"E5_6$(>MW%I,268#O%&URLLQZ"!"X<.6:6XXE_?@YC(U2G?(>U3)UV
MIQ:E#\_VT?ZRQBQAQ'+B.O'K2I:RIZ\LR-E=;T4P49 ;6F'E&PG1ST8E+LW"
M08O\<0P;A#>N(4=5E\CD,,VZ\':=[%@AF*K%[LV6U_8DJBLE">**+BN7A2.2
ML7N2[/^9^0G/Y.I-Q%D&]!QFLYX%-'X479H'K;7*L+V*XF\:KF&AG1/&_[(@
M17;3TW+SGUFH>#7D5C<*D_XL+RAU7U]K&CH9K6*M11>YNUI;UUGRR"'UZRB=
M%F -X&2%J,#-&B79Q:B%V30AZP?F3BO3FF(?@9FO]0WR-1S;A^LN'76E^I'K
M ([2<:K2&!0_/V0H-X#.KG1*$-Q\'LM+%5=I)30%A@:^DJ*![FT,LZ+!B)N-
M4#0H12\S:H/9 JRWI569-S.7C;O/29*@<Z% ^*+#D[Q%M/K/NSN\'% &/C?/
MFJ([&F5:7EBQ"(**'S#]6-/'ZV,0]>#).YA06KP/!280H.SI*5JL-;5'L!A&
M2ZO 4'%(Q.A,6@LMKD3_V.$ROPAVH..K.N.,8>A3ZU)ZT4<5_F<R4G;()J[@
MI:X1T;_909Z$E3*\P.);T!,\8A+NC78L8@7QZ8>5B6ILF8G+M\("GU"ACN0D
MF'.N8B.^$7[P[1G6 H-R$H\F6!F,3TDJ=!,\/4^AHY >>NA\1LK/XJ2@JA05
MI?T@BGU/SE=$'$:H-1'$4D!#K6C"<RX8#ZPM9'DM+@DT"L#0/FD<!>W#5,B@
MKF''MVD5I"_S-.'DFQ\$22$&E0N3IZB/5"@?Y1!EK7N4(7)+:]X-(S;S\"9%
MQ^)(>B4UV(NS"Z";2Q5$XQ$I,UCB2%DC(Y1*XP O\RQ>$KY*V&\_HTR5@O'F
M)HA<(TI(?*$;EMYD]8:3 0 U-BRZH*-CH(9,Z SY+!&VEF:KCF2#/1]B.V5D
M%FB9DX58A&!12LS2:%"3DBE%X4*QXT<-5W^R@WM9L2CP=)M^'&&N$*WSGQB1
M)'4!KK$-'^'>U8+I;TK&9ZM9U)T[ 4Y3DK"R9/OT-4H0+].GR_' W G"([^S
M. *N29*2WE2PPSE>)#7SUU,_.X$O#GPL7"NZ159U]'!'#?3,8$"F/+P^QV=#
M)N-_)I>H<17\- 0\1XEC'<8!/BHR5J\(=,2S;T+:O!YTN[]._23)U$I/)A8,
M$Q?M.;*%F4Q<YT>8YQOE@%BZA@R)(H()FOL4#+,;JE!"AA@_@PT:[-6AV+2L
M2#GJ$>NE;'O".GUE'&2:' U!.&3I$+HC@?63_- -F#GJ)LJY_F]^F*B)=I48
M5H(K/VAVFK\UT9>OKV^(@X-=W+Y-D\C%\4BK#RR!^8(9LK<-RA&0%1,?SL95
MJ7Z(!AP&TV-3<0E+E$DB^\,L42EJ7EJI^Q0E8S_%2+S=N;L@7L%A<Z?9;N9*
MP&^ "M'%A3CK#Z,HP,4<YH"!5QWAR-LKA;U<PX*_(L^D*JH)YMVUK^(A?!6%
M&3/+K23L%3*L"FF@=QUF\&/M8MR, #?=U"WBMCD0LP8AH)\0J,_Q(<L!YE2Q
M:*H<A?#HJ'[O.& BZRX*$/IC\&_GN'VZ5TCD%O#W\>%AYVCOVISNAUMJ6WPY
M/N^([I'8;W\Y/L4%=]J[GX2.AXJC]F%G3[1WCK]T'KKHM4[!<%,PWM4I&'4*
MQK-.P=!Y%@[#W#T^.N\>?<:4BBX6Q>QW=SOB,WQW8/(K-I]??D6%ZV4ZI;MV
MODS#Y+;)%":RLDZ6">^5GL?]<[1I'(H-QXTX[3^T!L%\;PV[8QQ#PT;68W61
M!3*E7M"#@?1U*K*34H"A;'(=4[#@+,_C-[Y;6XDT(Y 3H^(FDX)C1 =*UE8;
M8B< /@^@E*,(7ER1IU .17%,HQM=2OQ^QX_26?>8MY2B5VB-Y:#69^;N09N%
M4SL)OJD846T<]+7#QCK1./3 SB5<8B_(5 _KOGK6)>2ZHM;Q:K.\%ETP 25Y
MAK<*'WB&:K;C8'H)MCX<48".%FKR5 F(5_S(W/W"V1ZN7PJ.X$LTH<C'K"01
M9YMO:>&Y[[!%I\'PNJ+J'[VJ CP9#SPE<976U3VP41N.W<$_U]"_$>IKRQZE
M-J8@_ L,^SY:+_V&V,\ Y;]/99F8YZ[FS]W@Y^H;IA[<3^6EG_!#]U <C@/L
M+(KVO<E,<1UTJYM\?.RM6V6$/([5=Q_#-[.@:##8KLL!ZQL=PW*<?JL.1JV^
M=[$V]Y$!F_JFIOREN6<I#SWD5\I4[,1^DD:!.)R@B7<&@.CU&GFMB\O%=)Y/
MR6,5#8H// 1>\8UWV7K__@U'X59;F,@=!SIT@XT_.&$+\\QUS"KWB3FNIT*T
MZRL:>E.1V^,D5>08X2(4N"OJ8P([K/D*=3<,'1*+@R><C8#Y_4:]5_#B?>!=
M<-]+#$A^#.3W*/_]%?O ],8:%<RQ@2;NO[$GA+->'0,DYVI_J$8 W*;+9*BS
MG-1B B/ ]C+MR0$V?]@\ SS!#SOT+XQ-R10M=''&]#(K1K4K1[W8]RZ>9$>5
MJMS-J8H6HVXL1M7)(V9P3D&&5SM3\^"X!>"M\>K(S/-3$N[8UTA=E^?9:AC<
MIM8?)-[Y>7REEDZ8CI)4+2K78M8=+:88[ZS68$QTR 91:6/,]/)L!LWT9F@E
M3))<'<U,E393 H&%3SM.05UR!51!E[!IF9RF\9L?IG@8U^LK $1*7^217\%D
M!808%EWU@>-02U!73TM23-9TDC.F 5NAKTSI7#M*]N&"/3_I8RQZ4LKX?)<7
MM,'>W8B]FW_:JGK[%74^Q#:(HUG'@0N@? F_;W(ZY.S=\XZG%%83F?)#"M_P
M$9?3>J=>;?6V,RS&"R@*X)P,\?PO/G!+H,:*HWM5M=(1R)$^B $LR9,78910
MR$FOKS&51?NV(3ZID?R?K%)N&7!<<G+G"OHX;@Z-AJ/:\-LX2Q>.*,;"?W>;
MAX>G.OUDSMYN^]Y5G6"S^GZN:.=,6_)T:/)%I_'4R#LR2O;@94B).K)T'F4@
M&P6-U8.=G<1PK%?8=G,(RKO:C3!"G.#/5<A)>>C8(I6J.$MOQ%#+2T 8*I9]
MQ0AE0T$H@7?:#:%&8& E/BUXG[#+Q&8_J@BXL^2T$T<$F^2]G?+M;;M1_80O
M,O  >Z8?,2>]Q-FBB5-Z2I4#17V=C.-J40U-'6HJQV0._9!B9^*'&GR6&9E\
ME(3.^\X)*26A@X'"&/:3JC!!/7!*#&!%-QBNA4P#X*V7N%W2=GF9>B_A19(;
M)(>$4VT,$X:)U"V!'171/-=TG*+3MFG9L0JD;D<[S "P&'>$A9-@D(64:%H'
M@]XC0A"#+-1-<Q];7?FIWK+;N<O>+(6[S&UC\*P<9=>V$*_265UHW-E%9M50
MSGEQ%%I='&QZM>:,\ +U'N9_N:Y7UEK/RDDZK4W.K+2KI=(DJJ:_"K4"273N
M=LLAY1%Y%LA99!TTSX22(!IYF4=!J:&L*-;A9((]A/!Q@;J0_0EE2$B'Z7*A
MT@7F,.C?0(3$Z4HVUDE6>4>^0G:6+:+AZ $*/=UC*)8^Y3SVI<Z,L#NN4*'+
MN4;3(B-/CB(VBPX@,S/.RI23""& BS]2*::;@-4:2D]2&FFN'R9#3G1F*.G&
M+AQ]1J:JE1:M^9Y'<80-FLZP,8'H? >\",$(Y@7KHRTD4Z^5<KRTPX.QJJC3
M3N4>6<5RGYJ9BT_<!MDHEMKK4IG2ZJ:,YPELF"I;H;MK!R!KX*"GX_X*>\A/
MR^:2C+'_<H[Y50)TA/!D38PRP#GO3HIO:N+L%7;Q&CL&3!TQIA4963FE%3@U
M:BI/U9M#$Q;=K@JY?Y7*"!UT[/?04WJ2HXAA%&7GYGK1.]G:U&ZULI^V4#JP
M[BRI*K^]<F%GI FPCQ"4Z&]Z250DAMG>>NU@-ER@(0#;'P*=XDF5";PJJSGW
MQ4D+> _5#8"$YCAXR)''9H6^G)IQFO/%SO(\XR!7N/-: *7=8URK5]X+\TE0
M\]?F,X<I(Q3SGP[[NZ W]8<3<TH-9Q-:<0,+A%/6=4=6VE&HKI*Q1/V^X,=#
M8)^T3[EV,+>@S!.U?U/KIJS!JAB9@4=LKN%Z*HF7:C B&=MRB%3WDM<9YWI?
M1S+QY)\VD\^A<%#T@VCB\)#Y=@<2T,[>,>"=[P$M.E#-+1!=1N>.!.>T1E.K
MYUH,#ZSQ/93N--7TZ5DI4'?+X"J#Y <"C6>:KHV:,_5 B\[%Y-3B.[Y,,#W"
M_TZT2+^C,,,R9_2KQ$9IP92LP$=N1@0T-*FPMZI30\(Y J!\5.'1;\6H7NO]
MAQL5DNWXD2[CF,I\Q[3@JHJTLP@LY73";]=>>/9HI39]7@=_WC7+D+S>Z>F(
MW%Q8-[#5CBGNXFQ<4U6L8S#Y7<R[<75Z9SIAN2JYVQR'38O'9CW4A"=Q_*Q?
M?.Q'%3;0:X&I>Q2H&Y>]5_ ="O-29,RT=_L"K N#+.S(0=>;=K%A*,TT_LF+
M:@I,7N_=1@]=)(E!C<546^46LF'+[D$4^)$MVRI7'!0ACL,"?2/PB+<#$?^!
MFFA1?S280&-U&B!TD(,'-NV95;T]!:?[U:=Q1J=J$F* IX '+E?75=@&!Z><
M/X_-VGY:O;#;JN\F?/RAYES]_;_>;*Z]?;^@!K,+M1]@]8B,^B%5BMN-:UOV
M,[)W3-D?8"_\IG/\&^4&&?QN1KE"K<MNYUC7N3CKNM:;K\/F3A4MARTJW]<-
M68G#UZ"=1Y6B\BKWZTT';AM.#6E##&1?9[FPQQ3,<5T^Z^A]YJDEAZ!A9::8
M5A_$ZGO,8P8!/LQ+>V9V\:@T,SY%(T7<$\M#SE@.?%(R ":V*[&OA30*,"?W
MH-CPPY4AWC;DZ_ITG2T;F8*+%=QEB9%[17%1DAOLDD'K<O_\=A+S;ED)H:QN
M;F$-Z(,L_4^QBJ2A>3P+$T?]Q2Z9Y9R"]P74OM;ASY*OI&+O.X[Q=DG=+C7*
M4+U8)M_DR@$@>A2$=0^XQTI ?E\G(-<)R,\B 7G^) (_Q*K("TG%,+W(LT,)
MIG\HS"?H'NT?GQZVJ6_<:>=C^W0/ S$S2D':1WMB]_CTY/BT?=X1'X^_=$Z/
MVD>[G46PM'^..FI[YW6/]CHG'?CCN6ZW8D)@8H:">7HD:>[;TM;/(;G(; <(
M_LTT@.!-!#I,0;/Q,*>S43%*0+>)-^JI'DV ZAM'B6E @GZ)XQ=OZ%>1DIM7
M<@58>HMMTOVP-'[ C9CK0E5MVN%K4:(G*N!6RTFFBXSSNYW>S?QT$[J.E1GJ
M8'.F8Q4H*CA.0#F.<_60?:N!O#+6-64*TF,LE7+#:#4@]LDE;W/VGAOC*0<^
M%/D-TZ&NN,.YK5@M6CX'TE/HP!H\EM0,S^9\03U+"O]^?J;F-++OELZ/^XJ;
M0<5&UV=7.:JJL!;4:H,@/VFRBUBA+"0.N"D!0W^<V$X^U,,\;Z),B7<3TZ,0
M.XZC*4,0, 32L JVU8')A\8*?BFU%']Q@TB./V0ZIP:)I^$TD!_.(RE+%CRS
M@;U/ETJWO2]VYW=7X+01Y]%@3/LRU)$?2C4<CV%I).4UJYG"W*U"'[<\"N,Z
M)YV\YT8A':;A%%6;8$EN&2P#JG<Q5_D;,PR_Q,Q<%*"8G&G:;4-3B=M]?BC)
M":K'&^>C+$'CU(R;&PGEV,_4E25NS;L[#MP9]\ FM#]%/K0BHAT<<*DC*OFJ
M"'7U6]A+"T3*RP)3/=5U*G[<ST:(46B%YS+'4PJ[I><T'5KX:,;LQPY*<]Y/
MSG^QY7D(C)O-<0S]TYZU6-.!<VZ)3_W@9VZBU/>H4>P(-]?Y8IH3T)# L)+^
M^ )8P*4?IYG2+(>_Y:6,7$9H4ZZ6@S@X<R3'"43R,O,[!&XQQ'4TQ4D01<A6
M&V)W2/418T2U=A.3%V@(Q#]!*H^'F,QR)@/0!9B)[\E+WQ-G0 <^CI.=Z&8\
M=I8$RV3G[/+QKQS"Q7].G"JD?,%^F$_]<!-V\YD?L!_TKV2QLB(%6X;X_2'>
M_Q76+I-^I-&.G>OSFQ!B8S;TUP'.^OUOZ+"CJH7" YR&AC1.&1&T6CJ8#10P
ME/>P5.A))LA^^[![\ <89P=DI9U]ZIXLRW2U<W(^\L13HPD590$6_UT8M0EQ
MS0GAQ=/(^ES3*ME6/^BT]SJGB"#B[/ST\^[YY]-EL55W9)*G7VA^D"<ZZ0XD
M!:'O:CK%Y&GG$7F4NC A*$8YGZ2&^?8F)@[I*IIY#C,^@%^T2SF(1N4L]9DT
ME]YL4!)9LD95<BIT\[%J8Y18\+SBJW  'X4Z4?>C23YL8X9Y@F)A7B]I8>9)
M[O92$T)U $D6+K?:K#P)VV9\5M(EZ.&J.&*%=%0G*S/?'QU!K,C!Q;DXJJ":
M&8M":[-HU>864FG^\Y7[5E4X+9]#-"NFNI![TX FJ0N%J(;.VG0E&ZRX)D?&
MV;@1)Z&F5%1P0>4B YP_1JTX;4XD6#O$Z+1VG:5^$8%YI3A2QS;6<7ZE3'\N
MK'&[[$U-O>*G WU\4^[7IIVD'XZSU-!8?@RFSY8&3P'JI08]#I2CZ[#73*,:
MI_Z(&]3K'S!](=-3O?&B)7%0?(JN &ZQJYA2M[[<H@ZPXSQ:\QE1>9[H1U*3
M71997 UM3E">H&&(,Q%QF"BE-=@TPT'&UR&+(BN)9KW%$1AH0,%@:;-ZBEPB
MCC+T.3ENDFD/6M4B&B5&XO)A31O!Q!J+;"H6S#AV4EX-08UE@J)T%TSE*3'?
M&3P5'8 !%FYAXB7YPMCSP=RYBI]5B0?](X<[@44E.%X*"*2'UH,.]+K>M49A
MHP!2:=ZKP@MYH:JH54>' =!T,X]YC1"J<:@59<R'U-H^I;6XG>.H6:'6_'G.
M.Q7=N-A#H\=<XU9[-1,SV/Y"(K=@OXQ=V=1;&?)5IXVSR!I%[)KF:'XQV<MA
MKCCI+E(\&8WXUI5O>]=-2K:3^UP>.T:'YOE)'X=P8*J#BU1ZAN%(%ZQSRF@E
M%^=Y:F;D(;]FYL46:0I]E2FWB-!.)UTW0/2:(6JXN1X\TA_Y/.&QH8THDM+8
M+!A]&WK@7E*4=P7F@&TV+5F4 (POT3*CT%\U=%.\$U %3(OH.3*-6()MMU8D
M>3,7,.D/E9<%)MOO IXB-2XBYG.*>>!+'UO%&;$Z\YW%35NV,8/ S>\."!XV
M)7::KS^NR;#7_0(60_?\#W'8/C_M_O[ YD)*?EX,6H]1%PLO?GVQ^H(^)S@'
M17^^99[5M8'<VV9"P*K_^I>__N4OOZ2]R)ML_Y+&][ZDZ92!^*+W<FUUHR'6
MUM_!'YN;KV@9N K4MQ! X:\O-BUT+C'2@R6Y.BB=1F.[TW?O_G9_,7B=%K%B
MH(@9$/HKG0V01('OV2_U?GK8KL=LX=:Y<]<NZOK,Z9G-!)D9[-G\G4.9QOYW
M\;+-[6<H)VN]00VO7UGZP%V\3CW\!_P=T]\/AQ>;FX024WAQ US87/L)N-"+
MTC0:$3+PZ>OC-K\S=<WZ55-:^><'QA4'+^Q_K>GL^I46NZ8B].0?V4:B5M:6
ML:-(KQLSZ95!:(]I_<TC'--B',3U1/MN 4AP%FN^V?$^)2HT$MO!YYMMLO48
MFWPJ.(R>?077JBJ14@/YWH!\6(/X9X/X* I7=OQ0QI,:T#\5T'NPNB,PU[$_
M4X"Y7A_1'(Z?IE+Z$!+QB>F=E84]<.XG..&VNZ6/6W0IT2Q=2&I[(EI$O<Q'
M6.;B:^FUH7Q_AO*[<6&0R&T8E7L,M4XP1R=8JZ'Z$Z#ZIH;J/6@Q11"C+'BW
MUEK[4,/VX6"[^$; 3Q>X3T&@WJF_BS4+P"[84Z/H(I;CH=\7._9<;FL>_'1J
MNP=MME[CHJ^Q2KS69L(SY%J59L"[Z7C9&A>3#F+,/1+MD>)_8&<S7/;3X%!/
M0][7L+N!=M^JH59CW"+ KM;.GZ.<"[#O#PWAH;JCV/S+"+Z:@FKN4\.NAMVR
MPJZV[IZCU$O\6K+5'.:!85=;<C7&+03L:DON&<JT3SZF[/M]M.$.L$K[>TTR
M-;NI85?#;EEA5YMNSU#,:??D)WDE?9_C<B>RCYT"1#<)).>7US14\Y\:=C7L
MEA-VM7GW#.7>UZ&?JII*GGS2^5.!VD8-M5J:+0+L:BON24BSZY+";R#BSJ\B
M-.<.<;#DJ:1&Y['HI,/0[U/CL86BJF=>BE'#MH9M#=L:MK5=^>0D\>V$[L''
MG?/_^;]W[0+F GR)6X ])9):-.7VV;88F$ER4VUQ9M5#UC3YB#3Y5_B;^Z>^
MIK:O]3S<QYB'VUJM!^+6 W&K.,:3&X@[J[/UZ?%!!^?6YD-LNT?BM'OVFSBF
M9M<?/YTOR52<XU!5CU_XIB9BD(5Z0*6?Z%DC2D]O0<0V Y5B/_GF-MX?QU%?
M)87Y?;81_U#B%!M!@QII\%_I7IQ"XJ>ITDWN8QHA(*2'T_5PA%K"(SWR-9@U
MZG[OP<1,/G![ON.,@*MAA$/'),]JP;_-A0C"*#,#>.S2[%+TT!_I>3&.N\$E
M(SAP\A3/_YN:G29C)7E4K5FG"PPS$L)Y0:Q6@!WATZMF2!"05'CIQU'(,P="
MG-L7A1<1+K0G$S.:CR>MT-1:,[0VQ;$% F>YT8!9. :E/.5-SW#%G>@]TE,C
MN-T=M A8YO?]L<0Y WK6!X'"W9H*%,Y/A"?&*I6^.17GO JC#0#%HE@#E&$,
M#YT:KJ''!84X12GQ1[ W&2HX,/@IP($G/)*H%T<X0B*'O9WVJ+[3C-M$-45;
MC_/!B2<-''@0E&<3E0Z&Q[?2E!)>)LU4H/$VPRA.5QH\Q /H H><K/"0@@!.
M9@6_+8R50!_K ,<E T!Q=,>UH*)7\6OP8>B:]4?Z30;TW9"/MH^S3]S)+[XS
M12+@D3BC"&1+%//H!J2*1!^UGKD$JC!CVO=QE-"P#6?60W$(J.$9\,G,AL&C
M"/![>H8S^87>[0[AH[E4;7ANBE\QI&DD)X\X*N 'SQSAR1OX%IS(D24\CY-&
M1(N!CU.?<)IF8?&)G>0 ;&-L;K!\AEXGO^'<B,@ 1L\I"M,X"O0<4_LT%Q87
M&2P'M0(]_ @4[C[2%HX\H2E4/(*1N2 B+0_68+@0T.WP)V=%OIY.0ZLJ8VI4
MF$GMTX27_@3G_?+LZ(EY.F$#C89*-=^H8)7X9@0 [$)=2)X;0FLN'TJ!U1??
MET^#<H90@8CO#T/0WRXF+F^H?"Q25[Y]R^O\T3B@;RR>T1RHZ;T6!0[8<J/J
ME\D@B<R *E=P:!+P>3003\ *0\40L@._$4!!PPSACF+>N (A!.8?#;4*?+I?
MKX$XK$K0?/&3(4]^&TT/_-*CKW"]8<1$I:FR:N19SI"*LTQ>XC_-8/7B8W;M
M8S[FC[% ,?/7\Y.0)!+'Q)(,S*M6DJL$/)L\(/1QSAI!HL)$ZJ$YUZY[U[U^
M>H%,+YK2-)V"!!\JU@ORJ8Z%]UJ2U,/)^&0,BQE'--).ZC'N?;@=9]2I[TBO
M*+YQ.RLI#4!>AKEAAQ54&%Y&P:5F3"":Y&0EC58\.4U[*D3KHEIO\=C;@A+"
MT>N8&_9YFCIAFQY=7IS?U* 9>D2@=,#S!O;P;_M6$IC?].PHJTP Q\,A5XV<
M0OE-(TDSKB1-:V9QSY)<7<H@*TB\N7LDT6&QKJ\\%!U,%^7[W(T&S">NVV4^
M:RE5$G0+RRKYC4D&:LZEC\0RY[RT6,)E[41IM99LV931C*MT8E!6%*[%#)'#
MN8*@JB2L6.)>S,CJ:4VDM*B"5@YRED9;HD#73Y0(KI2T?QS.!8M"7:Z;F@F
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M*DU$$<&C(U+&JY;-=(>;9(K1"A?C NECUY)?SR8]>F9&0'EPD<Y;-JPQ%/O
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M8#Q"UB"#T<O S,//L0/1)DW)5DUN031D@W!47F)7T)&DK< A'7Y%+D-C&V>
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M)$TDE /&<I&"-!.U:FQDBIU35:8[HVV:1N:Z3M;(0_AW&@;1;,O51V; P4I
M=)S6/3[217&OF&H^JFY0R%"U&C-),R+L7J[M3<VD25R9K&HI:AW> @N[!@I'
MI;)$XLI>4(DR1K5F5(5O .VU%LCK[%X]B> VS, [0O<I'*+D$I*$K=.I0&W
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M8UT%?:%R$<-:9EVRE6N0LC;WW^VL>V=HQ'?"2+1IJK#.G:E -Q$*C>-^]C1
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M+SU)5,,94<]AC1;PLQJ21WLV'(4&G6%BF#VGO&<X&=69$_Q3<G$D#/!]GH6
MW\N]R&W@@B3B )QRK#G6ODZU?\G<:-(:L.M%"2HM*%0%$>:EMUCID[ ,$"'4
M.">6/9T**(R*)^DW"]LKHXYIB\@+IZ!-8BO6N/D/2TDQ6VA6M5H]IHJ9A2NV
M!R/G@0#M;JN7+BWE5_,M,JDY,7O_YTQN3&8TPKRRN.\_W0/GLF$P=HZZ'Q+&
MJU-_JEO03O1HL0N9@WG)<ZAYW T\;'L#UCO6\TE0E#KI":*/D;&'ZGG(UY":
MM?OJ4XUAOQRWLN\A%)A-O?\3'TWSHTH3:^YU7.4C>KW"]\K=%3N)@HQRO4<:
M:MA4QI2F#ICX+%:X4]U2/E&)Q,DJ8Z-10'2Z:.\HUZZG,S2H]G*[451D7%C4
M'!$1HT4*R.KT0#+Q;9G]7S%MO,Y46LG^:!8Y<Z>+YS%(L=1U^:W2>S3:/= J
MQ?ER(K_T7#"9_8OH[6.KV$L.3ZF4<O^@5$C)"'-<[R\0](W7/M8:[JD(9R<O
MFCE\]?AM<\UGM_YTZHEA6; 5*DG,DL5N#JDXJ42AC9CHB S E+O#N2DX#+P7
MI&RP8&<=_B'# ?4*)P#2FDG]9=J>ZZD@']"@3EW26@^52/$)6=.8.S>I<#6(
MI0F."HH%&;%6;CEO;)M'>$:SCN[!HW7UKXS%JY#@@TC8F1UJ%LXS<<JS9X*)
MH1ZK?G7\@HX7VK'%MI@WZ #)5?F4FTAN)>C+-P(2W]KXR=2B4YTV#ZA2N%N\
MG6,N&<+?SE_*OP@FXD(9@0Z5/J4E.&D"&OY>UD-N3;Q'FWB6"-NB_+D5Y>^U
M1?EM4?XR%>5+S'\T0@'$BO2".FB7V-5Z6 (@=-"5W&WB6/3+U=O7&I/WC$'/
MBFC*B-ER02*9,_IE)N:(O5:]W$0)<[?8GD8<E _ILYGV\LKEP8DIW?&E W4:
M.3NEPDZG)UPR*H" NPBVD@8]&L]LP(,S#1-($W8$I(X"'SFC"6 !60F^'UT.
M,UI)6IJY9WJH:J>:Z5JEOVUZL)V1]%)KB"7-$0M17/8T#6?P:ZI)_\@=N-GR
MS.2HI=M9/O59;L"%! &#9]&)2SL,>H0)DF#3?)<D*I,ZED?<8S04B'O05D/.
MFD[DZA(9) %7W8VYUYRQ;K"W/,SR3+>/QS&*:3.C7.M>*6;B7#%S WR[O>]O
M;6PT39)?23"A*=&"TAMT!SCM&[%(=MP[K-+5/**DW_S>F;?RYH#7^1OJYS<\
M](KFE80\R;AA^5P*A/>OO?%_$++1$ OFM6*5H)RV!SX2ND\7XYFH$#?7=V60
M)KUB=>H676>5F;MF?_K<4*J5JE3S.(-[=>,\75F"F*'I7TDY-I-Q!K^#9?]$
M9;ITJ.;G!B2A7V# ND2IE>FHU;%I$U "#.#@2X4"5@&,DBRCJ>\3XTH[6D:4
M>,)81%)A)XOJC,MX&K50&:9 &^G(D@YN4(UPIAI?8&B].GGRK%.B.:8( *%1
M!DQGA^F[04,M'Z\Q ,;T8;&+*;<61*9Z:_L-"P1=<V##N>>$=T8)*^_$@I L
MC>YY FP;GB:#D'<H<#'74%=ZZ>*Z(:$3;",P&]Z7P4"H-I(Z!QRP%PMO4FX9
M:\B:\KW=:+^4;SJ"QXHO9W8L^4<-:[3\=7PGB$[$K_D OK\>>%^"%'Z\M>5[
M6QM;.[^\Y)D1&?,?-A]R@B\^NO7%1@XAJOA33!SBI:YUDAQLJ%\(BM/;'-V9
M2%X%V1R!S7D!<OMFS/;OO?.3(J8[!",QU0G#V]@AI4Y9!&DU4K !_;W=PXD]
MG%80T6[I [;T5Q 6L5E[-:K^[WWZ'UQZ!'HJ2+T_=*!L]@'@C3_4G8,SQ:'Q
MP5YZW5G9VM@!7;"]!__:W5W5>[/X6ZTU1GFOPP^GP1"VZ]C8N6=BY^)HP%]^
M3&IM[]Q\Y_O3^>XND?C+T_G\_)=3%4;>IW7O2_=3D((5"!XI<,@Y@Q6B)WXX
M"%5_DEG(H#P2QY%G:CX?WSSSQC4Z#2*KW]"PT,VMAXR&>3YJEXDZ<U-6[S8V
M?%C60NS%XE'*WW;\C>VMN@WZ =3M_,3051K<A)GW)>Q^P\Z<\\'ZT3I)HD^<
M,?AA!-+3\]O;[;?^WO[>CVF7O.1&[>Z\\_=W=A=AH^BF?'ODZ W?P_^OOO>F
M#1"C9S1(E6U_<_>MO_EV>]Y&#5^W^ +E(NP.,,CYY[IW'F3=1+G2Y.E%R%,?
M^/[.GK^WL[<LS+XX9EJ[>P_=O7G9+3^*I#D<I&&&*=\OZU_6C05CA0VUIH;#
M)J&S3*;*SN:._V[OW;+QWS/X4.]FN5 _K*6RL[/M[VYMM';*/>V4=>]S<%0$
ML?(.H["?8_7@X?D!"1"6&)_".(B[6+@A$L/'^JY4Y5@92(.%L+ZQ2)=+E+Q]
MN^OOO'V[""RRV!NUN3TS'//#RI)W: 5O/$*6O$Y+Y!])-O NP>_IHY P N00
MJ[925X*0V#C^X]SW/A992!,XCM2-BI(15G:UT=Q6MHALV7B[M++E[>:&O_OV
M![-3GB<?>A!%WJ$4:4]F11G:]C<:2[OREL^+Q]9FJ\MD<6SZ>_M $N_V%X'<
M%WVK-O9K<QS+(1G\K;U]?_\Q/LP\[8[GEPVG2;QFAH\=V:)A1SZ\0XD@)Q=^
M6$8QL;.][^\N)^4;NVAI7^DU:WG-L,#&V%B@LE^>FRWG7SKT].0T[S=ZN6*H
MU^E#7PW@2> .KWL'6":?86_$<BBN78FE_(C\WH8,6A6Y( )BHF"R#97]>%)C
M+E61/ZJ <$L:6R/B/C+B(+K!@6^#<.![7]:/UEL38I&%P>L3I:T)\6Q>]C'B
M)P19EB  CPQ4&7,[KFFS]^MZ[!/$<V#'O$W M8*DW;VVRO%%91:C(G/$WKL=
M))X+^1]F+NS'+E[6U1@P*-H,C,%MD*:$.@(_2@6KKQ5F+3NVN[>8PFSY#+")
MA.5$EX=.84KF\EHRE[M+G[K<]G>V-OS-S;:J<K:GN_7.W]Q=B*:[9^@EV]A^
MZ^]L5\,Y_P;_9?B8GPG>YF6Q=!X"H/,8A.PJYK%L%.+K5!#!-ZNHX?#!!+[.
M0X7^;+CG"A'(^K9_>CI(:4_V%S7*73W]O/E F"&3-*FWZ]U3KJ=^E,PE05PQ
M7F"&<ZMO8Z^7$$0>CJ<M3Z<5,$%W=HF#C54!R.HBA%84X02]?I+V%6&9TD3
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M>P']+D1; <>T\\12W@3- EA,)75;-!$;;R$_?OY9O(_2,(MD'33-X@4SH3[
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MV'=HS3E!O675(ZP[,ZK9-T>[[GU4()Z5H5E\+;J=*/JWY4?F&.T'D@:J0F<
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MG)P>?[TX,$X_"FMP<U#I.:LN[P7JFBRXK24=[>,:+:OW@O,&V2 <E>-<%1N
M,X]5^V5CI^:(,! !-S@<A!%*>20?] K!NL50->4"0-790$227@=Q^#\!.\T3
MI++QEBL&HK&3S3@Y/#O%+"._YX6^524WN5F.<V&>L^2@NYN'&04=83<;:-;8
M5]C#B:_U]?#S@7<(=DGJ78)K'>I$,456F.!"!&Y)>V&RAO'LH L'GQ5HN9-Q
M=9P&V;#(7,6JRQ /J2"2M#1FNC-6GCKJ/N6'8"TD"4C$BR2'&P 7^R:<&>"Q
MYM=IT"O0XM GP=N-2ZWX(A(G4390\"GH@D$UUG:&<^T7?2W<YG,2]\A0<O84
M:)8M%9NR[9!5"C8&V\7FS1-@)Z"CE=^^'*Y.6Y7$AF /,"CP3^"?7C)\R;Q
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MV:&W4K@UQ#_\(QG$WL=U[V."LVDV-UH!/!=>W&X%\.L[]%8 MV;PAZ.DN([
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M>W^Z?8FIA:>%I<M/'^$3>N&-UXV"+/O[F_/?/O[S3=7XV]CXJ<Z0E$_2\'K
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MM*LB-0V>164'#@@L=63_4 (&(8],X<U(FTKX0(\FD].7F(W@.R;W!>B8H.,
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MX)Y.5&[ -KW?N;[X\R<M%C94CEO2+L.O#*&'A^PKV%V1%2U%WLSXNFJ"LWC
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M5#@-R&,DFN^?F+=K_9Z6!">02!,3C"!1<Z4))I"(U#^I?Z)Y22W ?DQ7/-!
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M>9$*L3!*L%$*(RP7N"4U>$S!D;>X)R.ANV6N;5I4G4A)U\1#=A9;$H[A(YC
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MB@NX) :;X/EG[+YCQ8<81.B)] ;4V*?(QT]!;:2_2%2I[6+J@LQ!DEFHX [
M#[$.1/JGTMJ)*A3I \7N$X3U"@T.9&R?5C;HYXJC&Y4[DKQZ_FNC7"?NBS1&
M4B,MX:8:.P-G##A!)+C@"W*L@W'!7G*9N9+:]8SZ4@B=8 <W.2I+'1RE;=',
M>")KR.!J?E$P;8#$$B]M)+K:2C)SDP!@MJ*)./44F^CS!]N+ D?RL.,%6'4A
M8H@KRP_99X-]#OF$-55-ZY]@>!UVE;Q.(E=G,N?DFH/<A.A6?0(Y!P5P_$?B
M'XJ8XU$5;8CP<0S,#C2%*5.+$_1%9H#MC1P!= X<RYX$>1:L\'#CS8ZQKR.(
MOLSZ7?O89#<6.(CLRH%H6Y>3ZC<R1?,&84F8M<X_$OPCE&\("Q0*!/^TAMXT
MC+/$TAL<5P-9J70QE?B%<JA^X7KN\;I?&?'/0*,(38[>*0KID(^$VPOL+"2J
M5>\=6J+DZ)K?1PJ'OSG^H\:N4DZ\C+K3XZ-82PL@"N+08Q$>N06FP_LN'>2[
MZ D1'P<4=>S1BA@"%\QCB9VI!F/F\L5I9O,U50:*=)P^9@_8G178*H182POE
M(CT]=UDB$U#$'GB OQG54D2SGD&VA&HB2!$['&LL6!9$HN 7!\KC .4)NV!A
M!H$[C>X<V W;Q?P&2UK*3%X<*'!;!)J"1JB1D1^"6.^#2;)1U\9+FGHPW%,1
M/N &@J>+8QAKR'/PIC"[C%V)7=LKS?@B[_BS*^H8I<%%58<>JV!"".RD@@%1
MQ4S0)R.EU@9J'Q,AD%PHBR75,W-[K9X4!<+6 +SE89;)OUK!T/HO6'69V2OR
M>:4;!BKB\H<JZCT#*5&">7%LUMA?PN\0*>/9Z0SE^R#R:<_RA.;SW7,2CG+4
MT:$U4\;2TUFRH",C/0OJ\#3"A3L9325Z*D+;V*OAON^Y7/I4POG$ "--@_0"
M%+XP][Y'2MOZ_#BT?DAE*S87MYL%4SZ04:GC>=_%SU1:;Z9<.X'-!K@Z),.U
MC%R$A[S!(C*J3$1=^.QDBC8'W"\5=LVP!UE2-C<*;ILG/'JN0JGAQ':!+_C,
MU19;G&P/_$.@7*I$392K([/':-[\!(]6#%D@NP= S;%]!T%)OQNC8,M]4^%2
M2M0QP+H(S(=F,M2;KW]H(JZ!2>8)D]]<GN-@9U/?=I@JDMBE/TK)S9GD9I.2
MFRFY>??)S3AU_(%:AOT#A-?]&H$! N<0W708XAHW>_@_J$F.ZR;\5_[5;!PW
MS0/F6A-8-A\,_W'U,!5O?@N_^8CD.V#V\)>#0>N <=!14V0?/^+($-L*2.>C
MSROPU?\)*CN"F)/[PK5%Z[XWSM6+O-_/^9X.&(',N8#C!='L+$Q"S?*,1_CW
ML+,/<F>GLYT5SMC5/Z_0WT X1V67*'PIB.<YCNUU[).EK2:X+I'(8KZR[*&1
M"H/.SZYJ[$R"A1F "X><FQ'=%!'^P8_0>.+.@2/#)MS"MPI8%$CGY]Z*[N69
M4.HU:N)G,!RX*!%X:N+M,?U,_EH$IIP]V/P1#;7CN?<BNDN-,)O("@3XJ$JM
M8H=O.K9A?[WI6**]08@%9/<"14M[6,>(!(KF'D"0*, U<R?@CQ*FD\X.^B2X
ME-BKF#F*&5]MZGOWOC4QXE#0YZ!?!^+-R@@];2CI4O566]Z%[^DYCDR5E,D0
MP%<"A0S'Z9 ?-3Q$%F[2JB;-0"K01_V>"XZ@ YK.@4XYHL%R3Q3^OR%$ /YB
MRD-PG 7/SMT!8A-IH4JF$&!2:H*5]0@ZXPS;=Z1/7Y[^]@R1E%Z>\"O3?KG(
M\,JXY4G.5R9S;CY!;-G5!]G$L<W:\[YXK'U:"_V^VK_7B1=?N):\_M.KUB?U
MW;$<"I3Y] <+/,<>BAX+=8/A?X_>LWV9.F=7WWP9.?TK9PG2\]'F]N)G<._^
M*?KI@6?Q68;G[)/] QR*=V"!4MY=8<O[/#O\_VBAE^ZY_TB6M20INNRRO:(U
M1)81)0\B-\9HT]QT:C8YV=HD\=>=4RM>G@\?_@U.Y%*"K16U,KSA333!=*XE
MPO+FTZ=#_*+6((/!6P]#^9'G%[85ZG#GZO);44LX?'<D^@.OUE!;8/*7&*XR
M2),.[)P!RECH$3^_/3^3TJZHTLYTMS/8U;AV42N2VQL%:>_2BI(.O*R+QJXD
M,U=7=2^+D*NBNZ_MP1C+K_X5=V\LDM>;I+A)<1,G:\IL&FGMBBOM\[%O8]=7
M]J7V)>[07"2WMTAOEX^7==';)6+FO8#GSF!)UGUA6TQ61!<K\M5SCZ\NO[&O
ME]^"(@6N36![::59!W'2Q9!579Y(6%=2)YV,N&-[@Y:F,'N/I<:R'T1AR  /
M([\P]00B2?;MY4J5A^RSBU?85HE^.9<FO>Q^I,V2E[:ZHYG]PT3VUR=Z%:2F
M7['F3(Z@R/9&9I(E8Y]\U?%*5'QU#C:I'?N?STG?K+,?=G"L\@K.+[]]$54#
M!RQR;3G"7S<7F4HS[@G]CY[:V20$50!+YR*U7=8V_')@_X#-B2;'0R\\'O*!
M#;MTP-1? GSRM&FT6FVCT30_G&3?X52KS-XW(5#W[0D4>[#HP+Z*3BVCWVT;
MW6Y]BW1:+GQO6SRRDBB]%Q'EDV@7 #0Q=R0U[3Y(3K.70XTWR'U]$^[OO_U&
M;Y'[F[VVT>_G[?=><;]9?QU5&CMA_Y9A-AI&NZT?^^M*5O/MR;HU86L:S7K/
M:/?Z;T!=/:G3>!UUFCL1.M/H=/I&O]TAH=N0K,VW)^O6A*YA-$P3U&IWIT)7
M_B#+;&U$Y.5$_.JY0,>O0,J'^]<+:<.H-_M&KZ-3.+77Y&]OD?R"\BF!?@47
M=!L0L/7S+&@Y@^H]YZ+-H)KE7"041PH/OP[=ES'/YZ^?#D[;O5IKFY$.D5Z0
M_C"?]INA0/FTCX+C>\N:_N,K#R64_:<7!"_2&2R M?YR< S!5<>HM_I&O;X(
M]>1>-O[**M8U*'2[+0!HC5'H!KF_^8R=AZ0U9HS=V!'^/,*:]>/_QWTOS?''
M3=QVT9-<PWAF5QB<F0?";9E&SPA17D*JO9*91A[\MIX>.T:?&T:K7C>:A 1L
M3-8\^&W+9-T:$F :33#_W7JS*O!;(P]^>P9UMH5YE\]0/6./\["P+>^QEH;F
M&5N4AR0]8XNVA0+OT@COC/WR8)HM[ZV6[+>O!C4/,%FDYZY05],P^WVCU6]H
MIZ'WE?YYH,E+Z;\UV!78H([@25Z.3-G98#_9:#.(8E>X:ZM>R\TP*3OO%$W[
M?."UL1GVL4/@U33:K>8RX'6[3+!/:<!F\1)2-(?G,G@S#TPR9PQN$@!;>&#2
MS$.&MDPC30,3/64F#PM:3X^= ["==M>HM]\B0VX_56$>_+1ELFXQ%:M7[QFF
MN?TPXAD;E@=&/6/#BL1$M=?Y>6#4EO=62YW_C"W*PW>>L46$A:[8VSSL9,M[
MJR7[[:MMRP,Q%NFY*RRTWVX:'5/'H^']I'X>BO%2ZF\-">WWL%+@+7+)BV:"
MO62BUF9(P:YPT&ZWUMU'WBF:]ODX:&LS"&)W.&C/:+?;.X5!?X(_Y25I)^(6
MMW57PI;XYL+T57FY-^H!FYA'[(M?8U\&GRS?L5S.[O@ J"VN"#P?VWS$+I.+
M"+_)BPCQ(NMO@]##:P;-NKQF<.4%ESMX/<UWN7'$+F"7,UW!\;JC!WD->=X%
M]<LVWW;518[)O8XCWYNPWRTWLOPG=;=XD^$U[D[R:8>HM &5FE(69-_?%Y(G
M0XQ.? >GHD8$\J4(5&-G 5X4BU?L<L=[--)36W@%[VQ^"^\:CYN"L6'DX^VA
M.==ZXO6\F0M%Y8WU7L#5':$VWB\\<O@ IU67VPX\)YJX>']H:(?.[,9@U1*.
MJ4Z++-/N?*[W($LW+8OO$\85S8VU_!9BO+4W/4A-C4(,NXIA6\"P08W->I]N
MHE@^8R&,/5G#P2E6C=F7=/ZSB-,^8F<3+Y*7>JO[N05!+"4-&5&U8FF8*FE
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MV"_F/F2^154ME#-E#9/OI==R2B.T6^I#_#9"2Q@Q"2T)[:+0;JG%\!L++2'
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M>>/.6_3<ZSWRS?4&E)\WX=@M<+WEQGLTBG0U<N\XP2QO&QLT.]$$&Y"/'#[
MVSBP:7GDJ/LVY!T6(\OVV8/E1-C/W%>W?@3);2"JQS3^\HE;/K9YGG KB'SX
M;AKY080#A1X[NSEGM][4'K"NV<.GQ-T9QW=6\/^W]R[,;2-9FNA?0<R=B2M&
MP"I+?K=[*T(MJ[J]4V5[;-?TSMRX,0&2((4R2+#QD,3^]7M>F7DRD2 I/V63
M&[U3%@D"B7R<YW>^DT]]HNB"::9G!78YQN8?30OCH!X>Q\GOR[+XD'-#E*R<
M=&7&P\'N%UF!=*L;?HX-6_"MW0^3:063CIS8<^28SJG-"PX7J;&Q/<="VGC
MJ\_RHNVPG4F=E]2_ RYKF!M;7L,T]$"N[:QI.EQ0ZC1"#4$,<SHU,5GE-9)\
MTS=U_H^N:(HV-[=+A'P[R9"6$I]#/4_@S7!QN#,*W5_6XCI/NH9?'1>*FI/(
M5UD-3\Z;25V,^8)7%3SGWUD@P(UQJK)N6N#[Q*8,?C(INZF;US-N@O(V7U5U
MBY3@O^!KG-R_]^]VU+.B@2GF[<#=<%[DDYQZPCPXX=8YQ\F[G%=1I%%>5M?V
M!JZ!C/28R9B>L^I:&-F2J/)A!\'W_1N')_*VPC8XAH=&*)^Q$<KC0R.40R.4
MF ;\!HU0-BOZC]:SNFW8H.;UI5YS65VSZLWF<^P%TNXF 5%:4BLHO&JP[\>0
MH/S3H36"V5S[W1KAZ:,[1ZC\35LCW%'VZ\$50L?I?IK@_T9?>Z%VXU:W4HUY
MX.\P";;0P+]V4M;1P?\_WY8?>X?0_;?N^1LEB[XS@:<]B&X^?9P^.CFEL,0=
MB6KOODN_6N_Z 5;5.[-Q]F"?;B<8N:N[]*O)TC[[X)W9,7NP09\\2I\\/@C2
MS4LW1--U9W;.'FS4!T_2^Z?W[_A&_<'QG >RGL-!_/G1T_3I_?M'IX>#^"U5
MTC<\B ?FCL,1O,-'<!]TX:&,_W .[_HYW =5>*CI/1S$.W\0]T$A'@K\[L9!
M?/HX?0('\<'A(.ZI1CP4^WSK(WAG=>$/7@6P"<(O"/IMR/FS.( M3;*R3)K+
M#"'9'08_R[4@T9O<XI^O\SHG]'0^/;ZU"/Q,I0I?N2KA]+NN2LBW+RGBYPT@
M/O\'HM$S!J47RZ:%3<' ]0I6,\D0:%]44]Q![66=<Y%"DXQS&,F2@/++/)EF
MZV0%E]4(M2>LOJ#^&<U>PZ/D"8L\)X0_?$?U"Y<5QAD:>.&RK*Y-(03>#Z[@
M(HIL.:7JA&+9&=0F8=SA_9/VNMIR9YCC;G+IJ@@$#DIS,.9BC;7L[^VOTEX6
M]33R0/QN^^O@/^F5<$SC/Z100EX-'B_%"T,(_(\]:%OL@TT'[=OO9[+YOM?#
M."AX']Q'"IE;R=[D]4QJ719900=ORZ_3Y"@;)4_21_ @V>T-U9N<=7,8(2PX
MC0:D\-%XE#QXEIZ:"Z_D0GP<'/:R8"#U43%*SN!HE+"1S$_AF!P5\/G6DR-5
M+[_QF4GI4!]-1C##N\W$EG']!L^&2=UE5.%(-AY%I?$_H23F,UL>AZ(8KRCF
MR:$HYE 4<T>*8H(G[G+.U6/D.'@G_\]C7+)B^K_^I<DGH.<NJQIN-\6*QW8-
M:[YL_B5IBQ8',GR!K#C<#:;RW<7Y[V]?OG]Y\2XY^_W]WUZ_??G?%R^27UZ_
M35Z^>_?[V:OSB^3W5R\NWB;O_W:17/S'[R_?_U=R_OJW-Q>OWIV]?_GZ5?+F
MU[-7[Q#+_2WFXTL_TVAO]5#MI#T3T$BN33S:L*NZNBJF.19\8F%J)F9F>PDJ
MNUF9JE@XNU)MQ OD5^[2<I%5SG6T0S6:R4OUC$+5F!KC&'3YD^0-W"V50E7Z
M[.0A?R:7G#Z@/TD7RR<GR84I@'J']FSRIJLGEQEH8KKR""]#\.GI_>=\];LW
M;^COD^>CXZ]8$/7E*M)V*G,8.A7)RU=PCGZC#]0!H1*(0T'7YPU$?D%JH^^@
MH(N.XSD8V/.J7A\JN[[3RJY7MDH5='=7@RF%A <5!B:*I@%'Q%9/=2N0]/E-
M7D\*=(MF]HLJ4FIE/<#KK,9X0T,BG@S_1M=CH8=XIVJR#IOV.]BT?R<W(9_>
MRT#29_/<[BB[/<'?GGRF3?JO(PQ/'#;I89-^!LEZAPMGLZNL*,DH!!/>;O]9
MAX0YI NRY<2=-(J3B0=A/]2>A/V0/8JC_ 8=!'W\U+0(>Y'2-N"!"+,1:(B1
MKS(F=^LTWJ%$_#X@8BX&O=9LA1XP^*#CM3ESZT3R(8>4_3=@[7N</KO_(#UY
M^"V)L3?GI[_C-8^][+_>L0WP[/@.M2GXL9;_CA[YT_3QTV?I_4>;6-&_^)%W
M$*$[I)OW 20WK)N1GW&3?MXMR_X=G]>=/9D[>*QW'OM)>G)Z_VOVIHG9Y_NF
M";X'0^#A\>.OUBOPL"?V1-H\>/H=R)H[9('L0W3@?=5FY7Y9$@_@?$RK#B-W
MW]_A'A[\TQ2!BIN#!U_T?#^XM=[X&AOJ:SSC2\;XO\:[19=ROQ3^#RH4'J3W
M'V\++]P!H; ?A4$_5LW-]]P)Y"6C[QI"HAO$>EMA]P[&SF7P%QA&F(U\E)X\
M/>7M(IAW@0-.JL6B6G(5">/@?2 ?(^:+[4]XG#Y]]B1]]OA^^)3!)P@L\%!W
MHNM.ON<BL'/8'D73TJJ?I \>/DV?/GVT<3O 9WE])0!2DVZ.;1+:AGC/^^G)
MD]Y&ON4]3T_X!H@BE5*+]U[WD@U'9/<14^T(KA3B96'OEFO$R]8YGANB_Z<^
M*W#C_YTMNZQ>)R?)K*X6[D\$W9X\3G416GL)^WU^Z5^#\-SQFJ3 P^/[_V:+
MQNAD[O12NCL!?*B O^9FJQH^H^_A3?+E%$:.PW<U+UE2Y@U,3?^!TQQ,R06U
M^(%1XK/_4F7U]!@QOK;+$ T8+FO, Q5J&%<?M!A*'WBAD_3Q8]@(3Q]OW 14
MP@2_XFX_;6QU=U[)5&#1V&C(F_C3AY];=GV"HOSVQ_^[KIG3LLN#J1]CHR38
MWDVW6.#*A]_C6'+ISI0$C9G@Y%(,*_O:79H.E6-WN7+LZ:%R[% Y=D<JQ[Y>
M\8J4D[5UMFRR"?D2=5ZNB/O6%9,-?>V5DKU_>_;JW=DYEKN\2_[^\OW?DK<7
MOYZ]OWB1O+EX^^XU5XE]Z[*@X!&?7@]&LR@O>H]?-/%FXLWK7U^>_U=R]@KF
MX>WK\XL7O[^]V+%@[KN<D'Z!W-_SY#*[0K_4]'KD#92H;96L0"5/T!A/KA&)
M2F9UUL(1:Y% H6XO21.OZ@HL7NH;:31O@4\J9F#,X7U2>,95D5^3@=[ =S5#
M']!38= #.L9U@A^;WZ"0&!Y9P[8&>->KJG&FNHRW6I;K=/.;%0UZY.X#N!PQ
M[G,R-F@LN?3=O"Q69+MCNTR4+?RTIH"% K-"C\F[1Q/>!+[&>;PLP)^YSOG=
MX9;!&,'>3MDD-VTTQ^!29&@7%ZN,[2"Y";536X">0I:0JZI$ SV_F>3YM$G^
M57 &Q\E[-4"YCGP3#4'!59-Z^L9429(WT%%O-? J;-,UN-)V^<3&FXA;F2 /
M"?LLU'R45^$X.0M?#B<=FX[>Y)..?(1J!LN=@V]D[PG_&^?+'#Y&\Z^Z7K(C
MLJAJY/: D3PBKPUO0VK3K/Q51=O38:93,1BID>;2&*,%^"^+!;AGW/85#UNR
M((NPL2N".[==T[.G.!YT*NNJ+ 68@UPE(FN_>3WE5Y 3OULOCY<5YG7F'QV0
M(\@VDR_MJ8>9PFVSX?R%JZ-O1R+F.A-,U*9#?'T)#ZW Z 5_ 8,&*%W0]VAY
MX3;>6(P;##7L/&I'4V&?1.^"&Q"F/Q/IL4#RCA4ZS70T71TP]@BKIX9S9L-S
MQ#DZ0^<(3*7%HFC;/$<Q1-,??.YDZ'75E5.J35O29S!>>$3*W7ZK%OL!X>*N
M<EKA!!T<<X HTI"2*+B]L.9^O?+*?#E-@OAL,*G<H'<EDCU%P841%!H2"(WE
MO.&:9UR\&H_^#*9"/BO03,H;_)/E!(T%7H3^2(V?Z<^G_):%2=N(-#,!'S77
M>"_82#*2/-02N!H4;:'=@R(/16=6DR'KA6-<@0@N7TTAJA2W%'=R;O#EUC @
M"M-T2]MBF1B+4,2O$]Y<\ELK=)MD#F]1XV;%[M#A>01E0HIB@C)JXN\XWO+8
M'SE?)!A0JY8PPG6R!#^X:=!)YR=AD,W(X+0OH'&24O.V(")P\\S@;@6\+5C<
M($QH*\"GBF,)K\^7-"$=S;\<M+4H@8([2:,:K_".N.HR*?<B&I^+X"N),'4H
MP'NA,*-Y7KHX6"IQ*MSCY]74.!_3CG8.5OG;6<8'N*:B-*=L(L'=8!YH3J]R
M(@O DS$N2M03,"3PT"9EA4'^0.($)@ OAUJ&B3FO^<V*ZGOP;M2FN\8J/3RV
M> IG\%8M#MR<!'I#<SQQ$C=82NF0*$EV$@@T#6WV@8XAC&<R(8M##EQ^1?Q?
MKC0*3RWS@17UI%M@K'22-T[:I]0Y' 5P"184O_&=[M/Z^5-_0['*9[MEQ9]M
MBVAN<XU#3W6'"7SV^,FS'L?21T4L/\?@MOE^M#>+YD.#*JR1_>@K@H\BC/(B
M")\2UCKLR#W<D058#1,*5&=6RU"7P"?/&R6$)RAH6<]>Y21HLS9F+I(#ZU3V
M@%=#OI+G7:$SQPX.,=^P*ZDNP?N"LBOQ7M/#,3D<DZ]\3,268-L*31$R4AJP
M2"827U+VMPU:5!2%0J.N>8[B_K!O#_OVZ^[;V_J ,0>PX)V\Q06\8QG+;\GP
M)O'>&GD6,/R,RI+"K 9)@;Z1=>XK4V&7<O!BS?X9<8MN#E9]D@=%D1#CK-'H
M2LS%X54?EM7UTG>5TDW!B&))CRU,"&O"J7A\,&IS'NB8>:,E9B+<<15Q$M'W
M/O<R$MA]RMM9S$IC[)9Y54W!"D'K0M$A)6A[HZ-<YQ0Q^N%"IY1S.@?QF\$\
M>%'W'S+%MHURD2)E,AL;DB3$**2S)&R62@P/SD+%*1',AF!69-K5)GXJM.>.
MY]Q'')WR:; !G4A8BZ2MQPH.QQ'OA$F&FI,.LMLU[LO IP@<]34W\@$<XH%#
MGAW (0=PR!T!AWP9=?(2Y.MBZ7+B9_,Z9\&Y)SKE-4($%XS=8U5!B, IJ1:>
M%S8NP!2J5Y6DJC!C"WI'<MD-*6$*-QO541;*PU0: A]1#3URO"ZS:YL?MZD5
M"I 7LE!K3J6(TG#)!$F=8"\+M,XDA;)"RZG%>W..X@4HPFM4G/"?X^3CWIW2
M=!N&GY5-9=_!VG&L=9UY1ND:^TZD (W*Q)LZMX12L JWK-*.C ?(!<.\!YO5
MRSI="[Z&%!VA5M64FO.<V?/,"^!O&IKIGLW"R!>R309SRYB*LK=FV*UP0E_8
M^YTK! C%(4^?_XIGA$TQC%/^:D\)CB241;]EL'-A.$(N?3"#OI$9].C^P0PZ
MF$%WQ SZZAC9RZIK<O3>+"Q6?>(A8?_V^O=W%W][_>N+EZ_^FKS^!7&?_^>_
MDM_.X#R\//OU3N!@/_OLV3+0_L*::++SW=]=G!.4*YM6*S08ZJZ4D)H8*AQY
M7Q8"E: 0$V6="!1YE!_/C]-D7%<?0"V,T() Y=+,V J8YB5HG=H&ZUCK83S_
M5=5R#'\&.@9NN<S;Y"S( KRIJYLUJAP"!S4N.N7W"K+PH:;7UP'[D!F]Z;G\
MZ,8;N[ !RPEU./RN0?-%!DWQC*2!_Y2Y#/<SCU:>:6JP,%JG!XGXJJ)AH&U#
M(4+,VL$G'(HH<59G>5WS[V$-1=O;LX#("U'4#FU#64(D'X/]4!/0Y"J'U<44
MY"P,C'"+-S!=FPSQHRH3@_MA'ZP[6@&NY#/P754I)]N>MYT!R9C)DRA6+_IJ
M ;Z1Y3*K)0!KV$]VMR"R]J,W8[I]-U)0& SY$DP] GB98<IQX%VVZ,JV6)4#
MIXDK$>D<=4NL=V08+8;GL(5AW4ELE&QD H]BV61!18:8^,#&8"H$1YE! GYA
MZR_O9+S&_;JN.KZ5O<N29X9NUM$17%-PG-;).F\,5U_OLA!XU+JE6+_DT=$-
MY2W333\5>!ZW+H/Y:(N21BP :L:>TII<4["\5M?4^16,F)^%X7[8D,?)W\6^
M)_ 9+PINDL6J1> [=2) P'Y+\%CX'R'K_M&!*XBP^";'_&F+2,:5K=(+]ACM
M ?E-/A4$Z=J#]PDN@<*@4[O:<*'!%,@>=4]!L3:M)IUX/%GC=M1Q\A)1H2U#
MZ. TI_3VRRHIJ^4\1RQ\<TD%]08+WQ)08L.L$["3 '8KDH[X:]D>>A*^A#Q/
M$S@8F.VCU5U[6P]^_-_Y59T=)R\8S$I?FN62*<>QTE4(K*VS50X^VP1N^W(Y
M 1U[<O+T?G*>E_E8G/Z_E%<P@^^Z M[GY/Z#5'^9)K_\FCQX^.3ADS0Y:ULP
M LXE7  J/T=_GVHU&>>."!60I?!VZ^1=MIP7U56V7!8I7+E$Z/-_XE2]@84F
M+&>J;G5N4/(U+>/1@].34?+LP;-[#QZ>/#[F7D5:'DXZ4%?+EE07KXD5*+!A
MI,H"]]>7,0]X\Q;V_(I-P_NE+#[DO%MX,3:)9U-6$(B'YI+N9.:4KQ$E<4@9
M?#-?^>3@*Q]\Y7WUE4DD+CAL9]UE_T//8W[]_F\7;]%#AF-P)_SCKY3$YH@X
M8C-(ZX -PLI$9DF,1U.;QT4O0HX1E,RTD7ZV:.EP19IW4[0%,72.W751470(
M$1GG,RY\RTTOZS0!/[QH;%W,TM1*2D:<LN9+<&.G!HZ!S@BZ:=2SEZT\4&U7
MR,* 26PL9S-C@%_@U?64^#W(E1'%A5KPCVXZ1\OM:ZJOCT7/W6+7L%0E.:[U
M("'+/#5HL68>\"X$IH4 O$4QG99.7SR"QVS"W&WY^>FC?]L(=_N($^)-_E_6
MR>MZRBZMS=U0ATN3E=@$RMMI\(/TK]]B)C_KS[_INWQ*.\1/W34_-3\E;X^3
M7[,7709^^WE9S-IJ^6/ME"\W>_V92Y/?_G(&SM6;L\,<[C:'YY=%/DM^L;Q!
MKTUAN?-PT;U[C[5W79W77V9>[Q0$][.8EYOS!@,$46>KNBB3!\S[M0<V(UC8
M9UXL[9P-+N83H0H?N*3Y3(Q5J6Y;_'.A,>=HL55=FTPN8;BY'P?\A,!2NB&R
ME')H:3BR=/R5'8=#P,,+>)P> AZ'@,?7#WC@H\T'=RWN\FD:04YEB-0\>_7J
MXO\D9]]_E"3Z?MCDUCNFTWPB@,,_,781#];S!'3_;Q>O7ER\(&:MMQ?OWA/5
M&/&#7OS'[R_?_U?R\M7YQ:OW+__S(GGSZ]FK/_^$M_[F4W;00:"#_ -[4!@'
MA?$]2>H&CF1Y;Y*MFHW2+#'__VD0'#]CS/3_7+Q\8V/C\EE"GWFA\2$3>IO\
M_RIO=*;@WV\-_)ME,/<?A)%BX/@J)UK>.S'FUX[%ZTSP9QH^[H4@_Y2\JJ[8
M*7I"S-\/[]PKJ$Z.^ XZ^_VGA/UC)BU_=*>&GEQ8^NX7L&OL4!^IL5*K\:%=
MMF'-?@&WD<KSL#*/(P-WX,TWK]3_]S_X__[_W<9[]VV[?C2C/R$GQ\E?N=3\
M:WON7_^%=2CGP6,S T?9*+F GR.Y67)VC3OY;3XI5@5J3YJ4Y,+4OZ1NA]-!
M0&[TKFR)J!,S>KFYC\(>T2U_/,CD+C,['AGH3JGF 284TZ[4"D(JDQR3[+Q&
MAC$)K+GR8O[QGZB5@U-G='J3URNI-*9V"Z_@GR"<.EBC=>0"N((_1$D R\QQ
MK[=HNV&[F*L1";>Z(.2A7$G/AE_'OOP=3#AU!=S^35Y3F0[F5,,;%,'WYUES
M:;^F?C)7-,37E"O6O][+_3,982L,I/PUVZ9HI+6 Z?=A]PQQ"\[L9!)[0LLJ
M"P[C95ZN=*R6F6-S*9GCJO5+33 S<V<Y(YE06YF0VGJZPNQ$WK^:*Y:H"V_R
MN@6S^*98= LD,JSJUNUTN!K1W4$0V=+2GAE6)MX8YI&98+A!?SE:8#M4-T@A
M'B$2-$;%FA8KE/>_RLHN5X_& G?:;L=ND@G= *9QUQ):CLL,B?%4%1HR?[+W
M"I;EZI:&*6%0"Z9LC98TNF8C;*></B--?9(<X=,%M8<F?O'SA:&;9(NW^-D$
MYT]/GH^(3C%"N16.WT,Z3RO=M)N9CWG4O.5X%]K:3KR?-X@ %0S;8XQ[8/R'
M*5API#*$O5]R9:'='_[-,EI%GA!'!@:FJ*6LI2(,9LTTZUDT7L_Q'[=8LV_F
MG!Z#GX$$,2"^,R$DV5MKQY\)W IF&XAJ-C7"V*9)KI4MS7U?W#4H9:9YF<]Q
MIV7^?67CTM8C:E/'8%S5[@_&GEL:<MC6[W)FP#D%!?!C[\UAN^E-=4T$);,-
M:T,5$,R#>XW);R=-6&=@?E 46ZE+?6>I$/NN",*OJN;5DGU-EM9O._%/3NW$
M%R.>Y\K5N(/->38B"+N! !I!SW+_>7+TEQ'7Q>.<7U;7S G GD3P&[CX'"]&
MA;->Y=9@B5SW8F3J--3BJ#L?L?I?YES\0BS@1+@\R<J1YEOGH1F>*XMCM%P$
M8JA,I!3%U:48!V:"1JJ<6&,F*"U'PX$!7XSBW<0H%JE^J7>IF$+T!&.2$%^V
MW)1,XE_XQK]D19W\EM4?\C;Y3[K6U2RQ?%'V\OZ(#;U[W?8ETZWN<E>Y"6>]
M=?(8/X[:+46;6N;M!E$M17.9LCDFQAC5)W&Q*'\P[X3/B4S;#4K /52ID-3R
MGRKR,.8T(+$&Z@&5S*2JA0H>%<Z,B> 71=,([[8B1^,.)O:I]"6;U'1P+*F*
M?(,7&M2$91?/!MPT&FV&[/]+IDD/6-(+00H3 ;MC78<G(>7WM,BYJ=\"";;U
M"'EHR!>R=F;NGFYBMXN;O&W1 1/#&2W7NL%:(;^SPK8=O9_S>&6G,0-'LT20
M>BX]::HRE\V/Y75L#6 1'B+8I9I/1+"XD?9P4J.-*P06'56UN]RHB &1+S?!
M5I+Y]-N;=(?T+Z9_S^X=JJ,.N=_O,??[N42DDY!-UR#G*=FC9/:;=B.L6ER9
M\G%R<3/)X;;(HVHM9>V\:JUNI:BU.5)YE#%;S--"4XF,"#3K30DK-BY:K- $
M!M/$]0>SL:J:(]BL\C#B S<75MGE/<UF:?P-AHZJ*XT-)%7GU%N,7U2_'ECO
MC;CG$JL>YV5U_<UE^C?9/\Y280/9+I\8G):/Q/KM:!<VOF&83<'!8^(%U3;%
M+)!SW*F5-9&U$.&""<8VPJ>*ME UE!OAF*+0LX+(_D<'[TTT!%-#).)UB.-M
M9.(P#^\_.W,QWBDY%3]QE'%<>T:8L61CT5 )*2_ 9\N$P%@:'00$,4/O0$9T
MOEA)/%L(2;;=[9/?-@VCM"J6PMW1EFMJ2J7<42+T>SDSHZ%PJ_\U#K^4B*X>
M<RHT<+&S9T;X#(-X>M7/LQ6,J"S^*;214]S/<CN=6R"ITN3Y!Y_8P7;YXD)%
M%^?W(G@8M,!0B)9(-J6PD^>O^@;%&XMS/!WC*>HAX#C!E BENND!B-W 8%XZ
MK.T?3KKV;WV^8?RV90S8RW4G4_M&]V+LW>Z%=SM8Z&XB-UO52)U@#>1=#..$
M.UQ.+K.F=W!2BJ]XLX+)K<:F#?1:<>_Y7P9G$4-/C4N6[;8NGZ[YEM7 UJ)M
M^5&*#A\VJ-OH_I$[!(IN3U67\K*[,;)]^4=?9!VM3\ .906&I[#Z?;Y2K:3T
M_71B5G.&>;(;-@A*&RN53T\]%>0B )+WL[E8'FI2L=:PQ!TUR96W'>SRD\?C
M>P_V==F5S2*I3 QS.7&@2(=IX;LFE 0F[.5L'A<VPSIW1>5DL_&WV2>6<9?N
M2O>995>5UX)1G>N$^L2NL(MEU364 O5E4L0$M_J<H !@H[%Y0&-J/%EFVT#B
MF-4/Q9RS#+K/DS\7/]LG7U;7^55>IYAYEEOL(LS6.AM@@OHD#,6$6$I#6G=.
MA6T+CXK6]%+^)5I3+/J06$N-2- G<$+H_GIZY=>-:@M]C"P]*&:MY&6T#AS*
MBA;YZ&2T^8WU&Z)-+"@-RPZVY:T+5:Y.,2U<M@;#6FY%O%X5-L=O[Y%2E\,E
M]X"ED!C\H,J; :]K2)GP^\CTG8XVV(I]$]%9C\Y!0(M@YX/EJ;K8LMIAFBU
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M-3!E64NE"[SC'-,K,&I,6NXXK6=N3I6'$DP$ @')"\D<2''0%VDH]-0[0TV
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M&6)S!EA^8/)^JFJ_5W&LH&S+D22S>=ET=?[99R-U<U%[21DEXSBYXJJ!>LW
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M-D00A1&NOPE'NYMO= '-@$/:*I%$ ]]D@.[CQE)AF>1"]?JC366_T2S4(F1
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M0Z*NMJQ'O,H]R'\[P;C,VJX&R\T &UP1B#P"]?[*+.Z18L,V;&VPG 8)=?(
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MDQ-#-?:RZ8P3!N98 =X0WO+AIEL2I9H%%>III4Z3QD_'H!W^ ^_W:-O]1/B
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MV2[*G_\O4$L! A0#%     @ Z8&#6"T#2]U8:P  B)<   T
M ( !     '!R;WAY,7!I8RYJ<&=02P$"% ,4    " #I@8-8"3SS+$EL  !E
ME@  #0              @ &#:P  <')O>'DR<&EC+FIP9U!+ 0(4 Q0    (
M .F!@U@;YQV1@-T! -A% @ 2              "  ??7  !Y=S!D7WIE<F]P
M86=E,2YJ<&=02P$"% ,4    " #I@8-80.B"PN\E @!_F0( $@
M    @ &GM0( >7<P9%]Z97)O<&%G93(N:G!G4$L! A0#%     @ Z8&#6($M
MX3O=!   %RD  !$              ( !QML$ 'IV<F$M,C R,S$R,S$N>'-D
M4$L! A0#%     @ Z8&#6%Q"]XSJ!   $#H  !4              ( !TN $
M 'IV<F$M,C R,S$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( .F!@UA"KL_WE0<
M &1Z   5              "  >_E! !Z=G)A+3(P,C,Q,C,Q7VQA8BYX;6Q0
M2P$"% ,4    " #I@8-8-US5T+ $  !'.@  %0              @ &W[00
M>G9R82TR,#(S,3(S,5]P<F4N>&UL4$L! A0#%     @ Z8&#6&R6MH,_P@$
MJ-82 !<              ( !FO($ 'IV<F$R,#(T,#,P,U]D968Q-&$N:'1M
64$L%!@     )  D 0P(   ZU!@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>zvra20240303_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:thunderdome="http://www.RDGFilings.com"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:zvra="http://www.kempharm.com/20231231">
    <link:schemaRef xlink:href="zvra-20231231.xsd" xlink:type="simple"/>
    <context id="d_2023-01-01_2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOTotalAdjustmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOTotalAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOTotalAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">zvra:PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2021-01-01_2021-12-31_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:FormerCEO1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_IndividualAxis-CurrentCEOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001434647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">zvra:CurrentCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="NonApplicable">
        <measure>thunderdome:item</measure>
    </unit>
    <dei:AmendmentFlag contextRef="d_2023-01-01_2023-12-31" id="ixv-8719">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d_2023-01-01_2023-12-31" id="ixv-8720">0001434647</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d_2023-01-01_2023-12-31" id="c2">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="d_2023-01-01_2023-12-31" id="c3">Zevra Therapeutics, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="d_2023-01-01_2023-12-31" id="c4">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Pay Versus Performance &lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;"&gt;In accordance with the SEC&#x2019;s disclosure requirements regarding pay versus performance, or PVP, this section presents the SEC-defined &#x201c;Compensation Actually Paid,&#x201d; or CAP. Also required by the SEC, this section compares CAP to various measures used to gauge our performance. CAP is a supplemental measure to be viewed alongside performance measures as an addition to the philosophy and strategy of compensation-setting discussed elsewhere in the overview of the executive compensation program, not in replacement.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Pay Versus Performance Table &lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;"&gt;The following table sets forth information concerning the compensation of our named executive officers for each of the fiscal years ended December 31, 2023, 2022 and 2021, and our financial performance for each such fiscal year:&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="vertical-align: bottom; width: auto; text-align: center;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center;"&gt;
			&lt;p style="text-indent: 0pt; margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;Value of Initial Fixed $100 &lt;/b&gt;&lt;/p&gt;

			&lt;p style="text-indent: 0pt; margin: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;&lt;b&gt;Investment Based on:&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Table Total for&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Current PEO&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(1)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Actually Paid to&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Current PEO&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(1)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Table Total for&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Travis Mickle, Ph.D.&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(2)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Actually Paid to&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Travis Mickle, Ph.D.&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(2)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation &lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Table Total for&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Richard W. Pascoe&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(3)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Actually Paid to&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Richard W. Pascoe&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(3)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Table Total for&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Christal M.M. Mickle&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(4)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Actually Paid to&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Christal M.M. Mickle&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(4)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Summary&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Table Total for&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Non-PEO NEOs&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(5)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Compensation&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Actually Paid to&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Non-PEO NEOs&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)(5)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Shareholder&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Return&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;Net Income&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;2023&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;3,445,231&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;4,975,770&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;3,593,438&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;4,385,998&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;4,122,558&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;3,308,589&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;1,669,956&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;2,211,127&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;2,039,861&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;2,724,999&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;58.48&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;(46,049,000)&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;&#x2014;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;2,400,356&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;1,349,703&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;&#x2014;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;1,199,492&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;1,106,040&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;40.98&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;(41,543,000)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;2021&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;&#x2014;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;2,657,059&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;2,808,110&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;953,616&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;989,957&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;77.77&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"&gt;(8,555,000)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: bottom; width: auto;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;"&gt;(1) Mr. McFarlane became our Chief Executive Officer on October 10, 2023.&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;"&gt;(2) Dr. Travis Mickle served as the Company&#x2019;s Chief Executive Officer in 2021, 2022 and from January 1, 2023 until January 6, 2023.&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;"&gt;(3) Mr. Pascoe served as the Company&#x2019;s Chief Executive Officer from January 6, 2023, until June 1, 2023. As noted below, Mr. Pascoe also served as a non-PEO NEO during 2022 and 2021, and his compensation for those years is reflected in the columns entitled &#x201c;Average Summary Compensation Table Total for Non-PEO NEOs&#x201d; and &#x201c;Average Compensation Actually Paid to Non-PEO NEOs.&#x201d;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;"&gt;(4) Ms. Christal Mickle served as the Company&#x2019;s Interim Chief Executive Officer from June 1, 2023, until October 10, 2023.&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;"&gt;(5) Amounts represent the average compensation actually paid to our remaining named executive officers for the relevant fiscal year, as determined under SEC rules (and described below), which includes the individuals indicated in the table below for each fiscal year.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 80%; margin-left: 10%; margin-right: 10%;"&gt;

		&lt;tbody&gt;&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Non-PEO NEOs&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2023&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;R. LaDuane Clifton, MBA, CPA and Joshua Schafer&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="vertical-align: top; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Richard W. Pascoe and R. LaDuane Clifton, MBA, CPA&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="vertical-align: top; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;2021&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="vertical-align: top; width: auto; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;Richard W. Pascoe, Sven Guenther, Ph.D. and R. LaDuane Clifton, MBA, CPA&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;
</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-CurrentCEOMember"
      decimals="0"
      id="c6"
      unitRef="USD">3445231</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-CurrentCEOMember"
      decimals="0"
      id="c7"
      unitRef="USD">4975770</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c8"
      unitRef="USD">3593438</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c9"
      unitRef="USD">4385998</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO2Member"
      decimals="0"
      id="c10"
      unitRef="USD">4122558</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO2Member"
      decimals="0"
      id="c11"
      unitRef="USD">3308589</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c12"
      unitRef="USD">1669956</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c13"
      unitRef="USD">2211127</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c14"
      unitRef="USD">2039861</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c15"
      unitRef="USD">2724999</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="INF"
      id="c16"
      unitRef="USD">58.48</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c17"
      unitRef="USD">-46049000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c18"
      unitRef="USD">0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c19"
      unitRef="USD">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c20"
      unitRef="USD">2400356</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c21"
      unitRef="USD">1349703</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c22"
      unitRef="USD">0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c23"
      unitRef="USD">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c24"
      unitRef="USD">0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c25"
      unitRef="USD">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c26"
      unitRef="USD">1199492</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c27"
      unitRef="USD">1106040</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="INF"
      id="c28"
      unitRef="USD">40.98</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c29"
      unitRef="USD">-41543000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c30"
      unitRef="USD">0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c31"
      unitRef="USD">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c32"
      unitRef="USD">2657059</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c33"
      unitRef="USD">2808110</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c34"
      unitRef="USD">0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c35"
      unitRef="USD">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c36"
      unitRef="USD">0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2021-01-01_2021-12-31_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c37"
      unitRef="USD">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c38"
      unitRef="USD">953616</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c39"
      unitRef="USD">989957</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2021-01-01_2021-12-31"
      decimals="INF"
      id="c40"
      unitRef="USD">77.77</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2021-01-01_2021-12-31"
      decimals="0"
      id="c41"
      unitRef="USD">-8555000</us-gaap:NetIncomeLoss>
    <ecd:AdjToPeoCompFnTextBlock contextRef="d_2023-01-01_2023-12-31" id="c42">
&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 5%; width: 90%; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr class="finHeading" style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="20" rowspan="1" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 13%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;2023&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr class="finHeading" style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt;"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; width: 28%; border-bottom: 1px solid black;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;b&gt;Adjustments&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="3" rowspan="1" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"&gt;&lt;b&gt;Current PEO&lt;/b&gt;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="3" rowspan="1" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;b&gt;Travis C. Mickle, Ph.D.&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="3" rowspan="1" style="text-align: center; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%;"&gt;&lt;b&gt;Richard W. Pascoe&lt;/b&gt;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="4" rowspan="1" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%; text-align: center;"&gt;&lt;b style="font-size: 10pt; text-align: center;"&gt;Christal M.M. Mickle&lt;/b&gt;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="4" rowspan="1" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;Non-PEO&lt;/b&gt;&lt;/p&gt;

			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"&gt;&lt;b&gt;NEOs&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Deduction for Amounts Reported under the &lt;/b&gt;&#x201c;&lt;b&gt;Stock Awards&lt;/b&gt;&#x201d; &lt;b&gt;and &lt;/b&gt;&#x201c;&lt;b&gt;Option Awards&lt;/b&gt;&#x201d; &lt;b&gt;Columns in the Summary Compensation Table for Applicable FY&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;(2,941,461&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;)&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;(2,558,873&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;)&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;(3,469,457&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;)&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;(1,047,596&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;)&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;(1,327,110&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;4,472,000&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;3,589,040&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;1,590,000&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;2,013,274&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;2,814,000&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;13,320&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;11,795&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;(237,607&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;)&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;(158,512&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;)&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;(14,553&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;)&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;(11,821&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited&lt;/b&gt; &lt;b&gt;during Applicable FY, determined as of Prior FY End&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 9%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid black;"&gt;&#x2014;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style="vertical-align: bottom; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 28%;"&gt;
			&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"&gt;&lt;b&gt;TOTAL ADJUSTMENTS&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;1,530,539&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;792,560&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
			&lt;td style="width: 9%; text-align: right; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black;"&gt;(813,969&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px; border-bottom: 1px solid black;"&gt;)&lt;/td&gt;
			&lt;td style="width: 1%; font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;541,171&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid black; width: 1%; text-align: right;"&gt;686,138&lt;/td&gt;
			&lt;td style="font-family: &amp;quot;Times New Roman&amp;quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; border-bottom: 1px solid black; width: 1%;"&gt;&#160;&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-CurrentCEOMember"
      decimals="0"
      id="c44"
      unitRef="USD">-2941461</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c45"
      unitRef="USD">-2558873</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO2Member"
      decimals="0"
      id="c46"
      unitRef="USD">-3469457</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c47"
      unitRef="USD">-1047596</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionForAmountsReportedUnderTheStockAwardsAndOptionAwardsColumnsInTheSummaryCompensationTableForApplicableFYMember"
      decimals="0"
      id="c48"
      unitRef="USD">-1327110</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-CurrentCEOMember"
      decimals="0"
      id="c49"
      unitRef="USD">4472000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c50"
      unitRef="USD">3589040</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c51"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c52"
      unitRef="USD">1590000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatRemainUnvestedAsOfApplicableFYEndDeterminedAsOfApplicableFYEndMember"
      decimals="0"
      id="c53"
      unitRef="USD">2013274</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c54"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO1Member"
      decimals="-3"
      id="c55"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO2Member"
      decimals="0"
      id="c56"
      unitRef="USD">2814000</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c57"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnASC718FairValueOfAwardsGrantedDuringApplicableFYThatVestedDuringApplicableFYDeterminedAsOfVestingDateMember"
      decimals="-3"
      id="c58"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c59"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO1Member"
      decimals="-3"
      id="c60"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c61"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c62"
      unitRef="USD">13320</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatWereOutstandingAndUnvestedAsOfApplicableFYEndDeterminedBasedOnChangesInASC718FairValueFromPriorFYEndToApplicableFYEndMember"
      decimals="0"
      id="c63"
      unitRef="USD">11795</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c64"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c65"
      unitRef="USD">-237607</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO2Member"
      decimals="0"
      id="c66"
      unitRef="USD">-158512</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c67"
      unitRef="USD">-14553</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseDeductionForAwardsGrantedDuringPriorFYThatVestedDuringApplicableFYDeterminedBasedOnChangeInASC718FairValueFromPriorFYEndToVestingDateMember"
      decimals="0"
      id="c68"
      unitRef="USD">-11821</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c69"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO1Member"
      decimals="-3"
      id="c70"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c71"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c72"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEODeductionOfASC718FairValueOfAwardsGrantedDuringPriorFYThatWereForfeitedDuringApplicableFYDeterminedAsOfPriorFYEndMember"
      decimals="-3"
      id="c73"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c74"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO1Member"
      decimals="-3"
      id="c75"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c76"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c77"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnDividendsOrOtherEarningsPaidDuringApplicableFYPriorToVestingDateMember"
      decimals="-3"
      id="c78"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-CurrentCEOMember"
      decimals="-3"
      id="c79"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO1Member"
      decimals="-3"
      id="c80"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO2Member"
      decimals="-3"
      id="c81"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember_IndividualAxis-FormerCEO3Member"
      decimals="-3"
      id="c82"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOIncreaseBasedOnIncrementalFairValueOfOptionsSARsModifiedDuringApplicableFYMember"
      decimals="-3"
      id="c83"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-CurrentCEOMember"
      decimals="0"
      id="c84"
      unitRef="USD">1530539</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO1Member"
      decimals="0"
      id="c85"
      unitRef="USD">792560</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO2Member"
      decimals="0"
      id="c86"
      unitRef="USD">-813969</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-PEOTotalAdjustmentsMember_IndividualAxis-FormerCEO3Member"
      decimals="0"
      id="c87"
      unitRef="USD">541171</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-NEOTotalAdjustmentsMember"
      decimals="0"
      id="c88"
      unitRef="USD">686138</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="d_2023-01-01_2023-12-31" id="c89">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;"&gt;&lt;b&gt;&lt;i&gt;Relationship Between Financial Performance Measures&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 9pt;"&gt;The graphs below compare the compensation actually paid to our PEOs and the average of the compensation actually paid to our remaining named executive officers, with (i) our cumulative TSR, and (ii) our net income, in each case, for the fiscal years ended December 31, 2023, 2022&#160;and 2021.&#160;TSR amounts reported in the graph assume an initial fixed investment of $100.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div style="text-align: center;"&gt;
&lt;div&gt;&lt;img alt="proxy1pic.jpg" src="proxy1pic.jpg"/&gt;&lt;/div&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;
</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="d_2023-01-01_2023-12-31" id="c91">
&lt;div style="text-align: center;"&gt;&lt;img alt="proxy2pic.jpg" src="proxy2pic.jpg"/&gt;&lt;/div&gt;

&lt;div style="text-align: center;"&gt;&#160;&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;
</ecd:CompActuallyPaidVsNetIncomeTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
